data_2n5b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n5b _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 121.075 0.464 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.9 148.08 25.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.905 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.439 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -111.92 120.08 40.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.817 174.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.562 ' H ' ' CD2' ' A' ' 55' ' ' LEU . 20.8 m-85 -73.43 164.41 26.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.219 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -116.23 -17.28 10.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.665 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.612 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 41.2 p -133.67 153.41 51.7 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.494 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.424 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.62 -31.37 66.17 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -60.91 -42.31 97.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.99 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.612 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.9 mm-40 -64.71 -42.68 95.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.391 0.615 . . . . 0.0 110.293 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.447 ' O ' HG12 ' A' ' 15' ' ' ILE . 5.3 t80 -66.42 -47.45 73.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.868 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.12 -47.7 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.408 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -68.93 -26.93 65.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.609 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -74.21 -54.57 7.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 27.4 pt -67.07 -19.71 25.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.23 -8.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.356 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 19' ' ' LYS . 76.2 mt-30 -74.24 160.36 31.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.5 19.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.481 0.657 . . . . 0.0 111.427 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.5 ptmt -118.7 166.15 13.12 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.249 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.546 ' CD2' HG11 ' A' ' 84' ' ' VAL . 2.4 tm? -78.72 112.16 15.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.7 t -117.94 108.18 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.654 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.25 108.42 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.822 0.82 . . . . 0.0 111.015 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.618 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 59.9 t -104.56 142.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.526 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.526 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -122.12 119.7 32.1 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.59 ' CD2' HG23 ' A' ' 69' ' ' VAL . 56.2 m-85 -71.41 125.43 26.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.352 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.755 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -120.98 -174.28 2.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.077 -173.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.2 155.12 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.151 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.08 -5.41 59.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -111.87 33.65 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -132.96 146.64 51.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.592 0.711 . . . . 0.0 112.135 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -85.17 -42.37 7.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.991 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 23.0 Cg_endo -61.34 -40.11 51.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 CA-C-N 119.817 1.808 . . . . 0.0 111.417 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 12.5 p -57.57 -31.6 66.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.761 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tptt -66.19 -53.6 35.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.789 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.693 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 21.5 ptm -63.09 -44.55 95.4 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.649 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.82 -18.83 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -57.39 -48.66 96.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.761 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.6 Cg_exo -70.92 -31.03 16.04 Favored 'Trans proline' 0 C--N 1.36 1.149 0 CA-C-N 120.537 1.228 . . . . 0.0 112.004 171.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 35' ' ' MET . 20.1 mmt -66.61 -56.37 11.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.582 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.695 HG22 ' CE2' ' A' ' 52' ' ' PHE . 6.5 mt -59.66 -27.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 31.8 tt0 -53.94 -48.64 70.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 16.0 tppt? -65.95 -47.77 73.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.945 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.629 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 3.4 m-30 -62.66 -26.55 68.7 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.777 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.638 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 92.3 p -85.1 -15.25 44.55 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 42.5 tt0 -79.66 -25.99 41.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.174 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.629 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -96.22 8.43 43.89 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.658 ' HE2' ' CD2' ' A' ' 52' ' ' PHE . 5.1 m-85 -103.52 100.0 17.36 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.729 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.54 -43.01 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.758 2.305 . . . . 0.0 112.677 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.27 -14.87 17.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.763 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . . . -104.68 165.04 11.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.48 137.37 51.76 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.695 ' CE2' HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -109.12 131.03 55.46 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.187 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 42.8 m-85 -136.65 151.93 49.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.755 ' HD2' ' CE1' ' A' ' 26' ' ' TYR . 10.0 mtmp? -139.57 120.54 14.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.618 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.7 mt -100.32 161.11 13.82 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.406 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 5.7 m-20 -94.22 107.5 19.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -13.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -172.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 5.5 p-10 -77.72 -25.23 49.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 109.59 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -93.97 -40.3 10.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.816 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.589 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -98.21 53.98 1.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.764 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.21 -45.89 10.91 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.86 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.7 t70 -61.11 -44.64 97.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.508 0.194 . . . . 0.0 111.189 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.589 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.5 p -65.1 -38.65 83.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.169 0.509 . . . . 0.0 110.611 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.63 78.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.909 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 13.4 mm100 -72.56 -31.62 65.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.702 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.41 -41.84 90.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.804 0.811 . . . . 0.0 110.223 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -98.44 21.49 11.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.381 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 38.2 50.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.936 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.59 HG23 ' CD2' ' A' ' 25' ' ' PHE . 76.2 t -81.18 115.87 24.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.945 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 p -122.42 17.54 10.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.294 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.04 157.97 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -138.58 122.29 11.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HG3' HD12 ' A' ' 36' ' ' ILE . 98.2 Cg_endo -83.79 166.2 64.04 Favored 'Cis proline' 0 C--O 1.235 0.349 0 C-N-CA 123.751 -1.354 . . . . 0.0 112.505 -5.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 78.2 m -123.75 122.73 38.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.634 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 HD22 ' OD1' ' A' ' 91' ' ' ASN . 4.3 mm? -105.42 109.66 21.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -173.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.632 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 21.5 mt -125.52 115.86 20.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.859 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.58 125.32 39.16 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 174.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.9 m-85 -108.05 154.48 21.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.468 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 50.7 tptt -143.37 116.57 8.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.198 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.518 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 43.0 m-80 56.26 27.15 11.34 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 123.424 0.452 . . . . 0.0 111.527 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.54 10.06 59.72 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.002 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 47.6 pttt -109.88 1.9 19.5 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.632 0.73 . . . . 0.0 109.354 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.4 tt0 78.47 172.6 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.546 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -144.2 -31.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 109.847 173.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -161.37 162.37 30.74 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.842 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.6 tttt -139.82 124.64 18.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.603 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.5 t -131.02 137.97 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.8 83.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.893 0.854 . . . . 0.0 111.609 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.12 53.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.833 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.89 81.84 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 111.324 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 11.3 p-10 -117.67 90.82 36.86 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.531 ' O ' HG21 ' A' ' 95' ' ' ILE . 3.9 Cg_exo -77.2 -43.15 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.441 1.427 . . . . 0.0 110.897 169.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.3 16.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.094 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -74.61 -17.57 60.69 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.053 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.705 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.43 -38.77 76.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.508 ' HD3' ' CD2' ' A' ' 43' ' ' PHE . 31.2 mmmt -61.87 -29.66 70.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.357 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -56.39 -57.88 10.39 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 174.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' C ' HD13 ' A' ' 77' ' ' LEU . . . -74.86 -37.87 62.1 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.705 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -72.61 -39.14 60.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.009 -170.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -86.0 -32.41 21.52 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.361 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.83 70.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.14 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.474 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 52.5 m-80 -96.83 -62.33 1.28 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.638 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.302 0 CA-C-O 121.255 0.55 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 146.02 37.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.555 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -104.95 136.23 44.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.261 171.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.564 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.7 m-85 -90.82 161.53 15.23 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.996 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -119.0 -18.54 8.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.284 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 58.7 p -133.08 151.57 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 111.121 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.521 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -60.44 -27.58 67.62 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -62.74 -43.73 98.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.387 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.465 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 9.4 mm-40 -60.46 -46.21 90.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.321 0.582 . . . . 0.0 110.251 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.438 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 9.5 t80 -64.85 -47.9 76.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.241 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' HA ' HG12 ' A' ' 15' ' ' ILE . 31.3 t70 -62.69 -33.69 75.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.608 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 m -73.43 -36.84 66.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.242 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.73 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.51 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.2 pt -67.78 -24.84 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.23 -15.68 60.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.084 0.468 . . . . 0.0 111.36 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.564 ' HB2' ' NZ ' ' A' ' 19' ' ' LYS . 98.2 mt-30 -76.46 156.47 33.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.802 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 17.9 t70 -48.38 -38.15 18.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -167.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.683 ' HE2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -109.1 -178.96 3.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -162.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.61 ' CD2' HG11 ' A' ' 84' ' ' VAL . 1.2 tm? -59.58 116.04 3.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.02 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.2 t -119.72 107.2 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.967 170.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.86 103.4 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.737 0.779 . . . . 0.0 111.008 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 3.5 t -108.14 144.23 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.99 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.511 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . . . -128.64 128.97 45.2 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 64' ' ' ALA . 80.9 m-85 -70.67 121.11 17.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.392 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.631 ' HH ' ' HA ' ' A' ' 37' ' ' ALA . 4.2 m-30 -120.19 176.1 5.62 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.251 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.65 16.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.889 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -84.48 -5.6 59.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -113.55 24.56 12.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.2 p -130.83 127.56 38.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.564 0.697 . . . . 0.0 111.65 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.04 -44.88 75.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.901 -1.045 . . . . 0.0 114.208 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 51.3 Cg_exo -57.6 -44.56 40.6 Favored 'Trans proline' 0 C--N 1.358 1.033 0 CA-C-N 119.98 1.89 . . . . 0.0 111.928 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 3.6 m -54.48 -37.19 64.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.391 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 38.6 ttpt -66.31 -47.04 74.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.149 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.416 ' O ' ' HG2' ' A' ' 39' ' ' MET . 24.8 ptt? -68.95 -45.25 71.22 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.668 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.32 -16.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.637 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -57.4 -55.41 44.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.508 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.7 Cg_endo -67.99 -27.85 35.98 Favored 'Trans proline' 0 C--N 1.358 1.032 0 CA-C-N 120.573 1.24 . . . . 0.0 111.993 172.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 35' ' ' MET . 96.6 mmm -67.08 -58.66 4.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.871 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.565 HG22 ' NZ ' ' A' ' 54' ' ' LYS . 65.0 mt -66.65 -20.39 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.994 -0.441 . . . . 0.0 111.794 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.87 -50.14 73.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.627 0.727 . . . . 0.0 109.531 164.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 43.3 tptt -60.19 -37.01 78.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.462 0.649 . . . . 0.0 109.83 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.8 m-30 -76.31 -15.07 60.06 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.379 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.736 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 24.2 p -73.58 -16.21 61.26 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 32.0 tt0 -87.6 -25.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.924 171.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.672 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 25.9 mm-40 -78.12 -30.03 49.2 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.716 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 4.1 p90 -120.39 83.6 33.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.25 -12.74 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.431 2.087 . . . . 0.0 111.438 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -6.11 49.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.602 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -127.87 165.55 19.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 12.4 m-20 -101.83 117.53 35.05 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.876 0.846 . . . . 0.0 112.617 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.736 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.2 p90 -98.02 113.66 25.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.545 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 32.7 m-85 -137.49 153.49 50.04 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.91 -0.494 . . . . 0.0 111.317 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.638 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 10.3 mmtt -128.3 142.95 50.99 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 72.7 mt -99.59 143.66 29.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.034 -0.416 . . . . 0.0 111.646 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 15.5 m-20 -86.51 100.66 12.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 166.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -59.01 -14.68 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.54 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 12.2 p-10 -71.76 -36.05 70.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 109.91 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.29 -15.08 16.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.386 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.609 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -109.22 44.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.91 -33.35 41.77 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.57 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.85 -45.85 80.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.702 0.287 . . . . 0.0 110.404 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.609 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -66.65 -36.91 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.492 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . . . -57.87 -50.17 74.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.358 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -63.77 -31.83 73.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.263 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -26.0 61.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.005 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -97.14 4.79 51.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.642 0.258 . . . . 0.0 110.975 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 62.82 43.75 6.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.847 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -88.33 121.66 38.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.889 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 p -123.67 -7.75 7.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.25 159.0 29.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.901 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.8 133.94 25.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.74 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.9 Cg_endo -86.05 171.05 41.6 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.903 -1.29 . . . . 0.0 111.199 -2.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.8 m -129.39 117.02 19.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 24' ' ' ALA . 4.3 mm? -101.4 109.59 21.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 -175.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.587 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 23.9 mt -124.25 113.05 17.76 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.44 127.26 43.25 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.593 174.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 32.7 m-85 -108.66 159.71 16.52 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.646 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.754 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 61.0 tttp -142.46 118.01 10.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.847 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.754 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 5.9 p30 40.34 43.99 1.56 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.951 0.782 . . . . 0.0 112.912 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.71 1.41 58.46 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 114.073 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.99 10.93 18.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.291 0.546 . . . . 0.0 110.558 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.86 175.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.116 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.61 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.97 -35.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 173.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.479 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.69 165.18 36.98 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.411 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.8 tttt -148.9 115.98 6.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.556 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.29 139.25 48.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.21 89.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.503 0.668 . . . . 0.0 111.711 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.97 -174.78 31.68 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.469 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . . . -72.91 93.15 1.69 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.883 0.373 . . . . 0.0 110.278 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 23.6 p-10 -119.49 69.21 11.37 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 12.4 Cg_exo -69.0 -32.98 20.54 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.063 1.175 . . . . 0.0 111.002 173.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.96 -44.22 10.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . . . -72.47 -17.13 61.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.659 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.2 tp -55.72 -39.51 55.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HD2' ' CG2' ' A' ' 99' ' ' ILE . 20.2 tptm -62.96 -32.44 73.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.368 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.18 -58.18 8.32 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.413 ' CB ' HD13 ' A' ' 77' ' ' LEU . . . -70.98 -36.67 72.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.539 0.685 . . . . 0.0 110.649 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -74.69 -42.04 47.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.178 -169.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.46 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -87.15 -39.42 15.53 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.961 0.41 . . . . 0.0 110.886 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.53 70.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.504 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 61.0 m-80 -89.04 -52.98 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.461 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.911 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.62 HG22 ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.655 0.74 . . . . 0.0 111.734 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.27 147.85 23.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.325 -175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 4.9 pt20 -99.85 120.31 39.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.114 169.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.579 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 16.7 m-85 -73.17 133.6 44.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.665 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -86.14 -16.85 36.61 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 74.5 p -131.79 151.86 51.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 111.432 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -60.32 -30.8 69.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.792 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -64.14 -37.09 86.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.79 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 25.3 mm-40 -62.01 -47.76 83.35 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.237 0.541 . . . . 0.0 110.04 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -47.03 87.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.967 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.09 -46.15 68.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.634 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 17.7 m -71.85 -32.66 67.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.568 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.02 -49.83 47.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.595 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.0 pt -67.99 -18.6 23.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.323 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.19 -10.03 59.69 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.282 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 13' ' ' SER . 78.2 mt-30 -79.62 150.72 30.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.46 56.23 2.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.926 0.87 . . . . 0.0 111.033 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 5.5 ptmt -150.72 169.22 22.14 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.042 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.58 ' HG ' ' CB ' ' A' ' 103' ' ' ALA . 1.2 tm? -74.62 108.01 7.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.037 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 84.6 t -116.45 107.37 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.794 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.89 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.568 0.699 . . . . 0.0 111.173 176.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.693 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 90.9 t -102.85 135.23 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.267 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -117.63 106.63 13.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' A' ' 55' ' ' LEU . 81.2 m-85 -71.42 107.57 4.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.866 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.714 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -162.77 152.23 15.48 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -178.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -129.04 141.65 51.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 p -68.25 -4.35 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -73.94 6.4 3.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.2 p -122.56 -172.89 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.979 0.418 . . . . 0.0 111.893 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.59 -59.23 2.14 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.95 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.86 -49.33 17.55 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.609 2.206 . . . . 0.0 111.944 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.2 p -49.82 -37.92 32.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.803 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.766 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 8.0 ttpm? -66.41 -56.46 10.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.536 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 39' ' ' MET . 22.8 ptm -59.54 -45.87 90.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.48 -22.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.524 -177.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -54.5 -57.06 20.5 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.222 -177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.766 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 20.9 Cg_endo -63.99 -35.01 56.97 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.294 1.329 . . . . 0.0 112.797 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 35' ' ' MET . 94.0 mmm -62.2 -56.36 19.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.511 ' CG2' ' HD3' ' A' ' 54' ' ' LYS . 23.6 mt -62.6 -23.81 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 120.782 0.325 . . . . 0.0 111.638 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.58 -43.94 79.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -62.18 -45.17 94.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.251 0.548 . . . . 0.0 110.239 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.647 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.9 m-30 -67.92 -15.32 63.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.462 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 13.5 p -87.11 -14.41 41.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.133 0.968 . . . . 0.0 108.697 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -86.68 -14.6 42.08 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.992 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.647 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -129.37 36.14 4.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.829 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -115.74 74.24 4.74 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.91 -36.09 90.93 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.337 2.024 . . . . 0.0 113.946 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -107.21 24.45 12.82 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.557 0.694 . . . . 0.0 111.54 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB3' ' CB ' ' A' ' 103' ' ' ALA . . . -138.95 165.6 26.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.337 -0.852 . . . . 0.0 111.803 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 117.67 19.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.89 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.829 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -93.2 129.57 39.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.575 -174.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 36.1 m-85 -137.49 135.56 36.9 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HG3' HG22 ' A' ' 2' ' ' VAL . 30.1 mtmt -125.08 121.7 35.06 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.057 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.579 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 54.6 mt -85.66 125.11 32.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.455 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.714 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.0 p-10 -70.95 105.61 3.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -58.23 -12.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.404 -175.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.53 -44.95 85.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.729 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.11 -18.14 17.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.164 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -106.8 51.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 110.825 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -78.22 -41.17 18.01 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.25 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.74 -41.49 83.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -65.51 -38.68 83.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.0 110.221 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.51 77.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.994 0.426 . . . . 0.0 110.796 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 78.3 mm-40 -70.66 -27.16 63.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.753 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -75.26 -25.09 57.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.266 0.555 . . . . 0.0 110.412 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -100.25 12.29 37.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.245 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.17 42.87 9.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.424 HG11 ' OG1' ' A' ' 74' ' ' THR . 85.0 t -91.71 124.63 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -138.03 17.75 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.109 0.481 . . . . 0.0 110.908 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -138.88 146.85 41.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.03 124.13 27.07 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.382 . . . . 0.0 110.194 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 58.0 Cg_endo -85.78 170.33 44.24 Favored 'Cis proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.55 -2.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 98.3 m -124.67 115.76 21.28 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HB2' HD22 ' A' ' 91' ' ' ASN . 4.1 mm? -105.63 108.51 20.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.98 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.8 mt -127.57 114.4 17.36 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.85 130.07 41.59 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.63 0.729 . . . . 0.0 110.259 174.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 88.7 m-85 -111.0 156.71 20.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.359 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.54 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.4 ttmt -141.63 116.13 9.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.349 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.54 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 42.33 43.81 3.13 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.769 0.828 . . . . 0.0 112.529 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.08 53.69 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.572 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.31 8.61 18.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.071 0.463 . . . . 0.0 110.183 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 45.8 mt-10 64.77 178.48 0.18 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.619 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.531 HG12 ' CD2' ' A' ' 20' ' ' LEU . 1.7 p -148.86 -33.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 170.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.425 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.41 163.66 35.26 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -146.41 120.52 9.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.497 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.9 t -127.05 131.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.89 79.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.024 0.44 . . . . 0.0 111.248 -171.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.5 -168.81 38.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -69.65 93.39 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.549 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 26.3 p-10 -123.74 63.4 28.31 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.413 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.1 Cg_exo -67.35 -37.76 16.91 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.038 1.159 . . . . 0.0 110.579 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.8 -40.36 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.939 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' A' ' 91' ' ' ASN . . . -73.26 -17.21 61.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.272 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.617 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.71 -37.15 69.72 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 29.2 mmtt -57.63 -34.79 69.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.538 0.524 . . . . 0.0 110.623 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -54.33 -56.4 18.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 77' ' ' LEU . . . -73.43 -44.09 59.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.478 0.656 . . . . 0.0 111.204 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -65.26 -41.43 91.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.858 -171.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -89.11 -42.06 11.92 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.826 0.346 . . . . 0.0 111.762 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.8 -39.1 73.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.408 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.3 m-80 -85.85 -56.73 3.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.072 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.58 ' CB ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.402 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 145.76 55.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 112.504 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.14 56.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.597 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.627 ' H ' HD22 ' A' ' 55' ' ' LEU . 18.4 m-85 -74.7 163.04 28.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.875 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -119.83 -13.83 9.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.523 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 82.2 p -135.05 152.29 51.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.882 0.372 . . . . 0.0 111.098 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.81 -30.53 67.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -64.06 -39.17 93.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.901 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.625 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 15.8 mm-40 -60.8 -42.3 97.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.996 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -64.94 -49.15 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.739 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.36 -43.23 83.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.759 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -70.8 -36.06 72.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.72 -52.16 40.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.519 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.551 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 28.4 pt -65.03 -21.04 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.191 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.03 -6.99 57.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.749 0.309 . . . . 0.0 111.687 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.456 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.9 mt-30 -81.56 159.05 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.876 0.369 . . . . 0.0 110.325 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.73 18.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.237 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 17' ' ' GLN . 30.3 mtpt -107.75 174.61 5.81 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.906 0.86 . . . . 0.0 112.68 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.539 ' CD2' HG12 ' A' ' 84' ' ' VAL . 1.5 tm? -91.2 107.06 18.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.355 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 67.3 t -106.0 115.45 47.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 77' ' ' LEU . 21.6 t -92.3 102.39 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.211 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.494 HG13 ' HG ' ' A' ' 55' ' ' LEU . 44.2 t -108.39 136.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.473 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . . . -128.92 141.55 51.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 120.764 0.316 . . . . 0.0 111.821 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' A' ' 69' ' ' VAL . 59.0 m-85 -95.11 122.52 37.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.336 0.589 . . . . 0.0 110.55 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.725 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.5 m-85 -119.98 -175.28 2.94 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.243 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.61 165.76 20.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -84.92 -5.55 59.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.317 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -122.88 34.59 5.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.776 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.655 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 6.9 p -132.11 121.82 24.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.527 0.68 . . . . 0.0 111.834 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.39 -42.12 97.79 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.923 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.591 ' O ' HG21 ' A' ' 36' ' ' ILE . 50.3 Cg_exo -57.47 -44.3 43.57 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.021 1.91 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 9.2 m -53.32 -41.35 65.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.69 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 37.5 ttpt -63.06 -56.36 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.6 ptp -60.65 -47.79 84.68 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.34 -13.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.014 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.67 -53.64 63.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.291 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.69 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.9 Cg_endo -65.53 -33.19 47.08 Favored 'Trans proline' 0 C--N 1.357 1.003 0 CA-C-N 120.281 1.136 . . . . 0.0 112.448 169.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.406 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 23.7 mmt -65.02 -58.92 4.85 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.969 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.487 HG12 HG21 ' A' ' 95' ' ' ILE . 51.6 mt -64.42 -23.04 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 122.107 -0.371 . . . . 0.0 111.399 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 42.6 tt0 -63.12 -41.51 99.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.66 0.743 . . . . 0.0 110.133 170.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 19.7 ttmt -64.56 -38.94 92.75 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.087 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.673 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.4 m-30 -69.63 -23.82 63.56 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.267 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 41' ' ' GLU . 2.0 p -73.81 -14.67 61.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.71 -23.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.673 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 53.5 mt-30 -80.65 -33.38 35.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.063 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.669 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 5.8 p90 -108.43 92.13 9.44 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.2 Cg_endo -84.39 -12.79 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.132 2.555 . . . . 0.0 111.37 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 50' ' ' ALA . 3.3 pt20 -88.2 -22.95 23.73 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.354 0.597 . . . . 0.0 110.385 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -113.68 148.16 36.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.527 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 7.0 m-20 -91.12 116.73 29.04 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.402 0.62 . . . . 0.0 111.523 -174.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.669 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 2.8 p90 -87.7 114.55 24.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.946 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 22.1 m-85 -130.78 164.85 24.22 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.238 170.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.648 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -153.29 119.9 5.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 5.4 mt -99.31 159.52 14.94 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.255 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.42 118.77 37.59 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -63.34 -11.48 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.636 -174.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.24 -37.48 78.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.975 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.21 -31.02 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.458 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.56 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.0 mm? -107.73 48.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.004 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.584 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.92 -41.78 17.89 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.117 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 4.5 m-20 -66.7 -44.1 82.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.509 0.195 . . . . 0.0 110.839 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.0 p -62.74 -38.03 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.202 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.89 85.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.167 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 17.1 mm100 -71.37 -32.13 68.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.901 0.382 . . . . 0.0 110.464 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.42 -42.63 92.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.6 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -94.81 14.74 20.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.044 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 58.86 43.79 17.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.602 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.648 HG22 ' CD2' ' A' ' 25' ' ' PHE . 94.8 t -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.979 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 p -125.87 22.43 7.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.156 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.91 151.01 40.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.655 ' SD ' ' HB3' ' A' ' 30' ' ' CYS . 16.2 ptt? -121.45 123.15 27.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.202 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 6.1 Cg_endo -86.88 172.35 35.47 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.428 -1.072 . . . . 0.0 111.511 -3.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 55.1 m -138.82 116.78 11.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.618 ' CD2' ' HB3' ' A' ' 24' ' ' ALA . 2.5 mp -107.13 142.53 36.67 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.093 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.8 mt -134.28 110.6 9.61 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.094 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.45 124.08 34.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.758 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 31.5 m-85 -109.68 154.65 22.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.955 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.61 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 58.5 tttp -142.95 115.06 8.34 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.961 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 9.6 p30 44.69 38.11 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.965 0.906 . . . . 0.0 112.45 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.43 3.93 63.42 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.697 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 16.8 ptmt -103.59 -3.7 24.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 109.412 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 29.3 tt0 77.23 -179.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.593 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 77' ' ' LEU . 2.1 p -152.2 -32.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.884 0.374 . . . . 0.0 110.04 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.25 162.13 40.17 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.129 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -138.17 122.49 18.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.029 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.52 HG12 ' ND2' ' A' ' 91' ' ' ASN . 10.1 p -128.98 131.22 68.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.302 0.572 . . . . 0.0 110.277 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.11 80.41 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.672 -170.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.36 -175.12 38.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.926 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 32' ' ' PRO . . . -74.42 94.72 2.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 22.8 p-10 -124.45 68.95 51.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 18.7 Cg_exo -64.68 -43.65 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 120.614 0.876 . . . . 0.0 110.991 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.88 -32.43 18.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -75.88 -18.76 59.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.429 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.644 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.0 tp -59.9 -38.12 75.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HD2' ' CG2' ' A' ' 99' ' ' ILE . 19.3 tptm -64.27 -26.82 68.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.168 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.593 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.4 tm0? -58.83 -59.26 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 170.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 -38.36 78.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.7 . . . . 0.0 110.741 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -71.63 -42.37 71.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.146 -170.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.446 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -87.19 -40.45 14.57 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.99 -173.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.76 -40.4 66.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.572 -175.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.8 m-80 -85.55 -56.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.469 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' CB ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.581 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.302 0.572 . . . . 0.0 110.483 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.73 148.25 33.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.899 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -112.46 118.49 35.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.391 172.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -69.9 163.06 26.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 110.68 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -115.59 -18.34 10.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.176 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 28.5 p -138.0 155.49 48.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.483 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.64 -34.85 73.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 m -57.24 -37.77 72.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.991 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.594 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 34.4 mm-40 -63.36 -45.03 93.07 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.307 0.575 . . . . 0.0 109.961 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.75 -50.36 62.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.747 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.53 -39.73 80.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.396 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.1 m -69.45 -37.05 77.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -66.62 -49.6 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.858 0.361 . . . . 0.0 110.814 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.5 pt -66.69 -24.26 32.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.649 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 -5.76 48.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 19' ' ' LYS . 26.0 mt-30 -75.94 157.04 33.64 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.985 0.421 . . . . 0.0 110.302 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.45 -1.78 3.91 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.73 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 11.1 ptmt -115.47 173.86 6.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.21 0.528 . . . . 0.0 111.812 -167.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.566 ' CD2' HG13 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.41 113.69 11.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -122.12 107.86 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.766 0.317 . . . . 0.0 110.641 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.93 109.2 26.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.867 0.842 . . . . 0.0 111.588 176.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.585 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 98.9 t -104.28 142.54 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.151 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -129.43 138.35 51.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 69' ' ' VAL . 70.1 m-85 -88.51 126.6 35.33 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.25 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.555 ' HH ' ' HA ' ' A' ' 37' ' ' ALA . 4.2 m-30 -120.82 -172.06 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.637 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -169.9 162.51 9.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.227 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 p -83.98 -4.85 59.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -122.8 35.0 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 -176.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 2.0 p -130.95 143.88 51.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.814 0.816 . . . . 0.0 111.911 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.48 -45.43 6.49 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.276 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 50.9 Cg_exo -57.11 -50.63 10.73 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.903 1.735 . . . . 0.0 112.17 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.633 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 28.5 p -53.5 -34.37 57.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.71 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' A' ' 34' ' ' LYS . 4.6 ttmp? -68.55 -45.17 72.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.064 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -72.86 -41.52 64.67 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.277 0.561 . . . . 0.0 112.444 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.663 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.91 -17.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.44 177.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -58.03 -49.22 94.89 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 34' ' ' LYS . 37.8 Cg_endo -69.84 -29.44 23.5 Favored 'Trans proline' 0 C--N 1.358 1.066 0 CA-C-N 120.56 1.236 . . . . 0.0 112.592 169.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.6 mmt -67.68 -52.21 40.57 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.958 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.769 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -55.8 -35.2 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 173.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 12.7 tp10 -55.45 -49.88 71.3 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.149 0.5 . . . . 0.0 110.254 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -61.63 -48.04 82.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.097 0.475 . . . . 0.0 110.493 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 m-30 -63.02 -22.36 66.8 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.981 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.466 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 34.9 p -82.03 -19.59 40.08 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.726 0.774 . . . . 0.0 108.949 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -77.48 -29.91 52.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.673 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.64 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -100.39 26.31 6.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.251 175.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.582 ' CE1' HD11 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -100.12 89.34 1.08 Allowed Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.889 170.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 83.0 Cg_endo -84.99 -45.18 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.125 1.883 . . . . 0.0 114.075 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.69 -24.19 14.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.226 0.536 . . . . 0.0 111.845 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.36 164.38 11.68 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.577 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.0 128.32 55.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.769 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.52 120.87 43.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 29.6 m-85 -132.39 142.03 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.737 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.563 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 7.8 mmtt -127.93 120.0 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.585 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.0 mt -100.67 167.73 10.14 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.53 120.41 40.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -15.96 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.281 -174.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.65 -51.04 46.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.913 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.16 -29.7 31.42 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.469 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.597 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.9 mm? -96.14 57.59 1.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 0.0 111.22 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.535 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.97 -45.43 10.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.375 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 33.3 t70 -61.25 -45.42 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.649 0.262 . . . . 0.0 111.165 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.9 p -64.82 -38.04 81.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.384 . . . . 0.0 110.557 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.05 74.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.0 110.81 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 16.9 mm100 -75.02 -28.79 60.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.607 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 87.7 mttt -61.84 -41.31 97.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.462 0.649 . . . . 0.0 110.549 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -92.2 7.75 41.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.125 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 55.16 46.61 23.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.058 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 25' ' ' PHE . 93.3 t -77.89 109.44 12.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.41 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.51 -2.57 11.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.357 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.03 23.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.994 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.89 145.6 32.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.629 0.252 . . . . 0.0 110.695 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 90.5 Cg_endo -82.04 171.24 56.4 Favored 'Cis proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.355 -1.519 . . . . 0.0 112.046 -3.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.431 HG21 ' CD1' ' A' ' 76' ' ' LEU . 19.2 m -127.11 119.0 25.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' HZ1' ' A' ' 54' ' ' LYS . 4.1 mm? -108.24 106.23 16.31 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.002 0.429 . . . . 0.0 111.016 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.517 HD12 ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -118.84 119.06 33.27 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.117 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.59 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -94.91 119.01 32.74 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.2 m-85 -105.37 160.25 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.86 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.499 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 65.8 tttp -150.68 125.5 9.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.014 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 55.2 m-80 53.9 33.76 17.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 111.882 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.19 60.91 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.719 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 47.3 mmtm -102.06 -73.55 0.65 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 9.5 pt-20 165.41 -170.98 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 124.724 1.265 . . . . 0.0 108.511 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 77' ' ' LEU . 1.5 p -156.62 -30.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.428 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -163.02 161.96 25.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.411 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HG3' HD12 ' A' ' 76' ' ' LEU . 71.5 tttt -146.61 124.38 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.184 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.47 132.95 70.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.26 78.67 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.124 0.488 . . . . 0.0 110.853 -171.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.42 -171.79 40.02 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 32' ' ' PRO . . . -74.38 93.57 2.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 25.0 p-10 -118.93 71.87 11.09 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.65 -31.75 8.33 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.264 1.309 . . . . 0.0 109.833 166.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.59 -44.1 10.32 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.432 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . . . -73.91 -16.9 61.09 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.424 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.676 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -57.09 -37.68 56.62 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 169.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 13.9 mmmm -56.96 -32.77 66.37 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.743 0.652 . . . . 0.0 110.37 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.518 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -57.99 -56.65 19.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.605 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.9 -28.33 49.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -74.43 -44.7 47.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.654 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -85.01 -32.44 22.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.279 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.88 82.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 17.9 m-80 -114.22 -77.21 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.192 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.917 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -171.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.584 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.575 0.702 . . . . 0.0 111.708 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.43 ' CG2' ' HD1' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -81.33 148.66 29.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.428 -177.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.5 141.08 35.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 170.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.506 ' H ' HD21 ' A' ' 55' ' ' LEU . 14.3 m-85 -98.77 157.15 16.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.044 0.449 . . . . 0.0 110.021 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -123.71 -17.42 6.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 50.0 p -130.08 150.88 51.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.952 0.406 . . . . 0.0 111.025 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.35 -30.39 69.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.396 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -67.77 -33.58 75.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.479 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 22.1 mm-40 -61.73 -47.16 86.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.264 0.554 . . . . 0.0 110.07 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.6 -45.98 81.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.059 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.99 -48.51 81.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.371 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -69.36 -26.74 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.478 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -70.66 -53.25 16.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.427 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 pt -65.35 -21.97 30.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.332 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.88 -2.75 48.77 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 14' ' ' ALA . 78.1 mt-30 -76.09 158.55 31.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 33.9 t70 -80.16 28.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.104 0.954 . . . . 0.0 110.026 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 7.8 ptmt -134.75 169.12 17.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.506 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tm? -82.53 116.92 22.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.896 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.574 HG11 ' CE2' ' A' ' 53' ' ' TYR . 56.6 t -115.32 107.63 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.72 103.69 15.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 122.164 0.983 . . . . 0.0 111.209 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 t -100.47 139.92 20.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.27 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -130.33 138.57 50.5 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.664 0.269 . . . . 0.0 111.698 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 69' ' ' VAL . 49.7 m-85 -88.59 128.17 35.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.92 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.602 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.4 m-30 -120.45 -170.93 2.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.04 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.24 172.39 12.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.252 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -20.74 65.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.225 0.536 . . . . 0.0 110.868 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 23.1 p90 -101.39 -147.45 0.36 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.254 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.9 p 56.73 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.408 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.86 -41.45 76.13 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 114.319 -1.309 . . . . 0.0 114.178 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.485 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 46.4 Cg_exo -58.82 -43.73 41.57 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 120.25 2.025 . . . . 0.0 112.154 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.571 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 8.4 m -53.21 -40.0 64.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.383 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.726 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 96.1 mttt -65.56 -53.34 43.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.499 -178.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.68 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.8 ptm -62.8 -45.36 92.99 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.645 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.62 -18.43 15.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.924 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -57.4 -48.16 97.78 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.726 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.9 Cg_exo -70.74 -32.53 14.34 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.174 1.249 . . . . 0.0 112.008 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.1 mmm -64.26 -51.02 65.65 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.614 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.52 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 0.8 OUTLIER -53.85 -36.94 31.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-O 120.624 0.249 . . . . 0.0 110.341 172.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.92 -44.49 97.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.721 0.296 . . . . 0.0 111.195 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.92 -50.13 75.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.577 0.703 . . . . 0.0 109.408 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.671 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 14.1 m-30 -63.7 -17.17 62.7 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 9.6 p -86.15 -14.05 45.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.978 0.894 . . . . 0.0 108.921 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -88.14 -16.63 32.91 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.671 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -128.77 29.92 5.17 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.787 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -108.58 100.83 40.45 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-O 122.193 0.997 . . . . 0.0 112.623 172.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.85 -44.12 10.9 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.826 2.35 . . . . 0.0 114.375 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.5 -13.45 17.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 111.349 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -103.33 158.19 16.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.786 0.803 . . . . 0.0 112.002 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -126.38 119.13 26.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.173 171.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.787 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -87.64 130.58 34.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 -175.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.574 ' CE2' HG11 ' A' ' 21' ' ' VAL . 37.9 m-85 -133.32 133.07 42.06 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.356 168.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.584 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 8.0 mmpt? -117.0 118.96 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.602 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 1.3 mt -102.4 175.22 5.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.017 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -115.88 121.46 42.42 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -67.89 -10.58 12.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.198 -175.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.64 -35.64 52.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.58 -27.49 21.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.706 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.661 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.0 mt -117.85 54.09 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.367 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.25 -39.16 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.112 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.6 t70 -68.07 -46.99 69.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.644 0.259 . . . . 0.0 110.632 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.661 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.6 p -62.18 -38.45 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.402 . . . . 0.0 110.35 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.31 77.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.918 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 27.5 mt-30 -76.42 -30.85 57.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.461 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 39.1 mtmt -58.62 -39.95 81.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.51 0.671 . . . . 0.0 110.056 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -91.26 9.44 31.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.691 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 56.44 45.62 22.27 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.348 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.488 HG13 ' OG1' ' A' ' 74' ' ' THR . 62.3 t -85.96 123.72 39.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.508 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -134.67 -35.56 0.88 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.53 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.32 119.84 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.979 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.57 136.93 19.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.417 . . . . 0.0 110.872 -175.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.98 169.88 52.84 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.124 -1.615 . . . . 0.0 111.714 -4.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.488 ' OG1' HG13 ' A' ' 69' ' ' VAL . 55.9 m -117.06 116.88 28.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.34 108.65 20.15 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.172 0.511 . . . . 0.0 111.084 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.4 mt -126.63 116.08 20.47 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.606 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.81 125.98 41.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.933 173.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 25.7 m-85 -108.73 154.28 22.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.381 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 80' ' ' ASN . 22.5 ttmm -139.99 111.6 7.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.536 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 30.8 m-80 57.32 31.75 20.64 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.652 0.595 . . . . 0.0 111.508 -176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.36 11.19 51.77 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.51 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -106.01 0.3 25.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.764 0.792 . . . . 0.0 109.097 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 72.05 175.51 0.28 Allowed 'General case' 0 CA--C 1.524 -0.049 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.246 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.506 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 1.1 p -148.61 -30.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.006 0.431 . . . . 0.0 109.917 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.626 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . . . -161.61 164.54 29.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.645 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.536 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.1 tttt -146.4 118.37 8.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.167 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.17 131.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.17 76.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.204 0.526 . . . . 0.0 111.376 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.47 -167.51 35.71 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.226 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.99 96.99 3.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 110.094 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.1 p-10 -122.27 67.17 25.77 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.1 -34.63 27.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.173 1.248 . . . . 0.0 110.944 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.21 -43.26 11.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.143 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.4 -17.75 60.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.624 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.646 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.8 tp -58.85 -37.57 67.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 170.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 21.4 tptm -60.65 -32.76 71.92 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.049 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -56.17 -55.83 28.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 173.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.484 ' CB ' HD12 ' A' ' 77' ' ' LEU . . . -73.53 -36.04 65.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.542 0.687 . . . . 0.0 111.106 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -71.71 -45.11 67.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.645 -171.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.492 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -89.1 -40.81 12.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.917 0.389 . . . . 0.0 111.706 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.93 83.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.295 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.626 ' ND2' ' HB3' ' A' ' 85' ' ' ALA . 79.1 m-20 -93.25 -56.88 2.79 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.629 -172.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.165 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.596 HG23 ' CG2' ' A' ' 40' ' ' ILE . 35.9 t . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.041 0.448 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 146.6 51.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.889 0.852 . . . . 0.0 112.397 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -103.38 141.52 35.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.804 -1.543 . . . . 0.0 109.463 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.63 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.7 m-85 -94.5 158.03 15.73 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -119.86 -15.08 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.704 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 37.2 p -135.07 151.5 50.82 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.76 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.6 t -59.88 -46.89 87.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.063 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.522 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.2 mm-40 -60.38 -42.94 96.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.414 0.626 . . . . 0.0 110.143 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 19.7 t80 -67.58 -47.28 70.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.087 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.96 -42.85 99.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.597 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 22.6 t -67.16 -39.33 86.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.713 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -50.84 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.981 0.419 . . . . 0.0 110.722 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 11' ' ' PHE . 35.5 pt -67.41 -18.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.632 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.62 -14.12 52.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 19' ' ' LYS . 54.7 mt-30 -69.16 150.19 47.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 39.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.482 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 10.5 ptmt -136.75 167.38 21.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -77.6 108.01 10.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG12 HG23 ' A' ' 23' ' ' VAL . 53.0 t -110.02 107.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.209 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.524 ' HB ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.93 103.12 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 122.062 0.934 . . . . 0.0 110.84 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 70.8 t -102.35 143.18 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 74' ' ' THR . . . -127.9 117.53 21.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -70.51 129.1 38.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.525 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 7.6 m-30 -118.5 -177.45 3.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -152.23 130.21 11.8 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -58.26 -24.74 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.716 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -96.75 8.99 43.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.797 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.944 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -107.07 138.29 43.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.307 0.575 . . . . 0.0 111.786 -177.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -81.72 -37.65 16.11 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.904 -1.044 . . . . 0.0 114.546 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.944 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.1 Cg_exo -66.25 -29.33 46.92 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 120.359 2.08 . . . . 0.0 110.378 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 58.5 m -51.12 -39.62 56.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.732 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.916 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 13.5 mptt -67.79 -57.37 6.43 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.801 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 23.4 ptp -54.19 -50.22 67.57 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.702 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.41 -21.19 16.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.931 -177.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -56.96 -60.06 10.7 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.01 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.916 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 9.3 Cg_endo -56.37 -36.22 96.96 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 121.268 1.312 . . . . 0.0 112.792 169.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.596 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 26.1 mmt -62.75 -51.58 66.56 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.371 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.596 ' CG2' HG23 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -52.51 -32.73 17.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 122.672 0.389 . . . . 0.0 111.509 176.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 44.8 mt-10 -59.64 -48.57 81.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.351 0.596 . . . . 0.0 110.479 173.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -61.22 -47.62 85.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.685 0.755 . . . . 0.0 109.874 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.644 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 34.0 m-85 -67.42 -20.55 65.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.757 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 84.9 p -77.09 -15.96 59.39 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 108.85 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.38 -20.7 43.46 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.537 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 7.3 mm100 -83.46 -7.05 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.984 175.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.708 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 7.5 p90 -134.68 85.44 36.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.36 0.6 . . . . 0.0 112.46 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.56 -21.9 4.05 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.218 2.612 . . . . 0.0 112.423 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.72 -1.0 50.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.438 0.637 . . . . 0.0 110.527 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 47' ' ' TYR . . . -119.12 165.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -108.84 117.59 34.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.297 0.57 . . . . 0.0 111.997 -175.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.757 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 1.6 p90 -83.55 121.48 27.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.048 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 31.5 m-85 -136.74 142.59 43.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.335 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG2' ' CG1' ' A' ' 2' ' ' VAL . 10.9 mmtt -126.91 124.13 38.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.63 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.8 mt -100.67 -178.24 3.72 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.169 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.466 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 11.5 t0 -133.89 131.32 38.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.34 -8.7 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.316 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -31.62 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 109.971 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.61 -27.05 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.046 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.604 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.87 52.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.0 -39.81 22.81 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.487 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -44.0 73.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.775 0.322 . . . . 0.0 110.694 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -65.39 -38.82 83.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.048 0.451 . . . . 0.0 110.394 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.36 69.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.6 mt-30 -72.89 -36.83 67.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.962 0.411 . . . . 0.0 110.245 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -91.66 10.17 29.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.82 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 56.47 44.15 24.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.425 HG12 ' OG1' ' A' ' 74' ' ' THR . 74.2 t -73.7 109.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.489 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -117.54 -25.92 6.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.541 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.78 117.57 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.036 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -100.63 150.41 36.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 14.1 Cg_exo -71.21 171.47 59.51 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 123.872 -1.303 . . . . 0.0 111.834 -6.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 19.9 m -131.07 115.52 16.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.607 HD11 ' OD1' ' A' ' 91' ' ' ASN . 3.8 mt -105.7 108.67 20.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.503 0.668 . . . . 0.0 111.115 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.592 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 25.5 mt -123.23 114.4 20.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.014 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.524 HD23 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -93.75 125.02 38.13 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.168 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 m-85 -107.37 155.64 19.79 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.431 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -141.04 131.94 25.99 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.02 44.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 19.02 60.0 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.579 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 14.7 tttp -126.39 0.92 6.99 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.338 0.59 . . . . 0.0 110.215 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 39.2 mt-10 73.14 -179.1 0.2 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.951 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.505 HG12 HD21 ' A' ' 20' ' ' LEU . 1.3 p -153.31 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.754 174.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.615 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . . . -157.71 163.0 38.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.119 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.592 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 77.0 tttt -144.26 116.69 8.55 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.944 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 t -123.89 133.88 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.13 78.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.283 0.563 . . . . 0.0 110.927 -170.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.59 -175.67 39.78 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 96.48 1.87 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.607 ' OD1' HD11 ' A' ' 75' ' ' LEU . 19.1 p-10 -119.41 78.8 20.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.46 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 3.4 Cg_exo -74.91 -29.94 7.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.469 1.446 . . . . 0.0 110.319 167.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -90.25 -51.03 5.64 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.618 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -67.68 -16.59 64.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.518 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.653 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -55.74 -37.59 47.49 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HD2' HG21 ' A' ' 99' ' ' ILE . 11.7 mmmm -58.39 -34.52 70.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.023 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.01 -58.66 6.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.37 55.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.784 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.653 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -80.49 -40.02 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.471 -172.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -85.63 -39.19 17.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.666 -175.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.19 70.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.615 ' ND2' ' HB3' ' A' ' 85' ' ' ALA . 89.0 m-20 -101.14 -68.92 0.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.273 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 120.961 0.41 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.18 149.24 47.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.065 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.14 134.08 52.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.492 175.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.586 ' H ' HD21 ' A' ' 55' ' ' LEU . 13.3 m-85 -86.75 164.4 16.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.164 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -123.22 -13.72 7.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.709 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.649 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 71.2 p -137.32 155.35 49.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.724 0.297 . . . . 0.0 111.017 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.85 -31.22 69.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 t -61.23 -42.09 98.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.649 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.7 mm-40 -59.0 -43.93 91.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.32 0.581 . . . . 0.0 109.992 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.42 ' CZ ' HD12 ' A' ' 15' ' ' ILE . 1.4 t80 -63.65 -49.18 74.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.843 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.1 -44.44 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.925 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 34.5 t -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.974 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -49.74 42.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.906 0.384 . . . . 0.0 110.666 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.43 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 29.3 pt -66.99 -21.71 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.548 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.67 -8.62 59.33 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.884 0.374 . . . . 0.0 111.371 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.6 mt-30 -75.63 158.99 31.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.733 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.04 36.24 0.34 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.42 0.628 . . . . 0.0 110.347 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 17' ' ' GLN . 29.1 mmmt -126.71 160.27 31.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.651 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HG ' ' HB1' ' A' ' 103' ' ' ALA . 1.7 tm? -77.57 105.56 8.8 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 53.3 t -110.23 107.12 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.024 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.73 108.99 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.684 0.754 . . . . 0.0 110.818 175.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 85.1 t -103.53 142.72 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.117 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . . . -126.72 113.68 16.98 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.81 106.48 7.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.063 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.64 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.2 m-85 -133.28 175.82 9.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 112.143 -171.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.07 163.56 39.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.49 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -85.49 -8.64 58.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -108.02 27.65 9.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -129.26 128.11 42.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.441 0.639 . . . . 0.0 111.306 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.14 97.49 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 114.713 -1.131 . . . . 0.0 114.107 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.544 ' O ' HG21 ' A' ' 36' ' ' ILE . 38.7 Cg_exo -58.15 -39.41 85.46 Favored 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 119.714 1.757 . . . . 0.0 110.674 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 39.0 m -58.57 -34.08 70.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.2 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.628 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 29.1 mtpp -63.87 -55.65 21.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.423 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 26.0 ptt? -61.03 -44.56 97.22 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.64 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.23 -24.15 18.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.796 -178.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -53.85 -51.36 77.46 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.619 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 35.6 Cg_endo -68.12 -32.46 27.5 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 120.215 1.113 . . . . 0.0 112.603 169.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.426 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.6 mmt -64.66 -57.59 8.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.559 HG21 ' CZ ' ' A' ' 52' ' ' PHE . 36.5 mt -66.46 -23.12 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.45 0.568 . . . . 0.0 111.39 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.94 -47.29 85.61 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.53 0.681 . . . . 0.0 109.46 168.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -63.41 -48.53 77.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.145 0.498 . . . . 0.0 110.516 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.627 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 11.7 m-30 -65.6 -15.56 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.975 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 p -87.21 -14.9 39.8 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 121.555 0.693 . . . . 0.0 109.274 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.27 -23.2 40.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 168.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.627 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -120.87 34.08 5.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.611 ' CE2' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -104.59 85.11 1.07 Allowed Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 122.016 0.912 . . . . 0.0 112.298 172.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 24.3 Cg_exo -64.02 -45.68 9.82 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.005 1.803 . . . . 0.0 113.916 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -107.81 24.65 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -128.98 156.38 43.88 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.798 -0.564 . . . . 0.0 111.914 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.76 120.26 40.2 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.24 169.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.611 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -103.35 116.74 33.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.5 -171.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.422 ' CD2' HG12 ' A' ' 21' ' ' VAL . 23.2 m-85 -129.17 136.26 49.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -121.18 119.06 31.25 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.586 HD21 ' H ' ' A' ' 5' ' ' PHE . 5.2 mt -100.96 160.55 14.28 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.776 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.48 114.56 26.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -11.25 9.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.44 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.02 -51.09 27.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.548 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -86.96 -25.68 24.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.438 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.536 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.6 mm? -99.99 45.06 0.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 111.316 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.05 -37.03 30.07 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.848 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.1 -42.41 94.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.695 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.1 p -67.19 -39.09 82.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.81 76.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.72 -33.08 72.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.204 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -27.73 64.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.667 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -95.18 10.83 34.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.88 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 60.09 41.33 17.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.791 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.5 t -99.95 110.53 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.571 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 p -110.73 -19.22 12.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.85 0.357 . . . . 0.0 110.727 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.15 168.39 10.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.13 148.53 35.47 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 18.8 Cg_exo -70.77 173.35 48.61 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.839 -0.901 . . . . 0.0 112.581 -6.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 87.6 m -147.23 117.32 7.28 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.839 0.352 . . . . 0.0 110.496 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.506 ' CD1' ' HB1' ' A' ' 24' ' ' ALA . 4.0 mm? -110.76 111.23 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.326 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.408 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 35.8 mt -125.87 115.39 19.9 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -96.86 128.82 44.19 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.018 174.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 29.0 m-85 -110.72 155.53 22.34 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.131 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.629 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.3 tttt -142.28 116.83 9.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.829 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.629 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.52 38.4 7.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.787 0.835 . . . . 0.0 111.847 -177.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.15 8.63 55.06 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.34 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -109.39 4.05 22.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 109.997 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 24.2 tt0 67.92 174.6 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.025 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.503 HG12 HD22 ' A' ' 20' ' ' LEU . 1.4 p -144.31 -32.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.933 0.396 . . . . 0.0 110.117 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -157.93 161.33 38.2 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.979 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.501 ' HB2' ' HZ3' ' A' ' 86' ' ' LYS . 1.7 ttmp? -139.72 117.48 11.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.245 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.08 125.71 73.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.05 87.0 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 111.296 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 -173.63 33.63 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.027 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 73' ' ' PRO . . . -71.91 103.62 3.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.5 p-10 -127.22 65.65 65.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.496 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 10.1 Cg_exo -69.21 -34.07 17.23 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 120.867 1.045 . . . . 0.0 110.871 174.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.53 -45.34 9.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -70.92 -17.24 62.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.58 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.618 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.7 tp -56.96 -38.45 59.77 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.59 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 30.5 mmtt -59.58 -35.37 74.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.761 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.14 -54.01 45.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 77' ' ' LEU . . . -76.7 -39.77 50.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.629 0.728 . . . . 0.0 111.3 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -69.57 -41.0 80.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.678 -171.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.459 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -88.53 -38.57 14.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.635 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.11 -31.13 55.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 45.5 m-80 -95.65 -60.07 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.33 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB1' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.245 0.867 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.463 170.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.659 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.597 0.713 . . . . 0.0 112.025 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.533 ' N ' HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -83.54 148.44 27.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.204 -178.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 133.33 50.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.061 170.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.562 ' H ' HD22 ' A' ' 55' ' ' LEU . 15.3 m-85 -84.38 164.32 19.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -117.79 -16.91 9.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.444 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.614 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 40.1 p -134.89 153.64 51.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.527 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.42 -33.71 68.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -64.29 -32.09 73.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.474 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.614 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 23.4 mm-40 -67.42 -44.09 79.62 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.093 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -44.38 94.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.633 176.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.33 -44.42 88.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.447 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -71.14 -25.7 62.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.788 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -77.14 -50.02 13.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.684 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 pt -66.53 -17.83 23.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.286 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.05 59.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.893 0.377 . . . . 0.0 111.586 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.51 ' NE2' ' HA ' ' A' ' 14' ' ' ALA . 77.3 mt-30 -71.55 150.77 44.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.343 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.68 28.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.41 0.624 . . . . 0.0 110.975 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 17' ' ' GLN . 15.0 ptmt -135.94 174.65 10.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.46 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.533 ' CD1' HG12 ' A' ' 84' ' ' VAL . 8.0 tt -85.62 134.64 33.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.413 0.625 . . . . 0.0 111.199 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.9 t -134.98 109.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.963 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.528 ' HB ' ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -103.17 107.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.147 0.975 . . . . 0.0 111.164 177.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.587 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 99.2 t -100.19 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.499 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . . . -127.6 122.58 33.52 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' HG23 ' A' ' 69' ' ' VAL . 95.8 m-85 -73.83 124.79 26.77 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.335 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HH ' ' HA ' ' A' ' 37' ' ' ALA . 6.4 m-30 -118.66 179.25 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.584 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -148.29 144.54 27.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -3.81 28.15 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.05 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -122.16 13.32 10.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 3.7 p -109.43 156.06 20.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.571 0.7 . . . . 0.0 112.617 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.53 -52.36 3.57 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.639 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 72.0 Cg_exo -53.96 -48.44 21.68 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.249 1.966 . . . . 0.0 112.621 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 7.8 p -51.17 -35.51 36.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.188 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.9 tptm -65.2 -53.1 49.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.161 0.288 . . . . 0.0 110.532 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.469 ' O ' ' HG2' ' A' ' 39' ' ' MET . 26.5 ptt? -66.66 -43.34 84.83 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.636 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.49 -18.19 16.75 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.09 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -56.77 -53.22 67.13 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.825 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 34.2 Cg_endo -67.13 -28.2 41.09 Favored 'Trans proline' 0 C--N 1.359 1.107 0 CA-C-N 120.567 1.238 . . . . 0.0 112.428 170.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.542 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.9 mmm -65.91 -56.32 12.35 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.183 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.493 ' CG2' HG13 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -52.86 -31.09 16.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 122.495 0.318 . . . . 0.0 110.74 176.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -61.33 -50.77 71.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.305 0.574 . . . . 0.0 109.599 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 1.4 tmtp? -61.53 -44.49 96.97 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.611 0.719 . . . . 0.0 109.781 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.648 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 76.5 m-85 -66.06 -23.23 66.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.624 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.63 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 83.5 p -74.1 -19.03 60.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -78.16 -23.64 47.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.648 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 5.3 mm100 -87.69 5.54 39.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.338 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 0.6 OUTLIER -99.46 102.14 15.48 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.4 Cg_exo -76.5 -45.93 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.686 1.591 . . . . 0.0 112.692 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.97 1.25 15.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -113.55 153.28 29.03 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.02 129.26 46.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.2 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.63 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.4 OUTLIER -105.06 121.45 43.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.677 -175.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 30.1 m-85 -135.5 144.64 46.45 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.519 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.659 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 11.9 mmtt -128.87 122.51 30.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.587 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.4 mt -98.48 170.75 8.61 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.136 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.08 120.5 34.48 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.41 -8.52 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.16 -28.65 61.41 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.762 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.527 ' CG ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -110.42 -35.65 5.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 169.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.629 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mm? -87.28 52.21 2.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.851 0.358 . . . . 0.0 111.006 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.559 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.48 -37.5 30.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.152 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 13.6 p-10 -66.99 -43.99 81.57 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.046 -0.09 . . . . 0.0 110.766 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.629 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.6 p -66.44 -34.85 72.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 110.614 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.7 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.622 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 33.7 mm-40 -77.47 -30.08 52.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.907 0.384 . . . . 0.0 110.422 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 74.5 mmtt -57.32 -47.95 80.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.289 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -94.26 15.85 16.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.328 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 48.89 52.88 13.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.818 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.424 HG23 ' CD2' ' A' ' 25' ' ' PHE . 97.7 t -81.42 113.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.731 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.7 p -118.55 1.07 11.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.9 154.21 45.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.776 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.94 128.86 20.87 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.773 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.3 171.7 53.63 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.932 -5.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 68.2 m -124.74 116.69 22.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.78 111.66 24.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.185 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.524 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.9 mt -127.49 113.52 16.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.47 127.57 38.01 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.554 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 m-85 -112.59 157.45 21.17 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.122 -176.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.6 tttt -143.26 118.68 10.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.021 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.51 44.77 2.63 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.825 0.85 . . . . 0.0 112.509 -178.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.41 10.09 52.16 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.148 -0.478 . . . . 0.0 113.512 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -109.3 0.06 19.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.033 0.444 . . . . 0.0 110.288 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 28.1 tt0 66.83 179.75 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.554 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.533 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -152.83 -33.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.746 0.308 . . . . 0.0 110.705 173.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.415 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.4 164.49 32.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.79 0.329 . . . . 0.0 111.023 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.3 tttt -145.92 123.81 12.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.568 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.31 133.45 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.76 78.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.196 0.522 . . . . 0.0 111.344 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.83 -172.3 37.11 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.684 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -73.04 97.02 2.25 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.547 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 26.3 p-10 -121.77 66.14 19.94 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 15.3 Cg_exo -66.03 -37.18 27.0 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.092 1.195 . . . . 0.0 110.946 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.92 -41.68 12.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.235 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 91' ' ' ASN . . . -73.03 -17.09 61.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.459 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.674 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.7 tp -56.25 -38.14 53.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 17.5 tppt? -61.5 -31.39 71.38 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.187 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -56.54 -55.61 31.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 174.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.427 ' HB3' HD13 ' A' ' 77' ' ' LEU . . . -74.65 -32.67 62.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.419 0.628 . . . . 0.0 110.751 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.76 -43.17 70.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.613 -172.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.473 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -86.59 -39.22 16.36 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.801 0.334 . . . . 0.0 110.802 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.47 77.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.966 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 42.0 m-80 -104.12 -66.39 0.96 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.554 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.649 -0.691 . . . . 0.0 111.271 179.476 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.491 HG22 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.132 0.491 . . . . 0.0 110.05 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.56 147.43 33.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.976 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -107.14 122.54 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.214 171.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.624 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 13.4 m-85 -76.4 152.67 36.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.215 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.62 -19.55 15.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.364 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.648 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 81.2 p -135.39 156.61 48.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.241 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.514 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.07 -31.88 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -62.91 -38.67 91.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.99 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.648 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.0 mm-40 -60.37 -51.98 67.19 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.355 0.598 . . . . 0.0 110.193 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 15' ' ' ILE . 2.1 t80 -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.727 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.97 -45.43 78.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.455 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.581 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 37.4 t -67.84 -42.1 81.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -61.39 -49.93 74.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 42.0 pt -67.27 -20.86 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.502 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.25 -2.56 58.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.733 0.302 . . . . 0.0 111.672 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.6 mt-30 -81.86 162.68 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.088 0.471 . . . . 0.0 111.08 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.1 26.04 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.687 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 9.0 ptmt -132.14 165.24 24.52 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.525 HD21 HG13 ' A' ' 84' ' ' VAL . 2.7 tm? -76.57 117.28 18.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 59.7 t -114.25 107.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.13 106.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.527 0.68 . . . . 0.0 110.343 175.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.634 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 34.5 t -108.4 143.36 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.551 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -122.32 120.83 35.21 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.338 0.59 . . . . 0.0 112.515 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CE2' HD12 ' A' ' 55' ' ' LEU . 95.4 m-85 -69.89 118.98 13.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.366 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.614 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -127.34 176.48 7.4 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.95 -164.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.29 146.87 14.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.165 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 p -84.48 -4.46 58.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -116.35 51.63 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -151.7 171.07 18.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.92 -54.16 2.83 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.632 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 35' ' ' MET . 74.9 Cg_exo -53.11 -35.0 70.98 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.321 2.014 . . . . 0.0 112.406 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 p -65.6 -32.23 73.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.948 0.404 . . . . 0.0 111.027 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -68.39 -34.46 76.07 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.205 -0.309 . . . . 0.0 110.927 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.561 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -80.7 -49.78 10.76 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.614 HD13 ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -76.75 -22.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.181 -0.949 . . . . 0.0 111.352 -175.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.77 -49.09 95.69 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.411 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 35' ' ' MET . 32.8 Cg_exo -63.47 -37.42 48.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.34 1.36 . . . . 0.0 111.806 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mmm -65.61 -61.6 1.99 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.449 HD13 HD12 ' A' ' 36' ' ' ILE . 57.7 mt -66.33 -19.1 25.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 118.58 0.627 . . . . 0.0 111.377 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.2 tt0 -60.84 -46.06 92.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.697 0.76 . . . . 0.0 109.471 167.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 23.1 ttmt -66.12 -42.09 89.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.601 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.599 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.1 m-30 -71.65 -17.42 62.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.312 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.788 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 96.9 p -77.67 -16.89 58.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -83.86 -19.05 35.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.405 168.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.606 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 10.0 mm100 -95.18 -1.08 52.53 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.585 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 9.0 m-30 -100.51 101.48 15.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.263 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.9 Cg_exo -80.61 -43.98 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.659 2.239 . . . . 0.0 112.438 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -107.84 7.23 28.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.882 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . . . -123.81 143.41 50.34 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.47 46.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.949 0.88 . . . . 0.0 111.014 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.788 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.6 OUTLIER -106.7 119.15 38.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.535 -169.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' HA ' HG23 ' A' ' 2' ' ' VAL . 29.0 m-85 -135.77 155.11 50.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -132.19 130.07 40.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.634 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 76.8 mt -95.34 128.42 42.17 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.128 -0.358 . . . . 0.0 111.128 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -70.91 97.53 1.44 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 168.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -19.7 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.53 -35.86 72.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.091 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.498 ' HG3' HD21 ' A' ' 60' ' ' LEU . 9.3 pt-20 -110.05 -38.59 5.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.462 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.619 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mm? -78.19 50.74 0.93 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.98 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.33 -42.05 24.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.644 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.7 p-10 -62.76 -46.71 86.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.315 0.103 . . . . 0.0 110.936 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.619 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -63.17 -38.56 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 110.254 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.91 70.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.547 ' HA ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -75.95 -40.06 54.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.153 0.501 . . . . 0.0 109.748 -177.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.644 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 58.4 mttm -59.34 -40.69 87.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.626 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -89.89 6.17 43.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.544 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 57.72 52.06 8.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.506 HG11 ' OG1' ' A' ' 74' ' ' THR . 57.1 t -75.52 116.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.856 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -113.93 -62.41 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.875 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.17 116.55 29.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.999 0.428 . . . . 0.0 110.568 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.68 145.95 30.79 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.464 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.06 162.03 92.58 Favored 'Cis proline' 0 C--O 1.235 0.359 0 C-N-CA 123.106 -1.623 . . . . 0.0 112.513 -5.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.506 ' OG1' HG11 ' A' ' 69' ' ' VAL . 52.5 m -118.45 117.24 28.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' CD1' ' HB1' ' A' ' 24' ' ' ALA . 4.3 mm? -102.2 108.62 20.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 31.3 mt -122.12 113.13 19.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.587 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.517 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -99.2 128.34 45.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.055 177.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 34.4 m-85 -112.09 153.71 26.51 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.3 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.594 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 24.1 tptm -135.97 115.0 12.27 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.389 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.594 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 9.8 p30 44.15 38.24 2.25 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.134 0.974 . . . . 0.0 112.731 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.69 7.05 73.61 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.292 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -105.2 -7.12 19.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 77.77 173.29 0.19 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.673 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.525 HG13 HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -147.28 -29.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.699 0.285 . . . . 0.0 110.789 173.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.709 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -161.69 162.68 29.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.21 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.522 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 1.8 tmtp? -142.82 108.99 5.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.33 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.5 t -119.56 143.43 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.17 86.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.761 0.791 . . . . 0.0 111.478 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 50.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.144 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.25 84.83 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.004 0.43 . . . . 0.0 111.005 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.54 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 14.3 p-10 -121.1 83.64 38.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 6.0 Cg_exo -75.14 -38.96 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.58 1.52 . . . . 0.0 111.03 168.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.31 -39.93 13.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.428 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.634 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -73.05 -17.29 61.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.078 0.466 . . . . 0.0 111.238 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.647 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -57.81 -36.72 56.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 31.5 mmmt -56.34 -40.11 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.831 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.634 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 4.0 tp60 -46.48 -60.22 2.49 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 123.346 0.403 . . . . 0.0 110.349 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.474 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -77.37 -29.24 53.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.475 0.655 . . . . 0.0 111.436 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -80.01 -41.37 21.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.956 -170.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.97 -35.65 18.74 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.796 -176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.35 -39.18 78.29 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.709 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 83.7 m-20 -96.16 -60.31 1.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.546 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG22 ' HG3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.52 149.83 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.064 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.65 133.25 44.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.691 170.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.6 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.9 m-85 -86.98 164.35 16.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.16 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -117.2 -23.32 7.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.919 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.649 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 39.9 p -132.4 157.4 44.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 112.035 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.68 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -61.43 -35.6 78.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.771 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.649 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.0 mm-40 -61.3 -49.65 76.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.311 0.577 . . . . 0.0 110.345 177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -63.14 -47.9 80.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.498 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.37 -44.42 95.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -67.61 -36.65 81.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.987 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.34 -49.26 61.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 pt -66.36 -20.74 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.94 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HA ' ' N ' ' A' ' 81' ' ' GLY . . . -80.84 -8.83 59.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -72.19 150.38 43.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.43 53.57 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.692 0.758 . . . . 0.0 110.221 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 10.0 ptmt -153.08 173.75 15.07 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.332 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.543 ' CD2' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -75.5 111.28 10.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.1 t -122.62 107.67 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.868 0.366 . . . . 0.0 110.442 169.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.13 115.36 47.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.56 0.695 . . . . 0.0 111.271 175.024 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.6 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 84.3 t -103.26 140.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.964 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.09 138.33 54.45 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CE2' HG23 ' A' ' 69' ' ' VAL . 71.5 m-85 -90.2 128.04 36.27 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.436 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 3.0 m-85 -120.68 -171.72 2.24 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.555 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.02 169.7 16.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.524 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.76 -30.34 69.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.591 0.71 . . . . 0.0 110.309 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -91.37 -138.84 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.5 p 56.3 110.41 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.73 1.212 . . . . 0.0 113.942 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.49 98.68 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.266 -1.334 . . . . 0.0 114.176 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.662 ' O ' HG21 ' A' ' 36' ' ' ILE . 31.5 Cg_exo -60.14 -41.76 49.06 Favored 'Trans proline' 0 C--N 1.36 1.139 0 CA-C-N 120.221 2.011 . . . . 0.0 111.663 -178.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.658 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 29.3 m -51.37 -43.21 61.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.466 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.3 mmtt -62.87 -55.54 25.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -63.87 -48.0 78.42 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.662 HG21 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -75.51 -11.59 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.897 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -58.21 -57.49 25.73 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.292 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 28.1 Cg_endo -64.91 -34.01 50.09 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 120.025 1.044 . . . . 0.0 111.958 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.489 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.8 mtt -64.7 -60.94 2.53 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.892 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.565 HG21 ' CE2' ' A' ' 52' ' ' PHE . 17.4 mt -58.56 -25.47 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 118.228 0.467 . . . . 0.0 112.109 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.31 -41.01 96.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 172.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.96 -46.04 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.826 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.67 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 66.0 m-85 -65.09 -24.38 67.43 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.267 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.647 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 33.9 t -85.57 -14.45 45.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.857 0.837 . . . . 0.0 109.232 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -84.27 -19.84 33.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.67 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 18.1 pt20 -104.66 26.01 9.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.869 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.58 ' HD1' ' O ' ' A' ' 43' ' ' PHE . 2.4 m-85 -97.97 89.95 0.85 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.44 166.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.22 -46.17 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.91 1.74 . . . . 0.0 112.714 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -11.45 14.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 149.27 24.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.98 126.87 50.33 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.637 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.647 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -110.15 125.5 53.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.54 -177.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 27.5 m-85 -130.96 143.4 50.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HD3' ' CG2' ' A' ' 40' ' ' ILE . 31.6 mtmt -133.02 119.9 20.66 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 5.7 mt -97.54 163.9 12.66 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.729 -173.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.67 111.74 24.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.208 0.528 . . . . 0.0 109.788 174.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -66.58 -15.4 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.481 -171.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.34 -26.62 63.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -106.89 -39.28 5.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.356 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.503 HD12 ' CG2' ' A' ' 63' ' ' VAL . 3.0 mm? -88.09 41.65 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.366 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -70.2 -35.29 70.18 Favored Glycine 0 CA--C 1.504 -0.616 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.45 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 29.7 m-20 -63.36 -40.61 97.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 109.951 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 60' ' ' LEU . 86.0 t -63.2 -42.42 96.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.246 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.28 83.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.126 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 24.0 mt-30 -71.72 -33.06 68.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.526 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 69.0 mttm -57.17 -40.9 78.25 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.438 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -96.44 10.34 38.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.101 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 55.91 40.7 30.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.625 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.565 HG23 ' CE2' ' A' ' 25' ' ' PHE . 49.2 t -83.0 127.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.347 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.4 t -134.14 -26.67 1.47 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.283 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.86 114.94 29.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 0.0 110.04 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 147.09 32.94 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.002 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.472 ' HD2' ' CA ' ' A' ' 90' ' ' ALA . 2.6 Cg_endo -84.23 161.98 68.23 Favored 'Cis proline' 0 N--CA 1.461 -0.424 0 C-N-CA 124.17 -1.179 . . . . 0.0 111.497 -8.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 m -119.64 121.32 39.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.83 109.93 21.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.607 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.539 HD22 ' HG2' ' A' ' 86' ' ' LYS . 7.6 mt -125.31 114.86 19.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.593 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -90.8 122.52 33.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.99 174.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.3 m-85 -106.31 162.19 13.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.36 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' HG2' HD21 ' A' ' 80' ' ' ASN . 24.7 ttmm -150.51 133.45 16.02 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.346 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.509 HD21 ' HG2' ' A' ' 79' ' ' LYS . 11.5 p30 48.02 29.79 1.85 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.056 0.942 . . . . 0.0 112.618 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.515 ' N ' ' HA ' ' A' ' 16' ' ' ALA . . . 74.69 9.38 82.61 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.855 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.673 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 13.4 tttp -107.25 -65.41 1.1 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.673 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 18.0 tt0 161.42 -178.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 123.976 0.798 . . . . 0.0 109.064 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 77' ' ' LEU . 2.2 p -154.53 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -160.45 165.1 31.64 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.906 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.539 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.7 tmtp? -142.7 119.52 11.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.257 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 t -131.55 144.1 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.74 91.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.888 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.8 53.59 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.643 172.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.472 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.31 86.76 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 111.303 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.561 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 14.2 p-10 -122.39 85.34 47.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.486 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 5.7 Cg_exo -77.34 -39.46 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.218 1.279 . . . . 0.0 110.308 166.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.641 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.47 -36.11 16.65 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.276 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.561 ' HB1' ' CB ' ' A' ' 91' ' ' ASN . . . -75.39 -17.33 60.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.136 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.69 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.8 tp -58.06 -37.95 64.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 170.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 19.4 mmtp -55.41 -37.37 67.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.914 0.758 . . . . 0.0 110.647 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.3 tm0? -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 176.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.16 -24.81 51.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.304 0.573 . . . . 0.0 111.352 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.69 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -78.01 -42.81 28.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.916 -173.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.45 -32.39 22.32 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.703 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.44 -41.62 93.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.274 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.528 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 41.2 m-80 -110.86 -90.39 0.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.859 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.713 -168.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 52' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.16 0.505 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -81.83 147.92 29.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.918 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.67 130.17 51.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.953 172.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.621 ' H ' HD23 ' A' ' 55' ' ' LEU . 13.0 m-85 -84.52 159.72 20.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -117.07 -19.06 9.9 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 25.7 p -135.01 153.65 52.01 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.779 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.96 -33.69 70.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 m -59.07 -36.34 74.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.106 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.555 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 39.4 mm-40 -65.99 -47.73 73.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.492 0.663 . . . . 0.0 110.062 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.409 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 1.6 t80 -62.15 -44.14 97.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.079 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -55.33 -49.53 71.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.893 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -67.46 -37.58 83.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.205 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.95 58.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 pt -68.04 -19.99 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.227 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 -13.8 59.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.975 0.417 . . . . 0.0 110.945 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -75.57 145.08 41.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.04 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.43 47.45 0.93 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.453 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 6.8 ptmt -138.96 168.35 20.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.064 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' HG13 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -74.92 105.84 6.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.214 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 53' ' ' TYR . 53.5 t -114.58 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 173.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.86 109.41 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.642 0.734 . . . . 0.0 110.74 175.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 66.2 t -103.17 135.19 41.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.052 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 54' ' ' LYS . . . -121.63 111.44 17.21 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 121.072 0.463 . . . . 0.0 112.093 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 69' ' ' VAL . 96.3 m-85 -69.05 112.56 5.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.227 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.666 ' OH ' HD12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.03 177.44 5.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.11 147.45 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.454 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 p -84.62 -4.72 59.14 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -117.24 53.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.63 173.08 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.77 2.56 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.238 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.496 ' O ' HG23 ' A' ' 36' ' ' ILE . 75.5 Cg_exo -51.56 -40.86 63.06 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.461 2.108 . . . . 0.0 112.142 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.402 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 8.5 p -66.04 -29.7 70.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.231 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -68.64 -35.91 77.9 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.943 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.55 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptm -80.84 -46.93 14.54 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.666 HD12 ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -75.93 -22.8 16.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.924 -175.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.501 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -58.46 -46.73 99.6 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.352 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 35' ' ' MET . 45.6 Cg_exo -59.96 -40.59 60.65 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.692 1.594 . . . . 0.0 112.395 167.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -65.02 -53.75 41.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -58.86 -35.71 57.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 9.5 tp10 -54.48 -47.45 72.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.503 0.668 . . . . 0.0 109.883 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -62.54 -48.89 77.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.631 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.652 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 12.1 m-30 -67.08 -17.27 64.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 29.0 p -87.25 -11.87 48.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.63 -24.18 29.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 168.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.652 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -119.36 36.38 4.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.722 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.475 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -99.55 90.66 1.27 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 122.039 0.924 . . . . 0.0 111.746 171.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 18.0 Cg_exo -65.35 -46.39 5.75 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.051 1.834 . . . . 0.0 113.359 -170.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -111.35 -7.7 14.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.91 163.18 12.36 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 111.656 -167.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.6 126.27 51.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.245 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.575 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 3.4 m-30 -99.57 121.69 41.55 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.689 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 29.9 m-85 -129.08 134.94 48.3 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 10.7 ttpp -127.45 117.43 22.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 5' ' ' PHE . 3.9 mt -96.13 156.99 16.1 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -165.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -91.25 99.15 12.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -18.65 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.271 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.76 -37.49 84.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.083 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.96 -38.49 10.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.036 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.639 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.09 49.55 1.65 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.643 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.35 34.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.659 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 12.5 p-10 -66.02 -40.73 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.523 0.202 . . . . 0.0 111.118 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.639 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -72.98 -35.08 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.47 -36.99 74.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.125 0.488 . . . . 0.0 110.308 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 14.9 mm-40 -73.4 -29.8 62.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.416 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 30.0 mtpp -61.91 -40.95 97.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -95.77 12.94 28.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.397 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 59.79 40.56 19.4 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.096 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 25' ' ' PHE . 75.0 t -76.95 110.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.857 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 p -113.57 -1.64 14.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.37 143.05 43.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.473 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.33 128.0 26.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 89.1 Cg_endo -84.1 170.57 50.34 Favored 'Cis proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.514 -5.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.7 m -121.89 122.75 40.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.946 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.471 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 3.9 mm? -107.65 110.47 22.35 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 86' ' ' LYS . 36.7 mt -126.81 119.37 26.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.356 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.881 173.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 26.1 m-85 -108.86 158.97 17.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.603 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 36.3 ttmt -143.44 116.03 8.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.338 173.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.577 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 10.9 p30 47.6 31.48 2.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.399 1.079 . . . . 0.0 112.816 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 10.07 79.0 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.851 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 12.4 tptm -106.22 -2.61 22.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.989 0.899 . . . . 0.0 108.629 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 40.7 mt-10 71.75 -178.47 0.21 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.888 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 ' CD2' ' A' ' 20' ' ' LEU . 1.3 p -152.06 -29.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.976 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.78 161.29 36.96 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.632 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HG2' HD21 ' A' ' 76' ' ' LEU . 1.4 tmtp? -143.24 115.84 8.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.971 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t -132.21 143.51 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 109.935 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.65 90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.686 0.755 . . . . 0.0 111.305 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.38 54.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.005 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 56.03 86.68 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.51 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.56 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 16.6 p-10 -125.13 89.41 52.66 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HG2' ' HE3' ' A' ' 35' ' ' MET . 1.2 Cg_endo -82.55 -29.68 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.965 1.777 . . . . 0.0 110.217 165.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 -49.07 6.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -72.61 -18.4 61.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.442 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.629 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -61.33 -37.67 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.59 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 24.3 tptp -60.94 -30.57 70.3 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.132 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -60.13 -53.24 60.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.952 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 77' ' ' LEU . . . -74.11 -33.98 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.587 0.708 . . . . 0.0 111.422 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -74.62 -37.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.414 -171.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.62 -44.42 11.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.054 0.454 . . . . 0.0 110.831 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.8 80.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.72 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.2 -61.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.791 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.369 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.449 ' CG2' ' HE3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.341 0 CA-C-O 121.4 0.619 . . . . 0.0 110.417 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.4 148.13 43.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.818 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.415 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -114.39 114.26 25.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.146 174.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.509 ' H ' HD23 ' A' ' 55' ' ' LEU . 20.0 m-85 -67.68 163.74 20.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.036 0.446 . . . . 0.0 110.076 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -130.23 -13.09 3.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.259 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.709 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 70.6 p -135.48 152.68 51.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.56 -27.22 68.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.615 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 p -68.8 -36.73 78.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.061 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.709 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 24.7 mm-40 -63.03 -46.72 86.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 109.778 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 3.8 t80 -63.16 -45.92 89.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.127 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.98 -49.33 76.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.858 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -66.68 -36.48 82.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.415 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.39 -52.16 55.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.792 0.329 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.79 -19.9 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.09 -9.02 59.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.708 0.289 . . . . 0.0 111.625 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -75.88 146.52 39.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.643 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.426 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 38.2 t70 -72.98 8.97 1.3 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.293 0.568 . . . . 0.0 111.827 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -111.53 178.34 4.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.026 0.441 . . . . 0.0 111.065 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.49 ' CD2' ' HD2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -76.06 108.07 8.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.768 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 14' ' ' ALA . 65.7 t -111.06 106.84 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.504 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.22 109.23 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.616 0.722 . . . . 0.0 111.128 175.263 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG22 HG13 ' A' ' 21' ' ' VAL . 92.9 t -102.47 143.48 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.747 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 26' ' ' TYR . . . -127.12 138.1 53.11 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.196 0.522 . . . . 0.0 111.715 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -101.04 103.38 14.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.516 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.658 ' CZ ' HD13 ' A' ' 36' ' ' ILE . 7.5 m-85 -128.22 178.4 6.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.759 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . . . -154.97 137.73 15.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.274 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -72.36 -6.04 40.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.417 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 13.7 p-90 -106.29 19.56 20.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.299 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.935 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -122.69 132.97 54.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.629 0.728 . . . . 0.0 110.965 178.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.46 88.84 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.628 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.935 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 22.2 Cg_exo -65.44 -31.81 50.94 Favored 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 120.29 2.045 . . . . 0.0 109.868 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.596 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 63.7 m -54.3 -41.13 68.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.154 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.675 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -62.98 -57.03 12.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.923 -178.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 ptm -55.55 -48.14 75.24 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -173.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.658 HD13 ' CZ ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.89 -23.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.99 -177.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -55.19 -49.63 91.22 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.91 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 11.0 Cg_exo -72.98 -29.74 11.68 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 120.718 1.292 . . . . 0.0 111.849 171.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.7 mmt -66.49 -60.32 2.84 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.2 mt -62.68 -30.68 49.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.156 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 27.9 tt0 -50.03 -48.22 52.86 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.066 0.46 . . . . 0.0 110.361 172.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -65.5 -41.97 92.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.598 0.714 . . . . 0.0 110.023 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.669 ' HA ' ' CG ' ' A' ' 46' ' ' GLN . 7.3 m-30 -63.89 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.302 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 1.006 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 4.0 m -74.47 -23.16 58.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.36 -20.51 51.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.554 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.669 ' CG ' ' HA ' ' A' ' 43' ' ' PHE . 17.2 pt20 -112.9 22.89 13.98 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' CE1' HD12 ' A' ' 99' ' ' ILE . 8.4 m-30 -100.44 100.29 11.77 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 163.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 14.1 Cg_exo -70.04 -44.72 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.769 1.646 . . . . 0.0 111.891 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -2.71 15.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -106.08 142.85 35.09 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.885 -0.509 . . . . 0.0 110.795 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.32 126.12 42.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.502 0.668 . . . . 0.0 111.301 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 1.006 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.7 OUTLIER -105.36 114.18 28.2 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.782 -173.213 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.6 142.09 50.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 110.74 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.99 119.55 27.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 5' ' ' PHE . 5.1 mt -101.73 161.81 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.273 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -102.8 115.05 29.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.628 0.728 . . . . 0.0 109.093 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -13.62 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.296 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.14 -35.12 79.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.185 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -96.84 -35.64 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.682 172.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.5 HD12 HG21 ' A' ' 63' ' ' VAL . 1.9 mm? -97.83 42.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.761 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.597 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -74.72 -40.81 36.42 Favored Glycine 0 CA--C 1.504 -0.628 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.694 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.64 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 9.7 p-10 -64.3 -34.59 78.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG21 HD12 ' A' ' 60' ' ' LEU . 87.8 t -65.31 -43.18 95.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.127 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.991 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 83.2 mm-40 -72.76 -36.31 67.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.3 mttm -61.6 -34.72 76.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.69 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -100.82 16.97 23.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 54.34 47.3 23.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.86 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.5 t -98.61 116.4 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.132 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 p -118.87 0.41 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.93 124.63 35.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 154.91 42.16 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.36 168.82 71.05 Favored 'Cis proline' 0 CA--C 1.533 0.43 0 C-N-CA 124.018 -1.243 . . . . 0.0 111.88 -6.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 m -137.26 128.35 27.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.511 -169.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.512 ' HB2' HD22 ' A' ' 91' ' ' ASN . 3.8 mm? -115.98 108.61 16.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.077 0.465 . . . . 0.0 110.357 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 20.1 mt -123.95 113.69 18.8 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.26 125.42 35.49 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.31 177.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 83.8 m-85 -110.47 148.11 32.73 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.119 -177.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HD2' ' CD2' ' A' ' 20' ' ' LEU . 8.5 mtpm? -146.2 126.16 13.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 10.8 p30 45.7 29.2 0.64 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.451 1.1 . . . . 0.0 112.733 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.03 17.03 73.31 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.188 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 31.6 pttt -114.75 -1.26 13.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.414 0.626 . . . . 0.0 109.531 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 42.6 mt-10 75.48 -172.55 0.11 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.356 -175.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' A' ' 77' ' ' LEU . 1.4 p -162.3 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.619 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -153.26 162.42 41.32 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.796 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.2 tmtp? -144.64 109.18 4.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.937 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.2 t -121.51 143.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.31 89.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.686 0.755 . . . . 0.0 111.596 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.0 62.96 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.923 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 50.68 81.27 0.07 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.639 0.376 . . . . 0.0 111.582 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 17.4 p-10 -117.71 88.0 28.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -172.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 2.6 Cg_endo -79.53 -34.42 1.04 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.762 1.641 . . . . 0.0 110.543 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.11 -44.63 10.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.39 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . . . -72.48 -17.02 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.455 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.697 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.0 tp -56.16 -39.4 58.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HD3' ' CG2' ' A' ' 99' ' ' ILE . 15.6 mmtt -59.71 -36.79 77.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.664 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -52.16 -57.36 9.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.859 174.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.35 -30.1 60.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.55 -39.63 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.679 -170.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.424 ' N ' HG22 ' A' ' 99' ' ' ILE . . . -86.42 -31.59 21.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.971 0.415 . . . . 0.0 110.452 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.83 62.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.209 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -98.06 -67.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.704 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.718 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.548 HG23 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.247 0.546 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.4 ' N ' HG21 ' A' ' 2' ' ' VAL . 0.9 OUTLIER -82.86 147.81 28.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.152 -176.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -98.68 134.42 41.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.905 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.63 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.0 m-85 -90.95 141.85 28.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -97.16 -14.84 21.22 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.715 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 62.6 p -132.58 153.13 51.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.94 0.4 . . . . 0.0 111.241 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.488 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -62.33 -28.66 69.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 172.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 t -66.19 -37.73 86.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.378 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.4 mm-40 -58.54 -49.15 78.44 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.424 0.631 . . . . 0.0 110.257 176.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.9 -44.9 88.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.992 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.81 -46.57 84.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -65.43 -33.69 76.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.147 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.14 -49.51 43.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.425 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 31.5 pt -67.93 -15.09 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.595 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.27 -8.33 58.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 0.0 111.171 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.5 mt-30 -76.35 153.89 35.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.571 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 20.2 t70 -68.47 2.56 2.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.554 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 17' ' ' GLN . 4.0 ptpt -109.45 -179.51 3.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.638 0.732 . . . . 0.0 111.507 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.579 ' HG ' ' HB3' ' A' ' 103' ' ' ALA . 1.3 tm? -86.53 114.15 23.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.659 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.1 t -118.77 111.17 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.1 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.471 ' HB ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -105.64 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.558 0.694 . . . . 0.0 111.058 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.625 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 22.6 t -111.4 143.45 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.329 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.49 ' HB2' ' HG2' ' A' ' 54' ' ' LYS . . . -120.49 123.94 44.19 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.2 m-85 -70.47 130.43 41.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.658 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -136.45 -178.19 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.349 -164.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -167.91 157.19 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.102 173.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -84.9 -5.34 59.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 111.256 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -117.31 42.28 2.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.93 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -144.07 123.47 13.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.575 0.702 . . . . 0.0 112.002 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.46 -44.13 98.0 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.438 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.26 -40.06 79.22 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 119.868 1.834 . . . . 0.0 111.232 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.582 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 22.9 m -56.86 -37.83 71.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 60.2 tttm -63.2 -53.54 51.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.897 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.653 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptp -60.34 -48.07 83.35 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.588 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.6 -18.6 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.435 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -57.48 -48.82 96.63 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.189 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.721 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.3 Cg_exo -72.55 -30.15 12.48 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.225 1.283 . . . . 0.0 111.878 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 35' ' ' MET . 24.8 mmt -64.47 -60.0 3.67 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.755 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.433 HD12 ' CG1' ' A' ' 36' ' ' ILE . 30.4 mt -65.4 -20.8 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 111.297 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 29.4 tt0 -59.68 -46.93 87.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.494 0.664 . . . . 0.0 109.692 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -64.98 -45.88 83.8 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.773 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.6 m-30 -63.71 -25.03 68.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.67 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.801 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 87.4 p -76.36 -19.67 57.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -83.08 -16.1 48.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.982 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.672 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -120.36 28.24 8.13 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 14.0 m-30 -101.07 100.44 13.11 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.493 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.28 -43.41 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 121.944 1.763 . . . . 0.0 112.623 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -95.93 -22.94 17.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 111.947 -173.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . . . -102.74 149.55 24.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.439 0.638 . . . . 0.0 110.879 -172.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.9 m-20 -104.3 133.27 49.48 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.752 176.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.801 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.7 p90 -110.39 116.28 31.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.628 -169.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 20.4 m-85 -137.33 158.47 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.18 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.658 ' HD2' ' CE1' ' A' ' 26' ' ' TYR . 10.4 mtmp? -141.36 127.38 19.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.718 0.294 . . . . 0.0 110.75 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.63 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 56.8 mt -95.49 129.14 42.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.218 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.69 119.25 18.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 166.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.27 -11.87 12.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.573 -173.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.22 -46.32 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.486 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.97 -31.8 31.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.062 0.458 . . . . 0.0 110.16 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.614 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.2 mm? -103.0 52.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.651 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.96 -40.83 20.02 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.414 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 26.4 t70 -64.35 -49.08 73.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.537 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -60.59 -38.25 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.392 . . . . 0.0 110.27 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.97 85.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.139 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -74.13 -34.94 64.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.421 . . . . 0.0 110.546 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 45.3 mtmt -61.99 -35.63 79.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.906 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -97.87 14.16 28.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.45 38.47 25.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.967 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.404 HG21 ' CD2' ' A' ' 25' ' ' PHE . 84.7 t -82.68 127.03 40.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.3 p -125.06 -56.56 1.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.406 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 159.75 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.659 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.96 144.8 42.76 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 111.493 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 63.3 Cg_endo -75.84 167.71 79.44 Favored 'Cis proline' 0 C--O 1.237 0.467 0 C-N-CA 123.03 -1.654 . . . . 0.0 111.694 -10.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 46.9 m -124.25 116.86 23.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.419 ' HB2' HD22 ' A' ' 91' ' ' ASN . 4.1 mm? -103.47 108.98 20.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.264 -174.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 33.3 mt -124.05 113.95 19.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.471 HD23 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.39 130.24 40.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.627 174.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 47.7 m-85 -111.2 160.05 17.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.605 -175.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.545 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 14.6 tppt? -144.04 124.11 13.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.592 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.545 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 0.3 OUTLIER 35.39 48.74 0.43 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 18.59 59.88 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.691 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -125.37 7.38 7.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.976 0.388 . . . . 0.0 110.785 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.36 176.51 0.25 Allowed 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.774 0.671 . . . . 0.0 109.572 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.548 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -146.28 -34.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.942 0.401 . . . . 0.0 110.422 172.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.479 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -158.86 161.18 36.82 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.514 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.6 tttt -140.97 122.22 14.81 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.13 136.51 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.2 88.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.752 0.787 . . . . 0.0 111.504 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.89 62.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.767 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 58.81 94.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.937 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 16.9 p-10 -132.93 80.12 61.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.439 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 2.8 Cg_exo -73.82 -41.08 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.367 1.378 . . . . 0.0 111.149 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.19 -39.72 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.113 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 91' ' ' ASN . . . -72.0 -17.57 62.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.269 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.1 tp -57.62 -38.1 62.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 20.4 mmtp -57.56 -36.95 72.32 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.796 0.685 . . . . 0.0 110.621 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -53.29 -57.05 11.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.88 175.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.39 -36.59 63.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.553 0.692 . . . . 0.0 110.818 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.37 -40.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.853 -171.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.09 -34.94 18.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.814 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.22 -35.29 68.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 50.5 m-80 -98.44 -59.82 1.67 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.507 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.579 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.047 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.419 0.628 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.62 145.44 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.917 -176.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.457 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -103.44 122.9 45.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.592 174.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 7.2 m-85 -76.07 165.84 24.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.009 0.433 . . . . 0.0 110.168 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -116.89 -30.0 5.85 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.528 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 19.4 p -127.2 145.27 50.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.004 0.43 . . . . 0.0 111.805 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.617 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -53.18 -40.41 64.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.766 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -61.03 -38.75 87.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.988 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 19.4 pt-20 -81.06 -22.03 39.58 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.817 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 3.3 t80 -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 168.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.449 ' HA ' HG12 ' A' ' 15' ' ' ILE . 4.8 m-20 -59.23 -38.66 80.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.151 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 t -66.46 -37.93 86.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -50.27 62.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 110.659 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.468 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 33.4 pt -69.97 -14.76 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.573 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.07 -6.19 59.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.95 0.405 . . . . 0.0 111.408 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.457 ' C ' ' H ' ' A' ' 19' ' ' LYS . 77.9 mt-30 -88.39 161.11 17.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.082 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 5.4 m-20 -76.44 27.81 0.12 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 17' ' ' GLN . 23.4 mtpp -108.05 178.06 4.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 122.069 0.938 . . . . 0.0 112.756 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.578 ' CD2' HG12 ' A' ' 84' ' ' VAL . 1.2 tm? -94.8 104.93 16.84 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.885 172.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.9 t -114.01 107.67 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.896 0.379 . . . . 0.0 110.96 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.482 ' HB ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -104.72 107.49 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.472 0.653 . . . . 0.0 110.728 175.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 27.0 t -108.95 133.02 55.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.793 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -108.54 122.41 47.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -74.12 127.84 33.97 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.118 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 2.3 m-85 -120.02 -171.46 2.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.145 -175.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.02 31.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.055 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.9 p -79.99 -4.81 54.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.166 0.508 . . . . 0.0 110.993 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -131.93 54.17 1.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.7 p -145.56 116.76 7.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.475 0.655 . . . . 0.0 112.257 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -66.47 -37.94 93.08 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.234 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 36' ' ' ILE . 31.6 Cg_exo -61.52 -35.32 82.66 Favored 'Trans proline' 0 C--N 1.36 1.18 0 CA-C-N 120.233 2.016 . . . . 0.0 111.408 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.65 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 57.1 m -54.6 -38.81 67.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.242 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.718 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.1 tptm -63.75 -54.81 29.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.675 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.0 ptp -59.98 -48.63 80.93 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.603 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.07 -16.29 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.207 -178.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -56.62 -50.31 88.62 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.787 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.718 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.4 Cg_exo -71.83 -31.4 12.92 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.1 1.2 . . . . 0.0 111.871 171.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 94.6 mmm -63.91 -59.46 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.161 -0.615 . . . . 0.0 112.006 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.41 HD12 HG13 ' A' ' 36' ' ' ILE . 53.4 mt -67.18 -19.4 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.03 -0.419 . . . . 0.0 111.428 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.3 tt0 -64.48 -43.29 94.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.478 0.656 . . . . 0.0 109.39 168.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 15.5 tttm -63.6 -39.76 95.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.681 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.2 m-30 -74.45 -15.16 60.91 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.741 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.795 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 25.1 p -74.71 -18.14 60.55 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -84.86 -21.75 29.67 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.899 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.681 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 6.5 mt-30 -95.98 5.48 51.1 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.488 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 3.8 m-30 -104.17 98.61 14.35 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.642 172.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 6.6 Cg_exo -73.83 -43.8 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.28 1.986 . . . . 0.0 112.201 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -108.52 -13.61 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.3 163.45 12.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.125 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.23 135.82 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.046 0.927 . . . . 0.0 112.568 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.795 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.8 p90 -115.02 116.94 29.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.468 -171.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 22.0 m-85 -136.33 158.64 43.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.638 ' HD2' ' CE1' ' A' ' 26' ' ' TYR . 10.3 mtmp? -142.58 129.49 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 110.969 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.657 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 18.2 mt -107.01 176.91 5.02 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.525 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 6.7 p-10 -131.24 130.49 42.95 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 26' ' ' TYR . 32.7 m -69.29 -8.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.71 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.06 -40.91 74.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.333 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -101.24 -28.11 12.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.666 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.643 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.9 mm? -101.11 53.66 0.84 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.01 -43.07 23.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.127 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 13.2 t70 -66.3 -45.61 79.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.861 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.643 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -61.42 -39.22 82.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.112 0.482 . . . . 0.0 110.142 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.62 -36.93 72.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.103 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 12.0 mm-40 -79.02 -31.51 44.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 38.5 mtmt -62.56 -37.4 86.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.0 110.458 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -96.0 8.17 44.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.21 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 55.44 45.96 24.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.892 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.482 HG13 ' OG1' ' A' ' 74' ' ' THR . 69.6 t -69.71 124.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.814 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -139.33 31.29 2.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.044 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.08 152.62 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.5 112.43 32.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.06 172.72 30.95 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.921 -0.866 . . . . 0.0 112.275 -0.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.482 ' OG1' HG13 ' A' ' 69' ' ' VAL . 92.3 m -120.31 115.89 24.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -102.39 108.65 20.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.826 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.515 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 30.7 mt -125.43 113.05 17.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.485 ' O ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -94.16 122.06 36.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.022 174.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 42.2 m-85 -106.85 152.89 23.28 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.457 -174.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 87.1 tttt -138.71 122.05 17.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.801 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.473 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.68 44.28 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.146 0.979 . . . . 0.0 112.67 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 17.41 57.46 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.206 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -116.43 -5.33 11.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.089 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 22.9 tt0 75.06 168.85 0.29 Allowed 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.648 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.578 HG12 ' CD2' ' A' ' 20' ' ' LEU . 1.2 p -136.66 -33.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.84 163.91 34.06 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.74 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.515 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.3 tttt -143.13 125.1 15.21 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.401 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.5 t -131.13 130.5 63.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.97 82.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.44 -170.44 35.1 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.791 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . . . -70.31 93.83 0.88 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 26.8 p-10 -121.77 67.33 21.91 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.5 -35.21 13.85 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 120.915 1.077 . . . . 0.0 110.743 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.62 -39.87 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.074 177.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . . . -76.25 -17.86 59.29 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.462 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.697 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.3 tp -57.3 -40.06 71.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 12.3 mmmm -57.94 -34.76 70.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.799 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.47 -58.14 8.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.21 64.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.635 0.731 . . . . 0.0 110.952 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -81.16 -38.94 17.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.483 -169.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.46 -36.78 18.86 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.377 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.84 68.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.277 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.9 m-80 -92.7 -65.05 1.03 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.574 -0.85 . . . . 0.0 112.477 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.522 ' CB ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.787 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.618 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.33 0.586 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.99 147.56 26.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.313 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.97 137.34 38.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.111 171.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.641 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 9.7 m-85 -90.71 137.96 31.95 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.222 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -90.74 -24.95 20.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.394 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.481 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.1 p -131.67 153.3 50.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.764 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.508 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.63 -34.42 71.16 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 t -62.81 -34.04 76.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.741 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.481 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 20.0 mm-40 -62.58 -49.18 76.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.353 0.596 . . . . 0.0 109.884 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.426 ' O ' HG12 ' A' ' 15' ' ' ILE . 1.7 t80 -62.91 -47.06 84.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.107 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.06 -44.1 78.58 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.346 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 m -70.1 -40.44 74.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.46 67.99 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.821 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.14 -20.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.174 -176.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.34 61.53 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.917 0.389 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.452 ' C ' ' H ' ' A' ' 19' ' ' LYS . 46.6 mt-30 -68.24 150.99 47.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.073 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.9 32.89 0.26 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.82 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.7 ptmt -135.57 173.62 11.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.29 -176.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -75.13 112.71 11.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.598 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.37 107.97 20.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.752 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.31 109.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.047 0.927 . . . . 0.0 111.622 176.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 39.5 t -105.02 144.31 14.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.072 177.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 74' ' ' THR . . . -129.51 122.64 29.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CE2' HD11 ' A' ' 55' ' ' LEU . 72.9 m-85 -72.89 115.91 12.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.414 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.706 ' CZ ' HD13 ' A' ' 36' ' ' ILE . 8.5 m-30 -121.91 -178.34 3.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 123.369 0.418 . . . . 0.0 110.358 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.62 34.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.689 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.48 -4.43 58.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.214 0.531 . . . . 0.0 111.139 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -126.16 47.2 2.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.077 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 p -143.1 126.39 16.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.53 0.681 . . . . 0.0 111.728 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.9 -40.44 98.35 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.21 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.724 ' O ' HG22 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -63.08 -38.65 44.46 Favored 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 120.272 2.036 . . . . 0.0 110.921 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 20.5 m -58.46 -31.22 67.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.581 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 87.2 tttt -67.94 -57.03 6.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.491 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 ptp -64.95 -44.38 89.62 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.235 0.54 . . . . 0.0 112.431 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.96 -13.73 14.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 C-N-CA 118.441 -1.304 . . . . 0.0 110.401 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -56.5 -52.35 74.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.085 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 19.8 Cg_endo -64.63 -32.63 57.75 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 120.955 1.103 . . . . 0.0 112.574 169.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.497 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 23.5 mmt -66.92 -55.57 14.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.014 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.803 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -49.0 -38.56 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.599 0.36 . . . . 0.0 110.529 175.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.35 -48.1 79.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 110.692 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -60.0 -51.77 68.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.975 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.0 m-85 -64.09 -19.57 65.34 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.17 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.476 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.1 p -83.6 -22.13 32.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -83.82 -20.99 32.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.656 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.644 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -107.85 16.38 23.59 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.745 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 13.9 m-30 -100.62 101.81 16.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.486 167.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.14 -40.88 2.94 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 121.88 1.72 . . . . 0.0 112.851 174.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -107.73 -16.0 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.09 146.74 27.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 110.88 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 2.2 m-20 -101.01 135.51 42.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.859 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.803 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -113.52 124.52 52.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.607 -177.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.522 ' C ' ' HE2' ' A' ' 54' ' ' LYS . 42.1 m-85 -135.79 147.58 48.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.618 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 8.2 mmpt? -117.23 142.43 47.06 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.641 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 60.6 mt -107.13 142.49 36.73 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.149 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.32 102.48 14.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 167.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -60.26 -15.23 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -171.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.44 -21.8 57.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -108.65 -31.24 7.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.923 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -96.77 52.19 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.818 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.21 -40.73 19.22 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.061 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.605 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 6.3 m-20 -60.56 -49.74 76.34 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.419 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.7 p -62.83 -38.69 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.313 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.44 -35.03 73.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.071 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 55.7 mt-30 -76.27 -37.85 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.38 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 66.0 mttm -57.24 -39.46 75.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.812 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -95.0 6.55 48.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.912 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.84 48.78 17.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.925 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.09 121.13 35.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.688 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -123.27 -16.08 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.732 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.57 161.86 15.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 142.96 26.83 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.519 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 2.9 Cg_exo -78.33 165.31 83.05 Favored 'Cis proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.862 -1.308 . . . . 0.0 111.75 -8.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 86.8 m -123.38 116.84 23.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.433 HD11 ' HB1' ' A' ' 24' ' ' ALA . 4.2 mm? -108.13 108.61 19.74 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -174.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.603 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 18.2 mt -125.71 116.13 21.16 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.814 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -91.53 122.42 34.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.054 173.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 33.5 m-85 -105.46 156.48 18.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.808 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.3 ttpt -142.44 120.09 11.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.378 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.512 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.5 37.11 5.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.8 0.84 . . . . 0.0 111.901 -177.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.16 12.55 50.38 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.746 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 61.7 mttp -120.83 19.47 11.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.553 0.341 . . . . 0.0 110.142 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 10.2 pt-20 61.66 175.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.869 1.356 . . . . 0.0 112.128 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -148.75 -32.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.832 174.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.79 166.92 25.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.081 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.603 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.9 tttt -144.34 126.51 15.61 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.2 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 19.3 t -131.96 138.84 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 87.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.796 0.807 . . . . 0.0 111.593 -170.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.66 63.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.061 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.455 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.28 86.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.111 0.482 . . . . 0.0 111.78 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.546 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 14.5 p-10 -126.41 78.57 71.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' ILE . 14.5 Cg_exo -68.14 -45.39 2.91 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.448 1.432 . . . . 0.0 110.955 168.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.44 -35.43 18.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.096 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 91' ' ' ASN . . . -76.59 -17.55 59.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.46 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.0 tp -59.18 -38.94 77.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -61.83 -27.37 68.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.995 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.2 tm0? -59.6 -59.66 5.08 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.67 -29.2 64.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.712 0.768 . . . . 0.0 110.503 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.745 HG13 ' CZ ' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -77.62 -39.44 26.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.321 -171.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.2 -34.45 20.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.043 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.24 89.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.63 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 51.2 m-80 -97.33 -63.06 1.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.79 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.671 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.637 0.732 . . . . 0.0 109.709 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.2 145.84 55.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.659 -168.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.56 136.35 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.655 170.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.619 ' H ' HD21 ' A' ' 55' ' ' LEU . 16.6 m-85 -88.13 166.13 14.62 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -124.52 -10.29 7.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.464 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 60.1 p -134.44 150.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.68 0.276 . . . . 0.0 110.912 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.477 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.49 -33.68 70.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.3 t -65.73 -36.38 83.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.747 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 51.0 mm-40 -61.29 -44.74 96.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 7.5 t80 -67.55 -49.21 64.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.947 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -59.75 -37.55 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.69 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.4 t -68.29 -40.71 81.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.819 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -64.77 -50.48 66.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.43 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 35.3 pt -66.83 -18.82 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.499 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.44 -10.4 59.05 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.745 0.307 . . . . 0.0 111.589 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 54.8 mt-30 -76.09 153.3 36.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.344 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.4 37.75 0.34 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.86 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.9 ptmt -140.21 167.92 21.01 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.064 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.547 ' HG ' ' CB ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -71.71 107.94 4.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.436 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' A' ' 53' ' ' TYR . 70.2 t -107.55 107.08 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 110.35 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.516 ' HB ' HD21 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -99.0 105.55 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.412 0.625 . . . . 0.0 110.294 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 53.5 t -107.01 139.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.371 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' THR . . . -128.39 122.4 31.34 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CD2' HG21 ' A' ' 69' ' ' VAL . 52.4 m-85 -70.6 124.1 23.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.537 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.683 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.9 m-85 -120.01 -176.86 3.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.612 -174.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HB1' ' SG ' ' A' ' 30' ' ' CYS . . . -161.77 156.68 23.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.144 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -84.09 -4.33 58.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.771 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -120.73 21.97 11.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.44 ' SG ' ' HB1' ' A' ' 27' ' ' ALA . 3.8 p -119.55 150.99 39.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.515 0.674 . . . . 0.0 112.253 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.75 -48.61 4.89 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.803 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 35' ' ' MET . 50.7 Cg_exo -55.25 -47.5 25.83 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.253 1.969 . . . . 0.0 112.307 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.9 p -51.07 -36.8 41.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.257 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.702 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 67.4 mttm -66.46 -50.31 63.76 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 123.212 0.32 . . . . 0.0 111.247 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 22.6 ptp -64.88 -44.7 88.81 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.424 0.631 . . . . 0.0 112.311 -175.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.695 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.0 -16.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.605 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.09 -55.26 47.14 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.909 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.702 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.7 Cg_endo -63.96 -30.42 67.0 Favored 'Trans proline' 0 C--N 1.358 1.054 0 CA-C-N 120.424 1.187 . . . . 0.0 112.1 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 25.4 mmt -65.98 -55.37 17.12 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.291 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.539 ' CG2' ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -57.11 -38.08 58.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.87 175.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -52.48 -47.34 66.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.0 0.429 . . . . 0.0 109.958 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.33 -47.88 83.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.671 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 7.9 m-30 -67.05 -15.34 63.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.075 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.776 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 5.7 m -86.62 -13.71 44.87 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.23 -15.21 31.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.681 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.671 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -126.59 35.66 4.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.23 177.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.453 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -104.31 72.52 0.19 Allowed Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 172.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 88.9 Cg_exo -45.88 -45.64 16.88 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.945 2.43 . . . . 0.0 115.161 -166.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.69 8.53 19.02 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -103.16 165.09 11.23 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.82 -0.55 . . . . 0.0 111.573 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.98 123.37 41.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.776 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.76 124.95 35.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 10.6 m-85 -143.04 136.29 28.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.366 168.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HD3' ' CG2' ' A' ' 40' ' ' ILE . 27.5 mtmt -134.0 120.3 20.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.683 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 4.7 mt -93.11 162.22 14.12 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.646 -167.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.19 108.63 21.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -61.14 -14.42 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.451 -175.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.87 -39.12 93.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -99.68 -32.14 11.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.568 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.99 47.25 1.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.9 -42.13 17.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.789 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 31.1 t70 -65.27 -44.17 88.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 110.956 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.568 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -63.7 -39.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.204 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.79 77.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.5 mm-40 -71.51 -34.34 70.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.928 0.394 . . . . 0.0 110.438 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 40.1 mtmt -61.25 -38.73 87.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.648 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -95.08 15.29 19.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.884 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.6 40.94 26.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.812 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 25' ' ' PHE . 86.4 t -88.9 113.38 25.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.15 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -116.06 -11.41 11.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.37 165.25 12.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.618 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.11 141.71 17.54 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.859 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.449 ' HG3' HD13 ' A' ' 36' ' ' ILE . 60.8 Cg_endo -75.28 163.41 90.62 Favored 'Cis proline' 0 C--O 1.234 0.301 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.795 -10.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.8 m -126.65 118.79 25.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.508 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.3 mt -110.34 107.65 17.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.379 0.609 . . . . 0.0 111.6 -172.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD22 ' HG3' ' A' ' 86' ' ' LYS . 18.9 mt -123.72 113.36 18.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.265 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.33 129.15 43.73 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.841 178.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 59.8 m-85 -112.27 154.09 26.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.441 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -136.52 117.54 14.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.393 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.55 43.83 2.4 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.065 0.853 . . . . 0.0 112.67 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.73 11.12 59.72 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.399 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -111.97 -0.32 15.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 32.9 tt0 69.79 172.77 0.3 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.137 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.46 -33.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.239 172.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -156.11 161.44 40.37 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.505 ' HG3' HD22 ' A' ' 76' ' ' LEU . 41.3 tttp -141.83 110.99 6.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.868 177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 t -123.58 135.1 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.23 82.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.951 0.881 . . . . 0.0 111.654 -168.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.5 64.27 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.235 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.433 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 54.78 83.85 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.021 0.438 . . . . 0.0 111.943 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 12.7 p-10 -125.02 83.99 59.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 95' ' ' ILE . 10.8 Cg_exo -74.15 -36.95 2.94 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.753 1.635 . . . . 0.0 111.654 168.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.3 -41.84 12.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 111.104 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.89 -17.37 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.603 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.5 tp -59.63 -38.16 74.28 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.284 171.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 26.7 mmmt -59.53 -32.99 70.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.725 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -54.67 -61.24 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.2 71.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.403 0.62 . . . . 0.0 111.649 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -68.74 -43.23 83.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.707 -171.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.424 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -88.47 -44.17 10.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.909 0.385 . . . . 0.0 111.567 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.11 74.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.485 -175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 56.8 m-80 -92.65 -63.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.003 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.547 ' CB ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.711 -0.661 . . . . 0.0 111.502 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.34 0 CA-C-O 121.323 0.582 . . . . 0.0 110.758 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -98.53 147.83 24.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.072 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -102.52 126.6 49.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 171.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.67 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 15.7 m-85 -80.42 157.39 26.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -113.05 -13.96 13.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.227 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -137.27 151.24 48.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.766 0.317 . . . . 0.0 111.126 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.64 67.42 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -63.58 -38.13 89.96 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.231 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 27.4 mm-40 -61.58 -43.14 99.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.468 0.652 . . . . 0.0 109.772 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.433 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 4.4 t80 -68.15 -49.16 62.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.373 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -59.78 -46.06 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 0.0 111.438 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 m -68.68 -25.78 64.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 21' ' ' VAL . . . -75.11 -51.6 13.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.826 0.346 . . . . 0.0 110.555 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.481 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.4 pt -65.22 -19.32 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.617 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.18 59.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.623 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -71.43 160.22 33.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.975 0.417 . . . . 0.0 110.861 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.493 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 4.8 m-20 -81.28 34.46 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.169 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -145.32 170.61 15.97 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.194 -174.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.563 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -72.16 105.44 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.02 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 14' ' ' ALA . 81.6 t -109.25 106.79 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.736 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.73 111.14 31.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.309 0.575 . . . . 0.0 111.116 175.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.667 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 44.8 t -110.69 131.15 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.294 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' THR . . . -109.32 110.82 22.09 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 55' ' ' LEU . 72.0 m-85 -70.77 107.72 4.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -162.93 151.37 14.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.298 0.571 . . . . 0.0 112.32 -178.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB3' HG13 ' A' ' 57' ' ' VAL . . . -120.03 158.66 26.34 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.0 p -81.11 -3.41 51.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -77.11 -16.63 59.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -172.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -98.26 -176.33 3.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.01 -60.19 1.98 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.153 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.516 ' O ' HG22 ' A' ' 36' ' ' ILE . 82.0 Cg_exo -50.58 -49.22 17.32 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.968 2.445 . . . . 0.0 112.445 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.644 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 2.0 p -50.77 -36.94 39.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.692 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.705 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 39.8 ttpt -66.09 -54.32 27.22 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.06 0.225 . . . . 0.0 110.602 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.49 -45.99 91.91 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.25 -18.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.289 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.644 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -56.0 -56.38 31.31 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.128 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.705 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 33.4 Cg_endo -66.41 -32.16 41.13 Favored 'Trans proline' 0 C--N 1.359 1.127 0 CA-C-N 120.287 1.138 . . . . 0.0 112.492 171.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.53 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 33.2 mmt -64.27 -61.2 2.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.129 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.489 ' CG2' ' HD3' ' A' ' 54' ' ' LYS . 61.0 mt -64.41 -21.93 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.233 0.469 . . . . 0.0 111.647 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -61.96 -43.78 98.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 109.675 168.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -65.6 -40.63 92.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.531 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.67 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 15.2 m-85 -68.09 -17.95 64.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.177 0.513 . . . . 0.0 110.854 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 p -87.24 -11.48 49.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -83.23 -31.11 27.18 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.68 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 28.2 pt20 -109.27 33.24 4.41 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.234 -176.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -100.1 76.6 0.13 Allowed Pre-proline 0 CA--C 1.556 1.207 0 CA-C-O 121.496 0.665 . . . . 0.0 112.711 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 32.2 Cg_exo -58.21 -46.07 27.44 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.115 1.877 . . . . 0.0 114.242 -170.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.82 16.51 19.5 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -124.23 165.89 16.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.954 0.406 . . . . 0.0 111.486 -171.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 6.2 m-20 -115.59 131.89 56.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.427 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 1.6 m-85 -114.28 124.71 52.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.464 -173.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 m-85 -139.85 151.54 45.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 2' ' ' VAL . 38.1 mtmt -140.06 121.25 14.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.67 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 70.6 mt -78.42 141.02 38.63 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.506 -171.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.74 91.08 0.8 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 27' ' ' ALA . 2.3 p -59.53 -6.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -172.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.95 -32.97 15.77 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.48 -36.17 26.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.246 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.622 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.0 52.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.547 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.72 -40.29 22.59 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.04 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.4 m-20 -69.79 -38.53 76.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.455 0.169 . . . . 0.0 110.995 -177.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.622 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -68.96 -37.53 77.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.435 . . . . 0.0 110.41 176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.8 73.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.029 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.4 mt-30 -70.91 -34.75 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 52.7 mttp -59.46 -43.99 93.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.553 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -91.55 10.52 27.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.146 -174.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 58.27 48.68 12.22 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.498 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.503 HG13 ' OG1' ' A' ' 74' ' ' THR . 71.8 t -78.64 118.58 26.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.83 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -124.25 -58.83 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.19 127.63 32.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.333 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.5 134.91 19.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.334 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 64.9 Cg_endo -83.31 171.25 51.57 Favored 'Cis proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.855 -1.31 . . . . 0.0 112.035 -1.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.7 m -117.93 114.76 23.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.23 107.46 18.45 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.323 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.495 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.2 mt -126.25 112.7 16.04 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -87.14 116.89 25.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 70.3 m-85 -104.45 145.99 29.5 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.665 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mtpt -143.83 120.96 11.46 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.969 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 38.8 m-80 61.14 21.85 12.22 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.715 0.634 . . . . 0.0 110.809 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.06 12.3 65.07 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -111.59 5.57 19.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.4 tt0 70.36 177.17 0.27 Allowed 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.123 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 77' ' ' LEU . 1.4 p -157.12 -31.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.5 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . . . -159.32 164.29 34.94 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.82 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 66.7 tttt -148.61 122.88 9.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.594 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.49 132.24 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.78 79.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.299 0.571 . . . . 0.0 111.065 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.09 -172.86 35.88 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.487 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -67.36 100.98 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.4 p-10 -124.07 63.55 32.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 90' ' ' ALA . 8.7 Cg_exo -70.75 -31.35 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 120.963 1.109 . . . . 0.0 110.098 172.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.601 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.65 -47.12 8.15 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.257 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -69.43 -16.31 63.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -177.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.1 tp -53.56 -38.29 33.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.114 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 169.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 36.0 mmtt -55.07 -41.7 71.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.937 0.773 . . . . 0.0 110.798 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -51.17 -53.72 32.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.523 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.49 -30.56 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 111.762 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -76.05 -39.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.982 -172.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.408 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -86.86 -41.4 14.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.708 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.93 75.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.621 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 85' ' ' ALA . 35.4 m-80 -107.26 -73.1 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.879 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.883 0 O-C-N 123.983 0.802 . . . . 0.0 112.632 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 52' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.138 0.494 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.12 148.43 26.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.087 -175.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.29 122.68 47.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.317 171.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' H ' HD21 ' A' ' 55' ' ' LEU . 12.4 m-85 -76.16 164.06 26.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.193 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -121.61 -20.26 6.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 61.1 p -131.63 155.12 48.12 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.296 -0.253 . . . . 0.0 111.312 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.46 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.29 -36.09 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 t -57.71 -41.15 81.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.572 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 19.6 mm-40 -59.59 -43.53 93.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.125 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 7.4 t80 -67.07 -53.2 33.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.437 ' HA ' HG12 ' A' ' 15' ' ' ILE . 10.9 m-20 -61.49 -37.19 82.76 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 111.781 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.822 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 21' ' ' VAL . . . -69.14 -48.55 62.09 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.0 110.579 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 34.2 pt -67.02 -20.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.97 -8.6 59.43 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.084 0.468 . . . . 0.0 111.306 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -75.73 152.58 37.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.889 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 2.3 m-20 -80.37 35.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.102 0.477 . . . . 0.0 111.634 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 4.4 ptpt -134.7 -179.06 5.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 0.0 111.346 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' CD2' HG11 ' A' ' 84' ' ' VAL . 1.3 tm? -84.36 108.26 17.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.445 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.771 HG11 ' CE1' ' A' ' 53' ' ' TYR . 78.3 t -112.88 106.92 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.019 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.34 106.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.341 0.591 . . . . 0.0 110.952 176.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 59.3 t -106.23 136.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.634 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 75' ' ' LEU . . . -118.1 115.45 24.85 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.161 0.505 . . . . 0.0 110.249 170.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.506 ' CD2' HG22 ' A' ' 69' ' ' VAL . 98.5 m-85 -70.06 109.96 4.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CZ ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.78 159.24 31.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -163.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.53 135.88 21.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.159 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -83.88 -5.7 59.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -170.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -89.28 57.59 4.1 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.9 p -157.41 -176.72 6.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.26 -53.04 3.22 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.205 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.419 ' O ' ' HG2' ' A' ' 35' ' ' MET . 87.9 Cg_exo -49.07 -43.0 37.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.561 2.174 . . . . 0.0 112.075 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.491 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -58.13 -35.17 71.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -62.4 -46.55 88.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.628 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.62 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.7 ptm -77.26 -45.92 24.8 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.643 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -75.79 -23.31 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.439 -176.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.06 -49.53 91.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.092 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 35' ' ' MET . 23.3 Cg_exo -66.67 -38.3 18.81 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.498 1.465 . . . . 0.0 112.442 171.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -63.94 -58.29 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.423 HG13 ' CG1' ' A' ' 36' ' ' ILE . 12.9 mm -56.21 -33.61 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.91 -49.17 78.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.248 0.547 . . . . 0.0 110.328 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -62.93 -47.33 83.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.262 0.553 . . . . 0.0 110.144 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.656 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.0 m-30 -64.52 -17.57 64.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.842 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.407 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.3 p -86.49 -13.37 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.873 0.844 . . . . 0.0 108.828 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -88.77 -19.35 26.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.328 169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.656 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -125.26 33.1 5.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.753 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -110.26 82.94 2.86 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-O 121.752 0.787 . . . . 0.0 111.659 169.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.13 -46.29 29.15 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.864 2.376 . . . . 0.0 114.561 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -112.71 6.33 18.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -105.63 165.08 11.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.954 -0.466 . . . . 0.0 110.743 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 1.0 OUTLIER -131.45 123.23 27.67 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.71 177.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.753 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.2 m-85 -92.24 131.74 37.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.771 ' CE1' HG11 ' A' ' 21' ' ' VAL . 7.4 m-85 -130.82 135.3 47.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.298 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.57 120.78 31.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.599 HD21 ' H ' ' A' ' 5' ' ' PHE . 5.9 mt -99.99 168.42 9.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.383 -171.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.69 104.08 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.991 0.9 . . . . 0.0 108.824 169.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -10.73 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.243 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.03 -33.84 65.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.081 0.467 . . . . 0.0 109.993 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -94.61 -36.39 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.903 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.573 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mm? -97.97 47.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.058 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.17 -39.12 27.94 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.886 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.44 -45.24 88.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.3 p -66.91 -37.76 80.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.112 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.3 mt-30 -62.8 -34.03 76.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -24.97 61.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.7 9.54 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.998 0.428 . . . . 0.0 110.84 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 59.06 45.28 14.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.653 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.506 HG22 ' CD2' ' A' ' 25' ' ' PHE . 72.5 t -74.74 117.3 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.908 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -133.24 -0.05 3.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.408 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.69 164.86 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 111.056 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.9 mtm -124.21 111.47 28.5 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.012 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.529 ' CB ' ' HE1' ' A' ' 26' ' ' TYR . 4.0 Cg_exo -77.63 170.32 71.27 Favored 'Cis proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.583 -5.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.416 ' OG1' HG12 ' A' ' 69' ' ' VAL . 77.1 m -115.29 112.38 22.32 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 158.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.554 ' CD2' ' HB1' ' A' ' 24' ' ' ALA . 6.0 mt -118.63 107.94 14.32 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.741 -167.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 5.4 mt -125.26 112.46 16.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.197 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.92 130.21 38.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.631 176.117 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 46.1 m-85 -111.11 154.15 24.69 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.143 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 27.8 ttpp -137.4 113.88 10.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.824 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.51 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 43.62 46.27 6.06 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.17 0.918 . . . . 0.0 111.941 -177.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 7.09 52.49 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.647 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.73 9.4 16.38 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 122.436 -0.449 . . . . 0.0 110.612 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.8 tt0 66.8 173.0 0.25 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.776 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.495 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.5 p -146.96 -32.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.728 0.299 . . . . 0.0 110.36 172.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.431 ' HB1' ' HG ' ' A' ' 77' ' ' LEU . . . -158.16 162.04 37.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.131 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.3 tmtp? -143.33 107.8 4.82 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.77 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.68 143.91 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -155.71 84.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.614 0.721 . . . . 0.0 111.74 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.09 81.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.644 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.507 ' HA ' ' CD ' ' A' ' 73' ' ' PRO . . . 45.13 74.76 0.12 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.05 0.54 . . . . 0.0 111.867 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 20.0 p-10 -123.59 75.53 54.69 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -171.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.577 ' O ' ' HE2' ' A' ' 43' ' ' PHE . 7.7 Cg_exo -74.07 -37.01 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.358 1.372 . . . . 0.0 110.4 166.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -87.4 -41.65 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.03 -17.78 60.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.517 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -63.14 -36.08 74.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 118.697 -1.201 . . . . 0.0 108.17 170.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.634 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 1.8 mmmp? -58.62 -33.73 70.36 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.389 0.431 . . . . 0.0 110.634 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -57.23 -54.95 40.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.63 173.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.465 ' HB1' HD13 ' A' ' 77' ' ' LEU . . . -71.81 -47.23 54.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.671 . . . . 0.0 111.229 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -61.44 -49.03 86.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.737 -172.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.549 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -88.35 -33.96 17.78 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -170.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.2 38.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.749 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -88.63 -54.65 4.06 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.195 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.433 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.535 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.2 m . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.519 ' CG2' ' HD2' ' A' ' 53' ' ' TYR . 1.3 m -74.03 144.76 44.96 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -111.63 118.56 36.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.595 172.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.608 ' H ' HD23 ' A' ' 55' ' ' LEU . 12.6 m-85 -71.22 163.37 27.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 110.063 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -112.33 -25.01 9.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.762 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.602 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 27.1 p -138.58 159.37 42.25 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -54.42 -39.29 67.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -53.67 -38.82 64.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.141 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.602 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 70.8 mm-40 -64.83 -50.46 66.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.519 0.675 . . . . 0.0 109.951 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 9.3 t80 -62.28 -48.1 81.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.497 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HA ' HG12 ' A' ' 15' ' ' ILE . 7.2 m-20 -58.87 -35.34 72.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.349 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -74.64 -29.27 61.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.52 -39.56 24.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.172 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 12' ' ' ASP . 43.8 pt -66.99 -22.28 29.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.698 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.77 -9.8 59.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.977 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.423 ' C ' ' H ' ' A' ' 19' ' ' LYS . 96.9 mt-30 -67.97 149.4 49.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.324 . . . . 0.0 110.507 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.31 39.19 0.31 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.214 0.53 . . . . 0.0 110.87 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.0 ptmt -147.32 173.75 12.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.817 -177.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.565 ' CD2' HG13 ' A' ' 84' ' ' VAL . 1.3 tm? -76.43 110.89 11.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.286 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.658 ' CG1' ' HB2' ' A' ' 78' ' ' PHE . 3.8 p -95.29 130.7 43.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.564 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -122.63 101.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.71 0.766 . . . . 0.0 109.71 169.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.626 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 57.7 t -109.12 143.28 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.874 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' A' ' 75' ' ' LEU . . . -124.28 120.51 32.41 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 83.7 m-85 -71.03 121.61 18.54 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.293 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.78 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 2.3 m-85 -119.99 177.78 4.86 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.127 0.489 . . . . 0.0 110.837 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.16 130.03 9.36 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 167.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -7.53 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 111.873 -174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -107.57 11.43 28.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.179 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.946 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -111.53 136.98 49.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.647 0.737 . . . . 0.0 111.649 -176.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.66 -41.46 50.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.589 -1.187 . . . . 0.0 114.325 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.946 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 16.5 Cg_exo -67.5 -27.96 38.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 CA-C-N 120.302 2.051 . . . . 0.0 110.441 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 58.9 m -55.26 -44.39 75.54 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.378 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.679 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 66.0 mttm -64.25 -51.33 64.12 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.561 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.662 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -62.05 -49.34 76.37 Favored 'General case' 0 C--O 1.252 1.185 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.04 -14.63 15.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.035 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -58.12 -49.68 92.26 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.971 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 24.5 Cg_exo -67.44 -35.1 24.46 Favored 'Trans proline' 0 C--N 1.36 1.156 0 CA-C-N 120.377 1.17 . . . . 0.0 111.645 169.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.445 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 97.1 mmm -62.36 -60.95 2.82 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.474 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.521 ' CG2' ' HD3' ' A' ' 54' ' ' LYS . 61.9 mt -65.07 -22.52 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.013 -0.429 . . . . 0.0 111.615 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.36 -46.67 85.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.522 0.677 . . . . 0.0 109.474 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 14.6 tptm -60.88 -37.17 81.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.694 0.759 . . . . 0.0 109.532 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.653 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 2.6 m-30 -76.76 -14.66 59.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.751 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.794 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 46.1 p -74.62 -16.13 60.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.48 -24.1 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.023 171.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.653 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 12.8 mm100 -76.35 -38.66 55.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.073 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' CE1' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -104.03 101.9 28.62 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.0 Cg_endo -83.89 -19.07 5.1 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.077 2.518 . . . . 0.0 111.599 169.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.46 -22.22 19.73 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 111.161 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -109.07 140.21 42.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.655 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.1 117.52 29.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.586 0.708 . . . . 0.0 111.643 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.794 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.3 p90 -89.11 115.04 26.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.698 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CE1' ' HB3' ' A' ' 51' ' ' ASP . 4.3 m-85 -133.41 150.7 51.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 171.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HD3' ' CG2' ' A' ' 40' ' ' ILE . 9.7 mtmp? -143.99 119.39 10.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.78 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 6.8 mt -97.37 158.58 15.39 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -168.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.02 113.22 26.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.203 0.525 . . . . 0.0 110.009 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.713 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.76 -14.53 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.3 -29.17 62.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.12 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -105.72 -18.96 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.721 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.9 mm? -106.87 45.28 0.99 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.28 0.562 . . . . 0.0 110.417 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -76.85 -34.01 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.415 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 2.9 m-20 -71.17 -43.53 67.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.51 0.195 . . . . 0.0 110.802 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.7 p -62.2 -39.74 85.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.76 81.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.161 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -71.46 -36.0 71.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.078 0.466 . . . . 0.0 110.496 -175.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 44.2 mtmt -62.45 -36.84 83.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.792 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.49 15.59 25.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.368 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 60.32 38.04 19.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.514 172.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.56 110.05 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.473 . . . . 0.0 111.008 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -109.6 -44.74 3.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.932 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.12 153.98 38.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.556 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.43 140.18 18.58 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.755 0.312 . . . . 0.0 110.317 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 72.9 Cg_endo -79.87 160.66 86.74 Favored 'Cis proline' 0 C--O 1.236 0.38 0 C-N-CA 123.276 -1.552 . . . . 0.0 112.629 -3.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 22.6 m -129.67 119.8 24.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.11 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.481 HD22 ' OD1' ' A' ' 91' ' ' ASN . 4.4 mm? -104.06 108.4 19.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.664 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -120.99 114.3 21.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.679 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -94.21 133.47 37.69 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.883 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.658 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 4.1 m-85 -117.53 156.03 28.76 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.436 -175.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.701 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 65.3 tttm -144.29 116.83 8.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.173 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.701 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.0 p30 45.66 36.22 2.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.198 0.999 . . . . 0.0 112.664 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.93 5.93 76.96 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.254 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -115.58 14.61 16.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.742 0.271 . . . . 0.0 110.849 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.6 tt0 67.67 173.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.414 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.565 HG13 ' CD2' ' A' ' 20' ' ' LEU . 1.6 p -148.99 -33.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.932 0.396 . . . . 0.0 110.039 172.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -155.82 162.86 40.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.596 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -146.29 110.89 5.16 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.032 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.1 t -122.51 125.92 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.79 84.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.697 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.1 78.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.743 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 51.29 80.86 0.08 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.7 p-10 -124.47 87.24 54.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.76 -38.89 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.523 1.482 . . . . 0.0 111.373 170.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.51 -44.55 10.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.913 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -68.68 -17.08 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.273 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.1 tp -58.69 -38.3 70.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 96' ' ' LYS . 12.8 mmmm -59.57 -36.25 75.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.162 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -51.91 -59.65 4.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.792 173.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -72.69 -36.22 67.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.345 0.593 . . . . 0.0 111.356 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.803 -171.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.434 ' N ' HG22 ' A' ' 99' ' ' ILE . . . -87.21 -32.75 19.62 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.852 0.358 . . . . 0.0 111.327 -172.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.53 48.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.792 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.56 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 66.9 m-80 -86.29 -53.99 4.7 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.802 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m -98.1 141.04 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.075 0.464 . . . . 0.0 109.916 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.9 148.08 25.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.905 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.439 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -111.92 120.08 40.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.817 174.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.562 ' H ' ' CD2' ' A' ' 55' ' ' LEU . 20.8 m-85 -73.43 164.41 26.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.219 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -116.23 -17.28 10.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.665 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.612 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 41.2 p -133.67 153.41 51.7 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.494 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.62 -31.37 66.17 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -60.91 -42.31 97.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.99 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.612 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.9 mm-40 -64.71 -42.68 95.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.391 0.615 . . . . 0.0 110.293 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.447 ' O ' HG12 ' A' ' 15' ' ' ILE . 5.3 t80 -66.42 -47.45 73.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.868 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.12 -47.7 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.408 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -68.93 -26.93 65.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.609 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -74.21 -54.57 7.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 27.4 pt -67.07 -19.71 25.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.23 -8.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.356 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 19' ' ' LYS . 76.2 mt-30 -74.24 160.36 31.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.5 19.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.481 0.657 . . . . 0.0 111.427 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.5 ptmt -118.7 166.15 13.12 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.249 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.546 ' CD2' HG11 ' A' ' 84' ' ' VAL . 2.4 tm? -78.72 112.16 15.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.7 t -117.94 108.18 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.654 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.25 108.42 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.822 0.82 . . . . 0.0 111.015 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.618 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 59.9 t -104.56 142.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.526 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.526 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -122.12 119.7 32.1 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.59 ' CD2' HG23 ' A' ' 69' ' ' VAL . 56.2 m-85 -71.41 125.43 26.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.352 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.755 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -120.98 -174.28 2.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.077 -173.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.2 155.12 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.151 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.08 -5.41 59.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -111.87 33.65 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -132.96 146.64 51.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.592 0.711 . . . . 0.0 112.135 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -85.17 -42.37 7.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.991 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 23.0 Cg_endo -61.34 -40.11 51.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 CA-C-N 119.817 1.808 . . . . 0.0 111.417 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 12.5 p -57.57 -31.6 66.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.761 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tptt -66.19 -53.6 35.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.789 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.693 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 21.5 ptm -63.09 -44.55 95.4 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.649 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.82 -18.83 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -57.39 -48.66 96.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.761 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.6 Cg_exo -70.92 -31.03 16.04 Favored 'Trans proline' 0 C--N 1.36 1.149 0 CA-C-N 120.537 1.228 . . . . 0.0 112.004 171.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 35' ' ' MET . 20.1 mmt -66.61 -56.37 11.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.582 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.695 HG22 ' CE2' ' A' ' 52' ' ' PHE . 6.5 mt -59.66 -27.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 31.8 tt0 -53.94 -48.64 70.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 16.0 tppt? -65.95 -47.77 73.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.945 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.629 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 3.4 m-30 -62.66 -26.55 68.7 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.777 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.638 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 92.3 p -85.1 -15.25 44.55 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 42.5 tt0 -79.66 -25.99 41.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.174 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.629 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -96.22 8.43 43.89 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.658 ' HE2' ' CD2' ' A' ' 52' ' ' PHE . 5.1 m-85 -103.52 100.0 17.36 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.729 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.54 -43.01 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.758 2.305 . . . . 0.0 112.677 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.27 -14.87 17.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.763 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . . . -104.68 165.04 11.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.48 137.37 51.76 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.695 ' CE2' HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -109.12 131.03 55.46 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.187 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 42.8 m-85 -136.65 151.93 49.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.755 ' HD2' ' CE1' ' A' ' 26' ' ' TYR . 10.0 mtmp? -139.57 120.54 14.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.618 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.7 mt -100.32 161.11 13.82 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.406 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 5.7 m-20 -94.22 107.5 19.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -13.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -172.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 5.5 p-10 -77.72 -25.23 49.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 109.59 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -93.97 -40.3 10.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.816 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.589 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -98.21 53.98 1.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.764 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.21 -45.89 10.91 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.86 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.7 t70 -61.11 -44.64 97.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.508 0.194 . . . . 0.0 111.189 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.589 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.5 p -65.1 -38.65 83.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.169 0.509 . . . . 0.0 110.611 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.63 78.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.909 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 13.4 mm100 -72.56 -31.62 65.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.702 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.41 -41.84 90.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.804 0.811 . . . . 0.0 110.223 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -98.44 21.49 11.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.381 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 38.2 50.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.936 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.59 HG23 ' CD2' ' A' ' 25' ' ' PHE . 76.2 t -81.18 115.87 24.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.945 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 p -122.42 17.54 10.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.294 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.04 157.97 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -138.58 122.29 11.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HG3' HD12 ' A' ' 36' ' ' ILE . 98.2 Cg_endo -83.79 166.2 64.04 Favored 'Cis proline' 0 C--O 1.235 0.349 0 C-N-CA 123.751 -1.354 . . . . 0.0 112.505 -5.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 78.2 m -123.75 122.73 38.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.634 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 HD22 ' OD1' ' A' ' 91' ' ' ASN . 4.3 mm? -105.42 109.66 21.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -173.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.632 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 21.5 mt -125.52 115.86 20.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.859 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.58 125.32 39.16 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 174.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.9 m-85 -108.05 154.48 21.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.468 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 50.7 tptt -143.37 116.57 8.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.198 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.518 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 43.0 m-80 56.26 27.15 11.34 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 123.424 0.452 . . . . 0.0 111.527 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.54 10.06 59.72 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.002 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 47.6 pttt -109.88 1.9 19.5 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.632 0.73 . . . . 0.0 109.354 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.4 tt0 78.47 172.6 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.546 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -144.2 -31.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 109.847 173.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -161.37 162.37 30.74 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.842 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.6 tttt -139.82 124.64 18.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.603 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.5 t -131.02 137.97 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.8 83.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.893 0.854 . . . . 0.0 111.609 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.12 53.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.833 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.89 81.84 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 111.324 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 11.3 p-10 -117.67 90.82 36.86 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.531 ' O ' HG21 ' A' ' 95' ' ' ILE . 3.9 Cg_exo -77.2 -43.15 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.441 1.427 . . . . 0.0 110.897 169.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.3 16.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.094 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -74.61 -17.57 60.69 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.053 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.705 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.43 -38.77 76.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.508 ' HD3' ' CD2' ' A' ' 43' ' ' PHE . 31.2 mmmt -61.87 -29.66 70.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.357 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -56.39 -57.88 10.39 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 174.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' C ' HD13 ' A' ' 77' ' ' LEU . . . -74.86 -37.87 62.1 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.705 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -72.61 -39.14 60.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.009 -170.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -86.0 -32.41 21.52 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.361 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.83 70.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.14 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.474 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 52.5 m-80 -96.83 -62.33 1.28 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.527 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.695 0.283 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.638 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -90.4 141.73 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.255 0.55 . . . . 0.0 110.86 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 146.02 37.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.555 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -104.95 136.23 44.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.261 171.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.564 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.7 m-85 -90.82 161.53 15.23 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.996 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -119.0 -18.54 8.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.284 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 58.7 p -133.08 151.57 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 111.121 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.521 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -60.44 -27.58 67.62 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -62.74 -43.73 98.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.387 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 9.4 mm-40 -60.46 -46.21 90.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.321 0.582 . . . . 0.0 110.251 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.438 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 9.5 t80 -64.85 -47.9 76.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.241 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' HA ' HG12 ' A' ' 15' ' ' ILE . 31.3 t70 -62.69 -33.69 75.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.608 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 m -73.43 -36.84 66.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.242 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.73 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.51 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.2 pt -67.78 -24.84 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.23 -15.68 60.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.084 0.468 . . . . 0.0 111.36 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.564 ' HB2' ' NZ ' ' A' ' 19' ' ' LYS . 98.2 mt-30 -76.46 156.47 33.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.802 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 17.9 t70 -48.38 -38.15 18.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -167.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.683 ' HE2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -109.1 -178.96 3.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -162.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.61 ' CD2' HG11 ' A' ' 84' ' ' VAL . 1.2 tm? -59.58 116.04 3.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.02 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.2 t -119.72 107.2 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.967 170.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.86 103.4 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.737 0.779 . . . . 0.0 111.008 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 3.5 t -108.14 144.23 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.99 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.511 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . . . -128.64 128.97 45.2 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 64' ' ' ALA . 80.9 m-85 -70.67 121.11 17.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.392 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.631 ' HH ' ' HA ' ' A' ' 37' ' ' ALA . 4.2 m-30 -120.19 176.1 5.62 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.251 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.65 16.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.889 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -84.48 -5.6 59.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -113.55 24.56 12.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.2 p -130.83 127.56 38.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.564 0.697 . . . . 0.0 111.65 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.04 -44.88 75.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.901 -1.045 . . . . 0.0 114.208 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 51.3 Cg_exo -57.6 -44.56 40.6 Favored 'Trans proline' 0 C--N 1.358 1.033 0 CA-C-N 119.98 1.89 . . . . 0.0 111.928 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 3.6 m -54.48 -37.19 64.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.391 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 38.6 ttpt -66.31 -47.04 74.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.149 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.416 ' O ' ' HG2' ' A' ' 39' ' ' MET . 24.8 ptt? -68.95 -45.25 71.22 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.668 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.32 -16.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.637 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -57.4 -55.41 44.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.508 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.7 Cg_endo -67.99 -27.85 35.98 Favored 'Trans proline' 0 C--N 1.358 1.032 0 CA-C-N 120.573 1.24 . . . . 0.0 111.993 172.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 35' ' ' MET . 96.6 mmm -67.08 -58.66 4.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.871 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.565 HG22 ' NZ ' ' A' ' 54' ' ' LYS . 65.0 mt -66.65 -20.39 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.994 -0.441 . . . . 0.0 111.794 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.87 -50.14 73.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.627 0.727 . . . . 0.0 109.531 164.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 43.3 tptt -60.19 -37.01 78.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.462 0.649 . . . . 0.0 109.83 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.8 m-30 -76.31 -15.07 60.06 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.379 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.736 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 24.2 p -73.58 -16.21 61.26 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 32.0 tt0 -87.6 -25.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.924 171.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.672 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 25.9 mm-40 -78.12 -30.03 49.2 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.716 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 4.1 p90 -120.39 83.6 33.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.25 -12.74 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.431 2.087 . . . . 0.0 111.438 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -6.11 49.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.602 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -127.87 165.55 19.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 12.4 m-20 -101.83 117.53 35.05 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.876 0.846 . . . . 0.0 112.617 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.736 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.2 p90 -98.02 113.66 25.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.545 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 32.7 m-85 -137.49 153.49 50.04 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.91 -0.494 . . . . 0.0 111.317 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.638 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 10.3 mmtt -128.3 142.95 50.99 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 72.7 mt -99.59 143.66 29.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.034 -0.416 . . . . 0.0 111.646 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 15.5 m-20 -86.51 100.66 12.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 166.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -59.01 -14.68 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.54 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 12.2 p-10 -71.76 -36.05 70.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 109.91 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.29 -15.08 16.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.386 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.609 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -109.22 44.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.91 -33.35 41.77 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.57 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.85 -45.85 80.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.702 0.287 . . . . 0.0 110.404 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.609 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -66.65 -36.91 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.492 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . . . -57.87 -50.17 74.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.358 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -63.77 -31.83 73.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.263 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -26.0 61.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.005 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -97.14 4.79 51.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.642 0.258 . . . . 0.0 110.975 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 62.82 43.75 6.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.847 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -88.33 121.66 38.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.889 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 p -123.67 -7.75 7.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.25 159.0 29.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.901 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.8 133.94 25.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.74 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.9 Cg_endo -86.05 171.05 41.6 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.903 -1.29 . . . . 0.0 111.199 -2.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.8 m -129.39 117.02 19.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 24' ' ' ALA . 4.3 mm? -101.4 109.59 21.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 -175.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.587 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 23.9 mt -124.25 113.05 17.76 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.44 127.26 43.25 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.593 174.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 32.7 m-85 -108.66 159.71 16.52 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.646 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.754 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 61.0 tttp -142.46 118.01 10.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.847 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.754 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 5.9 p30 40.34 43.99 1.56 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.951 0.782 . . . . 0.0 112.912 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.71 1.41 58.46 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 114.073 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.99 10.93 18.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.291 0.546 . . . . 0.0 110.558 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.86 175.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.116 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.61 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.97 -35.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 173.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.479 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.69 165.18 36.98 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.411 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.8 tttt -148.9 115.98 6.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.556 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.29 139.25 48.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.21 89.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.503 0.668 . . . . 0.0 111.711 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.97 -174.78 31.68 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.469 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . . . -72.91 93.15 1.69 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.883 0.373 . . . . 0.0 110.278 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 23.6 p-10 -119.49 69.21 11.37 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 12.4 Cg_exo -69.0 -32.98 20.54 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.063 1.175 . . . . 0.0 111.002 173.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.96 -44.22 10.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . . . -72.47 -17.13 61.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.659 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.2 tp -55.72 -39.51 55.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HD2' ' CG2' ' A' ' 99' ' ' ILE . 20.2 tptm -62.96 -32.44 73.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.368 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.18 -58.18 8.32 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.413 ' CB ' HD13 ' A' ' 77' ' ' LEU . . . -70.98 -36.67 72.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.539 0.685 . . . . 0.0 110.649 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -74.69 -42.04 47.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.178 -169.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.46 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -87.15 -39.42 15.53 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.961 0.41 . . . . 0.0 110.886 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.53 70.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.504 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 61.0 m-80 -89.04 -52.98 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.461 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.911 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.62 HG22 ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -121.29 135.39 61.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.655 0.74 . . . . 0.0 111.734 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.27 147.85 23.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.325 -175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 4.9 pt20 -99.85 120.31 39.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.114 169.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.579 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 16.7 m-85 -73.17 133.6 44.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.665 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -86.14 -16.85 36.61 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 74.5 p -131.79 151.86 51.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 111.432 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -60.32 -30.8 69.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.792 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -64.14 -37.09 86.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.79 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 25.3 mm-40 -62.01 -47.76 83.35 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.237 0.541 . . . . 0.0 110.04 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -47.03 87.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.967 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.09 -46.15 68.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.634 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 17.7 m -71.85 -32.66 67.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.568 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.02 -49.83 47.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.595 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.0 pt -67.99 -18.6 23.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.323 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.19 -10.03 59.69 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.282 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 13' ' ' SER . 78.2 mt-30 -79.62 150.72 30.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.46 56.23 2.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.926 0.87 . . . . 0.0 111.033 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 5.5 ptmt -150.72 169.22 22.14 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.042 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.58 ' HG ' ' CB ' ' A' ' 103' ' ' ALA . 1.2 tm? -74.62 108.01 7.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.037 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 84.6 t -116.45 107.37 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.794 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.89 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.568 0.699 . . . . 0.0 111.173 176.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.693 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 90.9 t -102.85 135.23 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.267 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -117.63 106.63 13.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' A' ' 55' ' ' LEU . 81.2 m-85 -71.42 107.57 4.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.866 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.714 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -162.77 152.23 15.48 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -178.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -129.04 141.65 51.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 p -68.25 -4.35 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -73.94 6.4 3.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.2 p -122.56 -172.89 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.979 0.418 . . . . 0.0 111.893 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.59 -59.23 2.14 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.95 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.86 -49.33 17.55 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.609 2.206 . . . . 0.0 111.944 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.2 p -49.82 -37.92 32.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.803 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.766 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 8.0 ttpm? -66.41 -56.46 10.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.536 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 39' ' ' MET . 22.8 ptm -59.54 -45.87 90.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.48 -22.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.524 -177.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -54.5 -57.06 20.5 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.222 -177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.766 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 20.9 Cg_endo -63.99 -35.01 56.97 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.294 1.329 . . . . 0.0 112.797 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 35' ' ' MET . 94.0 mmm -62.2 -56.36 19.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.511 ' CG2' ' HD3' ' A' ' 54' ' ' LYS . 23.6 mt -62.6 -23.81 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 120.782 0.325 . . . . 0.0 111.638 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.58 -43.94 79.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -62.18 -45.17 94.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.251 0.548 . . . . 0.0 110.239 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.647 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.9 m-30 -67.92 -15.32 63.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.462 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 13.5 p -87.11 -14.41 41.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.133 0.968 . . . . 0.0 108.697 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -86.68 -14.6 42.08 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.992 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.647 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -129.37 36.14 4.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.829 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -115.74 74.24 4.74 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.91 -36.09 90.93 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.337 2.024 . . . . 0.0 113.946 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -107.21 24.45 12.82 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.557 0.694 . . . . 0.0 111.54 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB3' ' CB ' ' A' ' 103' ' ' ALA . . . -138.95 165.6 26.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.337 -0.852 . . . . 0.0 111.803 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 117.67 19.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.89 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.829 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -93.2 129.57 39.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.575 -174.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 36.1 m-85 -137.49 135.56 36.9 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HG3' HG22 ' A' ' 2' ' ' VAL . 30.1 mtmt -125.08 121.7 35.06 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.057 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.579 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 54.6 mt -85.66 125.11 32.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.455 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.714 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.0 p-10 -70.95 105.61 3.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -58.23 -12.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.404 -175.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.53 -44.95 85.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.729 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.11 -18.14 17.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.164 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -106.8 51.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 110.825 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -78.22 -41.17 18.01 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.25 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.74 -41.49 83.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -65.51 -38.68 83.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.0 110.221 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.51 77.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.994 0.426 . . . . 0.0 110.796 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 78.3 mm-40 -70.66 -27.16 63.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.753 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -75.26 -25.09 57.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.266 0.555 . . . . 0.0 110.412 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -100.25 12.29 37.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.245 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.17 42.87 9.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.424 HG11 ' OG1' ' A' ' 74' ' ' THR . 85.0 t -91.71 124.63 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -138.03 17.75 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.109 0.481 . . . . 0.0 110.908 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -138.88 146.85 41.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.03 124.13 27.07 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.382 . . . . 0.0 110.194 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 58.0 Cg_endo -85.78 170.33 44.24 Favored 'Cis proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.55 -2.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 98.3 m -124.67 115.76 21.28 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HB2' HD22 ' A' ' 91' ' ' ASN . 4.1 mm? -105.63 108.51 20.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.98 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.8 mt -127.57 114.4 17.36 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.85 130.07 41.59 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.63 0.729 . . . . 0.0 110.259 174.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 88.7 m-85 -111.0 156.71 20.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.359 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.54 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.4 ttmt -141.63 116.13 9.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.349 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.54 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 42.33 43.81 3.13 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.769 0.828 . . . . 0.0 112.529 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.08 53.69 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.572 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.31 8.61 18.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.071 0.463 . . . . 0.0 110.183 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 45.8 mt-10 64.77 178.48 0.18 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.619 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.531 HG12 ' CD2' ' A' ' 20' ' ' LEU . 1.7 p -148.86 -33.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 170.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.425 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.41 163.66 35.26 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -146.41 120.52 9.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.497 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.9 t -127.05 131.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.89 79.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.024 0.44 . . . . 0.0 111.248 -171.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.5 -168.81 38.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -69.65 93.39 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.549 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 26.3 p-10 -123.74 63.4 28.31 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.1 Cg_exo -67.35 -37.76 16.91 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.038 1.159 . . . . 0.0 110.579 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.8 -40.36 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.939 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' A' ' 91' ' ' ASN . . . -73.26 -17.21 61.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.272 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.617 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.71 -37.15 69.72 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 29.2 mmtt -57.63 -34.79 69.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.538 0.524 . . . . 0.0 110.623 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -54.33 -56.4 18.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 77' ' ' LEU . . . -73.43 -44.09 59.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.478 0.656 . . . . 0.0 111.204 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -65.26 -41.43 91.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.858 -171.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -89.11 -42.06 11.92 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.826 0.346 . . . . 0.0 111.762 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.8 -39.1 73.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.408 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.3 m-80 -85.85 -56.73 3.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.072 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.58 ' CB ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.402 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 tmm? . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -88.33 144.66 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 145.76 55.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 112.504 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.14 56.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.597 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.627 ' H ' HD22 ' A' ' 55' ' ' LEU . 18.4 m-85 -74.7 163.04 28.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.875 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -119.83 -13.83 9.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.523 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 82.2 p -135.05 152.29 51.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.882 0.372 . . . . 0.0 111.098 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.81 -30.53 67.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -64.06 -39.17 93.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.901 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.625 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 15.8 mm-40 -60.8 -42.3 97.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.996 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -64.94 -49.15 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.739 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.36 -43.23 83.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.759 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -70.8 -36.06 72.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.72 -52.16 40.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.519 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.551 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 28.4 pt -65.03 -21.04 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.191 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.03 -6.99 57.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.749 0.309 . . . . 0.0 111.687 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.456 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.9 mt-30 -81.56 159.05 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.876 0.369 . . . . 0.0 110.325 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.73 18.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.237 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 17' ' ' GLN . 30.3 mtpt -107.75 174.61 5.81 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.906 0.86 . . . . 0.0 112.68 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.539 ' CD2' HG12 ' A' ' 84' ' ' VAL . 1.5 tm? -91.2 107.06 18.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.355 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 67.3 t -106.0 115.45 47.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 77' ' ' LEU . 21.6 t -92.3 102.39 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.211 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.494 HG13 ' HG ' ' A' ' 55' ' ' LEU . 44.2 t -108.39 136.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.473 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . . . -128.92 141.55 51.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 120.764 0.316 . . . . 0.0 111.821 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' A' ' 69' ' ' VAL . 59.0 m-85 -95.11 122.52 37.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.336 0.589 . . . . 0.0 110.55 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.725 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.5 m-85 -119.98 -175.28 2.94 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.243 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.61 165.76 20.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -84.92 -5.55 59.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.317 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -122.88 34.59 5.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.776 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.655 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 6.9 p -132.11 121.82 24.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.527 0.68 . . . . 0.0 111.834 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.39 -42.12 97.79 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.923 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.591 ' O ' HG21 ' A' ' 36' ' ' ILE . 50.3 Cg_exo -57.47 -44.3 43.57 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.021 1.91 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 9.2 m -53.32 -41.35 65.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.69 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 37.5 ttpt -63.06 -56.36 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.6 ptp -60.65 -47.79 84.68 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.34 -13.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.014 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.67 -53.64 63.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.291 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.69 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.9 Cg_endo -65.53 -33.19 47.08 Favored 'Trans proline' 0 C--N 1.357 1.003 0 CA-C-N 120.281 1.136 . . . . 0.0 112.448 169.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.406 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 23.7 mmt -65.02 -58.92 4.85 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.969 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.487 HG12 HG21 ' A' ' 95' ' ' ILE . 51.6 mt -64.42 -23.04 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 122.107 -0.371 . . . . 0.0 111.399 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 42.6 tt0 -63.12 -41.51 99.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.66 0.743 . . . . 0.0 110.133 170.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 19.7 ttmt -64.56 -38.94 92.75 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.087 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.673 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.4 m-30 -69.63 -23.82 63.56 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.267 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 41' ' ' GLU . 2.0 p -73.81 -14.67 61.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.71 -23.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.673 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 53.5 mt-30 -80.65 -33.38 35.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.063 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.669 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 5.8 p90 -108.43 92.13 9.44 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.2 Cg_endo -84.39 -12.79 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.132 2.555 . . . . 0.0 111.37 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 50' ' ' ALA . 3.3 pt20 -88.2 -22.95 23.73 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.354 0.597 . . . . 0.0 110.385 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -113.68 148.16 36.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.527 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 7.0 m-20 -91.12 116.73 29.04 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.402 0.62 . . . . 0.0 111.523 -174.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.669 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 2.8 p90 -87.7 114.55 24.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.946 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 22.1 m-85 -130.78 164.85 24.22 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.238 170.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.648 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -153.29 119.9 5.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 5.4 mt -99.31 159.52 14.94 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.255 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.42 118.77 37.59 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -63.34 -11.48 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.636 -174.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.24 -37.48 78.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.975 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.21 -31.02 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.458 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.56 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.0 mm? -107.73 48.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.004 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.584 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.92 -41.78 17.89 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.117 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 4.5 m-20 -66.7 -44.1 82.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.509 0.195 . . . . 0.0 110.839 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.0 p -62.74 -38.03 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.202 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.89 85.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.167 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 17.1 mm100 -71.37 -32.13 68.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.901 0.382 . . . . 0.0 110.464 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.42 -42.63 92.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.6 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -94.81 14.74 20.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.044 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 58.86 43.79 17.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.602 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.648 HG22 ' CD2' ' A' ' 25' ' ' PHE . 94.8 t -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.979 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 p -125.87 22.43 7.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.156 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.91 151.01 40.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.655 ' SD ' ' HB3' ' A' ' 30' ' ' CYS . 16.2 ptt? -121.45 123.15 27.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.202 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 6.1 Cg_endo -86.88 172.35 35.47 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.428 -1.072 . . . . 0.0 111.511 -3.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 55.1 m -138.82 116.78 11.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.618 ' CD2' ' HB3' ' A' ' 24' ' ' ALA . 2.5 mp -107.13 142.53 36.67 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.093 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.8 mt -134.28 110.6 9.61 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.094 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.45 124.08 34.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.758 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 31.5 m-85 -109.68 154.65 22.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.955 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.61 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 58.5 tttp -142.95 115.06 8.34 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.961 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 9.6 p30 44.69 38.11 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.965 0.906 . . . . 0.0 112.45 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.43 3.93 63.42 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.697 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 16.8 ptmt -103.59 -3.7 24.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 109.412 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 29.3 tt0 77.23 -179.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.593 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 77' ' ' LEU . 2.1 p -152.2 -32.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.884 0.374 . . . . 0.0 110.04 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.25 162.13 40.17 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.129 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -138.17 122.49 18.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.029 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.52 HG12 ' ND2' ' A' ' 91' ' ' ASN . 10.1 p -128.98 131.22 68.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.302 0.572 . . . . 0.0 110.277 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.11 80.41 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.672 -170.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.36 -175.12 38.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.926 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 32' ' ' PRO . . . -74.42 94.72 2.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 22.8 p-10 -124.45 68.95 51.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 18.7 Cg_exo -64.68 -43.65 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 120.614 0.876 . . . . 0.0 110.991 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.88 -32.43 18.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -75.88 -18.76 59.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.429 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.644 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.0 tp -59.9 -38.12 75.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HD2' ' CG2' ' A' ' 99' ' ' ILE . 19.3 tptm -64.27 -26.82 68.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.168 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.593 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.4 tm0? -58.83 -59.26 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 170.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 -38.36 78.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.7 . . . . 0.0 110.741 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -71.63 -42.37 71.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.146 -170.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.446 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -87.19 -40.45 14.57 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.99 -173.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.76 -40.4 66.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.572 -175.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.8 m-80 -85.55 -56.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.469 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' CB ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.581 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.661 0.267 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -121.59 140.08 46.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.302 0.572 . . . . 0.0 110.483 177.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.73 148.25 33.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.899 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -112.46 118.49 35.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.391 172.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -69.9 163.06 26.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 110.68 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -115.59 -18.34 10.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.176 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 28.5 p -138.0 155.49 48.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.483 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.64 -34.85 73.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 m -57.24 -37.77 72.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.991 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.594 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 34.4 mm-40 -63.36 -45.03 93.07 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.307 0.575 . . . . 0.0 109.961 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.75 -50.36 62.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.747 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.53 -39.73 80.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.396 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.1 m -69.45 -37.05 77.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -66.62 -49.6 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.858 0.361 . . . . 0.0 110.814 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.5 pt -66.69 -24.26 32.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.649 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 -5.76 48.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 19' ' ' LYS . 26.0 mt-30 -75.94 157.04 33.64 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.985 0.421 . . . . 0.0 110.302 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.45 -1.78 3.91 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.73 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 11.1 ptmt -115.47 173.86 6.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.21 0.528 . . . . 0.0 111.812 -167.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.566 ' CD2' HG13 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.41 113.69 11.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -122.12 107.86 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.766 0.317 . . . . 0.0 110.641 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.93 109.2 26.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.867 0.842 . . . . 0.0 111.588 176.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.585 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 98.9 t -104.28 142.54 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.151 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -129.43 138.35 51.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 69' ' ' VAL . 70.1 m-85 -88.51 126.6 35.33 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.25 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.555 ' HH ' ' HA ' ' A' ' 37' ' ' ALA . 4.2 m-30 -120.82 -172.06 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.637 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -169.9 162.51 9.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.227 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 p -83.98 -4.85 59.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -122.8 35.0 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 -176.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 2.0 p -130.95 143.88 51.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.814 0.816 . . . . 0.0 111.911 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.48 -45.43 6.49 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.276 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 50.9 Cg_exo -57.11 -50.63 10.73 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.903 1.735 . . . . 0.0 112.17 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.633 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 28.5 p -53.5 -34.37 57.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.71 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' A' ' 34' ' ' LYS . 4.6 ttmp? -68.55 -45.17 72.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.064 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -72.86 -41.52 64.67 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.277 0.561 . . . . 0.0 112.444 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.663 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.91 -17.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.44 177.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -58.03 -49.22 94.89 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 34' ' ' LYS . 37.8 Cg_endo -69.84 -29.44 23.5 Favored 'Trans proline' 0 C--N 1.358 1.066 0 CA-C-N 120.56 1.236 . . . . 0.0 112.592 169.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.6 mmt -67.68 -52.21 40.57 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.958 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.769 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -55.8 -35.2 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 173.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 12.7 tp10 -55.45 -49.88 71.3 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.149 0.5 . . . . 0.0 110.254 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -61.63 -48.04 82.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.097 0.475 . . . . 0.0 110.493 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 m-30 -63.02 -22.36 66.8 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.981 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.466 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 34.9 p -82.03 -19.59 40.08 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.726 0.774 . . . . 0.0 108.949 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -77.48 -29.91 52.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.673 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.64 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -100.39 26.31 6.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.251 175.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.582 ' CE1' HD11 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -100.12 89.34 1.08 Allowed Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.889 170.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 83.0 Cg_endo -84.99 -45.18 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.125 1.883 . . . . 0.0 114.075 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.69 -24.19 14.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.226 0.536 . . . . 0.0 111.845 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.36 164.38 11.68 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.577 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.0 128.32 55.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.769 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.52 120.87 43.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 29.6 m-85 -132.39 142.03 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.737 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.563 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 7.8 mmtt -127.93 120.0 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.585 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.0 mt -100.67 167.73 10.14 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.53 120.41 40.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -15.96 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.281 -174.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.65 -51.04 46.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.913 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.16 -29.7 31.42 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.469 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.597 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.9 mm? -96.14 57.59 1.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 0.0 111.22 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.535 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.97 -45.43 10.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.375 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 33.3 t70 -61.25 -45.42 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.649 0.262 . . . . 0.0 111.165 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.9 p -64.82 -38.04 81.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.384 . . . . 0.0 110.557 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.05 74.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.0 110.81 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 16.9 mm100 -75.02 -28.79 60.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.607 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 87.7 mttt -61.84 -41.31 97.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.462 0.649 . . . . 0.0 110.549 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -92.2 7.75 41.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.125 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 55.16 46.61 23.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.058 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 25' ' ' PHE . 93.3 t -77.89 109.44 12.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.41 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.51 -2.57 11.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.357 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.03 23.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.994 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.89 145.6 32.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.629 0.252 . . . . 0.0 110.695 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 90.5 Cg_endo -82.04 171.24 56.4 Favored 'Cis proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.355 -1.519 . . . . 0.0 112.046 -3.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.431 HG21 ' CD1' ' A' ' 76' ' ' LEU . 19.2 m -127.11 119.0 25.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' HZ1' ' A' ' 54' ' ' LYS . 4.1 mm? -108.24 106.23 16.31 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.002 0.429 . . . . 0.0 111.016 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.517 HD12 ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -118.84 119.06 33.27 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.117 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.59 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -94.91 119.01 32.74 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.2 m-85 -105.37 160.25 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.86 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.499 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 65.8 tttp -150.68 125.5 9.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.014 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 55.2 m-80 53.9 33.76 17.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 111.882 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.19 60.91 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.719 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 47.3 mmtm -102.06 -73.55 0.65 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 9.5 pt-20 165.41 -170.98 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 124.724 1.265 . . . . 0.0 108.511 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 77' ' ' LEU . 1.5 p -156.62 -30.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.428 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -163.02 161.96 25.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.411 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HG3' HD12 ' A' ' 76' ' ' LEU . 71.5 tttt -146.61 124.38 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.184 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.47 132.95 70.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.26 78.67 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.124 0.488 . . . . 0.0 110.853 -171.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.42 -171.79 40.02 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 32' ' ' PRO . . . -74.38 93.57 2.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 25.0 p-10 -118.93 71.87 11.09 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.65 -31.75 8.33 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.264 1.309 . . . . 0.0 109.833 166.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.59 -44.1 10.32 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.432 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . . . -73.91 -16.9 61.09 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.424 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.676 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -57.09 -37.68 56.62 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 169.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 13.9 mmmm -56.96 -32.77 66.37 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.743 0.652 . . . . 0.0 110.37 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.518 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -57.99 -56.65 19.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.605 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.9 -28.33 49.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -74.43 -44.7 47.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.654 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -85.01 -32.44 22.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.279 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.88 82.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 17.9 m-80 -114.22 -77.21 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.192 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.917 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -171.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 ttp . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.584 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -114.63 135.75 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.575 0.702 . . . . 0.0 111.708 -177.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.43 ' CG2' ' HD1' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -81.33 148.66 29.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.428 -177.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.5 141.08 35.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 170.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.506 ' H ' HD21 ' A' ' 55' ' ' LEU . 14.3 m-85 -98.77 157.15 16.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.044 0.449 . . . . 0.0 110.021 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -123.71 -17.42 6.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 50.0 p -130.08 150.88 51.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.952 0.406 . . . . 0.0 111.025 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.35 -30.39 69.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.396 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -67.77 -33.58 75.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.479 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 22.1 mm-40 -61.73 -47.16 86.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.264 0.554 . . . . 0.0 110.07 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.6 -45.98 81.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.059 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.99 -48.51 81.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.371 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -69.36 -26.74 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.478 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -70.66 -53.25 16.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.427 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 pt -65.35 -21.97 30.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.332 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.88 -2.75 48.77 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 14' ' ' ALA . 78.1 mt-30 -76.09 158.55 31.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 33.9 t70 -80.16 28.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.104 0.954 . . . . 0.0 110.026 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 7.8 ptmt -134.75 169.12 17.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.506 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tm? -82.53 116.92 22.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.896 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.574 HG11 ' CE2' ' A' ' 53' ' ' TYR . 56.6 t -115.32 107.63 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.72 103.69 15.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 122.164 0.983 . . . . 0.0 111.209 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 t -100.47 139.92 20.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.27 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -130.33 138.57 50.5 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.664 0.269 . . . . 0.0 111.698 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 69' ' ' VAL . 49.7 m-85 -88.59 128.17 35.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.92 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.602 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.4 m-30 -120.45 -170.93 2.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.04 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.24 172.39 12.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.252 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -20.74 65.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.225 0.536 . . . . 0.0 110.868 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 23.1 p90 -101.39 -147.45 0.36 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.254 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.9 p 56.73 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.408 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.86 -41.45 76.13 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 114.319 -1.309 . . . . 0.0 114.178 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.485 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 46.4 Cg_exo -58.82 -43.73 41.57 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 120.25 2.025 . . . . 0.0 112.154 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.571 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 8.4 m -53.21 -40.0 64.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.383 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.726 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 96.1 mttt -65.56 -53.34 43.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.499 -178.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.68 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.8 ptm -62.8 -45.36 92.99 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.645 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.62 -18.43 15.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.924 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -57.4 -48.16 97.78 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.726 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.9 Cg_exo -70.74 -32.53 14.34 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.174 1.249 . . . . 0.0 112.008 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.1 mmm -64.26 -51.02 65.65 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.614 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.52 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 0.8 OUTLIER -53.85 -36.94 31.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-O 120.624 0.249 . . . . 0.0 110.341 172.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.92 -44.49 97.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.721 0.296 . . . . 0.0 111.195 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.92 -50.13 75.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.577 0.703 . . . . 0.0 109.408 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.671 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 14.1 m-30 -63.7 -17.17 62.7 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 9.6 p -86.15 -14.05 45.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.978 0.894 . . . . 0.0 108.921 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -88.14 -16.63 32.91 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.671 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -128.77 29.92 5.17 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.787 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -108.58 100.83 40.45 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-O 122.193 0.997 . . . . 0.0 112.623 172.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.85 -44.12 10.9 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.826 2.35 . . . . 0.0 114.375 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.5 -13.45 17.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 111.349 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -103.33 158.19 16.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.786 0.803 . . . . 0.0 112.002 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -126.38 119.13 26.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.173 171.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.787 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -87.64 130.58 34.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 -175.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.574 ' CE2' HG11 ' A' ' 21' ' ' VAL . 37.9 m-85 -133.32 133.07 42.06 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.356 168.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.584 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 8.0 mmpt? -117.0 118.96 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.602 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 1.3 mt -102.4 175.22 5.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.017 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -115.88 121.46 42.42 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -67.89 -10.58 12.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.198 -175.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.64 -35.64 52.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.58 -27.49 21.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.706 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.661 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.0 mt -117.85 54.09 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.367 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.25 -39.16 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.112 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.6 t70 -68.07 -46.99 69.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.644 0.259 . . . . 0.0 110.632 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.661 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.6 p -62.18 -38.45 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.402 . . . . 0.0 110.35 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.31 77.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.918 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 27.5 mt-30 -76.42 -30.85 57.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.461 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 39.1 mtmt -58.62 -39.95 81.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.51 0.671 . . . . 0.0 110.056 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -91.26 9.44 31.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.691 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 56.44 45.62 22.27 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.348 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.488 HG13 ' OG1' ' A' ' 74' ' ' THR . 62.3 t -85.96 123.72 39.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.508 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -134.67 -35.56 0.88 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.53 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.32 119.84 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.979 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.57 136.93 19.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.417 . . . . 0.0 110.872 -175.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.98 169.88 52.84 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.124 -1.615 . . . . 0.0 111.714 -4.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.488 ' OG1' HG13 ' A' ' 69' ' ' VAL . 55.9 m -117.06 116.88 28.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.34 108.65 20.15 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.172 0.511 . . . . 0.0 111.084 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.4 mt -126.63 116.08 20.47 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.606 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.81 125.98 41.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.933 173.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 25.7 m-85 -108.73 154.28 22.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.381 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 80' ' ' ASN . 22.5 ttmm -139.99 111.6 7.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.536 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 30.8 m-80 57.32 31.75 20.64 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.652 0.595 . . . . 0.0 111.508 -176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.36 11.19 51.77 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.51 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -106.01 0.3 25.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.764 0.792 . . . . 0.0 109.097 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 72.05 175.51 0.28 Allowed 'General case' 0 CA--C 1.524 -0.049 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.246 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.506 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 1.1 p -148.61 -30.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.006 0.431 . . . . 0.0 109.917 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.626 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . . . -161.61 164.54 29.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.645 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.536 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.1 tttt -146.4 118.37 8.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.167 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.17 131.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.17 76.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.204 0.526 . . . . 0.0 111.376 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.47 -167.51 35.71 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.226 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.99 96.99 3.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 110.094 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.1 p-10 -122.27 67.17 25.77 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.1 -34.63 27.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.173 1.248 . . . . 0.0 110.944 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.21 -43.26 11.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.143 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.4 -17.75 60.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.624 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.646 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.8 tp -58.85 -37.57 67.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 170.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 21.4 tptm -60.65 -32.76 71.92 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.049 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -56.17 -55.83 28.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 173.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.484 ' CB ' HD12 ' A' ' 77' ' ' LEU . . . -73.53 -36.04 65.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.542 0.687 . . . . 0.0 111.106 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -71.71 -45.11 67.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.645 -171.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.492 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -89.1 -40.81 12.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.917 0.389 . . . . 0.0 111.706 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.93 83.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.295 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.626 ' ND2' ' HB3' ' A' ' 85' ' ' ALA . 79.1 m-20 -93.25 -56.88 2.79 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.629 -172.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.165 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG23 ' CG2' ' A' ' 40' ' ' ILE . 35.9 t -103.34 128.38 56.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.041 0.448 . . . . 0.0 110.34 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 146.6 51.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.889 0.852 . . . . 0.0 112.397 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -103.38 141.52 35.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.804 -1.543 . . . . 0.0 109.463 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.63 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.7 m-85 -94.5 158.03 15.73 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -119.86 -15.08 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.704 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 37.2 p -135.07 151.5 50.82 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.76 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.6 t -59.88 -46.89 87.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.063 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.522 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.2 mm-40 -60.38 -42.94 96.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.414 0.626 . . . . 0.0 110.143 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 19.7 t80 -67.58 -47.28 70.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.087 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.96 -42.85 99.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.597 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 22.6 t -67.16 -39.33 86.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.713 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -50.84 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.981 0.419 . . . . 0.0 110.722 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 11' ' ' PHE . 35.5 pt -67.41 -18.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.632 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.62 -14.12 52.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 19' ' ' LYS . 54.7 mt-30 -69.16 150.19 47.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 39.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.482 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 10.5 ptmt -136.75 167.38 21.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -77.6 108.01 10.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG12 HG23 ' A' ' 23' ' ' VAL . 53.0 t -110.02 107.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.209 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.524 ' HB ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.93 103.12 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 122.062 0.934 . . . . 0.0 110.84 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 70.8 t -102.35 143.18 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 74' ' ' THR . . . -127.9 117.53 21.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -70.51 129.1 38.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.525 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 7.6 m-30 -118.5 -177.45 3.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . . . -152.23 130.21 11.8 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -58.26 -24.74 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.716 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -96.75 8.99 43.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.797 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.944 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -107.07 138.29 43.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.307 0.575 . . . . 0.0 111.786 -177.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -81.72 -37.65 16.11 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.904 -1.044 . . . . 0.0 114.546 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.944 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.1 Cg_exo -66.25 -29.33 46.92 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 120.359 2.08 . . . . 0.0 110.378 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 58.5 m -51.12 -39.62 56.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.732 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.916 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 13.5 mptt -67.79 -57.37 6.43 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.801 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 23.4 ptp -54.19 -50.22 67.57 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.702 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.41 -21.19 16.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.931 -177.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -56.96 -60.06 10.7 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.01 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.916 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 9.3 Cg_endo -56.37 -36.22 96.96 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 121.268 1.312 . . . . 0.0 112.792 169.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.596 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 26.1 mmt -62.75 -51.58 66.56 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.371 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.596 ' CG2' HG23 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -52.51 -32.73 17.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 122.672 0.389 . . . . 0.0 111.509 176.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 44.8 mt-10 -59.64 -48.57 81.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.351 0.596 . . . . 0.0 110.479 173.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -61.22 -47.62 85.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.685 0.755 . . . . 0.0 109.874 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.644 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 34.0 m-85 -67.42 -20.55 65.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.757 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 84.9 p -77.09 -15.96 59.39 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 108.85 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.38 -20.7 43.46 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.537 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 7.3 mm100 -83.46 -7.05 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.984 175.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.708 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 7.5 p90 -134.68 85.44 36.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.36 0.6 . . . . 0.0 112.46 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.56 -21.9 4.05 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.218 2.612 . . . . 0.0 112.423 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.72 -1.0 50.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.438 0.637 . . . . 0.0 110.527 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 47' ' ' TYR . . . -119.12 165.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -108.84 117.59 34.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.297 0.57 . . . . 0.0 111.997 -175.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.757 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 1.6 p90 -83.55 121.48 27.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.048 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 31.5 m-85 -136.74 142.59 43.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.335 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG2' ' CG1' ' A' ' 2' ' ' VAL . 10.9 mmtt -126.91 124.13 38.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.63 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.8 mt -100.67 -178.24 3.72 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.169 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.466 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 11.5 t0 -133.89 131.32 38.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.34 -8.7 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.316 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -31.62 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 109.971 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.61 -27.05 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.046 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.604 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.87 52.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.0 -39.81 22.81 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.487 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -44.0 73.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.775 0.322 . . . . 0.0 110.694 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -65.39 -38.82 83.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.048 0.451 . . . . 0.0 110.394 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.36 69.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.6 mt-30 -72.89 -36.83 67.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.962 0.411 . . . . 0.0 110.245 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -91.66 10.17 29.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.82 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 56.47 44.15 24.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.425 HG12 ' OG1' ' A' ' 74' ' ' THR . 74.2 t -73.7 109.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.489 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -117.54 -25.92 6.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.541 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.78 117.57 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.036 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -100.63 150.41 36.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 14.1 Cg_exo -71.21 171.47 59.51 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 123.872 -1.303 . . . . 0.0 111.834 -6.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 19.9 m -131.07 115.52 16.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.607 HD11 ' OD1' ' A' ' 91' ' ' ASN . 3.8 mt -105.7 108.67 20.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.503 0.668 . . . . 0.0 111.115 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.592 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 25.5 mt -123.23 114.4 20.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.014 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.524 HD23 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -93.75 125.02 38.13 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.168 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 m-85 -107.37 155.64 19.79 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.431 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -141.04 131.94 25.99 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.02 44.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 19.02 60.0 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.579 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 14.7 tttp -126.39 0.92 6.99 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.338 0.59 . . . . 0.0 110.215 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 39.2 mt-10 73.14 -179.1 0.2 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.951 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.505 HG12 HD21 ' A' ' 20' ' ' LEU . 1.3 p -153.31 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.754 174.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.615 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . . . -157.71 163.0 38.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.119 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.592 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 77.0 tttt -144.26 116.69 8.55 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.944 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 t -123.89 133.88 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.13 78.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.283 0.563 . . . . 0.0 110.927 -170.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.59 -175.67 39.78 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 96.48 1.87 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.607 ' OD1' HD11 ' A' ' 75' ' ' LEU . 19.1 p-10 -119.41 78.8 20.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.46 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 3.4 Cg_exo -74.91 -29.94 7.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.469 1.446 . . . . 0.0 110.319 167.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -90.25 -51.03 5.64 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.618 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -67.68 -16.59 64.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.518 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.653 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -55.74 -37.59 47.49 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HD2' HG21 ' A' ' 99' ' ' ILE . 11.7 mmmm -58.39 -34.52 70.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.023 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.01 -58.66 6.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.37 55.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.784 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.653 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -80.49 -40.02 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.471 -172.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -85.63 -39.19 17.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.666 -175.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.19 70.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.615 ' ND2' ' HB3' ' A' ' 85' ' ' ALA . 89.0 m-20 -101.14 -68.92 0.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.273 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.727 0.298 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.46 109.6 25.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.961 0.41 . . . . 0.0 110.365 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.18 149.24 47.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.065 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.14 134.08 52.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.492 175.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.586 ' H ' HD21 ' A' ' 55' ' ' LEU . 13.3 m-85 -86.75 164.4 16.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.164 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -123.22 -13.72 7.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.709 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.649 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 71.2 p -137.32 155.35 49.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.724 0.297 . . . . 0.0 111.017 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.85 -31.22 69.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 t -61.23 -42.09 98.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.649 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.7 mm-40 -59.0 -43.93 91.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.32 0.581 . . . . 0.0 109.992 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.42 ' CZ ' HD12 ' A' ' 15' ' ' ILE . 1.4 t80 -63.65 -49.18 74.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.843 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.1 -44.44 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.925 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 34.5 t -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.974 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -49.74 42.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.906 0.384 . . . . 0.0 110.666 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.43 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 29.3 pt -66.99 -21.71 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.548 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.67 -8.62 59.33 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.884 0.374 . . . . 0.0 111.371 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.6 mt-30 -75.63 158.99 31.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.733 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.04 36.24 0.34 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.42 0.628 . . . . 0.0 110.347 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 17' ' ' GLN . 29.1 mmmt -126.71 160.27 31.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.651 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HG ' ' HB1' ' A' ' 103' ' ' ALA . 1.7 tm? -77.57 105.56 8.8 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 53.3 t -110.23 107.12 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.024 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.73 108.99 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.684 0.754 . . . . 0.0 110.818 175.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 85.1 t -103.53 142.72 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.117 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . . . -126.72 113.68 16.98 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.81 106.48 7.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.063 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.64 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.2 m-85 -133.28 175.82 9.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 112.143 -171.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.07 163.56 39.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.49 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -85.49 -8.64 58.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -108.02 27.65 9.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -129.26 128.11 42.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.441 0.639 . . . . 0.0 111.306 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.14 97.49 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 114.713 -1.131 . . . . 0.0 114.107 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.544 ' O ' HG21 ' A' ' 36' ' ' ILE . 38.7 Cg_exo -58.15 -39.41 85.46 Favored 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 119.714 1.757 . . . . 0.0 110.674 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 39.0 m -58.57 -34.08 70.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.2 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.628 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 29.1 mtpp -63.87 -55.65 21.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.423 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 26.0 ptt? -61.03 -44.56 97.22 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.64 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.23 -24.15 18.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.796 -178.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -53.85 -51.36 77.46 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.619 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 35.6 Cg_endo -68.12 -32.46 27.5 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 120.215 1.113 . . . . 0.0 112.603 169.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.426 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.6 mmt -64.66 -57.59 8.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.559 HG21 ' CZ ' ' A' ' 52' ' ' PHE . 36.5 mt -66.46 -23.12 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.45 0.568 . . . . 0.0 111.39 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.94 -47.29 85.61 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.53 0.681 . . . . 0.0 109.46 168.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -63.41 -48.53 77.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.145 0.498 . . . . 0.0 110.516 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.627 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 11.7 m-30 -65.6 -15.56 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.975 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 p -87.21 -14.9 39.8 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 121.555 0.693 . . . . 0.0 109.274 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.27 -23.2 40.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 168.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.627 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -120.87 34.08 5.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.611 ' CE2' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -104.59 85.11 1.07 Allowed Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 122.016 0.912 . . . . 0.0 112.298 172.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 24.3 Cg_exo -64.02 -45.68 9.82 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.005 1.803 . . . . 0.0 113.916 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -107.81 24.65 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -128.98 156.38 43.88 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.798 -0.564 . . . . 0.0 111.914 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.76 120.26 40.2 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.24 169.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.611 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -103.35 116.74 33.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.5 -171.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.422 ' CD2' HG12 ' A' ' 21' ' ' VAL . 23.2 m-85 -129.17 136.26 49.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -121.18 119.06 31.25 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.586 HD21 ' H ' ' A' ' 5' ' ' PHE . 5.2 mt -100.96 160.55 14.28 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.776 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.48 114.56 26.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -11.25 9.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.44 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.02 -51.09 27.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.548 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -86.96 -25.68 24.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.438 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.536 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.6 mm? -99.99 45.06 0.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 111.316 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.05 -37.03 30.07 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.848 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.1 -42.41 94.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.695 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.1 p -67.19 -39.09 82.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.81 76.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.72 -33.08 72.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.204 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -27.73 64.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.667 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -95.18 10.83 34.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.88 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 60.09 41.33 17.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.791 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.5 t -99.95 110.53 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.571 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 p -110.73 -19.22 12.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.85 0.357 . . . . 0.0 110.727 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.15 168.39 10.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.13 148.53 35.47 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 18.8 Cg_exo -70.77 173.35 48.61 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.839 -0.901 . . . . 0.0 112.581 -6.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 87.6 m -147.23 117.32 7.28 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.839 0.352 . . . . 0.0 110.496 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.506 ' CD1' ' HB1' ' A' ' 24' ' ' ALA . 4.0 mm? -110.76 111.23 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.326 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.408 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 35.8 mt -125.87 115.39 19.9 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -96.86 128.82 44.19 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.018 174.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 29.0 m-85 -110.72 155.53 22.34 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.131 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.629 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.3 tttt -142.28 116.83 9.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.829 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.629 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.52 38.4 7.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.787 0.835 . . . . 0.0 111.847 -177.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.15 8.63 55.06 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.34 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -109.39 4.05 22.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 109.997 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 24.2 tt0 67.92 174.6 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.025 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG12 HD22 ' A' ' 20' ' ' LEU . 1.4 p -144.31 -32.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.933 0.396 . . . . 0.0 110.117 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -157.93 161.33 38.2 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.979 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.501 ' HB2' ' HZ3' ' A' ' 86' ' ' LYS . 1.7 ttmp? -139.72 117.48 11.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.245 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.08 125.71 73.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.05 87.0 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 111.296 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 -173.63 33.63 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.027 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 73' ' ' PRO . . . -71.91 103.62 3.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.5 p-10 -127.22 65.65 65.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.496 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 10.1 Cg_exo -69.21 -34.07 17.23 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 120.867 1.045 . . . . 0.0 110.871 174.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.53 -45.34 9.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -70.92 -17.24 62.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.58 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.618 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.7 tp -56.96 -38.45 59.77 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.59 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 30.5 mmtt -59.58 -35.37 74.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.761 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.14 -54.01 45.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 77' ' ' LEU . . . -76.7 -39.77 50.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.629 0.728 . . . . 0.0 111.3 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -69.57 -41.0 80.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.678 -171.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.459 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -88.53 -38.57 14.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.635 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.11 -31.13 55.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 45.5 m-80 -95.65 -60.07 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.33 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB1' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.245 0.867 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.463 170.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.659 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -107.2 146.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.597 0.713 . . . . 0.0 112.025 -172.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.533 ' N ' HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -83.54 148.44 27.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.204 -178.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 133.33 50.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.061 170.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.562 ' H ' HD22 ' A' ' 55' ' ' LEU . 15.3 m-85 -84.38 164.32 19.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -117.79 -16.91 9.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.444 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.614 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 40.1 p -134.89 153.64 51.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.527 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.42 -33.71 68.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -64.29 -32.09 73.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.474 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.614 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 23.4 mm-40 -67.42 -44.09 79.62 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.093 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -44.38 94.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.633 176.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.33 -44.42 88.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.447 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -71.14 -25.7 62.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.788 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -77.14 -50.02 13.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.684 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 pt -66.53 -17.83 23.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.286 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.05 59.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.893 0.377 . . . . 0.0 111.586 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.51 ' NE2' ' HA ' ' A' ' 14' ' ' ALA . 77.3 mt-30 -71.55 150.77 44.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.343 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.68 28.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.41 0.624 . . . . 0.0 110.975 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 17' ' ' GLN . 15.0 ptmt -135.94 174.65 10.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.46 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.533 ' CD1' HG12 ' A' ' 84' ' ' VAL . 8.0 tt -85.62 134.64 33.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.413 0.625 . . . . 0.0 111.199 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.9 t -134.98 109.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.963 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.528 ' HB ' ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -103.17 107.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.147 0.975 . . . . 0.0 111.164 177.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.587 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 99.2 t -100.19 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.499 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . . . -127.6 122.58 33.52 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' HG23 ' A' ' 69' ' ' VAL . 95.8 m-85 -73.83 124.79 26.77 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.335 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HH ' ' HA ' ' A' ' 37' ' ' ALA . 6.4 m-30 -118.66 179.25 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.584 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -148.29 144.54 27.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -3.81 28.15 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.05 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -122.16 13.32 10.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 3.7 p -109.43 156.06 20.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.571 0.7 . . . . 0.0 112.617 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.53 -52.36 3.57 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.639 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 72.0 Cg_exo -53.96 -48.44 21.68 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.249 1.966 . . . . 0.0 112.621 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 7.8 p -51.17 -35.51 36.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.188 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.9 tptm -65.2 -53.1 49.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.161 0.288 . . . . 0.0 110.532 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.469 ' O ' ' HG2' ' A' ' 39' ' ' MET . 26.5 ptt? -66.66 -43.34 84.83 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.636 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.49 -18.19 16.75 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.09 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -56.77 -53.22 67.13 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.825 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 34.2 Cg_endo -67.13 -28.2 41.09 Favored 'Trans proline' 0 C--N 1.359 1.107 0 CA-C-N 120.567 1.238 . . . . 0.0 112.428 170.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.542 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.9 mmm -65.91 -56.32 12.35 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.183 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.493 ' CG2' HG13 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -52.86 -31.09 16.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 122.495 0.318 . . . . 0.0 110.74 176.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -61.33 -50.77 71.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.305 0.574 . . . . 0.0 109.599 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 1.4 tmtp? -61.53 -44.49 96.97 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.611 0.719 . . . . 0.0 109.781 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.648 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 76.5 m-85 -66.06 -23.23 66.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.624 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.63 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 83.5 p -74.1 -19.03 60.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -78.16 -23.64 47.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.648 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 5.3 mm100 -87.69 5.54 39.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.338 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 0.6 OUTLIER -99.46 102.14 15.48 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.4 Cg_exo -76.5 -45.93 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.686 1.591 . . . . 0.0 112.692 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.97 1.25 15.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -113.55 153.28 29.03 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.02 129.26 46.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.2 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.63 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.4 OUTLIER -105.06 121.45 43.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.677 -175.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 30.1 m-85 -135.5 144.64 46.45 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.519 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.659 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 11.9 mmtt -128.87 122.51 30.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.587 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.4 mt -98.48 170.75 8.61 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.136 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.08 120.5 34.48 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.41 -8.52 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.16 -28.65 61.41 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.762 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.527 ' CG ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -110.42 -35.65 5.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 169.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.629 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mm? -87.28 52.21 2.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.851 0.358 . . . . 0.0 111.006 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.559 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.48 -37.5 30.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.152 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 13.6 p-10 -66.99 -43.99 81.57 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.046 -0.09 . . . . 0.0 110.766 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.629 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.6 p -66.44 -34.85 72.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 110.614 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.7 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.622 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 33.7 mm-40 -77.47 -30.08 52.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.907 0.384 . . . . 0.0 110.422 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 74.5 mmtt -57.32 -47.95 80.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.289 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -94.26 15.85 16.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.328 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 48.89 52.88 13.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.818 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.424 HG23 ' CD2' ' A' ' 25' ' ' PHE . 97.7 t -81.42 113.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.731 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.7 p -118.55 1.07 11.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.9 154.21 45.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.776 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.94 128.86 20.87 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.773 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.3 171.7 53.63 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.932 -5.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 68.2 m -124.74 116.69 22.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.78 111.66 24.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.185 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.524 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.9 mt -127.49 113.52 16.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.47 127.57 38.01 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.554 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 m-85 -112.59 157.45 21.17 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.122 -176.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.6 tttt -143.26 118.68 10.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.021 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.51 44.77 2.63 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.825 0.85 . . . . 0.0 112.509 -178.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.41 10.09 52.16 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.148 -0.478 . . . . 0.0 113.512 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -109.3 0.06 19.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.033 0.444 . . . . 0.0 110.288 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 28.1 tt0 66.83 179.75 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.554 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.533 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -152.83 -33.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.746 0.308 . . . . 0.0 110.705 173.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.415 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.4 164.49 32.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.79 0.329 . . . . 0.0 111.023 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.3 tttt -145.92 123.81 12.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.568 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.31 133.45 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.76 78.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.196 0.522 . . . . 0.0 111.344 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.83 -172.3 37.11 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.684 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -73.04 97.02 2.25 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.547 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 26.3 p-10 -121.77 66.14 19.94 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 15.3 Cg_exo -66.03 -37.18 27.0 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.092 1.195 . . . . 0.0 110.946 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.92 -41.68 12.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.235 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 91' ' ' ASN . . . -73.03 -17.09 61.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.459 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.674 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.7 tp -56.25 -38.14 53.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 17.5 tppt? -61.5 -31.39 71.38 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.187 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -56.54 -55.61 31.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 174.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.427 ' HB3' HD13 ' A' ' 77' ' ' LEU . . . -74.65 -32.67 62.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.419 0.628 . . . . 0.0 110.751 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.76 -43.17 70.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.613 -172.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.473 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -86.59 -39.22 16.36 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.801 0.334 . . . . 0.0 110.802 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.47 77.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.966 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 42.0 m-80 -104.12 -66.39 0.96 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.554 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.649 -0.691 . . . . 0.0 111.271 179.476 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.706 0.288 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.491 HG22 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -101.92 136.11 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.132 0.491 . . . . 0.0 110.05 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.56 147.43 33.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.976 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -107.14 122.54 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.214 171.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.624 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 13.4 m-85 -76.4 152.67 36.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.215 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.62 -19.55 15.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.364 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.648 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 81.2 p -135.39 156.61 48.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.241 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.514 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.07 -31.88 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -62.91 -38.67 91.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.99 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.648 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.0 mm-40 -60.37 -51.98 67.19 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.355 0.598 . . . . 0.0 110.193 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 15' ' ' ILE . 2.1 t80 -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.727 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.97 -45.43 78.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.455 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.581 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 37.4 t -67.84 -42.1 81.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -61.39 -49.93 74.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 42.0 pt -67.27 -20.86 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.502 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.25 -2.56 58.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.733 0.302 . . . . 0.0 111.672 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.6 mt-30 -81.86 162.68 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.088 0.471 . . . . 0.0 111.08 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.1 26.04 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.687 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 9.0 ptmt -132.14 165.24 24.52 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.525 HD21 HG13 ' A' ' 84' ' ' VAL . 2.7 tm? -76.57 117.28 18.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 59.7 t -114.25 107.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.13 106.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.527 0.68 . . . . 0.0 110.343 175.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.634 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 34.5 t -108.4 143.36 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.551 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -122.32 120.83 35.21 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.338 0.59 . . . . 0.0 112.515 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CE2' HD12 ' A' ' 55' ' ' LEU . 95.4 m-85 -69.89 118.98 13.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.366 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -127.34 176.48 7.4 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.95 -164.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.29 146.87 14.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.165 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 p -84.48 -4.46 58.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -116.35 51.63 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -151.7 171.07 18.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.92 -54.16 2.83 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.632 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 35' ' ' MET . 74.9 Cg_exo -53.11 -35.0 70.98 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.321 2.014 . . . . 0.0 112.406 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 p -65.6 -32.23 73.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.948 0.404 . . . . 0.0 111.027 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -68.39 -34.46 76.07 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.205 -0.309 . . . . 0.0 110.927 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.561 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -80.7 -49.78 10.76 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.614 HD13 ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -76.75 -22.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.181 -0.949 . . . . 0.0 111.352 -175.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.77 -49.09 95.69 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.411 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 35' ' ' MET . 32.8 Cg_exo -63.47 -37.42 48.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.34 1.36 . . . . 0.0 111.806 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mmm -65.61 -61.6 1.99 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.449 HD13 HD12 ' A' ' 36' ' ' ILE . 57.7 mt -66.33 -19.1 25.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 118.58 0.627 . . . . 0.0 111.377 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.2 tt0 -60.84 -46.06 92.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.697 0.76 . . . . 0.0 109.471 167.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 23.1 ttmt -66.12 -42.09 89.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.601 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.599 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.1 m-30 -71.65 -17.42 62.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.312 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.788 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 96.9 p -77.67 -16.89 58.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -83.86 -19.05 35.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.405 168.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.606 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 10.0 mm100 -95.18 -1.08 52.53 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.585 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 9.0 m-30 -100.51 101.48 15.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.263 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.9 Cg_exo -80.61 -43.98 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.659 2.239 . . . . 0.0 112.438 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -107.84 7.23 28.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.882 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . . . -123.81 143.41 50.34 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.47 46.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.949 0.88 . . . . 0.0 111.014 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.788 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.6 OUTLIER -106.7 119.15 38.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.535 -169.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' HA ' HG23 ' A' ' 2' ' ' VAL . 29.0 m-85 -135.77 155.11 50.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -132.19 130.07 40.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.634 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 76.8 mt -95.34 128.42 42.17 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.128 -0.358 . . . . 0.0 111.128 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -70.91 97.53 1.44 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 168.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -19.7 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.53 -35.86 72.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.091 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.498 ' HG3' HD21 ' A' ' 60' ' ' LEU . 9.3 pt-20 -110.05 -38.59 5.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.462 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.619 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mm? -78.19 50.74 0.93 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.98 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.33 -42.05 24.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.644 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.7 p-10 -62.76 -46.71 86.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.315 0.103 . . . . 0.0 110.936 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.619 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -63.17 -38.56 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 110.254 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.91 70.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.547 ' HA ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -75.95 -40.06 54.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.153 0.501 . . . . 0.0 109.748 -177.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.644 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 58.4 mttm -59.34 -40.69 87.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.626 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -89.89 6.17 43.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.544 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 57.72 52.06 8.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.506 HG11 ' OG1' ' A' ' 74' ' ' THR . 57.1 t -75.52 116.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.856 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -113.93 -62.41 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.875 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.17 116.55 29.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.999 0.428 . . . . 0.0 110.568 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.68 145.95 30.79 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.464 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.06 162.03 92.58 Favored 'Cis proline' 0 C--O 1.235 0.359 0 C-N-CA 123.106 -1.623 . . . . 0.0 112.513 -5.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.506 ' OG1' HG11 ' A' ' 69' ' ' VAL . 52.5 m -118.45 117.24 28.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' CD1' ' HB1' ' A' ' 24' ' ' ALA . 4.3 mm? -102.2 108.62 20.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 31.3 mt -122.12 113.13 19.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.587 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.517 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -99.2 128.34 45.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.055 177.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 34.4 m-85 -112.09 153.71 26.51 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.3 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.594 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 24.1 tptm -135.97 115.0 12.27 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.389 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.594 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 9.8 p30 44.15 38.24 2.25 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.134 0.974 . . . . 0.0 112.731 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.69 7.05 73.61 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.292 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -105.2 -7.12 19.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 77.77 173.29 0.19 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.673 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.525 HG13 HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -147.28 -29.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.699 0.285 . . . . 0.0 110.789 173.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.709 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -161.69 162.68 29.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.21 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.522 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 1.8 tmtp? -142.82 108.99 5.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.33 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.5 t -119.56 143.43 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.17 86.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.761 0.791 . . . . 0.0 111.478 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 50.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.144 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.25 84.83 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.004 0.43 . . . . 0.0 111.005 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.54 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 14.3 p-10 -121.1 83.64 38.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 6.0 Cg_exo -75.14 -38.96 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.58 1.52 . . . . 0.0 111.03 168.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.31 -39.93 13.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.428 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.634 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -73.05 -17.29 61.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.078 0.466 . . . . 0.0 111.238 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.647 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -57.81 -36.72 56.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 31.5 mmmt -56.34 -40.11 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.831 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.634 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 4.0 tp60 -46.48 -60.22 2.49 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 123.346 0.403 . . . . 0.0 110.349 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.474 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -77.37 -29.24 53.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.475 0.655 . . . . 0.0 111.436 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -80.01 -41.37 21.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.956 -170.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.97 -35.65 18.74 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.796 -176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.35 -39.18 78.29 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.709 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 83.7 m-20 -96.16 -60.31 1.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.546 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.61 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 26.3 ptt? . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.948 0.404 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG22 ' HG3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -97.91 145.14 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 -179.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.52 149.83 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.064 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.65 133.25 44.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.691 170.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.6 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.9 m-85 -86.98 164.35 16.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.16 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -117.2 -23.32 7.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.919 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.649 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 39.9 p -132.4 157.4 44.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 112.035 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.68 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -61.43 -35.6 78.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.771 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.649 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.0 mm-40 -61.3 -49.65 76.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.311 0.577 . . . . 0.0 110.345 177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -63.14 -47.9 80.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.498 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.37 -44.42 95.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -67.61 -36.65 81.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.987 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.34 -49.26 61.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 pt -66.36 -20.74 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.94 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HA ' ' N ' ' A' ' 81' ' ' GLY . . . -80.84 -8.83 59.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -72.19 150.38 43.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.43 53.57 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.692 0.758 . . . . 0.0 110.221 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 10.0 ptmt -153.08 173.75 15.07 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.332 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.543 ' CD2' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -75.5 111.28 10.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.1 t -122.62 107.67 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.868 0.366 . . . . 0.0 110.442 169.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.13 115.36 47.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.56 0.695 . . . . 0.0 111.271 175.024 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.6 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 84.3 t -103.26 140.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.964 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.09 138.33 54.45 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CE2' HG23 ' A' ' 69' ' ' VAL . 71.5 m-85 -90.2 128.04 36.27 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.436 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 3.0 m-85 -120.68 -171.72 2.24 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.555 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.02 169.7 16.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.524 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.76 -30.34 69.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.591 0.71 . . . . 0.0 110.309 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -91.37 -138.84 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.5 p 56.3 110.41 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.73 1.212 . . . . 0.0 113.942 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.49 98.68 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.266 -1.334 . . . . 0.0 114.176 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.662 ' O ' HG21 ' A' ' 36' ' ' ILE . 31.5 Cg_exo -60.14 -41.76 49.06 Favored 'Trans proline' 0 C--N 1.36 1.139 0 CA-C-N 120.221 2.011 . . . . 0.0 111.663 -178.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.658 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 29.3 m -51.37 -43.21 61.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.466 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.3 mmtt -62.87 -55.54 25.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -63.87 -48.0 78.42 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.662 HG21 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -75.51 -11.59 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.897 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -58.21 -57.49 25.73 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.292 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 28.1 Cg_endo -64.91 -34.01 50.09 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 120.025 1.044 . . . . 0.0 111.958 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.489 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.8 mtt -64.7 -60.94 2.53 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.892 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.565 HG21 ' CE2' ' A' ' 52' ' ' PHE . 17.4 mt -58.56 -25.47 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 118.228 0.467 . . . . 0.0 112.109 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.61 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 8.3 tp10 -61.31 -41.01 96.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 172.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.96 -46.04 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.826 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.67 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 66.0 m-85 -65.09 -24.38 67.43 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.267 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.647 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 33.9 t -85.57 -14.45 45.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.857 0.837 . . . . 0.0 109.232 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -84.27 -19.84 33.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.67 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 18.1 pt20 -104.66 26.01 9.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.869 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.58 ' HD1' ' O ' ' A' ' 43' ' ' PHE . 2.4 m-85 -97.97 89.95 0.85 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.44 166.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.22 -46.17 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.91 1.74 . . . . 0.0 112.714 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -11.45 14.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 149.27 24.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.98 126.87 50.33 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.637 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.647 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -110.15 125.5 53.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.54 -177.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 27.5 m-85 -130.96 143.4 50.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HD3' ' CG2' ' A' ' 40' ' ' ILE . 31.6 mtmt -133.02 119.9 20.66 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 5.7 mt -97.54 163.9 12.66 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.729 -173.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.67 111.74 24.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.208 0.528 . . . . 0.0 109.788 174.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -66.58 -15.4 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.481 -171.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.34 -26.62 63.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -106.89 -39.28 5.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.356 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.503 HD12 ' CG2' ' A' ' 63' ' ' VAL . 3.0 mm? -88.09 41.65 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.366 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -70.2 -35.29 70.18 Favored Glycine 0 CA--C 1.504 -0.616 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.45 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 29.7 m-20 -63.36 -40.61 97.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 109.951 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 60' ' ' LEU . 86.0 t -63.2 -42.42 96.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.246 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.28 83.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.126 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 24.0 mt-30 -71.72 -33.06 68.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.526 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 69.0 mttm -57.17 -40.9 78.25 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.438 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -96.44 10.34 38.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.101 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 55.91 40.7 30.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.625 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.565 HG23 ' CE2' ' A' ' 25' ' ' PHE . 49.2 t -83.0 127.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.347 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.4 t -134.14 -26.67 1.47 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.283 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.86 114.94 29.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 0.0 110.04 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 147.09 32.94 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.002 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.472 ' HD2' ' CA ' ' A' ' 90' ' ' ALA . 2.6 Cg_endo -84.23 161.98 68.23 Favored 'Cis proline' 0 N--CA 1.461 -0.424 0 C-N-CA 124.17 -1.179 . . . . 0.0 111.497 -8.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 m -119.64 121.32 39.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.83 109.93 21.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.607 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.539 HD22 ' HG2' ' A' ' 86' ' ' LYS . 7.6 mt -125.31 114.86 19.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.593 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -90.8 122.52 33.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.99 174.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.3 m-85 -106.31 162.19 13.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.36 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' HG2' HD21 ' A' ' 80' ' ' ASN . 24.7 ttmm -150.51 133.45 16.02 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.346 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.509 HD21 ' HG2' ' A' ' 79' ' ' LYS . 11.5 p30 48.02 29.79 1.85 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.056 0.942 . . . . 0.0 112.618 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.515 ' N ' ' HA ' ' A' ' 16' ' ' ALA . . . 74.69 9.38 82.61 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.855 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.673 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 13.4 tttp -107.25 -65.41 1.1 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.673 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 18.0 tt0 161.42 -178.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 123.976 0.798 . . . . 0.0 109.064 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 77' ' ' LEU . 2.2 p -154.53 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -160.45 165.1 31.64 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.906 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.539 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.7 tmtp? -142.7 119.52 11.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.257 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 t -131.55 144.1 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.74 91.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.888 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.8 53.59 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.643 172.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.472 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.31 86.76 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 111.303 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.561 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 14.2 p-10 -122.39 85.34 47.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.486 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 5.7 Cg_exo -77.34 -39.46 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.218 1.279 . . . . 0.0 110.308 166.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.641 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.47 -36.11 16.65 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.276 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.561 ' HB1' ' CB ' ' A' ' 91' ' ' ASN . . . -75.39 -17.33 60.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.136 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.69 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.8 tp -58.06 -37.95 64.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 170.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 19.4 mmtp -55.41 -37.37 67.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.914 0.758 . . . . 0.0 110.647 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.3 tm0? -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 176.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.16 -24.81 51.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.304 0.573 . . . . 0.0 111.352 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.69 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -78.01 -42.81 28.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.916 -173.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.45 -32.39 22.32 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.703 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.44 -41.62 93.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.274 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.528 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 41.2 m-80 -110.86 -90.39 0.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.859 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.713 -168.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.695 0.283 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -121.14 131.65 72.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.16 0.505 . . . . 0.0 110.913 178.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -81.83 147.92 29.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.918 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.67 130.17 51.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.953 172.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.621 ' H ' HD23 ' A' ' 55' ' ' LEU . 13.0 m-85 -84.52 159.72 20.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -117.07 -19.06 9.9 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 25.7 p -135.01 153.65 52.01 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.779 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.96 -33.69 70.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 m -59.07 -36.34 74.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.106 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.555 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 39.4 mm-40 -65.99 -47.73 73.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.492 0.663 . . . . 0.0 110.062 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.409 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 1.6 t80 -62.15 -44.14 97.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.079 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -55.33 -49.53 71.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.893 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -67.46 -37.58 83.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.205 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.95 58.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 pt -68.04 -19.99 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.227 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 -13.8 59.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.975 0.417 . . . . 0.0 110.945 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -75.57 145.08 41.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.04 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.43 47.45 0.93 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.453 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 6.8 ptmt -138.96 168.35 20.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.064 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' HG13 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -74.92 105.84 6.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.214 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 53' ' ' TYR . 53.5 t -114.58 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 173.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.86 109.41 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.642 0.734 . . . . 0.0 110.74 175.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 66.2 t -103.17 135.19 41.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.052 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 54' ' ' LYS . . . -121.63 111.44 17.21 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 121.072 0.463 . . . . 0.0 112.093 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 69' ' ' VAL . 96.3 m-85 -69.05 112.56 5.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.227 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.666 ' OH ' HD12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.03 177.44 5.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.11 147.45 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.454 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 p -84.62 -4.72 59.14 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -117.24 53.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.63 173.08 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.77 2.56 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.238 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.496 ' O ' HG23 ' A' ' 36' ' ' ILE . 75.5 Cg_exo -51.56 -40.86 63.06 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.461 2.108 . . . . 0.0 112.142 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.402 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 8.5 p -66.04 -29.7 70.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.231 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -68.64 -35.91 77.9 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.943 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.55 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptm -80.84 -46.93 14.54 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.666 HD12 ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -75.93 -22.8 16.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.924 -175.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -58.46 -46.73 99.6 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.352 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 35' ' ' MET . 45.6 Cg_exo -59.96 -40.59 60.65 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.692 1.594 . . . . 0.0 112.395 167.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -65.02 -53.75 41.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -58.86 -35.71 57.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 9.5 tp10 -54.48 -47.45 72.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.503 0.668 . . . . 0.0 109.883 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -62.54 -48.89 77.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.631 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.652 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 12.1 m-30 -67.08 -17.27 64.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 29.0 p -87.25 -11.87 48.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.63 -24.18 29.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 168.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.652 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -119.36 36.38 4.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.722 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.475 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -99.55 90.66 1.27 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 122.039 0.924 . . . . 0.0 111.746 171.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 18.0 Cg_exo -65.35 -46.39 5.75 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.051 1.834 . . . . 0.0 113.359 -170.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -111.35 -7.7 14.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.91 163.18 12.36 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 111.656 -167.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.6 126.27 51.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.245 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.575 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 3.4 m-30 -99.57 121.69 41.55 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.689 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 29.9 m-85 -129.08 134.94 48.3 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 10.7 ttpp -127.45 117.43 22.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 5' ' ' PHE . 3.9 mt -96.13 156.99 16.1 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -165.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -91.25 99.15 12.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -18.65 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.271 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.76 -37.49 84.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.083 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.96 -38.49 10.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.036 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.639 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.09 49.55 1.65 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.643 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.35 34.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.659 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 12.5 p-10 -66.02 -40.73 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.523 0.202 . . . . 0.0 111.118 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.639 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -72.98 -35.08 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.47 -36.99 74.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.125 0.488 . . . . 0.0 110.308 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 14.9 mm-40 -73.4 -29.8 62.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.416 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 30.0 mtpp -61.91 -40.95 97.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -95.77 12.94 28.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.397 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 59.79 40.56 19.4 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.096 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 25' ' ' PHE . 75.0 t -76.95 110.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.857 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 p -113.57 -1.64 14.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.37 143.05 43.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.473 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.33 128.0 26.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 89.1 Cg_endo -84.1 170.57 50.34 Favored 'Cis proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.514 -5.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.7 m -121.89 122.75 40.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.946 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.471 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 3.9 mm? -107.65 110.47 22.35 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 86' ' ' LYS . 36.7 mt -126.81 119.37 26.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.356 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.881 173.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 26.1 m-85 -108.86 158.97 17.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.603 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 36.3 ttmt -143.44 116.03 8.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.338 173.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.577 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 10.9 p30 47.6 31.48 2.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.399 1.079 . . . . 0.0 112.816 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 10.07 79.0 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.851 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 12.4 tptm -106.22 -2.61 22.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.989 0.899 . . . . 0.0 108.629 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 40.7 mt-10 71.75 -178.47 0.21 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.888 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 ' CD2' ' A' ' 20' ' ' LEU . 1.3 p -152.06 -29.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.976 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.78 161.29 36.96 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.632 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HG2' HD21 ' A' ' 76' ' ' LEU . 1.4 tmtp? -143.24 115.84 8.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.971 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t -132.21 143.51 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 109.935 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.65 90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.686 0.755 . . . . 0.0 111.305 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.38 54.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.005 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 56.03 86.68 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.51 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.56 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 16.6 p-10 -125.13 89.41 52.66 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HG2' ' HE3' ' A' ' 35' ' ' MET . 1.2 Cg_endo -82.55 -29.68 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.965 1.777 . . . . 0.0 110.217 165.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 -49.07 6.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -72.61 -18.4 61.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.442 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.629 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -61.33 -37.67 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.59 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 24.3 tptp -60.94 -30.57 70.3 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.132 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -60.13 -53.24 60.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.952 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 77' ' ' LEU . . . -74.11 -33.98 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.587 0.708 . . . . 0.0 111.422 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -74.62 -37.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.414 -171.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.62 -44.42 11.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.054 0.454 . . . . 0.0 110.831 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.8 80.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.72 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.2 -61.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.791 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.369 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.449 ' CG2' ' HE3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -80.5 132.28 32.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.4 0.619 . . . . 0.0 110.417 -178.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.4 148.13 43.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.818 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.415 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -114.39 114.26 25.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.146 174.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.509 ' H ' HD23 ' A' ' 55' ' ' LEU . 20.0 m-85 -67.68 163.74 20.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.036 0.446 . . . . 0.0 110.076 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -130.23 -13.09 3.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.259 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.709 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 70.6 p -135.48 152.68 51.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.56 -27.22 68.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.615 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 p -68.8 -36.73 78.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.061 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.709 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 24.7 mm-40 -63.03 -46.72 86.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 109.778 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 3.8 t80 -63.16 -45.92 89.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.127 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.98 -49.33 76.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.858 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -66.68 -36.48 82.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.415 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.39 -52.16 55.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.792 0.329 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.79 -19.9 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.09 -9.02 59.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.708 0.289 . . . . 0.0 111.625 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -75.88 146.52 39.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.643 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.426 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 38.2 t70 -72.98 8.97 1.3 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.293 0.568 . . . . 0.0 111.827 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -111.53 178.34 4.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.026 0.441 . . . . 0.0 111.065 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.49 ' CD2' ' HD2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -76.06 108.07 8.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.768 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 14' ' ' ALA . 65.7 t -111.06 106.84 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.504 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.22 109.23 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.616 0.722 . . . . 0.0 111.128 175.263 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG22 HG13 ' A' ' 21' ' ' VAL . 92.9 t -102.47 143.48 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.747 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 26' ' ' TYR . . . -127.12 138.1 53.11 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.196 0.522 . . . . 0.0 111.715 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -101.04 103.38 14.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.516 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.658 ' CZ ' HD13 ' A' ' 36' ' ' ILE . 7.5 m-85 -128.22 178.4 6.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.759 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . . . -154.97 137.73 15.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.274 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -72.36 -6.04 40.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.417 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 13.7 p-90 -106.29 19.56 20.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.299 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.935 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -122.69 132.97 54.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.629 0.728 . . . . 0.0 110.965 178.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.46 88.84 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.628 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.935 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 22.2 Cg_exo -65.44 -31.81 50.94 Favored 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 120.29 2.045 . . . . 0.0 109.868 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.596 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 63.7 m -54.3 -41.13 68.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.154 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.675 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -62.98 -57.03 12.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.923 -178.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 ptm -55.55 -48.14 75.24 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -173.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.658 HD13 ' CZ ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.89 -23.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.99 -177.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -55.19 -49.63 91.22 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.91 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 11.0 Cg_exo -72.98 -29.74 11.68 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 120.718 1.292 . . . . 0.0 111.849 171.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.7 mmt -66.49 -60.32 2.84 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.2 mt -62.68 -30.68 49.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.156 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 27.9 tt0 -50.03 -48.22 52.86 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.066 0.46 . . . . 0.0 110.361 172.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -65.5 -41.97 92.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.598 0.714 . . . . 0.0 110.023 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.669 ' HA ' ' CG ' ' A' ' 46' ' ' GLN . 7.3 m-30 -63.89 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.302 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 1.006 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 4.0 m -74.47 -23.16 58.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.36 -20.51 51.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.554 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.669 ' CG ' ' HA ' ' A' ' 43' ' ' PHE . 17.2 pt20 -112.9 22.89 13.98 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' CE1' HD12 ' A' ' 99' ' ' ILE . 8.4 m-30 -100.44 100.29 11.77 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 163.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 14.1 Cg_exo -70.04 -44.72 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.769 1.646 . . . . 0.0 111.891 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -2.71 15.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -106.08 142.85 35.09 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.885 -0.509 . . . . 0.0 110.795 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.32 126.12 42.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.502 0.668 . . . . 0.0 111.301 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 1.006 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.7 OUTLIER -105.36 114.18 28.2 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.782 -173.213 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.6 142.09 50.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 110.74 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.99 119.55 27.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 5' ' ' PHE . 5.1 mt -101.73 161.81 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.273 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -102.8 115.05 29.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.628 0.728 . . . . 0.0 109.093 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -13.62 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.296 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.14 -35.12 79.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.185 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -96.84 -35.64 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.682 172.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.5 HD12 HG21 ' A' ' 63' ' ' VAL . 1.9 mm? -97.83 42.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.761 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.597 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -74.72 -40.81 36.42 Favored Glycine 0 CA--C 1.504 -0.628 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.694 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.64 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 9.7 p-10 -64.3 -34.59 78.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.5 HG21 HD12 ' A' ' 60' ' ' LEU . 87.8 t -65.31 -43.18 95.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.127 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.991 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 83.2 mm-40 -72.76 -36.31 67.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.3 mttm -61.6 -34.72 76.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.69 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -100.82 16.97 23.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 54.34 47.3 23.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.86 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.5 t -98.61 116.4 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.132 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 p -118.87 0.41 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.93 124.63 35.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 154.91 42.16 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.36 168.82 71.05 Favored 'Cis proline' 0 CA--C 1.533 0.43 0 C-N-CA 124.018 -1.243 . . . . 0.0 111.88 -6.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 m -137.26 128.35 27.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.511 -169.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.512 ' HB2' HD22 ' A' ' 91' ' ' ASN . 3.8 mm? -115.98 108.61 16.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.077 0.465 . . . . 0.0 110.357 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 20.1 mt -123.95 113.69 18.8 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.26 125.42 35.49 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.31 177.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 83.8 m-85 -110.47 148.11 32.73 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.119 -177.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HD2' ' CD2' ' A' ' 20' ' ' LEU . 8.5 mtpm? -146.2 126.16 13.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 10.8 p30 45.7 29.2 0.64 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.451 1.1 . . . . 0.0 112.733 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.03 17.03 73.31 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.188 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 31.6 pttt -114.75 -1.26 13.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.414 0.626 . . . . 0.0 109.531 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 42.6 mt-10 75.48 -172.55 0.11 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.356 -175.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' A' ' 77' ' ' LEU . 1.4 p -162.3 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.619 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -153.26 162.42 41.32 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.796 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.2 tmtp? -144.64 109.18 4.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.937 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.2 t -121.51 143.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.31 89.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.686 0.755 . . . . 0.0 111.596 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.0 62.96 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.923 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 50.68 81.27 0.07 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.639 0.376 . . . . 0.0 111.582 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 17.4 p-10 -117.71 88.0 28.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -172.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 2.6 Cg_endo -79.53 -34.42 1.04 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.762 1.641 . . . . 0.0 110.543 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.11 -44.63 10.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.39 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . . . -72.48 -17.02 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.455 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.697 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.0 tp -56.16 -39.4 58.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HD3' ' CG2' ' A' ' 99' ' ' ILE . 15.6 mmtt -59.71 -36.79 77.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.664 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -52.16 -57.36 9.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.859 174.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.35 -30.1 60.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.55 -39.63 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.679 -170.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.424 ' N ' HG22 ' A' ' 99' ' ' ILE . . . -86.42 -31.59 21.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.971 0.415 . . . . 0.0 110.452 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.83 62.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.209 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -98.06 -67.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.704 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.718 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HA ' ' HG3' ' A' ' 41' ' ' GLU . 12.8 tpt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.548 HG23 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m -109.51 147.65 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 0.0 111.072 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.4 ' N ' HG21 ' A' ' 2' ' ' VAL . 0.9 OUTLIER -82.86 147.81 28.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.152 -176.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -98.68 134.42 41.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.905 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.63 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.0 m-85 -90.95 141.85 28.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -97.16 -14.84 21.22 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.715 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 62.6 p -132.58 153.13 51.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.94 0.4 . . . . 0.0 111.241 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.488 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -62.33 -28.66 69.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 172.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 t -66.19 -37.73 86.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.378 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.4 mm-40 -58.54 -49.15 78.44 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.424 0.631 . . . . 0.0 110.257 176.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.9 -44.9 88.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.992 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.81 -46.57 84.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -65.43 -33.69 76.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.147 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.14 -49.51 43.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.425 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 31.5 pt -67.93 -15.09 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.595 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.27 -8.33 58.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 0.0 111.171 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.5 mt-30 -76.35 153.89 35.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.571 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 20.2 t70 -68.47 2.56 2.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.554 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 17' ' ' GLN . 4.0 ptpt -109.45 -179.51 3.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.638 0.732 . . . . 0.0 111.507 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.579 ' HG ' ' HB3' ' A' ' 103' ' ' ALA . 1.3 tm? -86.53 114.15 23.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.659 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.1 t -118.77 111.17 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.1 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.471 ' HB ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -105.64 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.558 0.694 . . . . 0.0 111.058 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.625 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 22.6 t -111.4 143.45 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.329 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.49 ' HB2' ' HG2' ' A' ' 54' ' ' LYS . . . -120.49 123.94 44.19 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.2 m-85 -70.47 130.43 41.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.658 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -136.45 -178.19 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.349 -164.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -167.91 157.19 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.102 173.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -84.9 -5.34 59.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 111.256 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -117.31 42.28 2.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.93 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -144.07 123.47 13.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.575 0.702 . . . . 0.0 112.002 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.46 -44.13 98.0 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.438 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.26 -40.06 79.22 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 119.868 1.834 . . . . 0.0 111.232 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.582 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 22.9 m -56.86 -37.83 71.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 60.2 tttm -63.2 -53.54 51.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.897 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.653 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptp -60.34 -48.07 83.35 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.588 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.6 -18.6 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.435 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -57.48 -48.82 96.63 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.189 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.721 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.3 Cg_exo -72.55 -30.15 12.48 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.225 1.283 . . . . 0.0 111.878 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 35' ' ' MET . 24.8 mmt -64.47 -60.0 3.67 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.755 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.433 HD12 ' CG1' ' A' ' 36' ' ' ILE . 30.4 mt -65.4 -20.8 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 111.297 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 29.4 tt0 -59.68 -46.93 87.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.494 0.664 . . . . 0.0 109.692 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -64.98 -45.88 83.8 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.773 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.6 m-30 -63.71 -25.03 68.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.67 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.801 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 87.4 p -76.36 -19.67 57.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -83.08 -16.1 48.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.982 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.672 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -120.36 28.24 8.13 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 14.0 m-30 -101.07 100.44 13.11 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.493 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.28 -43.41 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 121.944 1.763 . . . . 0.0 112.623 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -95.93 -22.94 17.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 111.947 -173.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . . . -102.74 149.55 24.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.439 0.638 . . . . 0.0 110.879 -172.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.9 m-20 -104.3 133.27 49.48 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.752 176.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.801 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.7 p90 -110.39 116.28 31.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.628 -169.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 20.4 m-85 -137.33 158.47 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.18 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.658 ' HD2' ' CE1' ' A' ' 26' ' ' TYR . 10.4 mtmp? -141.36 127.38 19.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.718 0.294 . . . . 0.0 110.75 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.63 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 56.8 mt -95.49 129.14 42.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.218 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.69 119.25 18.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 166.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.27 -11.87 12.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.573 -173.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.22 -46.32 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.486 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.97 -31.8 31.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.062 0.458 . . . . 0.0 110.16 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.614 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.2 mm? -103.0 52.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.651 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.96 -40.83 20.02 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.414 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 26.4 t70 -64.35 -49.08 73.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.537 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -60.59 -38.25 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.392 . . . . 0.0 110.27 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.97 85.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.139 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -74.13 -34.94 64.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.421 . . . . 0.0 110.546 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 45.3 mtmt -61.99 -35.63 79.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.906 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -97.87 14.16 28.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.45 38.47 25.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.967 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.404 HG21 ' CD2' ' A' ' 25' ' ' PHE . 84.7 t -82.68 127.03 40.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.3 p -125.06 -56.56 1.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.406 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 159.75 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.659 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.96 144.8 42.76 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 111.493 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 63.3 Cg_endo -75.84 167.71 79.44 Favored 'Cis proline' 0 C--O 1.237 0.467 0 C-N-CA 123.03 -1.654 . . . . 0.0 111.694 -10.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 46.9 m -124.25 116.86 23.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.419 ' HB2' HD22 ' A' ' 91' ' ' ASN . 4.1 mm? -103.47 108.98 20.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.264 -174.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 33.3 mt -124.05 113.95 19.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.471 HD23 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.39 130.24 40.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.627 174.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 47.7 m-85 -111.2 160.05 17.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.605 -175.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.545 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 14.6 tppt? -144.04 124.11 13.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.592 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.545 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 0.3 OUTLIER 35.39 48.74 0.43 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 18.59 59.88 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.691 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -125.37 7.38 7.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.976 0.388 . . . . 0.0 110.785 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.36 176.51 0.25 Allowed 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.774 0.671 . . . . 0.0 109.572 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.548 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -146.28 -34.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.942 0.401 . . . . 0.0 110.422 172.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.479 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -158.86 161.18 36.82 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.514 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.6 tttt -140.97 122.22 14.81 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.13 136.51 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.2 88.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.752 0.787 . . . . 0.0 111.504 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.89 62.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.767 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 58.81 94.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.937 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 16.9 p-10 -132.93 80.12 61.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.439 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 2.8 Cg_exo -73.82 -41.08 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.367 1.378 . . . . 0.0 111.149 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.19 -39.72 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.113 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 91' ' ' ASN . . . -72.0 -17.57 62.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.269 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.1 tp -57.62 -38.1 62.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 20.4 mmtp -57.56 -36.95 72.32 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.796 0.685 . . . . 0.0 110.621 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -53.29 -57.05 11.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.88 175.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.39 -36.59 63.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.553 0.692 . . . . 0.0 110.818 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.37 -40.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.853 -171.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.09 -34.94 18.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.814 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.22 -35.29 68.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 50.5 m-80 -98.44 -59.82 1.67 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.507 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.579 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.047 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.3 m -97.43 145.69 8.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.419 0.628 . . . . 0.0 111.237 -174.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.62 145.44 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.917 -176.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.457 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -103.44 122.9 45.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.592 174.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 7.2 m-85 -76.07 165.84 24.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.009 0.433 . . . . 0.0 110.168 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -116.89 -30.0 5.85 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.528 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 19.4 p -127.2 145.27 50.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.004 0.43 . . . . 0.0 111.805 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.617 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -53.18 -40.41 64.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.766 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -61.03 -38.75 87.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.988 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 19.4 pt-20 -81.06 -22.03 39.58 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.817 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 3.3 t80 -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 168.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' HA ' HG12 ' A' ' 15' ' ' ILE . 4.8 m-20 -59.23 -38.66 80.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.151 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 t -66.46 -37.93 86.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -50.27 62.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 110.659 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.468 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 33.4 pt -69.97 -14.76 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.573 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.07 -6.19 59.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.95 0.405 . . . . 0.0 111.408 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.457 ' C ' ' H ' ' A' ' 19' ' ' LYS . 77.9 mt-30 -88.39 161.11 17.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.082 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 5.4 m-20 -76.44 27.81 0.12 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 17' ' ' GLN . 23.4 mtpp -108.05 178.06 4.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 122.069 0.938 . . . . 0.0 112.756 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.578 ' CD2' HG12 ' A' ' 84' ' ' VAL . 1.2 tm? -94.8 104.93 16.84 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.885 172.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.9 t -114.01 107.67 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.896 0.379 . . . . 0.0 110.96 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.482 ' HB ' HD23 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -104.72 107.49 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.472 0.653 . . . . 0.0 110.728 175.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 27.0 t -108.95 133.02 55.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.793 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -108.54 122.41 47.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -74.12 127.84 33.97 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.118 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 2.3 m-85 -120.02 -171.46 2.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.145 -175.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.02 31.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.055 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.9 p -79.99 -4.81 54.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.166 0.508 . . . . 0.0 110.993 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -131.93 54.17 1.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.7 p -145.56 116.76 7.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.475 0.655 . . . . 0.0 112.257 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -66.47 -37.94 93.08 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.234 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 36' ' ' ILE . 31.6 Cg_exo -61.52 -35.32 82.66 Favored 'Trans proline' 0 C--N 1.36 1.18 0 CA-C-N 120.233 2.016 . . . . 0.0 111.408 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.65 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 57.1 m -54.6 -38.81 67.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.242 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.718 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.1 tptm -63.75 -54.81 29.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.675 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.0 ptp -59.98 -48.63 80.93 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.603 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.07 -16.29 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.207 -178.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -56.62 -50.31 88.62 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.787 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.718 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.4 Cg_exo -71.83 -31.4 12.92 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.1 1.2 . . . . 0.0 111.871 171.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 94.6 mmm -63.91 -59.46 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.161 -0.615 . . . . 0.0 112.006 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.41 HD12 HG13 ' A' ' 36' ' ' ILE . 53.4 mt -67.18 -19.4 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.03 -0.419 . . . . 0.0 111.428 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.3 tt0 -64.48 -43.29 94.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.478 0.656 . . . . 0.0 109.39 168.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 15.5 tttm -63.6 -39.76 95.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.681 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.2 m-30 -74.45 -15.16 60.91 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.741 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.795 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 25.1 p -74.71 -18.14 60.55 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -84.86 -21.75 29.67 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.899 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.681 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 6.5 mt-30 -95.98 5.48 51.1 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.488 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 3.8 m-30 -104.17 98.61 14.35 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.642 172.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 6.6 Cg_exo -73.83 -43.8 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.28 1.986 . . . . 0.0 112.201 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -108.52 -13.61 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.3 163.45 12.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.125 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.23 135.82 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.046 0.927 . . . . 0.0 112.568 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.795 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.8 p90 -115.02 116.94 29.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.468 -171.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 22.0 m-85 -136.33 158.64 43.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.638 ' HD2' ' CE1' ' A' ' 26' ' ' TYR . 10.3 mtmp? -142.58 129.49 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 110.969 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.657 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 18.2 mt -107.01 176.91 5.02 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.525 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 6.7 p-10 -131.24 130.49 42.95 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 26' ' ' TYR . 32.7 m -69.29 -8.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.71 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.06 -40.91 74.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.333 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -101.24 -28.11 12.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.666 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.643 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.9 mm? -101.11 53.66 0.84 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.01 -43.07 23.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.127 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 13.2 t70 -66.3 -45.61 79.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.861 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.643 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -61.42 -39.22 82.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.112 0.482 . . . . 0.0 110.142 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.62 -36.93 72.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.103 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 12.0 mm-40 -79.02 -31.51 44.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 38.5 mtmt -62.56 -37.4 86.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.0 110.458 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -96.0 8.17 44.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.21 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 55.44 45.96 24.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.892 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.482 HG13 ' OG1' ' A' ' 74' ' ' THR . 69.6 t -69.71 124.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.814 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -139.33 31.29 2.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.044 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.08 152.62 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.5 112.43 32.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.06 172.72 30.95 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.921 -0.866 . . . . 0.0 112.275 -0.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.482 ' OG1' HG13 ' A' ' 69' ' ' VAL . 92.3 m -120.31 115.89 24.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -102.39 108.65 20.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.826 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.515 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 30.7 mt -125.43 113.05 17.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.485 ' O ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -94.16 122.06 36.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.022 174.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 42.2 m-85 -106.85 152.89 23.28 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.457 -174.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 87.1 tttt -138.71 122.05 17.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.801 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.473 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.68 44.28 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.146 0.979 . . . . 0.0 112.67 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 17.41 57.46 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.206 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -116.43 -5.33 11.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.089 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 22.9 tt0 75.06 168.85 0.29 Allowed 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.648 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.578 HG12 ' CD2' ' A' ' 20' ' ' LEU . 1.2 p -136.66 -33.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.84 163.91 34.06 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.74 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.515 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.3 tttt -143.13 125.1 15.21 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.401 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.5 t -131.13 130.5 63.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.97 82.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.44 -170.44 35.1 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.791 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . . . -70.31 93.83 0.88 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 26.8 p-10 -121.77 67.33 21.91 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.5 -35.21 13.85 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 120.915 1.077 . . . . 0.0 110.743 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.62 -39.87 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.074 177.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . . . -76.25 -17.86 59.29 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.462 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.697 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.3 tp -57.3 -40.06 71.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 12.3 mmmm -57.94 -34.76 70.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.799 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.47 -58.14 8.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.21 64.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.635 0.731 . . . . 0.0 110.952 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -81.16 -38.94 17.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.483 -169.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.46 -36.78 18.86 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.377 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.84 68.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.277 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.9 m-80 -92.7 -65.05 1.03 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.574 -0.85 . . . . 0.0 112.477 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.522 ' CB ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.787 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.618 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -121.52 141.03 43.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.33 0.586 . . . . 0.0 111.094 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.99 147.56 26.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.313 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.97 137.34 38.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.111 171.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.641 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 9.7 m-85 -90.71 137.96 31.95 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.222 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -90.74 -24.95 20.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.394 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.481 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.1 p -131.67 153.3 50.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.764 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.508 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.63 -34.42 71.16 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 t -62.81 -34.04 76.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.741 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.481 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 20.0 mm-40 -62.58 -49.18 76.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.353 0.596 . . . . 0.0 109.884 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.426 ' O ' HG12 ' A' ' 15' ' ' ILE . 1.7 t80 -62.91 -47.06 84.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.107 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.06 -44.1 78.58 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.346 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 m -70.1 -40.44 74.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.46 67.99 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.821 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.14 -20.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.174 -176.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.34 61.53 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.917 0.389 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' C ' ' H ' ' A' ' 19' ' ' LYS . 46.6 mt-30 -68.24 150.99 47.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.073 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.9 32.89 0.26 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.82 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.7 ptmt -135.57 173.62 11.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.29 -176.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -75.13 112.71 11.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.598 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.37 107.97 20.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.752 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.31 109.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.047 0.927 . . . . 0.0 111.622 176.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 39.5 t -105.02 144.31 14.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.072 177.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 74' ' ' THR . . . -129.51 122.64 29.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CE2' HD11 ' A' ' 55' ' ' LEU . 72.9 m-85 -72.89 115.91 12.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.414 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.706 ' CZ ' HD13 ' A' ' 36' ' ' ILE . 8.5 m-30 -121.91 -178.34 3.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 123.369 0.418 . . . . 0.0 110.358 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.62 34.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.689 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.48 -4.43 58.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.214 0.531 . . . . 0.0 111.139 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -126.16 47.2 2.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.077 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 p -143.1 126.39 16.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.53 0.681 . . . . 0.0 111.728 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.9 -40.44 98.35 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.21 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.724 ' O ' HG22 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -63.08 -38.65 44.46 Favored 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 120.272 2.036 . . . . 0.0 110.921 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 20.5 m -58.46 -31.22 67.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.581 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 87.2 tttt -67.94 -57.03 6.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.491 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 ptp -64.95 -44.38 89.62 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.235 0.54 . . . . 0.0 112.431 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.96 -13.73 14.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 C-N-CA 118.441 -1.304 . . . . 0.0 110.401 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -56.5 -52.35 74.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.085 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 19.8 Cg_endo -64.63 -32.63 57.75 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 120.955 1.103 . . . . 0.0 112.574 169.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.497 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 23.5 mmt -66.92 -55.57 14.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.014 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.803 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -49.0 -38.56 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.599 0.36 . . . . 0.0 110.529 175.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.35 -48.1 79.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 110.692 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -60.0 -51.77 68.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.975 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.0 m-85 -64.09 -19.57 65.34 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.17 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.476 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.1 p -83.6 -22.13 32.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -83.82 -20.99 32.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.656 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.644 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -107.85 16.38 23.59 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.745 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 13.9 m-30 -100.62 101.81 16.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.486 167.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.14 -40.88 2.94 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 121.88 1.72 . . . . 0.0 112.851 174.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -107.73 -16.0 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.09 146.74 27.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 110.88 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 2.2 m-20 -101.01 135.51 42.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.859 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.803 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -113.52 124.52 52.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.607 -177.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.522 ' C ' ' HE2' ' A' ' 54' ' ' LYS . 42.1 m-85 -135.79 147.58 48.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.618 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 8.2 mmpt? -117.23 142.43 47.06 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.641 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 60.6 mt -107.13 142.49 36.73 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.149 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.32 102.48 14.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 167.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -60.26 -15.23 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -171.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.44 -21.8 57.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -108.65 -31.24 7.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.923 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -96.77 52.19 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.818 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.21 -40.73 19.22 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.061 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.605 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 6.3 m-20 -60.56 -49.74 76.34 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.419 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.7 p -62.83 -38.69 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.313 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.44 -35.03 73.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.071 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 55.7 mt-30 -76.27 -37.85 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.38 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 66.0 mttm -57.24 -39.46 75.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.812 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -95.0 6.55 48.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.912 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.84 48.78 17.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.925 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.09 121.13 35.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.688 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -123.27 -16.08 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.732 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.57 161.86 15.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 142.96 26.83 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.519 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 2.9 Cg_exo -78.33 165.31 83.05 Favored 'Cis proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.862 -1.308 . . . . 0.0 111.75 -8.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 86.8 m -123.38 116.84 23.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.433 HD11 ' HB1' ' A' ' 24' ' ' ALA . 4.2 mm? -108.13 108.61 19.74 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -174.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.603 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 18.2 mt -125.71 116.13 21.16 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.814 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -91.53 122.42 34.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.054 173.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 33.5 m-85 -105.46 156.48 18.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.808 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.3 ttpt -142.44 120.09 11.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.378 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.512 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.5 37.11 5.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.8 0.84 . . . . 0.0 111.901 -177.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.16 12.55 50.38 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.746 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 61.7 mttp -120.83 19.47 11.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.553 0.341 . . . . 0.0 110.142 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 10.2 pt-20 61.66 175.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.869 1.356 . . . . 0.0 112.128 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -148.75 -32.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.832 174.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.79 166.92 25.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.081 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.603 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.9 tttt -144.34 126.51 15.61 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.2 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 19.3 t -131.96 138.84 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 87.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.796 0.807 . . . . 0.0 111.593 -170.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.66 63.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.061 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.455 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.28 86.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.111 0.482 . . . . 0.0 111.78 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.546 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . 14.5 p-10 -126.41 78.57 71.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' ILE . 14.5 Cg_exo -68.14 -45.39 2.91 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.448 1.432 . . . . 0.0 110.955 168.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.44 -35.43 18.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.096 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 91' ' ' ASN . . . -76.59 -17.55 59.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.46 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.0 tp -59.18 -38.94 77.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -61.83 -27.37 68.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.995 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.2 tm0? -59.6 -59.66 5.08 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.67 -29.2 64.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.712 0.768 . . . . 0.0 110.503 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.745 HG13 ' CZ ' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -77.62 -39.44 26.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.321 -171.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.2 -34.45 20.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.043 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.24 89.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.63 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 51.2 m-80 -97.33 -63.06 1.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.79 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.4 mmm . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.858 0.361 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.671 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 0.3 OUTLIER -79.59 125.85 38.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.637 0.732 . . . . 0.0 109.709 177.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.2 145.84 55.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.659 -168.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.56 136.35 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.655 170.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.619 ' H ' HD21 ' A' ' 55' ' ' LEU . 16.6 m-85 -88.13 166.13 14.62 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -124.52 -10.29 7.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.464 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 60.1 p -134.44 150.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.68 0.276 . . . . 0.0 110.912 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.477 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.49 -33.68 70.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.3 t -65.73 -36.38 83.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.747 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 51.0 mm-40 -61.29 -44.74 96.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 7.5 t80 -67.55 -49.21 64.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.947 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -59.75 -37.55 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.69 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.4 t -68.29 -40.71 81.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.819 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -64.77 -50.48 66.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.43 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 35.3 pt -66.83 -18.82 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.499 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.44 -10.4 59.05 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.745 0.307 . . . . 0.0 111.589 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 54.8 mt-30 -76.09 153.3 36.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.344 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.4 37.75 0.34 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.86 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.9 ptmt -140.21 167.92 21.01 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.064 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.547 ' HG ' ' CB ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -71.71 107.94 4.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.436 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' A' ' 53' ' ' TYR . 70.2 t -107.55 107.08 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 110.35 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.516 ' HB ' HD21 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -99.0 105.55 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.412 0.625 . . . . 0.0 110.294 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 53.5 t -107.01 139.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.371 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' THR . . . -128.39 122.4 31.34 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CD2' HG21 ' A' ' 69' ' ' VAL . 52.4 m-85 -70.6 124.1 23.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.537 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.683 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.9 m-85 -120.01 -176.86 3.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.612 -174.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HB1' ' SG ' ' A' ' 30' ' ' CYS . . . -161.77 156.68 23.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.144 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -84.09 -4.33 58.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.771 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -120.73 21.97 11.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.44 ' SG ' ' HB1' ' A' ' 27' ' ' ALA . 3.8 p -119.55 150.99 39.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.515 0.674 . . . . 0.0 112.253 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.75 -48.61 4.89 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.803 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 35' ' ' MET . 50.7 Cg_exo -55.25 -47.5 25.83 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.253 1.969 . . . . 0.0 112.307 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.9 p -51.07 -36.8 41.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.257 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.702 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 67.4 mttm -66.46 -50.31 63.76 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 123.212 0.32 . . . . 0.0 111.247 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 22.6 ptp -64.88 -44.7 88.81 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.424 0.631 . . . . 0.0 112.311 -175.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.695 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.0 -16.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.605 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.09 -55.26 47.14 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.909 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.702 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.7 Cg_endo -63.96 -30.42 67.0 Favored 'Trans proline' 0 C--N 1.358 1.054 0 CA-C-N 120.424 1.187 . . . . 0.0 112.1 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 25.4 mmt -65.98 -55.37 17.12 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.291 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.539 ' CG2' ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -57.11 -38.08 58.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.87 175.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -52.48 -47.34 66.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.0 0.429 . . . . 0.0 109.958 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.33 -47.88 83.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.671 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 7.9 m-30 -67.05 -15.34 63.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.075 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.776 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 5.7 m -86.62 -13.71 44.87 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.23 -15.21 31.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.681 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.671 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -126.59 35.66 4.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.23 177.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.453 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -104.31 72.52 0.19 Allowed Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 172.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 88.9 Cg_exo -45.88 -45.64 16.88 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.945 2.43 . . . . 0.0 115.161 -166.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.69 8.53 19.02 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -103.16 165.09 11.23 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.82 -0.55 . . . . 0.0 111.573 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.98 123.37 41.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.776 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.76 124.95 35.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 10.6 m-85 -143.04 136.29 28.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.366 168.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HD3' ' CG2' ' A' ' 40' ' ' ILE . 27.5 mtmt -134.0 120.3 20.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.683 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 4.7 mt -93.11 162.22 14.12 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.646 -167.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.19 108.63 21.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -61.14 -14.42 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.451 -175.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.87 -39.12 93.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -99.68 -32.14 11.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.568 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.99 47.25 1.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.9 -42.13 17.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.789 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 31.1 t70 -65.27 -44.17 88.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 110.956 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.568 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -63.7 -39.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.204 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.79 77.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.5 mm-40 -71.51 -34.34 70.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.928 0.394 . . . . 0.0 110.438 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 40.1 mtmt -61.25 -38.73 87.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.648 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -95.08 15.29 19.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.884 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.6 40.94 26.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.812 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 25' ' ' PHE . 86.4 t -88.9 113.38 25.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.15 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -116.06 -11.41 11.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.37 165.25 12.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.618 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.11 141.71 17.54 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.859 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.449 ' HG3' HD13 ' A' ' 36' ' ' ILE . 60.8 Cg_endo -75.28 163.41 90.62 Favored 'Cis proline' 0 C--O 1.234 0.301 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.795 -10.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.8 m -126.65 118.79 25.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.508 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.3 mt -110.34 107.65 17.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.379 0.609 . . . . 0.0 111.6 -172.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD22 ' HG3' ' A' ' 86' ' ' LYS . 18.9 mt -123.72 113.36 18.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.265 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.33 129.15 43.73 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.841 178.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 59.8 m-85 -112.27 154.09 26.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.441 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -136.52 117.54 14.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.393 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.55 43.83 2.4 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.065 0.853 . . . . 0.0 112.67 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.73 11.12 59.72 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.399 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -111.97 -0.32 15.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 32.9 tt0 69.79 172.77 0.3 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.137 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.46 -33.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.239 172.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -156.11 161.44 40.37 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' HG3' HD22 ' A' ' 76' ' ' LEU . 41.3 tttp -141.83 110.99 6.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.868 177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 t -123.58 135.1 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.23 82.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.951 0.881 . . . . 0.0 111.654 -168.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.5 64.27 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.235 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.433 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 54.78 83.85 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.021 0.438 . . . . 0.0 111.943 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 12.7 p-10 -125.02 83.99 59.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 95' ' ' ILE . 10.8 Cg_exo -74.15 -36.95 2.94 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.753 1.635 . . . . 0.0 111.654 168.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.3 -41.84 12.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 111.104 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.89 -17.37 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.603 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.5 tp -59.63 -38.16 74.28 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.284 171.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 26.7 mmmt -59.53 -32.99 70.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.725 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -54.67 -61.24 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.2 71.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.403 0.62 . . . . 0.0 111.649 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -68.74 -43.23 83.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.707 -171.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.424 ' N ' HG23 ' A' ' 99' ' ' ILE . . . -88.47 -44.17 10.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.909 0.385 . . . . 0.0 111.567 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.11 74.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.485 -175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 56.8 m-80 -92.65 -63.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.003 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.547 ' CB ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.711 -0.661 . . . . 0.0 111.502 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.693 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 51.8 ttm . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -83.21 143.53 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.323 0.582 . . . . 0.0 110.758 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -98.53 147.83 24.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.072 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -102.52 126.6 49.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 171.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.67 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 15.7 m-85 -80.42 157.39 26.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -113.05 -13.96 13.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.227 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -137.27 151.24 48.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.766 0.317 . . . . 0.0 111.126 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.64 67.42 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -63.58 -38.13 89.96 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.231 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 27.4 mm-40 -61.58 -43.14 99.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.468 0.652 . . . . 0.0 109.772 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.433 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 4.4 t80 -68.15 -49.16 62.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.373 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -59.78 -46.06 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 0.0 111.438 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 m -68.68 -25.78 64.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 21' ' ' VAL . . . -75.11 -51.6 13.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.826 0.346 . . . . 0.0 110.555 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.481 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.4 pt -65.22 -19.32 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.617 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.18 59.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.623 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -71.43 160.22 33.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.975 0.417 . . . . 0.0 110.861 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.493 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 4.8 m-20 -81.28 34.46 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.169 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -145.32 170.61 15.97 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.194 -174.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.563 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -72.16 105.44 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.02 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 14' ' ' ALA . 81.6 t -109.25 106.79 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.736 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.73 111.14 31.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.309 0.575 . . . . 0.0 111.116 175.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.667 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 44.8 t -110.69 131.15 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.294 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' THR . . . -109.32 110.82 22.09 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 55' ' ' LEU . 72.0 m-85 -70.77 107.72 4.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -162.93 151.37 14.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.298 0.571 . . . . 0.0 112.32 -178.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB3' HG13 ' A' ' 57' ' ' VAL . . . -120.03 158.66 26.34 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.0 p -81.11 -3.41 51.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -77.11 -16.63 59.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -172.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -98.26 -176.33 3.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.01 -60.19 1.98 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.153 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.516 ' O ' HG22 ' A' ' 36' ' ' ILE . 82.0 Cg_exo -50.58 -49.22 17.32 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.968 2.445 . . . . 0.0 112.445 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.644 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 2.0 p -50.77 -36.94 39.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.692 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.705 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 39.8 ttpt -66.09 -54.32 27.22 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.06 0.225 . . . . 0.0 110.602 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.49 -45.99 91.91 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.25 -18.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.289 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.644 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -56.0 -56.38 31.31 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.128 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.705 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 33.4 Cg_endo -66.41 -32.16 41.13 Favored 'Trans proline' 0 C--N 1.359 1.127 0 CA-C-N 120.287 1.138 . . . . 0.0 112.492 171.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.53 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 33.2 mmt -64.27 -61.2 2.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.129 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.489 ' CG2' ' HD3' ' A' ' 54' ' ' LYS . 61.0 mt -64.41 -21.93 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.233 0.469 . . . . 0.0 111.647 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.693 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 11.2 tp10 -61.96 -43.78 98.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 109.675 168.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -65.6 -40.63 92.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.531 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.67 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 15.2 m-85 -68.09 -17.95 64.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.177 0.513 . . . . 0.0 110.854 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 p -87.24 -11.48 49.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -83.23 -31.11 27.18 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.68 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 28.2 pt20 -109.27 33.24 4.41 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.234 -176.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -100.1 76.6 0.13 Allowed Pre-proline 0 CA--C 1.556 1.207 0 CA-C-O 121.496 0.665 . . . . 0.0 112.711 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 32.2 Cg_exo -58.21 -46.07 27.44 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.115 1.877 . . . . 0.0 114.242 -170.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.82 16.51 19.5 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -124.23 165.89 16.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.954 0.406 . . . . 0.0 111.486 -171.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 6.2 m-20 -115.59 131.89 56.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.427 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 1.6 m-85 -114.28 124.71 52.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.464 -173.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 m-85 -139.85 151.54 45.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 2' ' ' VAL . 38.1 mtmt -140.06 121.25 14.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.67 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 70.6 mt -78.42 141.02 38.63 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.506 -171.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.74 91.08 0.8 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 27' ' ' ALA . 2.3 p -59.53 -6.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -172.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.95 -32.97 15.77 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.48 -36.17 26.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.246 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.622 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.0 52.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.547 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.72 -40.29 22.59 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.04 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.4 m-20 -69.79 -38.53 76.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.455 0.169 . . . . 0.0 110.995 -177.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.622 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -68.96 -37.53 77.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.435 . . . . 0.0 110.41 176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.8 73.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.029 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.4 mt-30 -70.91 -34.75 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 52.7 mttp -59.46 -43.99 93.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.553 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -91.55 10.52 27.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.146 -174.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 58.27 48.68 12.22 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.498 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.503 HG13 ' OG1' ' A' ' 74' ' ' THR . 71.8 t -78.64 118.58 26.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.83 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -124.25 -58.83 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.19 127.63 32.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.333 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.5 134.91 19.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.334 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 64.9 Cg_endo -83.31 171.25 51.57 Favored 'Cis proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.855 -1.31 . . . . 0.0 112.035 -1.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.7 m -117.93 114.76 23.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.23 107.46 18.45 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.323 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.495 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.2 mt -126.25 112.7 16.04 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -87.14 116.89 25.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 70.3 m-85 -104.45 145.99 29.5 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.665 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mtpt -143.83 120.96 11.46 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.969 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 38.8 m-80 61.14 21.85 12.22 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.715 0.634 . . . . 0.0 110.809 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.06 12.3 65.07 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -111.59 5.57 19.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.4 tt0 70.36 177.17 0.27 Allowed 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.123 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 77' ' ' LEU . 1.4 p -157.12 -31.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.5 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . . . -159.32 164.29 34.94 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.82 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 66.7 tttt -148.61 122.88 9.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.594 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.49 132.24 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.78 79.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.299 0.571 . . . . 0.0 111.065 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.09 -172.86 35.88 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.487 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -67.36 100.98 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.4 p-10 -124.07 63.55 32.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 90' ' ' ALA . 8.7 Cg_exo -70.75 -31.35 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 120.963 1.109 . . . . 0.0 110.098 172.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.601 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.65 -47.12 8.15 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.257 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -69.43 -16.31 63.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -177.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.1 tp -53.56 -38.29 33.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.114 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 169.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 36.0 mmtt -55.07 -41.7 71.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.937 0.773 . . . . 0.0 110.798 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -51.17 -53.72 32.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.523 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.49 -30.56 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 111.762 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -76.05 -39.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.982 -172.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.408 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -86.86 -41.4 14.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.708 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.93 75.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.621 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 85' ' ' ALA . 35.4 m-80 -107.26 -73.1 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.879 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.883 0 O-C-N 123.983 0.802 . . . . 0.0 112.632 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.905 0.383 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 52' ' ' PHE . 0.2 OUTLIER -122.63 135.6 62.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 177.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.12 148.43 26.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.087 -175.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.29 122.68 47.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.317 171.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' H ' HD21 ' A' ' 55' ' ' LEU . 12.4 m-85 -76.16 164.06 26.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.193 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -121.61 -20.26 6.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 61.1 p -131.63 155.12 48.12 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.296 -0.253 . . . . 0.0 111.312 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.29 -36.09 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 t -57.71 -41.15 81.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.572 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 19.6 mm-40 -59.59 -43.53 93.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.125 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 7.4 t80 -67.07 -53.2 33.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.437 ' HA ' HG12 ' A' ' 15' ' ' ILE . 10.9 m-20 -61.49 -37.19 82.76 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 111.781 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.822 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 21' ' ' VAL . . . -69.14 -48.55 62.09 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.0 110.579 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 34.2 pt -67.02 -20.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.97 -8.6 59.43 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.084 0.468 . . . . 0.0 111.306 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -75.73 152.58 37.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.889 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 2.3 m-20 -80.37 35.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.102 0.477 . . . . 0.0 111.634 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 4.4 ptpt -134.7 -179.06 5.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 0.0 111.346 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' CD2' HG11 ' A' ' 84' ' ' VAL . 1.3 tm? -84.36 108.26 17.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.445 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.771 HG11 ' CE1' ' A' ' 53' ' ' TYR . 78.3 t -112.88 106.92 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.019 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.34 106.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.341 0.591 . . . . 0.0 110.952 176.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 59.3 t -106.23 136.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.634 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 75' ' ' LEU . . . -118.1 115.45 24.85 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.161 0.505 . . . . 0.0 110.249 170.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.506 ' CD2' HG22 ' A' ' 69' ' ' VAL . 98.5 m-85 -70.06 109.96 4.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CZ ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.78 159.24 31.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -163.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.53 135.88 21.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.159 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -83.88 -5.7 59.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -170.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -89.28 57.59 4.1 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.9 p -157.41 -176.72 6.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.26 -53.04 3.22 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.205 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.419 ' O ' ' HG2' ' A' ' 35' ' ' MET . 87.9 Cg_exo -49.07 -43.0 37.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.561 2.174 . . . . 0.0 112.075 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.491 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -58.13 -35.17 71.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -62.4 -46.55 88.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.628 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.62 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.7 ptm -77.26 -45.92 24.8 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.643 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -75.79 -23.31 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.439 -176.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.06 -49.53 91.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.092 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 35' ' ' MET . 23.3 Cg_exo -66.67 -38.3 18.81 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.498 1.465 . . . . 0.0 112.442 171.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -63.94 -58.29 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.423 HG13 ' CG1' ' A' ' 36' ' ' ILE . 12.9 mm -56.21 -33.61 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.91 -49.17 78.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.248 0.547 . . . . 0.0 110.328 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -62.93 -47.33 83.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.262 0.553 . . . . 0.0 110.144 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.656 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.0 m-30 -64.52 -17.57 64.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.842 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.407 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.3 p -86.49 -13.37 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.873 0.844 . . . . 0.0 108.828 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -88.77 -19.35 26.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.328 169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.656 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -125.26 33.1 5.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.753 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -110.26 82.94 2.86 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-O 121.752 0.787 . . . . 0.0 111.659 169.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.13 -46.29 29.15 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.864 2.376 . . . . 0.0 114.561 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -112.71 6.33 18.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -105.63 165.08 11.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.954 -0.466 . . . . 0.0 110.743 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 1.0 OUTLIER -131.45 123.23 27.67 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.71 177.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.753 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.2 m-85 -92.24 131.74 37.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.771 ' CE1' HG11 ' A' ' 21' ' ' VAL . 7.4 m-85 -130.82 135.3 47.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.298 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.57 120.78 31.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.599 HD21 ' H ' ' A' ' 5' ' ' PHE . 5.9 mt -99.99 168.42 9.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.383 -171.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.69 104.08 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.991 0.9 . . . . 0.0 108.824 169.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -10.73 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.243 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.03 -33.84 65.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.081 0.467 . . . . 0.0 109.993 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -94.61 -36.39 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.903 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.573 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mm? -97.97 47.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.058 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.17 -39.12 27.94 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.886 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.44 -45.24 88.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.3 p -66.91 -37.76 80.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.112 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.3 mt-30 -62.8 -34.03 76.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -24.97 61.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.7 9.54 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.998 0.428 . . . . 0.0 110.84 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 59.06 45.28 14.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.653 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.506 HG22 ' CD2' ' A' ' 25' ' ' PHE . 72.5 t -74.74 117.3 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.908 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -133.24 -0.05 3.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.408 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.69 164.86 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 111.056 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.9 mtm -124.21 111.47 28.5 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.012 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.529 ' CB ' ' HE1' ' A' ' 26' ' ' TYR . 4.0 Cg_exo -77.63 170.32 71.27 Favored 'Cis proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.583 -5.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.416 ' OG1' HG12 ' A' ' 69' ' ' VAL . 77.1 m -115.29 112.38 22.32 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 158.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.554 ' CD2' ' HB1' ' A' ' 24' ' ' ALA . 6.0 mt -118.63 107.94 14.32 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.741 -167.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 5.4 mt -125.26 112.46 16.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.197 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.92 130.21 38.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.631 176.117 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 46.1 m-85 -111.11 154.15 24.69 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.143 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 27.8 ttpp -137.4 113.88 10.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.824 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.51 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 43.62 46.27 6.06 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.17 0.918 . . . . 0.0 111.941 -177.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 7.09 52.49 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.647 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.73 9.4 16.38 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 122.436 -0.449 . . . . 0.0 110.612 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.8 tt0 66.8 173.0 0.25 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.776 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.495 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.5 p -146.96 -32.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.728 0.299 . . . . 0.0 110.36 172.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.431 ' HB1' ' HG ' ' A' ' 77' ' ' LEU . . . -158.16 162.04 37.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.131 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.3 tmtp? -143.33 107.8 4.82 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.77 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.68 143.91 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -155.71 84.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.614 0.721 . . . . 0.0 111.74 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.09 81.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.644 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.507 ' HA ' ' CD ' ' A' ' 73' ' ' PRO . . . 45.13 74.76 0.12 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.05 0.54 . . . . 0.0 111.867 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 20.0 p-10 -123.59 75.53 54.69 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -171.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.577 ' O ' ' HE2' ' A' ' 43' ' ' PHE . 7.7 Cg_exo -74.07 -37.01 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.358 1.372 . . . . 0.0 110.4 166.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -87.4 -41.65 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.03 -17.78 60.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.517 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -63.14 -36.08 74.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 118.697 -1.201 . . . . 0.0 108.17 170.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.634 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 1.8 mmmp? -58.62 -33.73 70.36 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.389 0.431 . . . . 0.0 110.634 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -57.23 -54.95 40.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.63 173.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.465 ' HB1' HD13 ' A' ' 77' ' ' LEU . . . -71.81 -47.23 54.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.671 . . . . 0.0 111.229 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -61.44 -49.03 86.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.737 -172.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.549 ' N ' HG21 ' A' ' 99' ' ' ILE . . . -88.35 -33.96 17.78 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -170.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.2 38.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.749 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -88.63 -54.65 4.06 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.195 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.433 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.535 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.2 m -93.82 145.11 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 173.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.519 ' CG2' ' HD2' ' A' ' 53' ' ' TYR . 1.3 m -74.03 144.76 44.96 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -111.63 118.56 36.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.595 172.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.608 ' H ' HD23 ' A' ' 55' ' ' LEU . 12.6 m-85 -71.22 163.37 27.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 110.063 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -112.33 -25.01 9.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.762 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.602 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 27.1 p -138.58 159.37 42.25 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -54.42 -39.29 67.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -53.67 -38.82 64.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.141 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.602 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 70.8 mm-40 -64.83 -50.46 66.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.519 0.675 . . . . 0.0 109.951 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 9.3 t80 -62.28 -48.1 81.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.497 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HA ' HG12 ' A' ' 15' ' ' ILE . 7.2 m-20 -58.87 -35.34 72.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.349 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -74.64 -29.27 61.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.52 -39.56 24.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.172 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 12' ' ' ASP . 43.8 pt -66.99 -22.28 29.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.698 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.77 -9.8 59.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.977 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.423 ' C ' ' H ' ' A' ' 19' ' ' LYS . 96.9 mt-30 -67.97 149.4 49.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.324 . . . . 0.0 110.507 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.31 39.19 0.31 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.214 0.53 . . . . 0.0 110.87 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.0 ptmt -147.32 173.75 12.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.817 -177.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.565 ' CD2' HG13 ' A' ' 84' ' ' VAL . 1.3 tm? -76.43 110.89 11.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.286 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.658 ' CG1' ' HB2' ' A' ' 78' ' ' PHE . 3.8 p -95.29 130.7 43.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.564 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -122.63 101.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.71 0.766 . . . . 0.0 109.71 169.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.626 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 57.7 t -109.12 143.28 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.874 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' A' ' 75' ' ' LEU . . . -124.28 120.51 32.41 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 83.7 m-85 -71.03 121.61 18.54 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.293 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.78 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 2.3 m-85 -119.99 177.78 4.86 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.127 0.489 . . . . 0.0 110.837 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.16 130.03 9.36 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 167.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -7.53 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 111.873 -174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -107.57 11.43 28.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.179 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.946 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -111.53 136.98 49.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.647 0.737 . . . . 0.0 111.649 -176.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.66 -41.46 50.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.589 -1.187 . . . . 0.0 114.325 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.946 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 16.5 Cg_exo -67.5 -27.96 38.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 CA-C-N 120.302 2.051 . . . . 0.0 110.441 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 58.9 m -55.26 -44.39 75.54 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.378 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.679 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 66.0 mttm -64.25 -51.33 64.12 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.561 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.662 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -62.05 -49.34 76.37 Favored 'General case' 0 C--O 1.252 1.185 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.04 -14.63 15.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.035 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -58.12 -49.68 92.26 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.971 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 24.5 Cg_exo -67.44 -35.1 24.46 Favored 'Trans proline' 0 C--N 1.36 1.156 0 CA-C-N 120.377 1.17 . . . . 0.0 111.645 169.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.445 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 97.1 mmm -62.36 -60.95 2.82 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.474 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.521 ' CG2' ' HD3' ' A' ' 54' ' ' LYS . 61.9 mt -65.07 -22.52 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.013 -0.429 . . . . 0.0 111.615 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.36 -46.67 85.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.522 0.677 . . . . 0.0 109.474 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 14.6 tptm -60.88 -37.17 81.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.694 0.759 . . . . 0.0 109.532 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.653 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 2.6 m-30 -76.76 -14.66 59.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.751 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.794 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 46.1 p -74.62 -16.13 60.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.48 -24.1 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.023 171.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.653 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 12.8 mm100 -76.35 -38.66 55.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.073 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' CE1' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -104.03 101.9 28.62 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.0 Cg_endo -83.89 -19.07 5.1 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.077 2.518 . . . . 0.0 111.599 169.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.46 -22.22 19.73 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 111.161 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -109.07 140.21 42.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.655 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.1 117.52 29.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.586 0.708 . . . . 0.0 111.643 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.794 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.3 p90 -89.11 115.04 26.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.698 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CE1' ' HB3' ' A' ' 51' ' ' ASP . 4.3 m-85 -133.41 150.7 51.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 171.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HD3' ' CG2' ' A' ' 40' ' ' ILE . 9.7 mtmp? -143.99 119.39 10.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.78 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 6.8 mt -97.37 158.58 15.39 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -168.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.02 113.22 26.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.203 0.525 . . . . 0.0 110.009 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.713 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.76 -14.53 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.3 -29.17 62.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.12 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -105.72 -18.96 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.721 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.9 mm? -106.87 45.28 0.99 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.28 0.562 . . . . 0.0 110.417 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -76.85 -34.01 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.415 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 2.9 m-20 -71.17 -43.53 67.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.51 0.195 . . . . 0.0 110.802 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.7 p -62.2 -39.74 85.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.76 81.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.161 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -71.46 -36.0 71.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.078 0.466 . . . . 0.0 110.496 -175.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 44.2 mtmt -62.45 -36.84 83.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.792 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.49 15.59 25.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.368 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 60.32 38.04 19.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.514 172.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.56 110.05 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.473 . . . . 0.0 111.008 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -109.6 -44.74 3.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.932 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.12 153.98 38.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.556 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.43 140.18 18.58 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.755 0.312 . . . . 0.0 110.317 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 72.9 Cg_endo -79.87 160.66 86.74 Favored 'Cis proline' 0 C--O 1.236 0.38 0 C-N-CA 123.276 -1.552 . . . . 0.0 112.629 -3.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 22.6 m -129.67 119.8 24.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.11 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.481 HD22 ' OD1' ' A' ' 91' ' ' ASN . 4.4 mm? -104.06 108.4 19.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.664 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -120.99 114.3 21.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.679 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -94.21 133.47 37.69 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.883 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.658 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 4.1 m-85 -117.53 156.03 28.76 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.436 -175.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.701 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 65.3 tttm -144.29 116.83 8.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.173 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.701 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.0 p30 45.66 36.22 2.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.198 0.999 . . . . 0.0 112.664 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.93 5.93 76.96 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.254 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -115.58 14.61 16.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.742 0.271 . . . . 0.0 110.849 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.6 tt0 67.67 173.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.414 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.565 HG13 ' CD2' ' A' ' 20' ' ' LEU . 1.6 p -148.99 -33.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.932 0.396 . . . . 0.0 110.039 172.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.56 ' HB1' ' ND2' ' A' ' 102' ' ' ASN . . . -155.82 162.86 40.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.596 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -146.29 110.89 5.16 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.032 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.1 t -122.51 125.92 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.79 84.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.697 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.1 78.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.743 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 51.29 80.86 0.08 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.7 p-10 -124.47 87.24 54.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.76 -38.89 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.523 1.482 . . . . 0.0 111.373 170.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.51 -44.55 10.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.913 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -68.68 -17.08 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.273 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.1 tp -58.69 -38.3 70.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 96' ' ' LYS . 12.8 mmmm -59.57 -36.25 75.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.162 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -51.91 -59.65 4.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.792 173.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -72.69 -36.22 67.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.345 0.593 . . . . 0.0 111.356 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.803 -171.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.434 ' N ' HG22 ' A' ' 99' ' ' ILE . . . -87.21 -32.75 19.62 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.852 0.358 . . . . 0.0 111.327 -172.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.53 48.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.792 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.56 ' ND2' ' HB1' ' A' ' 85' ' ' ALA . 66.9 m-80 -86.29 -53.99 4.7 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.802 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 121.075 0.464 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.9 148.08 25.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.905 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.452 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -111.92 120.08 40.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.817 174.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.618 ' H ' HD22 ' A' ' 55' ' ' LEU . 20.8 m-85 -73.43 164.41 26.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.219 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -116.23 -17.28 10.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.665 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.62 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 41.2 p -133.67 153.41 51.7 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.494 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.62 -31.37 66.17 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -60.91 -42.31 97.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.99 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.62 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.9 mm-40 -64.71 -42.68 95.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.391 0.615 . . . . 0.0 110.293 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 15' ' ' ILE . 5.3 t80 -66.42 -47.45 73.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.868 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.12 -47.7 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.408 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 20.1 m -68.93 -26.93 65.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.609 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.21 -54.57 7.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 27.4 pt -67.07 -19.71 25.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.23 -8.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.356 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.445 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.9 mt-30 -74.24 160.36 31.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.47 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 p-10 -77.5 19.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.481 0.657 . . . . 0.0 111.427 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.5 ptmt -118.7 166.15 13.12 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.249 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.612 ' CD2' HG11 ' A' ' 84' ' ' VAL . 2.4 tm? -78.72 112.16 15.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 HG23 ' A' ' 23' ' ' VAL . 88.7 t -117.94 108.18 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.654 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.25 108.42 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.822 0.82 . . . . 0.0 111.015 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.624 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 59.9 t -104.56 142.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.526 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.872 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -122.12 119.7 32.1 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' A' ' 69' ' ' VAL . 56.2 m-85 -71.41 125.43 26.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.352 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.774 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -120.98 -174.28 2.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.077 -173.095 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.2 155.12 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.151 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.08 -5.41 59.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -111.87 33.65 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -132.96 146.64 51.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.592 0.711 . . . . 0.0 112.135 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.562 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -85.17 -42.37 7.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.991 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 23.0 Cg_endo -61.34 -40.11 51.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 CA-C-N 119.817 1.808 . . . . 0.0 111.417 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 12.5 p -57.57 -31.6 66.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.792 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tptt -66.19 -53.6 35.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.789 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.707 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 21.5 ptm -63.09 -44.55 95.4 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.684 ' CG1' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -74.82 -18.83 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.39 -48.66 96.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.6 Cg_exo -70.92 -31.03 16.04 Favored 'Trans proline' 0 C--N 1.36 1.149 0 CA-C-N 120.537 1.228 . . . . 0.0 112.004 171.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 35' ' ' MET . 20.1 mmt -66.61 -56.37 11.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.582 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.717 HG23 ' CE2' ' A' ' 52' ' ' PHE . 6.5 mt -59.66 -27.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 31.8 tt0 -53.94 -48.64 70.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 16.0 tppt? -65.95 -47.77 73.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.945 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.635 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 3.4 m-30 -62.66 -26.55 68.7 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.777 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 92.3 p -85.1 -15.25 44.55 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 42.5 tt0 -79.66 -25.99 41.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.174 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.635 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -96.22 8.43 43.89 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.66 ' HE2' ' CD2' ' A' ' 52' ' ' PHE . 5.1 m-85 -103.52 100.0 17.36 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.729 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.54 -43.01 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.758 2.305 . . . . 0.0 112.677 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.27 -14.87 17.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.763 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB2' ' HB1' ' A' ' 103' ' ' ALA . . . -104.68 165.04 11.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.48 137.37 51.76 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.717 ' CE2' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -109.12 131.03 55.46 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.187 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 42.8 m-85 -136.65 151.93 49.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.872 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 10.0 mtmp? -139.57 120.54 14.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.624 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.7 mt -100.32 161.11 13.82 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 5.7 m-20 -94.22 107.5 19.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -13.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -172.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 5.5 p-10 -77.72 -25.23 49.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 109.59 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -93.97 -40.3 10.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.816 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -98.21 53.98 1.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.764 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.621 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.21 -45.89 10.91 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.86 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.7 t70 -61.11 -44.64 97.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.508 0.194 . . . . 0.0 111.189 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.586 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.5 p -65.1 -38.65 83.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.169 0.509 . . . . 0.0 110.611 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.63 78.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.909 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 13.4 mm100 -72.56 -31.62 65.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.702 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.41 -41.84 90.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.804 0.811 . . . . 0.0 110.223 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -98.44 21.49 11.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.381 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 38.2 50.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.936 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.618 HG21 ' CD2' ' A' ' 25' ' ' PHE . 76.2 t -81.18 115.87 24.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.945 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 p -122.42 17.54 10.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.294 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.04 157.97 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -138.58 122.29 11.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 36' ' ' ILE . 98.2 Cg_endo -83.79 166.2 64.04 Favored 'Cis proline' 0 C--O 1.235 0.349 0 C-N-CA 123.751 -1.354 . . . . 0.0 112.505 -5.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 78.2 m -123.75 122.73 38.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.634 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -105.42 109.66 21.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -173.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 21.5 mt -125.52 115.86 20.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.859 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.579 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.58 125.32 39.16 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 174.677 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.9 m-85 -108.05 154.48 21.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.468 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 50.7 tptt -143.37 116.57 8.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.198 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.47 ' ND2' ' HA ' ' A' ' 18' ' ' ASP . 23.4 m120 56.26 27.15 11.34 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 123.424 0.452 . . . . 0.0 111.527 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.54 10.06 59.72 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.002 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 47.6 pttt -109.88 1.9 19.5 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.632 0.73 . . . . 0.0 109.354 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.4 tt0 78.47 172.6 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.612 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -144.2 -31.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 109.847 173.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.454 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.37 162.37 30.74 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.842 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.6 tttt -139.82 124.64 18.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.603 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.5 t -131.02 137.97 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.8 83.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.893 0.854 . . . . 0.0 111.609 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.12 53.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.833 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.89 81.84 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 111.324 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 11.3 p-10 -117.67 90.82 36.86 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 95' ' ' ILE . 3.9 Cg_exo -77.2 -43.15 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.441 1.427 . . . . 0.0 110.897 169.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.3 16.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.094 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -74.61 -17.57 60.69 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.053 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.729 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.43 -38.77 76.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.618 ' HA ' HG22 ' A' ' 99' ' ' ILE . 31.2 mmmt -61.87 -29.66 70.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.357 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -56.39 -57.88 10.39 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 174.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.431 ' C ' HD11 ' A' ' 77' ' ' LEU . . . -74.86 -37.87 62.1 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -72.61 -39.14 60.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.009 -170.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.0 -32.41 21.52 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.361 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.83 70.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.14 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 52.5 m-80 -96.83 -62.33 1.28 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.603 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.87 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.302 0 CA-C-O 121.255 0.55 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 146.02 37.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.555 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.5 pp0? -104.95 136.23 44.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.261 171.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.572 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.7 m-85 -90.82 161.53 15.23 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.996 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -119.0 -18.54 8.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.284 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 58.7 p -133.08 151.57 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 111.121 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -60.44 -27.58 67.62 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -62.74 -43.73 98.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.387 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 9.4 mm-40 -60.46 -46.21 90.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.321 0.582 . . . . 0.0 110.251 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.43 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 9.5 t80 -64.85 -47.9 76.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.241 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HA ' HG12 ' A' ' 15' ' ' ILE . 31.3 t70 -62.69 -33.69 75.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.608 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 m -73.43 -36.84 66.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.242 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.73 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.507 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.2 pt -67.78 -24.84 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.23 -15.68 60.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.084 0.468 . . . . 0.0 111.36 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.59 ' HB2' ' NZ ' ' A' ' 19' ' ' LYS . 98.2 mt-30 -76.46 156.47 33.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.802 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 17.9 t70 -48.38 -38.15 18.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -167.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.668 ' HE2' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -109.1 -178.96 3.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -162.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.669 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -59.58 116.04 3.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.02 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.2 t -119.72 107.2 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.967 170.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.664 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.86 103.4 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.737 0.779 . . . . 0.0 111.008 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 3.5 t -108.14 144.23 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.99 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -128.64 128.97 45.2 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CE2' HD12 ' A' ' 55' ' ' LEU . 80.9 m-85 -70.67 121.11 17.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.392 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.52 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 m-30 -120.19 176.1 5.62 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.251 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.65 16.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.889 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -84.48 -5.6 59.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -113.55 24.56 12.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 8.2 p -130.83 127.56 38.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.564 0.697 . . . . 0.0 111.65 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.04 -44.88 75.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.901 -1.045 . . . . 0.0 114.208 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 51.3 Cg_exo -57.6 -44.56 40.6 Favored 'Trans proline' 0 C--N 1.358 1.033 0 CA-C-N 119.98 1.89 . . . . 0.0 111.928 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 3.6 m -54.48 -37.19 64.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.391 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 38.6 ttpt -66.31 -47.04 74.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.149 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.435 ' O ' ' HG2' ' A' ' 39' ' ' MET . 24.8 ptt? -68.95 -45.25 71.22 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.665 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.32 -16.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.637 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.4 -55.41 44.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.508 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.7 Cg_endo -67.99 -27.85 35.98 Favored 'Trans proline' 0 C--N 1.358 1.032 0 CA-C-N 120.573 1.24 . . . . 0.0 111.993 172.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 35' ' ' MET . 96.6 mmm -67.08 -58.66 4.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.871 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.566 HG21 ' NZ ' ' A' ' 54' ' ' LYS . 65.0 mt -66.65 -20.39 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.994 -0.441 . . . . 0.0 111.794 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.87 -50.14 73.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.627 0.727 . . . . 0.0 109.531 164.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 43.3 tptt -60.19 -37.01 78.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.462 0.649 . . . . 0.0 109.83 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.691 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.8 m-30 -76.31 -15.07 60.06 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.379 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.758 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 24.2 p -73.58 -16.21 61.26 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 32.0 tt0 -87.6 -25.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.924 171.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.691 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 25.9 mm-40 -78.12 -30.03 49.2 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.729 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 4.1 p90 -120.39 83.6 33.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.25 -12.74 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.431 2.087 . . . . 0.0 111.438 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -6.11 49.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.602 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -127.87 165.55 19.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.557 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 12.4 m-20 -101.83 117.53 35.05 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.876 0.846 . . . . 0.0 112.617 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.2 p90 -98.02 113.66 25.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.545 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.695 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 32.7 m-85 -137.49 153.49 50.04 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.91 -0.494 . . . . 0.0 111.317 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.87 ' HG2' HG21 ' A' ' 2' ' ' VAL . 10.3 mmtt -128.3 142.95 50.99 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.572 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 72.7 mt -99.59 143.66 29.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.034 -0.416 . . . . 0.0 111.646 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 15.5 m-20 -86.51 100.66 12.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 166.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -59.01 -14.68 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 12.2 p-10 -71.76 -36.05 70.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 109.91 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.29 -15.08 16.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.386 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.593 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -109.22 44.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.91 -33.35 41.77 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.57 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.85 -45.85 80.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.702 0.287 . . . . 0.0 110.404 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -66.65 -36.91 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.492 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . . . -57.87 -50.17 74.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.358 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -63.77 -31.83 73.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.263 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -26.0 61.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.005 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -97.14 4.79 51.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.642 0.258 . . . . 0.0 110.975 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 62.82 43.75 6.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.847 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -88.33 121.66 38.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.889 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 p -123.67 -7.75 7.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.25 159.0 29.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.901 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -129.8 133.94 25.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.74 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.9 Cg_endo -86.05 171.05 41.6 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.903 -1.29 . . . . 0.0 111.199 -2.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.8 m -129.39 117.02 19.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -101.4 109.59 21.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 -175.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.593 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 23.9 mt -124.25 113.05 17.76 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.664 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.44 127.26 43.25 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.593 174.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 32.7 m-85 -108.66 159.71 16.52 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.646 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 61.0 tttp -142.46 118.01 10.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.847 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.625 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 2.3 p-10 40.34 43.99 1.56 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.951 0.782 . . . . 0.0 112.912 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.71 1.41 58.46 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 114.073 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.99 10.93 18.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.291 0.546 . . . . 0.0 110.558 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.86 175.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.116 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.97 -35.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 173.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.483 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.69 165.18 36.98 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.411 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.593 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.8 tttt -148.9 115.98 6.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.556 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.29 139.25 48.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.21 89.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.503 0.668 . . . . 0.0 111.711 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.97 -174.78 31.68 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.469 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -72.91 93.15 1.69 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.883 0.373 . . . . 0.0 110.278 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 23.6 p-10 -119.49 69.21 11.37 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.0 -32.98 20.54 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.063 1.175 . . . . 0.0 111.002 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.96 -44.22 10.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.703 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.47 -17.13 61.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.2 tp -55.72 -39.51 55.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 99' ' ' ILE . 20.2 tptm -62.96 -32.44 73.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.368 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -54.18 -58.18 8.32 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.503 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.467 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -70.98 -36.67 72.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.539 0.685 . . . . 0.0 110.649 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -74.69 -42.04 47.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.178 -169.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -87.15 -39.42 15.53 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.961 0.41 . . . . 0.0 110.886 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.53 70.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.504 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 61.0 m-80 -89.04 -52.98 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.669 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.911 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.652 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.655 0.74 . . . . 0.0 111.734 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.27 147.85 23.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.325 -175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 4' ' ' GLN . 4.9 pt20 -99.85 120.31 39.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.114 169.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.588 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 16.7 m-85 -73.17 133.6 44.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.665 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -86.14 -16.85 36.61 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 74.5 p -131.79 151.86 51.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 111.432 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.549 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -60.32 -30.8 69.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.792 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -64.14 -37.09 86.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.79 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.489 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 25.3 mm-40 -62.01 -47.76 83.35 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.237 0.541 . . . . 0.0 110.04 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -47.03 87.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.967 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.09 -46.15 68.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.634 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 17.7 m -71.85 -32.66 67.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.568 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.02 -49.83 47.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.595 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.0 pt -67.99 -18.6 23.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.323 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.19 -10.03 59.69 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.282 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 13' ' ' SER . 78.2 mt-30 -79.62 150.72 30.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.46 56.23 2.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.926 0.87 . . . . 0.0 111.033 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 5.5 ptmt -150.72 169.22 22.14 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.042 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.939 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -74.62 108.01 7.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.037 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 84.6 t -116.45 107.37 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.794 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.717 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.89 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.568 0.699 . . . . 0.0 111.173 176.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 90.9 t -102.85 135.23 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.267 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -117.63 106.63 13.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE2' HD12 ' A' ' 55' ' ' LEU . 81.2 m-85 -71.42 107.57 4.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.866 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -162.77 152.23 15.48 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -178.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -129.04 141.65 51.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 p -68.25 -4.35 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -73.94 6.4 3.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.2 p -122.56 -172.89 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.979 0.418 . . . . 0.0 111.893 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.59 -59.23 2.14 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.95 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 51.2 Cg_exo -53.86 -49.33 17.55 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.609 2.206 . . . . 0.0 111.944 -176.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.2 p -49.82 -37.92 32.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.803 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.791 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 8.0 ttpm? -66.41 -56.46 10.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.536 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 39' ' ' MET . 22.8 ptm -59.54 -45.87 90.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.695 HG13 HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -74.48 -22.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.524 -177.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -54.5 -57.06 20.5 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.222 -177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.791 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 20.9 Cg_endo -63.99 -35.01 56.97 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.294 1.329 . . . . 0.0 112.797 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 35' ' ' MET . 94.0 mmm -62.2 -56.36 19.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.695 HD12 HG13 ' A' ' 36' ' ' ILE . 23.6 mt -62.6 -23.81 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 120.782 0.325 . . . . 0.0 111.638 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.58 -43.94 79.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HG3' HE21 ' A' ' 46' ' ' GLN . 2.5 tppp? -62.18 -45.17 94.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.251 0.548 . . . . 0.0 110.239 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.66 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.9 m-30 -67.92 -15.32 63.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 13.5 p -87.11 -14.41 41.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.133 0.968 . . . . 0.0 108.697 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -86.68 -14.6 42.08 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.992 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.66 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -129.37 36.14 4.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.844 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -115.74 74.24 4.74 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.91 -36.09 90.93 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.337 2.024 . . . . 0.0 113.946 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -107.21 24.45 12.82 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.557 0.694 . . . . 0.0 111.54 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' HB2' ' CB ' ' A' ' 103' ' ' ALA . . . -138.95 165.6 26.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.337 -0.852 . . . . 0.0 111.803 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 117.67 19.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.89 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.844 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -93.2 129.57 39.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.575 -174.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 36.1 m-85 -137.49 135.56 36.9 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.841 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 30.1 mtmt -125.08 121.7 35.06 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.057 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.588 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 54.6 mt -85.66 125.11 32.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.455 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.693 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.0 p-10 -70.95 105.61 3.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -58.23 -12.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.404 -175.345 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.53 -44.95 85.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.729 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.11 -18.14 17.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.164 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -106.8 51.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 110.825 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -78.22 -41.17 18.01 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.25 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.74 -41.49 83.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 7.7 p -65.51 -38.68 83.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.0 110.221 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.51 77.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.994 0.426 . . . . 0.0 110.796 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 78.3 mm-40 -70.66 -27.16 63.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.753 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -75.26 -25.09 57.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.266 0.555 . . . . 0.0 110.412 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -100.25 12.29 37.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.245 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.17 42.87 9.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG13 ' OG1' ' A' ' 74' ' ' THR . 85.0 t -91.71 124.63 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -138.03 17.75 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.109 0.481 . . . . 0.0 110.908 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -138.88 146.85 41.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.03 124.13 27.07 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.382 . . . . 0.0 110.194 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 58.0 Cg_endo -85.78 170.33 44.24 Favored 'Cis proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.55 -2.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 98.3 m -124.67 115.76 21.28 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -105.63 108.51 20.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.98 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.8 mt -127.57 114.4 17.36 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.85 130.07 41.59 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.63 0.729 . . . . 0.0 110.259 174.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.651 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 88.7 m-85 -111.0 156.71 20.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.359 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.4 ttmt -141.63 116.13 9.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.349 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.55 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 42.33 43.81 3.13 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.769 0.828 . . . . 0.0 112.529 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.08 53.69 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.572 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.31 8.61 18.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.071 0.463 . . . . 0.0 110.183 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.651 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 45.8 mt-10 64.77 178.48 0.18 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.619 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.571 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.7 p -148.86 -33.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 170.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.408 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.41 163.66 35.26 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 88' ' ' VAL . 30.4 tttm -146.41 120.52 9.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.497 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.9 t -127.05 131.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.411 HG21 ' HE2' ' A' ' 86' ' ' LYS . 2.5 t -125.89 79.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.024 0.44 . . . . 0.0 111.248 -171.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.5 -168.81 38.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -69.65 93.39 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.3 p-10 -123.74 63.4 28.31 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.453 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.1 Cg_exo -67.35 -37.76 16.91 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.038 1.159 . . . . 0.0 110.579 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.8 -40.36 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.939 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.26 -17.21 61.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.272 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.71 -37.15 69.72 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.612 ' HA ' HG22 ' A' ' 99' ' ' ILE . 29.2 mmtt -57.63 -34.79 69.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.538 0.524 . . . . 0.0 110.623 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -54.33 -56.4 18.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -73.43 -44.09 59.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.478 0.656 . . . . 0.0 111.204 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.678 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -65.26 -41.43 91.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.858 -171.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.11 -42.06 11.92 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.826 0.346 . . . . 0.0 111.762 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.8 -39.1 73.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.408 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.3 m-80 -85.85 -56.73 3.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.072 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.402 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.821 HG21 ' HE2' ' A' ' 54' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 145.76 55.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 112.504 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -112.9 127.14 56.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.597 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.7 ' H ' HD22 ' A' ' 55' ' ' LEU . 18.4 m-85 -74.7 163.04 28.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.875 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -119.83 -13.83 9.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.523 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.641 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 82.2 p -135.05 152.29 51.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.882 0.372 . . . . 0.0 111.098 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.81 -30.53 67.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -64.06 -39.17 93.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.901 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.641 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 15.8 mm-40 -60.8 -42.3 97.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.996 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -64.94 -49.15 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.739 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.36 -43.23 83.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.759 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -70.8 -36.06 72.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.72 -52.16 40.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.519 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 28.4 pt -65.03 -21.04 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.191 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.03 -6.99 57.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.749 0.309 . . . . 0.0 111.687 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' A' ' 19' ' ' LYS . 93.1 mt-30 -81.56 159.05 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.876 0.369 . . . . 0.0 110.325 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.73 18.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.237 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 17' ' ' GLN . 30.3 mtpt -107.75 174.61 5.81 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.906 0.86 . . . . 0.0 112.68 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.646 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tm? -91.2 107.06 18.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.355 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 67.3 t -106.0 115.45 47.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.547 HG22 HD22 ' A' ' 77' ' ' LEU . 21.6 t -92.3 102.39 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.211 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.576 HG23 HG12 ' A' ' 21' ' ' VAL . 44.2 t -108.39 136.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.473 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' CG ' ' A' ' 54' ' ' LYS . . . -128.92 141.55 51.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 120.764 0.316 . . . . 0.0 111.821 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.666 ' CD2' HG21 ' A' ' 69' ' ' VAL . 59.0 m-85 -95.11 122.52 37.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.336 0.589 . . . . 0.0 110.55 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.733 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.5 m-85 -119.98 -175.28 2.94 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.243 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.61 165.76 20.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -84.92 -5.55 59.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.317 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -122.88 34.59 5.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.776 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.673 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 6.9 p -132.11 121.82 24.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.527 0.68 . . . . 0.0 111.834 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.39 -42.12 97.79 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.923 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.611 ' O ' HG23 ' A' ' 36' ' ' ILE . 50.3 Cg_exo -57.47 -44.3 43.57 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.021 1.91 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 9.2 m -53.32 -41.35 65.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.718 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 37.5 ttpt -63.06 -56.36 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.6 ptp -60.65 -47.79 84.68 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.34 -13.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.014 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.67 -53.64 63.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.291 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.9 Cg_endo -65.53 -33.19 47.08 Favored 'Trans proline' 0 C--N 1.357 1.003 0 CA-C-N 120.281 1.136 . . . . 0.0 112.448 169.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 mmt -65.02 -58.92 4.85 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.969 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.521 HG12 HG21 ' A' ' 95' ' ' ILE . 51.6 mt -64.42 -23.04 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 122.107 -0.371 . . . . 0.0 111.399 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 42.6 tt0 -63.12 -41.51 99.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.66 0.743 . . . . 0.0 110.133 170.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 19.7 ttmt -64.56 -38.94 92.75 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.087 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.68 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.4 m-30 -69.63 -23.82 63.56 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.267 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 2.0 p -73.81 -14.67 61.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.71 -23.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.68 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 53.5 mt-30 -80.65 -33.38 35.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.063 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 5.8 p90 -108.43 92.13 9.44 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.2 Cg_endo -84.39 -12.79 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.132 2.555 . . . . 0.0 111.37 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 50' ' ' ALA . 3.3 pt20 -88.2 -22.95 23.73 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.354 0.597 . . . . 0.0 110.385 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -113.68 148.16 36.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 7.0 m-20 -91.12 116.73 29.04 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.402 0.62 . . . . 0.0 111.523 -174.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.686 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 2.8 p90 -87.7 114.55 24.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.946 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 22.1 m-85 -130.78 164.85 24.22 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.238 170.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.821 ' HE2' HG21 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -153.29 119.9 5.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 5.4 mt -99.31 159.52 14.94 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.255 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.42 118.77 37.59 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -63.34 -11.48 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.636 -174.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.24 -37.48 78.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.975 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.21 -31.02 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.458 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.579 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.0 mm? -107.73 48.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.004 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.598 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.92 -41.78 17.89 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.117 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 4.5 m-20 -66.7 -44.1 82.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.509 0.195 . . . . 0.0 110.839 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.0 p -62.74 -38.03 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.202 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.89 85.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.167 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 88.7 mm-40 -71.37 -32.13 68.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.901 0.382 . . . . 0.0 110.464 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.42 -42.63 92.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.6 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -94.81 14.74 20.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.044 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 58.86 43.79 17.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.602 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.666 HG21 ' CD2' ' A' ' 25' ' ' PHE . 94.8 t -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.979 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 p -125.87 22.43 7.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.156 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 88' ' ' VAL . . . -142.91 151.01 40.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.673 ' SD ' ' HB3' ' A' ' 30' ' ' CYS . 16.2 ptt? -121.45 123.15 27.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.202 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 6.1 Cg_endo -86.88 172.35 35.47 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.428 -1.072 . . . . 0.0 111.511 -3.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 55.1 m -138.82 116.78 11.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.698 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.5 mp -107.13 142.53 36.67 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.093 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 86' ' ' LYS . 21.8 mt -134.28 110.6 9.61 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.094 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.45 124.08 34.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.758 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 31.5 m-85 -109.68 154.65 22.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.955 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.611 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 58.5 tttp -142.95 115.06 8.34 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.961 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.603 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 9.6 p30 44.69 38.11 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.965 0.906 . . . . 0.0 112.45 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.43 3.93 63.42 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.697 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 16.8 ptmt -103.59 -3.7 24.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 109.412 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 29.3 tt0 77.23 -179.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.593 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.602 HG11 ' CD2' ' A' ' 20' ' ' LEU . 2.1 p -152.2 -32.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.884 0.374 . . . . 0.0 110.04 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.25 162.13 40.17 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.129 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.434 ' HG3' HD22 ' A' ' 76' ' ' LEU . 35.0 tttp -138.17 122.49 18.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.029 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.616 HG11 ' ND2' ' A' ' 91' ' ' ASN . 10.1 p -128.98 131.22 68.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.302 0.572 . . . . 0.0 110.277 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.0 t -131.11 80.41 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.672 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.36 -175.12 38.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.926 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.42 94.72 2.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.941 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 22.8 p-10 -124.45 68.95 51.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 95' ' ' ILE . 18.7 Cg_exo -64.68 -43.65 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 120.614 0.876 . . . . 0.0 110.991 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.88 -32.43 18.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.941 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.88 -18.76 59.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.429 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.0 tp -59.9 -38.12 75.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.589 ' HA ' HG22 ' A' ' 99' ' ' ILE . 19.3 tptm -64.27 -26.82 68.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.168 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.4 tm0? -58.83 -59.26 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 170.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 -38.36 78.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.7 . . . . 0.0 110.741 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -71.63 -42.37 71.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.146 -170.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.19 -40.45 14.57 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.99 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.76 -40.4 66.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.572 -175.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.8 m-80 -85.55 -56.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.469 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.646 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.581 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.958 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.302 0.572 . . . . 0.0 110.483 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.73 148.25 33.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.899 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.483 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -112.46 118.49 35.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.391 172.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.611 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -69.9 163.06 26.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 110.68 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -115.59 -18.34 10.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.176 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.61 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 28.5 p -138.0 155.49 48.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.501 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.64 -34.85 73.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 m -57.24 -37.77 72.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.991 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.61 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 34.4 mm-40 -63.36 -45.03 93.07 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.307 0.575 . . . . 0.0 109.961 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HD2' HG21 ' A' ' 23' ' ' VAL . 1.9 t80 -66.75 -50.36 62.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.747 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.53 -39.73 80.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.396 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.1 m -69.45 -37.05 77.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -66.62 -49.6 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.858 0.361 . . . . 0.0 110.814 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.5 pt -66.69 -24.26 32.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.649 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 -5.76 48.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.42 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 26.0 mt-30 -75.94 157.04 33.64 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.985 0.421 . . . . 0.0 110.302 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . 26.6 t70 -66.45 -1.78 3.91 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.73 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 11.1 ptmt -115.47 173.86 6.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.21 0.528 . . . . 0.0 111.812 -167.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.574 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.41 113.69 11.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -122.12 107.86 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.766 0.317 . . . . 0.0 110.641 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.587 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.93 109.2 26.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.867 0.842 . . . . 0.0 111.588 176.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 98.9 t -104.28 142.54 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.151 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.856 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -129.43 138.35 51.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 69' ' ' VAL . 70.1 m-85 -88.51 126.6 35.33 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.25 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.2 m-30 -120.82 -172.06 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.637 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -169.9 162.51 9.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.227 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 p -83.98 -4.85 59.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -122.8 35.0 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 -176.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -130.95 143.88 51.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.814 0.816 . . . . 0.0 111.911 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.48 -45.43 6.49 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.276 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 50.9 Cg_exo -57.11 -50.63 10.73 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.903 1.735 . . . . 0.0 112.17 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 28.5 p -53.5 -34.37 57.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.71 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 4.6 ttmp? -68.55 -45.17 72.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.064 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 24.9 ptt? -72.86 -41.52 64.67 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.277 0.561 . . . . 0.0 112.444 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.664 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.91 -17.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.44 177.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.03 -49.22 94.89 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.8 Cg_endo -69.84 -29.44 23.5 Favored 'Trans proline' 0 C--N 1.358 1.066 0 CA-C-N 120.56 1.236 . . . . 0.0 112.592 169.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.6 mmt -67.68 -52.21 40.57 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.958 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.786 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -55.8 -35.2 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 173.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 12.7 tp10 -55.45 -49.88 71.3 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.149 0.5 . . . . 0.0 110.254 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -61.63 -48.04 82.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.097 0.475 . . . . 0.0 110.493 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.661 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 m-30 -63.02 -22.36 66.8 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.981 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.471 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 34.9 p -82.03 -19.59 40.08 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.726 0.774 . . . . 0.0 108.949 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -77.48 -29.91 52.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.673 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.661 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -100.39 26.31 6.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.251 175.097 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.747 ' CE1' HD11 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -100.12 89.34 1.08 Allowed Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.889 170.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 83.0 Cg_endo -84.99 -45.18 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.125 1.883 . . . . 0.0 114.075 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.69 -24.19 14.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.226 0.536 . . . . 0.0 111.845 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.36 164.38 11.68 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.577 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.0 128.32 55.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.786 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.52 120.87 43.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.642 ' HA ' HG23 ' A' ' 2' ' ' VAL . 29.6 m-85 -132.39 142.03 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.737 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.958 ' HG2' HG21 ' A' ' 2' ' ' VAL . 7.8 mmtt -127.93 120.0 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.654 HD13 ' HG ' ' A' ' 60' ' ' LEU . 6.0 mt -100.67 167.73 10.14 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.53 120.41 40.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -15.96 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.281 -174.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.65 -51.04 46.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.913 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.16 -29.7 31.42 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.469 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.9 mm? -96.14 57.59 1.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 0.0 111.22 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.545 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.97 -45.43 10.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.375 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 33.3 t70 -61.25 -45.42 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.649 0.262 . . . . 0.0 111.165 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.9 p -64.82 -38.04 81.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.384 . . . . 0.0 110.557 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.05 74.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.0 110.81 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 88.8 mm-40 -75.02 -28.79 60.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.607 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 87.7 mttt -61.84 -41.31 97.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.462 0.649 . . . . 0.0 110.549 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -92.2 7.75 41.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.125 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 55.16 46.61 23.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.058 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 25' ' ' PHE . 93.3 t -77.89 109.44 12.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.41 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.51 -2.57 11.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.357 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.03 23.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.994 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.89 145.6 32.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.629 0.252 . . . . 0.0 110.695 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 90.5 Cg_endo -82.04 171.24 56.4 Favored 'Cis proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.355 -1.519 . . . . 0.0 112.046 -3.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.594 HG22 HD11 ' A' ' 76' ' ' LEU . 19.2 m -127.11 119.0 25.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -108.24 106.23 16.31 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.002 0.429 . . . . 0.0 111.016 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.594 HD11 HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -118.84 119.06 33.27 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.117 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -94.91 119.01 32.74 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.2 m-85 -105.37 160.25 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.86 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 65.8 tttp -150.68 125.5 9.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.014 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 18' ' ' ASP . 29.0 m120 53.9 33.76 17.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 111.882 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.19 60.91 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.719 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 47.3 mmtm -102.06 -73.55 0.65 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 9.5 pt-20 165.41 -170.98 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 124.724 1.265 . . . . 0.0 108.511 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 77' ' ' LEU . 1.5 p -156.62 -30.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.446 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -163.02 161.96 25.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.411 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.573 ' HG3' HD12 ' A' ' 76' ' ' LEU . 71.5 tttt -146.61 124.38 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.184 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.47 132.95 70.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.26 78.67 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.124 0.488 . . . . 0.0 110.853 -171.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.42 -171.79 40.02 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.609 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.38 93.57 2.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.0 p-10 -118.93 71.87 11.09 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 95' ' ' ILE . 7.3 Cg_exo -73.65 -31.75 8.33 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.264 1.309 . . . . 0.0 109.833 166.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.59 -44.1 10.32 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.432 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.91 -16.9 61.09 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.424 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.715 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -57.09 -37.68 56.62 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 169.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.683 ' HA ' HG22 ' A' ' 99' ' ' ILE . 13.9 mmmm -56.96 -32.77 66.37 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.743 0.652 . . . . 0.0 110.37 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.99 -56.65 19.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.605 174.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -77.9 -28.33 49.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.747 HD11 ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -74.43 -44.7 47.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.654 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 -32.44 22.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.279 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.88 82.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 17.9 m-80 -114.22 -77.21 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.192 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.917 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -171.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.903 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.575 0.702 . . . . 0.0 111.708 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.437 ' CG2' ' HD1' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -81.33 148.66 29.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.428 -177.098 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.5 141.08 35.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 170.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.545 ' HB2' HD22 ' A' ' 55' ' ' LEU . 14.3 m-85 -98.77 157.15 16.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.044 0.449 . . . . 0.0 110.021 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -123.71 -17.42 6.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 50.0 p -130.08 150.88 51.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.952 0.406 . . . . 0.0 111.025 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -60.35 -30.39 69.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.396 175.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -67.77 -33.58 75.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.479 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 22.1 mm-40 -61.73 -47.16 86.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.264 0.554 . . . . 0.0 110.07 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.6 -45.98 81.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.059 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.99 -48.51 81.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.371 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -69.36 -26.74 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -70.66 -53.25 16.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.427 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 pt -65.35 -21.97 30.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.332 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.88 -2.75 48.77 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 19' ' ' LYS . 28.3 mt-30 -76.09 158.55 31.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.646 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . 33.9 t70 -80.16 28.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.104 0.954 . . . . 0.0 110.026 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 7.8 ptmt -134.75 169.12 17.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.506 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.811 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tm? -82.53 116.92 22.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.896 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.6 t -115.32 107.63 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.742 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.72 103.69 15.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 122.164 0.983 . . . . 0.0 111.209 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 21' ' ' VAL . 18.0 t -100.47 139.92 20.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.27 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -130.33 138.57 50.5 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.664 0.269 . . . . 0.0 111.698 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CD2' HG21 ' A' ' 69' ' ' VAL . 49.7 m-85 -88.59 128.17 35.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.92 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.4 m-30 -120.45 -170.93 2.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.04 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.24 172.39 12.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.252 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -20.74 65.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.225 0.536 . . . . 0.0 110.868 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 23.1 p90 -101.39 -147.45 0.36 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.254 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.9 p 56.73 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.408 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.86 -41.45 76.13 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 114.319 -1.309 . . . . 0.0 114.178 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.677 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 46.4 Cg_exo -58.82 -43.73 41.57 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 120.25 2.025 . . . . 0.0 112.154 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.4 m -53.21 -40.0 64.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.383 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.758 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 96.1 mttt -65.56 -53.34 43.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.499 -178.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.8 ptm -62.8 -45.36 92.99 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.649 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.62 -18.43 15.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.924 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.4 -48.16 97.78 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.758 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.9 Cg_exo -70.74 -32.53 14.34 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.174 1.249 . . . . 0.0 112.008 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.1 mmm -64.26 -51.02 65.65 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.614 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.57 HD13 ' CG1' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -53.85 -36.94 31.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-O 120.624 0.249 . . . . 0.0 110.341 172.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.92 -44.49 97.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.721 0.296 . . . . 0.0 111.195 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.92 -50.13 75.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.577 0.703 . . . . 0.0 109.408 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.704 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 14.1 m-30 -63.7 -17.17 62.7 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.482 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 9.6 p -86.15 -14.05 45.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.978 0.894 . . . . 0.0 108.921 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -88.14 -16.63 32.91 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.704 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -128.77 29.92 5.17 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.809 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -108.58 100.83 40.45 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-O 122.193 0.997 . . . . 0.0 112.623 172.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.85 -44.12 10.9 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.826 2.35 . . . . 0.0 114.375 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.5 -13.45 17.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 111.349 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -103.33 158.19 16.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.786 0.803 . . . . 0.0 112.002 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -126.38 119.13 26.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.173 171.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.809 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -87.64 130.58 34.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 -175.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.572 ' CE2' HG13 ' A' ' 21' ' ' VAL . 37.9 m-85 -133.32 133.07 42.06 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.356 168.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.903 ' HG2' HG21 ' A' ' 2' ' ' VAL . 8.0 mmpt? -117.0 118.96 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 1.3 mt -102.4 175.22 5.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.017 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -115.88 121.46 42.42 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -67.89 -10.58 12.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.198 -175.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.64 -35.64 52.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.58 -27.49 21.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.706 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.657 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.0 mt -117.85 54.09 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.367 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.25 -39.16 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.112 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.6 t70 -68.07 -46.99 69.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.644 0.259 . . . . 0.0 110.632 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.657 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.6 p -62.18 -38.45 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.402 . . . . 0.0 110.35 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.31 77.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.918 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 95.2 mt-30 -76.42 -30.85 57.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.461 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 39.1 mtmt -58.62 -39.95 81.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.51 0.671 . . . . 0.0 110.056 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -91.26 9.44 31.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.691 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 56.44 45.62 22.27 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.348 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 25' ' ' PHE . 62.3 t -85.96 123.72 39.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.508 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -134.67 -35.56 0.88 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.53 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.32 119.84 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.979 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.57 136.93 19.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.417 . . . . 0.0 110.872 -175.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 85.2 Cg_endo -83.98 169.88 52.84 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.124 -1.615 . . . . 0.0 111.714 -4.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.489 ' OG1' HG13 ' A' ' 69' ' ' VAL . 55.9 m -117.06 116.88 28.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.579 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.34 108.65 20.15 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.172 0.511 . . . . 0.0 111.084 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.538 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.4 mt -126.63 116.08 20.47 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.606 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.742 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.81 125.98 41.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.933 173.244 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 25.7 m-85 -108.73 154.28 22.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.381 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -139.99 111.6 7.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.536 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.646 ' ND2' ' HA ' ' A' ' 18' ' ' ASP . 17.9 m120 57.32 31.75 20.64 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.652 0.595 . . . . 0.0 111.508 -176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.36 11.19 51.77 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.51 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -106.01 0.3 25.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.764 0.792 . . . . 0.0 109.097 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 72.05 175.51 0.28 Allowed 'General case' 0 CA--C 1.524 -0.049 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.246 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.76 HG11 HD21 ' A' ' 20' ' ' LEU . 1.1 p -148.61 -30.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.006 0.431 . . . . 0.0 109.917 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . . . -161.61 164.54 29.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.645 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.1 tttt -146.4 118.37 8.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.167 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.17 131.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.17 76.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.204 0.526 . . . . 0.0 111.376 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.47 -167.51 35.71 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.226 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.99 96.99 3.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 110.094 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.1 p-10 -122.27 67.17 25.77 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.1 -34.63 27.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.173 1.248 . . . . 0.0 110.944 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.21 -43.26 11.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.143 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.4 -17.75 60.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.624 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.684 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.8 tp -58.85 -37.57 67.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 170.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.592 ' HA ' HG22 ' A' ' 99' ' ' ILE . 21.4 tptm -60.65 -32.76 71.92 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.049 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -56.17 -55.83 28.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 173.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.74 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -73.53 -36.04 65.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.542 0.687 . . . . 0.0 111.106 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -71.71 -45.11 67.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.645 -171.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.498 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -89.1 -40.81 12.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.917 0.389 . . . . 0.0 111.706 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.93 83.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.295 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 85' ' ' ALA . 18.9 m120 -93.25 -56.88 2.79 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.629 -172.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.811 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.165 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.651 HG11 ' HG2' ' A' ' 54' ' ' LYS . 35.9 t . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.041 0.448 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 146.6 51.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.889 0.852 . . . . 0.0 112.397 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -103.38 141.52 35.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.804 -1.543 . . . . 0.0 109.463 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.729 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.7 m-85 -94.5 158.03 15.73 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -119.86 -15.08 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.704 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 37.2 p -135.07 151.5 50.82 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.41 -29.76 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.6 t -59.88 -46.89 87.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.063 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.2 mm-40 -60.38 -42.94 96.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.414 0.626 . . . . 0.0 110.143 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 19.7 t80 -67.58 -47.28 70.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.087 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' HA ' HG12 ' A' ' 15' ' ' ILE . 25.3 t70 -60.96 -42.85 99.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.597 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 22.6 t -67.16 -39.33 86.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.713 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -65.49 -50.84 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.981 0.419 . . . . 0.0 110.722 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 11' ' ' PHE . 35.5 pt -67.41 -18.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.632 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.62 -14.12 52.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 13' ' ' SER . 54.7 mt-30 -69.16 150.19 47.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 39.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.482 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 10.5 ptmt -136.75 167.38 21.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.588 HD21 HG11 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -77.6 108.01 10.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.475 HG12 HG23 ' A' ' 23' ' ' VAL . 53.0 t -110.02 107.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.209 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.693 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.93 103.12 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 122.062 0.934 . . . . 0.0 110.84 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 70.8 t -102.35 143.18 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.866 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -127.9 117.53 21.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -70.51 129.1 38.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.525 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.581 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 7.6 m-30 -118.5 -177.45 3.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . . . -152.23 130.21 11.8 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -58.26 -24.74 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.716 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -96.75 8.99 43.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.797 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.942 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -107.07 138.29 43.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.307 0.575 . . . . 0.0 111.786 -177.09 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -81.72 -37.65 16.11 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.904 -1.044 . . . . 0.0 114.546 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.942 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.1 Cg_exo -66.25 -29.33 46.92 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 120.359 2.08 . . . . 0.0 110.378 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 58.5 m -51.12 -39.62 56.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.732 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.931 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 13.5 mptt -67.79 -57.37 6.43 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.801 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 23.4 ptp -54.19 -50.22 67.57 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.692 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.41 -21.19 16.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.931 -177.297 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.96 -60.06 10.7 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.01 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.931 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 9.3 Cg_endo -56.37 -36.22 96.96 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 121.268 1.312 . . . . 0.0 112.792 169.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.597 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 26.1 mmt -62.75 -51.58 66.56 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.371 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.594 ' CG2' HG21 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -52.51 -32.73 17.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 122.672 0.389 . . . . 0.0 111.509 176.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 44.8 mt-10 -59.64 -48.57 81.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.351 0.596 . . . . 0.0 110.479 173.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 18.5 tptm -61.22 -47.62 85.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.685 0.755 . . . . 0.0 109.874 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.664 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 34.0 m-85 -67.42 -20.55 65.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.78 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 84.9 p -77.09 -15.96 59.39 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 108.85 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 37.1 tt0 -80.38 -20.7 43.46 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.537 171.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.664 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 7.3 mm100 -83.46 -7.05 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.984 175.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.715 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 7.5 p90 -134.68 85.44 36.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.36 0.6 . . . . 0.0 112.46 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.56 -21.9 4.05 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.218 2.612 . . . . 0.0 112.423 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.72 -1.0 50.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.438 0.637 . . . . 0.0 110.527 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -119.12 165.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -108.84 117.59 34.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.297 0.57 . . . . 0.0 111.997 -175.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 1.6 p90 -83.55 121.48 27.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.048 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 31.5 m-85 -136.74 142.59 43.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.335 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.866 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 10.9 mmtt -126.91 124.13 38.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.729 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.8 mt -100.67 -178.24 3.72 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.169 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 11.5 t0 -133.89 131.32 38.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.34 -8.7 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.316 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -31.62 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 109.971 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.61 -27.05 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.046 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.595 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.87 52.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.0 -39.81 22.81 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.487 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -44.0 73.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.775 0.322 . . . . 0.0 110.694 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.595 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -65.39 -38.82 83.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.048 0.451 . . . . 0.0 110.394 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.36 69.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.6 mt-30 -72.89 -36.83 67.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.962 0.411 . . . . 0.0 110.245 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -91.66 10.17 29.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.82 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 56.47 44.15 24.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.423 HG13 ' OG1' ' A' ' 74' ' ' THR . 74.2 t -73.7 109.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.489 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -117.54 -25.92 6.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.541 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.78 117.57 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.036 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -100.63 150.41 36.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 14.1 Cg_exo -71.21 171.47 59.51 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 123.872 -1.303 . . . . 0.0 111.834 -6.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 19.9 m -131.07 115.52 16.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.596 HD13 HD13 ' A' ' 95' ' ' ILE . 3.8 mt -105.7 108.67 20.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.503 0.668 . . . . 0.0 111.115 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.602 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 25.5 mt -123.23 114.4 20.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.014 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.693 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -93.75 125.02 38.13 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.168 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 m-85 -107.37 155.64 19.79 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.431 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -141.04 131.94 25.99 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 36.02 44.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 19.02 60.0 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.579 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 14.7 tttp -126.39 0.92 6.99 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.338 0.59 . . . . 0.0 110.215 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 39.2 mt-10 73.14 -179.1 0.2 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.951 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.588 HG11 HD21 ' A' ' 20' ' ' LEU . 1.3 p -153.31 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.754 174.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.599 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . . . -157.71 163.0 38.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.119 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 77.0 tttt -144.26 116.69 8.55 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.944 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 t -123.89 133.88 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.13 78.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.283 0.563 . . . . 0.0 110.927 -170.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.59 -175.67 39.78 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 96.48 1.87 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 19.1 p-10 -119.41 78.8 20.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 3.4 Cg_exo -74.91 -29.94 7.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.469 1.446 . . . . 0.0 110.319 167.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -90.25 -51.03 5.64 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.618 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -67.68 -16.59 64.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.518 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -55.74 -37.59 47.49 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.726 ' HA ' HG22 ' A' ' 99' ' ' ILE . 11.7 mmmm -58.39 -34.52 70.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.023 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -54.01 -58.66 6.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.37 55.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.784 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -80.49 -40.02 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.471 -172.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.19 17.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.666 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.19 70.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 85' ' ' ALA . 20.3 m120 -101.14 -68.92 0.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.273 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.419 HG11 ' HE3' ' A' ' 54' ' ' LYS . 39.4 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 120.961 0.41 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -70.18 149.24 47.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.065 -176.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 3.2 pp0? -109.14 134.08 52.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.492 175.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.674 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.3 m-85 -86.75 164.4 16.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.164 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -123.22 -13.72 7.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.709 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 71.2 p -137.32 155.35 49.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.724 0.297 . . . . 0.0 111.017 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.553 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.85 -31.22 69.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 t -61.23 -42.09 98.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.7 mm-40 -59.0 -43.93 91.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.32 0.581 . . . . 0.0 109.992 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 15' ' ' ILE . 1.4 t80 -63.65 -49.18 74.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.843 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.1 -44.44 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.925 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 34.5 t -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.974 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -49.74 42.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.906 0.384 . . . . 0.0 110.666 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 29.3 pt -66.99 -21.71 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.548 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.67 -8.62 59.33 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.884 0.374 . . . . 0.0 111.371 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 13' ' ' SER . 27.6 mt-30 -75.63 158.99 31.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.733 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.04 36.24 0.34 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.42 0.628 . . . . 0.0 110.347 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' GLN . 29.1 mmmt -126.71 160.27 31.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.651 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.74 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.7 tm? -77.57 105.56 8.8 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 53.3 t -110.23 107.12 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.024 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.744 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.73 108.99 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.684 0.754 . . . . 0.0 110.818 175.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 85.1 t -103.53 142.72 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.117 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.711 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -126.72 113.68 16.98 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.81 106.48 7.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.063 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.708 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.2 m-85 -133.28 175.82 9.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 112.143 -171.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.07 163.56 39.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.49 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -85.49 -8.64 58.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -108.02 27.65 9.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -129.26 128.11 42.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.441 0.639 . . . . 0.0 111.306 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.14 97.49 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 114.713 -1.131 . . . . 0.0 114.107 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.572 ' O ' HG22 ' A' ' 36' ' ' ILE . 38.7 Cg_exo -58.15 -39.41 85.46 Favored 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 119.714 1.757 . . . . 0.0 110.674 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 39.0 m -58.57 -34.08 70.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.2 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 29.1 mtpp -63.87 -55.65 21.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.423 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 26.0 ptt? -61.03 -44.56 97.22 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.708 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.23 -24.15 18.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.796 -178.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -53.85 -51.36 77.46 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.619 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 35.6 Cg_endo -68.12 -32.46 27.5 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 120.215 1.113 . . . . 0.0 112.603 169.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.422 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.6 mmt -64.66 -57.59 8.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.597 HD12 ' CG1' ' A' ' 36' ' ' ILE . 36.5 mt -66.46 -23.12 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.45 0.568 . . . . 0.0 111.39 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.94 -47.29 85.61 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.53 0.681 . . . . 0.0 109.46 168.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -63.41 -48.53 77.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.145 0.498 . . . . 0.0 110.516 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.642 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 11.7 m-30 -65.6 -15.56 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.975 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 p -87.21 -14.9 39.8 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 121.555 0.693 . . . . 0.0 109.274 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.27 -23.2 40.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 168.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.642 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -120.87 34.08 5.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -104.59 85.11 1.07 Allowed Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 122.016 0.912 . . . . 0.0 112.298 172.568 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 24.3 Cg_exo -64.02 -45.68 9.82 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.005 1.803 . . . . 0.0 113.916 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -107.81 24.65 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 103' ' ' ALA . . . -128.98 156.38 43.88 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.798 -0.564 . . . . 0.0 111.914 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.76 120.26 40.2 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.24 169.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.613 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -103.35 116.74 33.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.5 -171.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CD2' HG13 ' A' ' 21' ' ' VAL . 23.2 m-85 -129.17 136.26 49.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.711 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -121.18 119.06 31.25 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.675 HD13 ' HG ' ' A' ' 60' ' ' LEU . 5.2 mt -100.96 160.55 14.28 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.776 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.48 114.56 26.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -11.25 9.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.44 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.02 -51.09 27.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.548 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -86.96 -25.68 24.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.438 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.675 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.6 mm? -99.99 45.06 0.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 111.316 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.05 -37.03 30.07 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.848 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.1 -42.41 94.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.695 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 8' ' ' ALA . 3.1 p -67.19 -39.09 82.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.81 76.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.72 -33.08 72.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.204 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -27.73 64.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.667 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -95.18 10.83 34.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.88 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 60.09 41.33 17.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.791 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.5 t -99.95 110.53 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.571 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 p -110.73 -19.22 12.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.85 0.357 . . . . 0.0 110.727 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.15 168.39 10.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.13 148.53 35.47 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.66 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 18.8 Cg_exo -70.77 173.35 48.61 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.839 -0.901 . . . . 0.0 112.581 -6.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 87.6 m -147.23 117.32 7.28 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.839 0.352 . . . . 0.0 110.496 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.463 ' HG ' HD13 ' A' ' 95' ' ' ILE . 4.0 mm? -110.76 111.23 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.326 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.413 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 35.8 mt -125.87 115.39 19.9 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -96.86 128.82 44.19 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.018 174.344 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 29.0 m-85 -110.72 155.53 22.34 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.131 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.641 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.3 tttt -142.28 116.83 9.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.829 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.641 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.52 38.4 7.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.787 0.835 . . . . 0.0 111.847 -177.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.15 8.63 55.06 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.34 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -109.39 4.05 22.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 109.997 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 24.2 tt0 67.92 174.6 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.025 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.4 p -144.31 -32.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.933 0.396 . . . . 0.0 110.117 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.411 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -157.93 161.33 38.2 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.979 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.413 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 1.7 ttmp? -139.72 117.48 11.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.245 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.08 125.71 73.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.05 87.0 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 111.296 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 -173.63 33.63 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.027 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 73' ' ' PRO . . . -71.91 103.62 3.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.5 p-10 -127.22 65.65 65.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 10.1 Cg_exo -69.21 -34.07 17.23 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 120.867 1.045 . . . . 0.0 110.871 174.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.53 -45.34 9.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -70.92 -17.24 62.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.58 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.652 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.7 tp -56.96 -38.45 59.77 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HA ' HG22 ' A' ' 99' ' ' ILE . 30.5 mmtt -59.58 -35.37 74.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.761 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 23.0 tm0? -54.14 -54.01 45.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -76.7 -39.77 50.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.629 0.728 . . . . 0.0 111.3 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -69.57 -41.0 80.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.678 -171.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 -38.57 14.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.635 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.11 -31.13 55.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 45.5 m-80 -95.65 -60.07 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.33 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.74 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.245 0.867 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.463 170.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.94 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.597 0.713 . . . . 0.0 112.025 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.54 148.44 27.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.204 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -105.3 133.33 50.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.061 170.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.634 ' H ' HD22 ' A' ' 55' ' ' LEU . 15.3 m-85 -84.38 164.32 19.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -117.79 -16.91 9.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.444 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 40.1 p -134.89 153.64 51.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.42 -33.71 68.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -64.29 -32.09 73.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.474 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.625 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 23.4 mm-40 -67.42 -44.09 79.62 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.093 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -44.38 94.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.633 176.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.33 -44.42 88.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.447 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -71.14 -25.7 62.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.788 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' HG11 ' A' ' 21' ' ' VAL . . . -77.14 -50.02 13.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.684 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 pt -66.53 -17.83 23.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.286 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.05 59.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.893 0.377 . . . . 0.0 111.586 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.463 ' C ' ' H ' ' A' ' 19' ' ' LYS . 28.4 mt-30 -71.55 150.77 44.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.343 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.68 28.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.41 0.624 . . . . 0.0 110.975 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 17' ' ' GLN . 15.0 ptmt -135.94 174.65 10.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.46 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.552 ' CD1' HG11 ' A' ' 84' ' ' VAL . 8.0 tt -85.62 134.64 33.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.413 0.625 . . . . 0.0 111.199 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.438 HG11 ' HB1' ' A' ' 14' ' ' ALA . 55.9 t -134.98 109.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.963 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.63 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -103.17 107.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.147 0.975 . . . . 0.0 111.164 177.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 99.2 t -100.19 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.499 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -127.6 122.58 33.52 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CD2' HG21 ' A' ' 69' ' ' VAL . 95.8 m-85 -73.83 124.79 26.77 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.335 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.4 m-30 -118.66 179.25 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.29 144.54 27.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -3.81 28.15 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.05 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -122.16 13.32 10.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 3.7 p -109.43 156.06 20.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.571 0.7 . . . . 0.0 112.617 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.53 -52.36 3.57 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.639 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 72.0 Cg_exo -53.96 -48.44 21.68 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.249 1.966 . . . . 0.0 112.621 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 7.8 p -51.17 -35.51 36.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.188 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.9 tptm -65.2 -53.1 49.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.161 0.288 . . . . 0.0 110.532 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 39' ' ' MET . 26.5 ptt? -66.66 -43.34 84.83 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.629 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.49 -18.19 16.75 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.09 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.77 -53.22 67.13 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.825 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 34.2 Cg_endo -67.13 -28.2 41.09 Favored 'Trans proline' 0 C--N 1.359 1.107 0 CA-C-N 120.567 1.238 . . . . 0.0 112.428 170.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.541 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.9 mmm -65.91 -56.32 12.35 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.183 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.495 ' CG2' HG11 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -52.86 -31.09 16.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 122.495 0.318 . . . . 0.0 110.74 176.186 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -61.33 -50.77 71.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.305 0.574 . . . . 0.0 109.599 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 1.4 tmtp? -61.53 -44.49 96.97 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.611 0.719 . . . . 0.0 109.781 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.666 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 76.5 m-85 -66.06 -23.23 66.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.624 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.66 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 83.5 p -74.1 -19.03 60.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -78.16 -23.64 47.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.666 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 5.3 mm100 -87.69 5.54 39.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.338 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 0.6 OUTLIER -99.46 102.14 15.48 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.012 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.4 Cg_exo -76.5 -45.93 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.686 1.591 . . . . 0.0 112.692 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.97 1.25 15.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -113.55 153.28 29.03 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.02 129.26 46.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.2 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.4 OUTLIER -105.06 121.45 43.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.677 -175.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.763 ' HA ' HG23 ' A' ' 2' ' ' VAL . 30.1 m-85 -135.5 144.64 46.45 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.519 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.96 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 11.9 mmtt -128.87 122.51 30.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.655 HD13 ' HG ' ' A' ' 60' ' ' LEU . 6.4 mt -98.48 170.75 8.61 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.136 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.08 120.5 34.48 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.41 -8.52 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.16 -28.65 61.41 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.762 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG2' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -110.42 -35.65 5.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 169.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.655 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.7 mm? -87.28 52.21 2.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.851 0.358 . . . . 0.0 111.006 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.48 -37.5 30.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.152 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.648 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 13.6 p-10 -66.99 -43.99 81.57 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.046 -0.09 . . . . 0.0 110.766 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.6 p -66.44 -34.85 72.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 110.614 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.7 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.622 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 33.7 mm-40 -77.47 -30.08 52.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.907 0.384 . . . . 0.0 110.422 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 74.5 mmtt -57.32 -47.95 80.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.289 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -94.26 15.85 16.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.328 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 48.89 52.88 13.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.818 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 25' ' ' PHE . 97.7 t -81.42 113.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.731 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.7 p -118.55 1.07 11.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.9 154.21 45.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.776 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.94 128.86 20.87 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.773 178.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 84.9 Cg_endo -82.3 171.7 53.63 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.932 -5.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 68.2 m -124.74 116.69 22.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.716 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.78 111.66 24.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.185 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.9 mt -127.49 113.52 16.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.47 127.57 38.01 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.554 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 m-85 -112.59 157.45 21.17 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.122 -176.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.6 tttt -143.26 118.68 10.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.021 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.542 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.51 44.77 2.63 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.825 0.85 . . . . 0.0 112.509 -178.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.41 10.09 52.16 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.148 -0.478 . . . . 0.0 113.512 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -109.3 0.06 19.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.033 0.444 . . . . 0.0 110.288 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 28.1 tt0 66.83 179.75 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.554 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.561 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -152.83 -33.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.746 0.308 . . . . 0.0 110.705 173.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.4 164.49 32.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.79 0.329 . . . . 0.0 111.023 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.3 tttt -145.92 123.81 12.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.568 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.31 133.45 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.76 78.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.196 0.522 . . . . 0.0 111.344 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.83 -172.3 37.11 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.684 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -73.04 97.02 2.25 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.3 p-10 -121.77 66.14 19.94 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.485 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 15.3 Cg_exo -66.03 -37.18 27.0 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.092 1.195 . . . . 0.0 110.946 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 96' ' ' LYS . . . -88.92 -41.68 12.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.235 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.03 -17.09 61.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.459 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.711 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.7 tp -56.25 -38.14 53.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.616 ' HD3' HG22 ' A' ' 99' ' ' ILE . 17.5 tppt? -61.5 -31.39 71.38 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.187 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 20.1 tm0? -56.54 -55.61 31.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 174.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.65 -32.67 62.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.419 0.628 . . . . 0.0 110.751 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.76 -43.17 70.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.613 -172.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.59 -39.22 16.36 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.801 0.334 . . . . 0.0 110.802 -175.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.47 77.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.966 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 42.0 m-80 -104.12 -66.39 0.96 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.554 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.607 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.649 -0.691 . . . . 0.0 111.271 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.515 HG21 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.132 0.491 . . . . 0.0 110.05 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.56 147.43 33.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.976 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -107.14 122.54 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.214 171.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.633 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 13.4 m-85 -76.4 152.67 36.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.215 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.62 -19.55 15.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.364 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 81.2 p -135.39 156.61 48.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.241 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -59.07 -31.88 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -62.91 -38.67 91.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.99 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.0 mm-40 -60.37 -51.98 67.19 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.355 0.598 . . . . 0.0 110.193 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 2.1 t80 -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.727 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.97 -45.43 78.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.455 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 37.4 t -67.84 -42.1 81.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -61.39 -49.93 74.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.556 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 42.0 pt -67.27 -20.86 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.502 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.25 -2.56 58.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.733 0.302 . . . . 0.0 111.672 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 13' ' ' SER . 99.1 mt-30 -81.86 162.68 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.088 0.471 . . . . 0.0 111.08 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.1 26.04 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.687 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 9.0 ptmt -132.14 165.24 24.52 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.78 HD21 HG11 ' A' ' 84' ' ' VAL . 2.7 tm? -76.57 117.28 18.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG12 HG23 ' A' ' 23' ' ' VAL . 59.7 t -114.25 107.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.723 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.13 106.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.527 0.68 . . . . 0.0 110.343 175.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.637 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 34.5 t -108.4 143.36 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.551 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.915 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -122.32 120.83 35.21 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.338 0.59 . . . . 0.0 112.515 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CE2' HD12 ' A' ' 55' ' ' LEU . 95.4 m-85 -69.89 118.98 13.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.366 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.495 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -127.34 176.48 7.4 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.95 -164.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.29 146.87 14.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.165 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 p -84.48 -4.46 58.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -116.35 51.63 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -151.7 171.07 18.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.92 -54.16 2.83 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.632 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' A' ' 35' ' ' MET . 74.9 Cg_exo -53.11 -35.0 70.98 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.321 2.014 . . . . 0.0 112.406 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 p -65.6 -32.23 73.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.948 0.404 . . . . 0.0 111.027 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -68.39 -34.46 76.07 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.205 -0.309 . . . . 0.0 110.927 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -80.7 -49.78 10.76 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -76.75 -22.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.181 -0.949 . . . . 0.0 111.352 -175.106 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.77 -49.09 95.69 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.411 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 35' ' ' MET . 32.8 Cg_exo -63.47 -37.42 48.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.34 1.36 . . . . 0.0 111.806 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mmm -65.61 -61.6 1.99 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 36' ' ' ILE . 57.7 mt -66.33 -19.1 25.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 118.58 0.627 . . . . 0.0 111.377 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.2 tt0 -60.84 -46.06 92.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.697 0.76 . . . . 0.0 109.471 167.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 23.1 ttmt -66.12 -42.09 89.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.601 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.596 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.1 m-30 -71.65 -17.42 62.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.312 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.823 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 96.9 p -77.67 -16.89 58.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -83.86 -19.05 35.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.405 168.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.609 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 10.0 mm100 -95.18 -1.08 52.53 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.59 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 9.0 m-30 -100.51 101.48 15.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.263 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.9 Cg_exo -80.61 -43.98 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.659 2.239 . . . . 0.0 112.438 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -107.84 7.23 28.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.882 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -123.81 143.41 50.34 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.47 46.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.949 0.88 . . . . 0.0 111.014 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.823 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.6 OUTLIER -106.7 119.15 38.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.535 -169.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.504 ' HB2' HG22 ' A' ' 23' ' ' VAL . 29.0 m-85 -135.77 155.11 50.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.915 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -132.19 130.07 40.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.637 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 76.8 mt -95.34 128.42 42.17 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.128 -0.358 . . . . 0.0 111.128 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -70.91 97.53 1.44 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 168.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -56.52 -19.7 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.53 -35.86 72.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.091 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HG3' HD22 ' A' ' 60' ' ' LEU . 9.3 pt-20 -110.05 -38.59 5.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.462 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.606 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mm? -78.19 50.74 0.93 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.98 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.33 -42.05 24.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.7 p-10 -62.76 -46.71 86.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.315 0.103 . . . . 0.0 110.936 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.606 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -63.17 -38.56 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 110.254 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.91 70.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 22.1 mm-40 -75.95 -40.06 54.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.153 0.501 . . . . 0.0 109.748 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.657 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 58.4 mttm -59.34 -40.69 87.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.626 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -89.89 6.17 43.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.544 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 57.72 52.06 8.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.516 HG13 ' OG1' ' A' ' 74' ' ' THR . 57.1 t -75.52 116.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.856 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -113.93 -62.41 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.875 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.17 116.55 29.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.999 0.428 . . . . 0.0 110.568 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.68 145.95 30.79 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.464 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.06 162.03 92.58 Favored 'Cis proline' 0 C--O 1.235 0.359 0 C-N-CA 123.106 -1.623 . . . . 0.0 112.513 -5.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.516 ' OG1' HG13 ' A' ' 69' ' ' VAL . 52.5 m -118.45 117.24 28.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -102.2 108.62 20.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 31.3 mt -122.12 113.13 19.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.587 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -99.2 128.34 45.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.055 177.015 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 34.4 m-85 -112.09 153.71 26.51 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.3 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.454 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 24.1 tptm -135.97 115.0 12.27 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.389 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 2.6 p-10 44.15 38.24 2.25 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.134 0.974 . . . . 0.0 112.731 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.69 7.05 73.61 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.292 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -105.2 -7.12 19.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 77.77 173.29 0.19 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.673 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.78 HG11 HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -147.28 -29.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.699 0.285 . . . . 0.0 110.789 173.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.501 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . . . -161.69 162.68 29.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.21 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 1.8 tmtp? -142.82 108.99 5.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.33 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.5 t -119.56 143.43 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.17 86.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.761 0.791 . . . . 0.0 111.478 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 50.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.144 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.25 84.83 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.004 0.43 . . . . 0.0 111.005 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.3 p-10 -121.1 83.64 38.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 6.0 Cg_exo -75.14 -38.96 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.58 1.52 . . . . 0.0 111.03 168.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.31 -39.93 13.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.428 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -73.05 -17.29 61.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.078 0.466 . . . . 0.0 111.238 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.675 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -57.81 -36.72 56.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 99' ' ' ILE . 31.5 mmmt -56.34 -40.11 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.831 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.627 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 4.0 tp60 -46.48 -60.22 2.49 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 123.346 0.403 . . . . 0.0 110.349 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -77.37 -29.24 53.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.475 0.655 . . . . 0.0 111.436 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -80.01 -41.37 21.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.956 -170.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.97 -35.65 18.74 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.796 -176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.35 -39.18 78.29 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 85' ' ' ALA . 22.4 m120 -96.16 -60.31 1.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 50' ' ' ALA . . . . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.546 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.609 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.52 149.83 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.064 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -99.65 133.25 44.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.691 170.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.683 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.9 m-85 -86.98 164.35 16.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.16 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -117.2 -23.32 7.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.919 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.666 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 39.9 p -132.4 157.4 44.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 112.035 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.68 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -61.43 -35.6 78.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.771 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.0 mm-40 -61.3 -49.65 76.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.311 0.577 . . . . 0.0 110.345 177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -47.9 80.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.498 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.37 -44.42 95.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -67.61 -36.65 81.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.987 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.34 -49.26 61.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 pt -66.36 -20.74 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.94 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HA ' ' N ' ' A' ' 81' ' ' GLY . . . -80.84 -8.83 59.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -72.19 150.38 43.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.43 53.57 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.692 0.758 . . . . 0.0 110.221 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 10.0 ptmt -153.08 173.75 15.07 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.332 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.555 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -75.5 111.28 10.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.1 t -122.62 107.67 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.868 0.366 . . . . 0.0 110.442 169.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.13 115.36 47.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.56 0.695 . . . . 0.0 111.271 175.024 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.606 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 84.3 t -103.26 140.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.964 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.845 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.09 138.33 54.45 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 69' ' ' VAL . 71.5 m-85 -90.2 128.04 36.27 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.436 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.618 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 3.0 m-85 -120.68 -171.72 2.24 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.555 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.02 169.7 16.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.524 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.76 -30.34 69.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.591 0.71 . . . . 0.0 110.309 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -91.37 -138.84 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.5 p 56.3 110.41 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.73 1.212 . . . . 0.0 113.942 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.49 98.68 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.266 -1.334 . . . . 0.0 114.176 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.671 ' O ' HG23 ' A' ' 36' ' ' ILE . 31.5 Cg_exo -60.14 -41.76 49.06 Favored 'Trans proline' 0 C--N 1.36 1.139 0 CA-C-N 120.221 2.011 . . . . 0.0 111.663 -178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 29.3 m -51.37 -43.21 61.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.466 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.661 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.3 mmtt -62.87 -55.54 25.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -63.87 -48.0 78.42 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -75.51 -11.59 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.897 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.21 -57.49 25.73 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.292 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 28.1 Cg_endo -64.91 -34.01 50.09 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 120.025 1.044 . . . . 0.0 111.958 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.491 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.8 mtt -64.7 -60.94 2.53 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.892 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.647 HG21 ' HD3' ' A' ' 54' ' ' LYS . 17.4 mt -58.56 -25.47 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 118.228 0.467 . . . . 0.0 112.109 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.31 -41.01 96.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 172.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.96 -46.04 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.826 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.684 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 66.0 m-85 -65.09 -24.38 67.43 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.267 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.625 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 33.9 t -85.57 -14.45 45.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.857 0.837 . . . . 0.0 109.232 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -84.27 -19.84 33.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.684 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 18.1 pt20 -104.66 26.01 9.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.869 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.579 ' HD1' ' O ' ' A' ' 43' ' ' PHE . 2.4 m-85 -97.97 89.95 0.85 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.44 166.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.22 -46.17 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.91 1.74 . . . . 0.0 112.714 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -11.45 14.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 149.27 24.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.98 126.87 50.33 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.637 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.629 ' CE2' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -110.15 125.5 53.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.54 -177.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 27.5 m-85 -130.96 143.4 50.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.845 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 31.6 mtmt -133.02 119.9 20.66 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.7 mt -97.54 163.9 12.66 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.729 -173.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.41 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -102.67 111.74 24.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.208 0.528 . . . . 0.0 109.788 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -66.58 -15.4 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.481 -171.63 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 56' ' ' ASP . 5.9 p-10 -70.34 -26.62 63.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -106.89 -39.28 5.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.356 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.0 mm? -88.09 41.65 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.366 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -70.2 -35.29 70.18 Favored Glycine 0 CA--C 1.504 -0.616 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.45 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 29.7 m-20 -63.36 -40.61 97.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 109.951 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 60' ' ' LEU . 86.0 t -63.2 -42.42 96.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.246 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.28 83.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.126 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 96.6 mt-30 -71.72 -33.06 68.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.526 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 69.0 mttm -57.17 -40.9 78.25 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.438 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -96.44 10.34 38.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.101 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 55.91 40.7 30.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.625 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 25' ' ' PHE . 49.2 t -83.0 127.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.347 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.4 t -134.14 -26.67 1.47 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.283 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.86 114.94 29.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 0.0 110.04 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 147.09 32.94 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.002 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.6 Cg_endo -84.23 161.98 68.23 Favored 'Cis proline' 0 N--CA 1.461 -0.424 0 C-N-CA 124.17 -1.179 . . . . 0.0 111.497 -8.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 m -119.64 121.32 39.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.664 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -107.83 109.93 21.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.607 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.614 HD22 ' HG2' ' A' ' 86' ' ' LYS . 7.6 mt -125.31 114.86 19.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -90.8 122.52 33.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.99 174.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.3 m-85 -106.31 162.19 13.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.36 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 24.7 ttmm -150.51 133.45 16.02 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.346 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 82' ' ' LYS . 1.8 p-10 48.02 29.79 1.85 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.056 0.942 . . . . 0.0 112.618 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.532 ' N ' ' HA ' ' A' ' 16' ' ' ALA . . . 74.69 9.38 82.61 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.855 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 13.4 tttp -107.25 -65.41 1.1 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 18.0 tt0 161.42 -178.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 123.976 0.798 . . . . 0.0 109.064 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 77' ' ' LEU . 2.2 p -154.53 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.532 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.45 165.1 31.64 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.906 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.614 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.7 tmtp? -142.7 119.52 11.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.257 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 t -131.55 144.1 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.74 91.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.888 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.8 53.59 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.643 172.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.492 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.31 86.76 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 111.303 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.2 p-10 -122.39 85.34 47.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.496 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.7 Cg_exo -77.34 -39.46 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.218 1.279 . . . . 0.0 110.308 166.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.47 -36.11 16.65 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.276 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.39 -17.33 60.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.136 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.8 tp -58.06 -37.95 64.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 170.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 19.4 mmtp -55.41 -37.37 67.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.914 0.758 . . . . 0.0 110.647 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.3 tm0? -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 176.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -77.16 -24.81 51.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.304 0.573 . . . . 0.0 111.352 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.731 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -78.01 -42.81 28.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.916 -173.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.45 -32.39 22.32 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.703 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.44 -41.62 93.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.274 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 41.2 m-80 -110.86 -90.39 0.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.859 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.547 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.713 -168.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.16 0.505 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -81.83 147.92 29.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.918 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -103.67 130.17 51.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.953 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.699 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.0 m-85 -84.52 159.72 20.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -117.07 -19.06 9.9 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.57 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 25.7 p -135.01 153.65 52.01 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.779 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.96 -33.69 70.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 m -59.07 -36.34 74.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.106 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 39.4 mm-40 -65.99 -47.73 73.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.492 0.663 . . . . 0.0 110.062 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HD1' HG21 ' A' ' 23' ' ' VAL . 1.6 t80 -62.15 -44.14 97.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.079 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -55.33 -49.53 71.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.893 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -67.46 -37.58 83.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.205 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.95 58.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.04 -19.99 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.227 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 -13.8 59.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.975 0.417 . . . . 0.0 110.945 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -75.57 145.08 41.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.04 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.43 47.45 0.93 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.453 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 6.8 ptmt -138.96 168.35 20.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.064 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.552 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -74.92 105.84 6.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.214 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.469 HG13 ' CD2' ' A' ' 53' ' ' TYR . 53.5 t -114.58 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 173.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.747 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.86 109.41 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.642 0.734 . . . . 0.0 110.74 175.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 66.2 t -103.17 135.19 41.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.052 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -121.63 111.44 17.21 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 121.072 0.463 . . . . 0.0 112.093 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 69' ' ' VAL . 96.3 m-85 -69.05 112.56 5.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.227 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.03 177.44 5.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.11 147.45 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.454 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 p -84.62 -4.72 59.14 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -117.24 53.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.63 173.08 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.77 2.56 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.238 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 36' ' ' ILE . 75.5 Cg_exo -51.56 -40.86 63.06 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.461 2.108 . . . . 0.0 112.142 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 8.5 p -66.04 -29.7 70.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.231 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -68.64 -35.91 77.9 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.943 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.546 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptm -80.84 -46.93 14.54 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.691 HD11 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.93 -22.8 16.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.924 -175.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.503 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -58.46 -46.73 99.6 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.352 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 35' ' ' MET . 45.6 Cg_exo -59.96 -40.59 60.65 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.692 1.594 . . . . 0.0 112.395 167.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -65.02 -53.75 41.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -58.86 -35.71 57.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.223 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 9.5 tp10 -54.48 -47.45 72.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.503 0.668 . . . . 0.0 109.883 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -62.54 -48.89 77.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.631 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 12.1 m-30 -67.08 -17.27 64.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.452 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 29.0 p -87.25 -11.87 48.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.63 -24.18 29.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 168.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -119.36 36.38 4.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.722 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.475 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -99.55 90.66 1.27 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 122.039 0.924 . . . . 0.0 111.746 171.204 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 18.0 Cg_exo -65.35 -46.39 5.75 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.051 1.834 . . . . 0.0 113.359 -170.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -111.35 -7.7 14.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.91 163.18 12.36 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 111.656 -167.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.6 126.27 51.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.245 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 3.4 m-30 -99.57 121.69 41.55 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.689 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 29.9 m-85 -129.08 134.94 48.3 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.703 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 10.7 ttpp -127.45 117.43 22.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.699 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.9 mt -96.13 156.99 16.1 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -165.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -91.25 99.15 12.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -18.65 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.271 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.76 -37.49 84.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.083 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.96 -38.49 10.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.036 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.09 49.55 1.65 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.643 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.35 34.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.659 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 12.5 p-10 -66.02 -40.73 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.523 0.202 . . . . 0.0 111.118 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -72.98 -35.08 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.47 -36.99 74.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.125 0.488 . . . . 0.0 110.308 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 14.9 mm-40 -73.4 -29.8 62.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.416 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 30.0 mtpp -61.91 -40.95 97.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -95.77 12.94 28.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.397 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 59.79 40.56 19.4 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.096 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 25' ' ' PHE . 75.0 t -76.95 110.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.857 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 p -113.57 -1.64 14.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.37 143.05 43.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.473 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.33 128.0 26.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 89.1 Cg_endo -84.1 170.57 50.34 Favored 'Cis proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.514 -5.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.7 m -121.89 122.75 40.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.946 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.476 ' HB3' HD13 ' A' ' 95' ' ' ILE . 3.9 mm? -107.65 110.47 22.35 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.71 HD22 ' HG2' ' A' ' 86' ' ' LYS . 36.7 mt -126.81 119.37 26.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.356 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.747 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.881 173.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 26.1 m-85 -108.86 158.97 17.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.603 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.445 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 36.3 ttmt -143.44 116.03 8.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.338 173.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.445 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 1.8 p-10 47.6 31.48 2.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.399 1.079 . . . . 0.0 112.816 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 10.07 79.0 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.851 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 12.4 tptm -106.22 -2.61 22.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.989 0.899 . . . . 0.0 108.629 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 40.7 mt-10 71.75 -178.47 0.21 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.888 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.3 p -152.06 -29.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.976 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.78 161.29 36.96 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.632 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.71 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.4 tmtp? -143.24 115.84 8.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.971 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t -132.21 143.51 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 109.935 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.65 90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.686 0.755 . . . . 0.0 111.305 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.38 54.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.005 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 56.03 86.68 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.51 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.577 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 16.6 p-10 -125.13 89.41 52.66 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.446 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.2 Cg_endo -82.55 -29.68 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.965 1.777 . . . . 0.0 110.217 165.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 -49.07 6.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -72.61 -18.4 61.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.442 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.66 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -61.33 -37.67 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.739 ' HA ' HG22 ' A' ' 99' ' ' ILE . 24.3 tptp -60.94 -30.57 70.3 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.132 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -60.13 -53.24 60.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.952 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.596 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.11 -33.98 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.587 0.708 . . . . 0.0 111.422 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -74.62 -37.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.414 -171.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.62 -44.42 11.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.054 0.454 . . . . 0.0 110.831 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.8 80.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.72 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.2 -61.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.791 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.369 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.621 HG21 ' HE3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.341 0 CA-C-O 121.4 0.619 . . . . 0.0 110.417 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.4 148.13 43.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.818 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.501 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -114.39 114.26 25.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.146 174.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.574 ' H ' HD22 ' A' ' 55' ' ' LEU . 20.0 m-85 -67.68 163.74 20.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.036 0.446 . . . . 0.0 110.076 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -130.23 -13.09 3.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.259 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.719 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 70.6 p -135.48 152.68 51.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.56 -27.22 68.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.615 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 p -68.8 -36.73 78.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.061 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 24.7 mm-40 -63.03 -46.72 86.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 109.778 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 3.8 t80 -63.16 -45.92 89.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.127 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.98 -49.33 76.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.858 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -66.68 -36.48 82.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.415 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.39 -52.16 55.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.792 0.329 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.79 -19.9 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.09 -9.02 59.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.708 0.289 . . . . 0.0 111.625 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -75.88 146.52 39.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.643 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 38.2 t70 -72.98 8.97 1.3 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.293 0.568 . . . . 0.0 111.827 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -111.53 178.34 4.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.026 0.441 . . . . 0.0 111.065 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.591 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -76.06 108.07 8.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.768 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 14' ' ' ALA . 65.7 t -111.06 106.84 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.504 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.939 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.22 109.23 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.616 0.722 . . . . 0.0 111.128 175.263 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 21' ' ' VAL . 92.9 t -102.47 143.48 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.747 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB1' ' CE1' ' A' ' 26' ' ' TYR . . . -127.12 138.1 53.11 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.196 0.522 . . . . 0.0 111.715 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -101.04 103.38 14.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.516 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.671 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.5 m-85 -128.22 178.4 6.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.759 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -154.97 137.73 15.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.274 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -72.36 -6.04 40.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 13.7 p-90 -106.29 19.56 20.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.299 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.935 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -122.69 132.97 54.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.629 0.728 . . . . 0.0 110.965 178.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.46 88.84 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.628 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.935 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 22.2 Cg_exo -65.44 -31.81 50.94 Favored 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 120.29 2.045 . . . . 0.0 109.868 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 63.7 m -54.3 -41.13 68.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.154 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.706 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -62.98 -57.03 12.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.923 -178.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 ptm -55.55 -48.14 75.24 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -173.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.671 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.89 -23.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.99 -177.516 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 41' ' ' GLU . . . -55.19 -49.63 91.22 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.91 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 11.0 Cg_exo -72.98 -29.74 11.68 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 120.718 1.292 . . . . 0.0 111.849 171.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.7 mmt -66.49 -60.32 2.84 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.462 HD12 ' CG1' ' A' ' 36' ' ' ILE . 51.2 mt -62.68 -30.68 49.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.156 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 27.9 tt0 -50.03 -48.22 52.86 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.066 0.46 . . . . 0.0 110.361 172.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -65.5 -41.97 92.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.598 0.714 . . . . 0.0 110.023 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.689 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 7.3 m-30 -63.89 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.302 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 1.026 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 4.0 m -74.47 -23.16 58.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 41.4 mt-10 -78.36 -20.51 51.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.554 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 17.2 pt20 -112.9 22.89 13.98 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.573 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 8.4 m-30 -100.44 100.29 11.77 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 163.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 14.1 Cg_exo -70.04 -44.72 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.769 1.646 . . . . 0.0 111.891 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -2.71 15.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . . . -106.08 142.85 35.09 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.885 -0.509 . . . . 0.0 110.795 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.32 126.12 42.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.502 0.668 . . . . 0.0 111.301 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 1.026 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.7 OUTLIER -105.36 114.18 28.2 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.782 -173.213 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.6 142.09 50.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 110.74 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.621 ' HE3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -125.99 119.55 27.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.574 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.1 mt -101.73 161.81 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.273 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -102.8 115.05 29.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.628 0.728 . . . . 0.0 109.093 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -13.62 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.296 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.14 -35.12 79.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.185 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -96.84 -35.64 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.682 172.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.62 HD12 HG21 ' A' ' 63' ' ' VAL . 1.9 mm? -97.83 42.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.761 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -74.72 -40.81 36.42 Favored Glycine 0 CA--C 1.504 -0.628 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.694 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.65 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 9.7 p-10 -64.3 -34.59 78.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.62 HG21 HD12 ' A' ' 60' ' ' LEU . 87.8 t -65.31 -43.18 95.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.127 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.991 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 83.2 mm-40 -72.76 -36.31 67.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.3 mttm -61.6 -34.72 76.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.69 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -100.82 16.97 23.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 54.34 47.3 23.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.86 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.5 t -98.61 116.4 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.132 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 p -118.87 0.41 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.93 124.63 35.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 154.91 42.16 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.36 168.82 71.05 Favored 'Cis proline' 0 CA--C 1.533 0.43 0 C-N-CA 124.018 -1.243 . . . . 0.0 111.88 -6.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 m -137.26 128.35 27.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.511 -169.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' HB2' HD21 ' A' ' 91' ' ' ASN . 3.8 mm? -115.98 108.61 16.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.077 0.465 . . . . 0.0 110.357 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 20.1 mt -123.95 113.69 18.8 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.939 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.26 125.42 35.49 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.31 177.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 83.8 m-85 -110.47 148.11 32.73 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.119 -177.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.515 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 8.5 mtpm? -146.2 126.16 13.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 10.8 p30 45.7 29.2 0.64 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.451 1.1 . . . . 0.0 112.733 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.03 17.03 73.31 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.188 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 31.6 pttt -114.75 -1.26 13.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.414 0.626 . . . . 0.0 109.531 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 42.6 mt-10 75.48 -172.55 0.11 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.356 -175.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.564 HG12 ' HB2' ' A' ' 77' ' ' LEU . 1.4 p -162.3 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.619 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -153.26 162.42 41.32 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.796 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.474 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.2 tmtp? -144.64 109.18 4.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.937 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.2 t -121.51 143.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.31 89.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.686 0.755 . . . . 0.0 111.596 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.0 62.96 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.923 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 50.68 81.27 0.07 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.639 0.376 . . . . 0.0 111.582 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 17.4 p-10 -117.71 88.0 28.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -172.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.403 ' O ' HG22 ' A' ' 95' ' ' ILE . 2.6 Cg_endo -79.53 -34.42 1.04 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.762 1.641 . . . . 0.0 110.543 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.11 -44.63 10.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.39 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.48 -17.02 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.455 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.724 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.0 tp -56.16 -39.4 58.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.622 ' HA ' HG22 ' A' ' 99' ' ' ILE . 15.6 mmtt -59.71 -36.79 77.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.664 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -52.16 -57.36 9.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.859 174.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HB1' ' CB ' ' A' ' 85' ' ' ALA . . . -75.35 -30.1 60.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.55 -39.63 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.679 -170.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.59 21.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.971 0.415 . . . . 0.0 110.452 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.83 62.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.209 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.7 m-80 -98.06 -67.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.704 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.591 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.718 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.875 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.247 0.546 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.86 147.81 28.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.152 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -98.68 134.42 41.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.905 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.647 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.0 m-85 -90.95 141.85 28.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -97.16 -14.84 21.22 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.715 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.523 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 62.6 p -132.58 153.13 51.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.94 0.4 . . . . 0.0 111.241 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.5 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -62.33 -28.66 69.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 172.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 t -66.19 -37.73 86.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.378 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.523 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.4 mm-40 -58.54 -49.15 78.44 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.424 0.631 . . . . 0.0 110.257 176.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.401 ' HD1' HG21 ' A' ' 23' ' ' VAL . 2.1 t80 -64.9 -44.9 88.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.992 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.81 -46.57 84.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -65.43 -33.69 76.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.147 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.14 -49.51 43.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 31.5 pt -67.93 -15.09 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.595 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.27 -8.33 58.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 0.0 111.171 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -76.35 153.89 35.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.571 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 20.2 t70 -68.47 2.56 2.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.554 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 4.0 ptpt -109.45 -179.51 3.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.638 0.732 . . . . 0.0 111.507 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.3 tm? -86.53 114.15 23.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.659 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.1 t -118.77 111.17 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.1 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.714 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -105.64 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.558 0.694 . . . . 0.0 111.058 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.629 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 22.6 t -111.4 143.45 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.329 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -120.49 123.94 44.19 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.2 m-85 -70.47 130.43 41.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.679 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -136.45 -178.19 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.349 -164.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -167.91 157.19 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.102 173.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -84.9 -5.34 59.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 111.256 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -117.31 42.28 2.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.93 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -144.07 123.47 13.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.575 0.702 . . . . 0.0 112.002 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.46 -44.13 98.0 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.438 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.441 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 44.0 Cg_exo -58.26 -40.06 79.22 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 119.868 1.834 . . . . 0.0 111.232 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 22.9 m -56.86 -37.83 71.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.754 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 60.2 tttm -63.2 -53.54 51.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.897 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.666 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptp -60.34 -48.07 83.35 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.601 ' CG1' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.6 -18.6 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.435 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.48 -48.82 96.63 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.189 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.754 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.3 Cg_exo -72.55 -30.15 12.48 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.225 1.283 . . . . 0.0 111.878 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' MET . 24.8 mmt -64.47 -60.0 3.67 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.755 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.601 HD12 ' CG1' ' A' ' 36' ' ' ILE . 30.4 mt -65.4 -20.8 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 111.297 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 29.4 tt0 -59.68 -46.93 87.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.494 0.664 . . . . 0.0 109.692 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -64.98 -45.88 83.8 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.773 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.701 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.6 m-30 -63.71 -25.03 68.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.67 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.827 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 87.4 p -76.36 -19.67 57.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -83.08 -16.1 48.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.982 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.701 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -120.36 28.24 8.13 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.58 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 14.0 m-30 -101.07 100.44 13.11 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.493 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.28 -43.41 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 121.944 1.763 . . . . 0.0 112.623 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -95.93 -22.94 17.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 111.947 -173.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -102.74 149.55 24.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.439 0.638 . . . . 0.0 110.879 -172.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.485 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.9 m-20 -104.3 133.27 49.48 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.752 176.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.827 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.7 p90 -110.39 116.28 31.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.628 -169.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 20.4 m-85 -137.33 158.47 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.18 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.875 ' HG3' HG21 ' A' ' 2' ' ' VAL . 10.4 mtmp? -141.36 127.38 19.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.718 0.294 . . . . 0.0 110.75 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.647 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 56.8 mt -95.49 129.14 42.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.218 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.69 119.25 18.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 166.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.27 -11.87 12.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.573 -173.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.22 -46.32 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.486 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.97 -31.8 31.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.062 0.458 . . . . 0.0 110.16 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.61 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.2 mm? -103.0 52.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.651 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.96 -40.83 20.02 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.414 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.587 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 26.4 t70 -64.35 -49.08 73.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.537 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -60.59 -38.25 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.392 . . . . 0.0 110.27 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.97 85.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.139 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -74.13 -34.94 64.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.421 . . . . 0.0 110.546 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 45.3 mtmt -61.99 -35.63 79.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.906 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -97.87 14.16 28.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.45 38.47 25.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.967 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.411 HG21 ' CD2' ' A' ' 25' ' ' PHE . 84.7 t -82.68 127.03 40.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.3 p -125.06 -56.56 1.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.406 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 159.75 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.659 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.96 144.8 42.76 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 111.493 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 63.3 Cg_endo -75.84 167.71 79.44 Favored 'Cis proline' 0 C--O 1.237 0.467 0 C-N-CA 123.03 -1.654 . . . . 0.0 111.694 -10.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 46.9 m -124.25 116.86 23.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -103.47 108.98 20.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.264 -174.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.516 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 33.3 mt -124.05 113.95 19.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.714 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.39 130.24 40.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.627 174.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 47.7 m-85 -111.2 160.05 17.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.605 -175.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.422 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 14.6 tppt? -144.04 124.11 13.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.592 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.422 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 8.7 p30 35.39 48.74 0.43 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 18.59 59.88 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.691 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -125.37 7.38 7.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.976 0.388 . . . . 0.0 110.785 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.36 176.51 0.25 Allowed 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.774 0.671 . . . . 0.0 109.572 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -146.28 -34.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.942 0.401 . . . . 0.0 110.422 172.124 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -158.86 161.18 36.82 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.6 tttt -140.97 122.22 14.81 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.13 136.51 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.2 88.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.752 0.787 . . . . 0.0 111.504 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.89 62.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.767 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . 58.81 94.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.937 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.9 p-10 -132.93 80.12 61.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.426 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 2.8 Cg_exo -73.82 -41.08 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.367 1.378 . . . . 0.0 111.149 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.19 -39.72 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.113 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.0 -17.57 62.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.269 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.724 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.1 tp -57.62 -38.1 62.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 20.4 mmtp -57.56 -36.95 72.32 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.796 0.685 . . . . 0.0 110.621 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -53.29 -57.05 11.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.88 175.257 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.39 -36.59 63.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.553 0.692 . . . . 0.0 110.818 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.37 -40.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.853 -171.274 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.09 -34.94 18.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.814 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.22 -35.29 68.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 50.5 m-80 -98.44 -59.82 1.67 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.507 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.047 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.596 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.419 0.628 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.62 145.44 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.917 -176.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -103.44 122.9 45.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.592 174.21 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.826 ' HB2' HD21 ' A' ' 55' ' ' LEU . 7.2 m-85 -76.07 165.84 24.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.009 0.433 . . . . 0.0 110.168 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -116.89 -30.0 5.85 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.528 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 19.4 p -127.2 145.27 50.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.004 0.43 . . . . 0.0 111.805 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.629 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -53.18 -40.41 64.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.766 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -61.03 -38.75 87.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.988 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.479 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 19.4 pt-20 -81.06 -22.03 39.58 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.817 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.483 ' HD1' HG21 ' A' ' 23' ' ' VAL . 3.3 t80 -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 168.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' A' ' 15' ' ' ILE . 4.8 m-20 -59.23 -38.66 80.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.151 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 t -66.46 -37.93 86.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -50.27 62.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 110.659 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 33.4 pt -69.97 -14.76 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.573 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.07 -6.19 59.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.95 0.405 . . . . 0.0 111.408 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 19' ' ' LYS . 77.9 mt-30 -88.39 161.11 17.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.082 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 5.4 m-20 -76.44 27.81 0.12 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 17' ' ' GLN . 23.4 mtpp -108.05 178.06 4.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 122.069 0.938 . . . . 0.0 112.756 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.609 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -94.8 104.93 16.84 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.885 172.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.9 t -114.01 107.67 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.896 0.379 . . . . 0.0 110.96 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.706 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -104.72 107.49 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.472 0.653 . . . . 0.0 110.728 175.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 53' ' ' TYR . 27.0 t -108.95 133.02 55.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.793 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.82 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -108.54 122.41 47.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CD2' HG21 ' A' ' 69' ' ' VAL . 68.8 m-85 -74.12 127.84 33.97 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.118 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.659 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 2.3 m-85 -120.02 -171.46 2.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.145 -175.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.02 31.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.055 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.9 p -79.99 -4.81 54.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.166 0.508 . . . . 0.0 110.993 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -131.93 54.17 1.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.7 p -145.56 116.76 7.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.475 0.655 . . . . 0.0 112.257 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -66.47 -37.94 93.08 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.234 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 31.6 Cg_exo -61.52 -35.32 82.66 Favored 'Trans proline' 0 C--N 1.36 1.18 0 CA-C-N 120.233 2.016 . . . . 0.0 111.408 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 57.1 m -54.6 -38.81 67.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.242 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.751 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.1 tptm -63.75 -54.81 29.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.683 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.0 ptp -59.98 -48.63 80.93 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.697 HG13 HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -76.07 -16.29 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.207 -178.365 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.62 -50.31 88.62 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.787 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.751 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.4 Cg_exo -71.83 -31.4 12.92 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.1 1.2 . . . . 0.0 111.871 171.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.431 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 94.6 mmm -63.91 -59.46 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.161 -0.615 . . . . 0.0 112.006 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 36' ' ' ILE . 53.4 mt -67.18 -19.4 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.03 -0.419 . . . . 0.0 111.428 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.3 tt0 -64.48 -43.29 94.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.478 0.656 . . . . 0.0 109.39 168.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 15.5 tttm -63.6 -39.76 95.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.2 m-30 -74.45 -15.16 60.91 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.741 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.823 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 25.1 p -74.71 -18.14 60.55 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -84.86 -21.75 29.67 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.899 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.672 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 6.5 mt-30 -95.98 5.48 51.1 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.484 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 3.8 m-30 -104.17 98.61 14.35 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.642 172.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 6.6 Cg_exo -73.83 -43.8 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.28 1.986 . . . . 0.0 112.201 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -108.52 -13.61 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.3 163.45 12.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.125 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.23 135.82 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.046 0.927 . . . . 0.0 112.568 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.823 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.8 p90 -115.02 116.94 29.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.468 -171.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.583 ' HB2' HG22 ' A' ' 23' ' ' VAL . 22.0 m-85 -136.33 158.64 43.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.82 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 10.3 mtmp? -142.58 129.49 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 110.969 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' A' ' 5' ' ' PHE . 18.2 mt -107.01 176.91 5.02 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.525 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 6.7 p-10 -131.24 130.49 42.95 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 26' ' ' TYR . 32.7 m -69.29 -8.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.71 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.06 -40.91 74.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.333 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -101.24 -28.11 12.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.666 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HG ' HD22 ' A' ' 55' ' ' LEU . 3.9 mm? -101.11 53.66 0.84 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.01 -43.07 23.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.127 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 13.2 t70 -66.3 -45.61 79.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.861 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.646 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -61.42 -39.22 82.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.112 0.482 . . . . 0.0 110.142 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.62 -36.93 72.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.103 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 12.0 mm-40 -79.02 -31.51 44.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 38.5 mtmt -62.56 -37.4 86.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.0 110.458 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -96.0 8.17 44.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.21 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 55.44 45.96 24.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.892 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.492 HG13 ' OG1' ' A' ' 74' ' ' THR . 69.6 t -69.71 124.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.814 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -139.33 31.29 2.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.044 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.08 152.62 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.5 112.43 32.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.06 172.72 30.95 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.921 -0.866 . . . . 0.0 112.275 -0.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.492 ' OG1' HG13 ' A' ' 69' ' ' VAL . 92.3 m -120.31 115.89 24.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.554 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -102.39 108.65 20.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.826 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.516 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 30.7 mt -125.43 113.05 17.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.706 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.16 122.06 36.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.022 174.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 42.2 m-85 -106.85 152.89 23.28 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.457 -174.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 87.1 tttt -138.71 122.05 17.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.801 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.68 44.28 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.146 0.979 . . . . 0.0 112.67 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 17.41 57.46 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.206 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 2.8 tttp -116.43 -5.33 11.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.089 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 22.9 tt0 75.06 168.85 0.29 Allowed 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.648 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.601 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.2 p -136.66 -33.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.84 163.91 34.06 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.74 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.3 tttt -143.13 125.1 15.21 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.401 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.5 t -131.13 130.5 63.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.97 82.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.44 -170.44 35.1 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.791 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -70.31 93.83 0.88 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.676 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.8 p-10 -121.77 67.33 21.91 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.5 -35.21 13.85 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 120.915 1.077 . . . . 0.0 110.743 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.62 -39.87 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.074 177.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -76.25 -17.86 59.29 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.462 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.715 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.3 tp -57.3 -40.06 71.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HA ' HG22 ' A' ' 99' ' ' ILE . 12.3 mmmm -57.94 -34.76 70.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.799 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -54.47 -58.14 8.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.21 64.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.635 0.731 . . . . 0.0 110.952 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -81.16 -38.94 17.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.483 -169.253 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.46 -36.78 18.86 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.377 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.84 68.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.277 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.9 m-80 -92.7 -65.05 1.03 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.574 -0.85 . . . . 0.0 112.477 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.609 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.787 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.877 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.33 0.586 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.99 147.56 26.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.313 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.1 pp0? -99.97 137.34 38.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.111 171.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.658 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 9.7 m-85 -90.71 137.96 31.95 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.222 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -90.74 -24.95 20.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.394 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.1 p -131.67 153.3 50.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.764 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.63 -34.42 71.16 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 t -62.81 -34.04 76.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.741 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 20.0 mm-40 -62.58 -49.18 76.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.353 0.596 . . . . 0.0 109.884 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.464 ' HD1' HG21 ' A' ' 23' ' ' VAL . 1.7 t80 -62.91 -47.06 84.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.107 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.06 -44.1 78.58 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.346 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 m -70.1 -40.44 74.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.46 67.99 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.821 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.14 -20.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.174 -176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.34 61.53 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.917 0.389 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 19' ' ' LYS . 59.6 mt-30 -68.24 150.99 47.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.073 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.9 32.89 0.26 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.82 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.7 ptmt -135.57 173.62 11.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.29 -176.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.747 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -75.13 112.71 11.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.598 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.37 107.97 20.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.752 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.31 109.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.047 0.927 . . . . 0.0 111.622 176.122 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 39.5 t -105.02 144.31 14.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.072 177.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.72 ' HB2' HD13 ' A' ' 75' ' ' LEU . . . -129.51 122.64 29.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 55' ' ' LEU . 72.9 m-85 -72.89 115.91 12.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.414 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.72 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 8.5 m-30 -121.91 -178.34 3.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 123.369 0.418 . . . . 0.0 110.358 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.62 34.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.689 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.48 -4.43 58.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.214 0.531 . . . . 0.0 111.139 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -126.16 47.2 2.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.077 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 p -143.1 126.39 16.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.53 0.681 . . . . 0.0 111.728 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.9 -40.44 98.35 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.21 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.75 ' O ' HG23 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -63.08 -38.65 44.46 Favored 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 120.272 2.036 . . . . 0.0 110.921 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 20.5 m -58.46 -31.22 67.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.581 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 87.2 tttt -67.94 -57.03 6.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.491 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 ptp -64.95 -44.38 89.62 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.235 0.54 . . . . 0.0 112.431 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.96 -13.73 14.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 C-N-CA 118.441 -1.304 . . . . 0.0 110.401 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.5 -52.35 74.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.085 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 19.8 Cg_endo -64.63 -32.63 57.75 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 120.955 1.103 . . . . 0.0 112.574 169.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 23.5 mmt -66.92 -55.57 14.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.014 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.808 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -49.0 -38.56 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.599 0.36 . . . . 0.0 110.529 175.243 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.35 -48.1 79.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 110.692 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -60.0 -51.77 68.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.975 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.0 m-85 -64.09 -19.57 65.34 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.17 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.1 p -83.6 -22.13 32.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -83.82 -20.99 32.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.656 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.676 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -107.85 16.38 23.59 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.75 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 13.9 m-30 -100.62 101.81 16.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.486 167.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.14 -40.88 2.94 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 121.88 1.72 . . . . 0.0 112.851 174.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -107.73 -16.0 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.09 146.74 27.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 110.88 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -101.01 135.51 42.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.859 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.808 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -113.52 124.52 52.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.607 -177.219 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.656 ' HA ' HG23 ' A' ' 2' ' ' VAL . 42.1 m-85 -135.79 147.58 48.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.877 ' HG2' HG21 ' A' ' 2' ' ' VAL . 8.2 mmpt? -117.23 142.43 47.06 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.658 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 60.6 mt -107.13 142.49 36.73 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.149 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.32 102.48 14.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 167.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -60.26 -15.23 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -171.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.44 -21.8 57.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -108.65 -31.24 7.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.923 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.598 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -96.77 52.19 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.818 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.21 -40.73 19.22 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.061 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.619 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 6.3 m-20 -60.56 -49.74 76.34 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.419 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.7 p -62.83 -38.69 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.313 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.44 -35.03 73.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.071 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 55.7 mt-30 -76.27 -37.85 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.38 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 66.0 mttm -57.24 -39.46 75.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.812 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -95.0 6.55 48.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.912 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.84 48.78 17.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.925 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.09 121.13 35.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.688 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -123.27 -16.08 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.732 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.57 161.86 15.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 142.96 26.83 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.519 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 2.9 Cg_exo -78.33 165.31 83.05 Favored 'Cis proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.862 -1.308 . . . . 0.0 111.75 -8.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 86.8 m -123.38 116.84 23.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.2 mm? -108.13 108.61 19.74 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -174.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.609 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 18.2 mt -125.71 116.13 21.16 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.814 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -91.53 122.42 34.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.054 173.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 33.5 m-85 -105.46 156.48 18.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.808 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.3 ttpt -142.44 120.09 11.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.378 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.5 37.11 5.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.8 0.84 . . . . 0.0 111.901 -177.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.16 12.55 50.38 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.746 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 61.7 mttp -120.83 19.47 11.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.553 0.341 . . . . 0.0 110.142 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 10.2 pt-20 61.66 175.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.869 1.356 . . . . 0.0 112.128 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.532 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -148.75 -32.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.832 174.083 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.79 166.92 25.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.081 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.609 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.9 tttt -144.34 126.51 15.61 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.2 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 19.3 t -131.96 138.84 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 87.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.796 0.807 . . . . 0.0 111.593 -170.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.66 63.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.061 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.474 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.28 86.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.111 0.482 . . . . 0.0 111.78 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.609 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.5 p-10 -126.41 78.57 71.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.519 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.5 Cg_exo -68.14 -45.39 2.91 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.448 1.432 . . . . 0.0 110.955 168.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.44 -35.43 18.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.096 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -76.59 -17.55 59.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.46 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.751 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.0 tp -59.18 -38.94 77.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HD2' HG22 ' A' ' 99' ' ' ILE . 54.5 tptt -61.83 -27.37 68.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.995 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 18.3 tm0? -59.6 -59.66 5.08 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -71.67 -29.2 64.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.712 0.768 . . . . 0.0 110.503 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -77.62 -39.44 26.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.321 -171.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.2 -34.45 20.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.043 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.24 89.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.63 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 51.2 m-80 -97.33 -63.06 1.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.747 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.79 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.688 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.637 0.732 . . . . 0.0 109.709 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.2 145.84 55.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.659 -168.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -108.56 136.35 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.655 170.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.809 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.6 m-85 -88.13 166.13 14.62 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -124.52 -10.29 7.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 60.1 p -134.44 150.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.68 0.276 . . . . 0.0 110.912 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.513 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.49 -33.68 70.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.3 t -65.73 -36.38 83.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.747 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 51.0 mm-40 -61.29 -44.74 96.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 7.5 t80 -67.55 -49.21 64.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.947 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.449 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -59.75 -37.55 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.69 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.4 t -68.29 -40.71 81.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.819 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -64.77 -50.48 66.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.43 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.51 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 35.3 pt -66.83 -18.82 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.499 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.44 -10.4 59.05 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.745 0.307 . . . . 0.0 111.589 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 54.8 mt-30 -76.09 153.3 36.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.344 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.4 37.75 0.34 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.86 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.9 ptmt -140.21 167.92 21.01 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.064 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.945 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -71.71 107.94 4.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.436 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.55 HG13 ' CD2' ' A' ' 53' ' ' TYR . 70.2 t -107.55 107.08 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 110.35 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.611 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -99.0 105.55 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.412 0.625 . . . . 0.0 110.294 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 53.5 t -107.01 139.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.371 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.749 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -128.39 122.4 31.34 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' HG21 ' A' ' 69' ' ' VAL . 52.4 m-85 -70.6 124.1 23.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.537 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.697 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.9 m-85 -120.01 -176.86 3.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.612 -174.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -161.77 156.68 23.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.144 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -84.09 -4.33 58.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.771 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -120.73 21.97 11.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 3.8 p -119.55 150.99 39.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.515 0.674 . . . . 0.0 112.253 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.75 -48.61 4.89 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.803 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 35' ' ' MET . 50.7 Cg_exo -55.25 -47.5 25.83 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.253 1.969 . . . . 0.0 112.307 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.9 p -51.07 -36.8 41.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.257 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.731 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 67.4 mttm -66.46 -50.31 63.76 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 123.212 0.32 . . . . 0.0 111.247 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 22.6 ptp -64.88 -44.7 88.81 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.424 0.631 . . . . 0.0 112.311 -175.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.686 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.0 -16.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.605 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.09 -55.26 47.14 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.909 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.731 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.7 Cg_endo -63.96 -30.42 67.0 Favored 'Trans proline' 0 C--N 1.358 1.054 0 CA-C-N 120.424 1.187 . . . . 0.0 112.1 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 25.4 mmt -65.98 -55.37 17.12 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.291 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.996 HG21 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -57.11 -38.08 58.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.87 175.175 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -52.48 -47.34 66.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.0 0.429 . . . . 0.0 109.958 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.33 -47.88 83.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.696 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 7.9 m-30 -67.05 -15.34 63.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.075 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.788 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 5.7 m -86.62 -13.71 44.87 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.23 -15.21 31.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.681 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.696 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -126.59 35.66 4.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.23 177.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -104.31 72.52 0.19 Allowed Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 172.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 88.9 Cg_exo -45.88 -45.64 16.88 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.945 2.43 . . . . 0.0 115.161 -166.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.69 8.53 19.02 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -103.16 165.09 11.23 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.82 -0.55 . . . . 0.0 111.573 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.98 123.37 41.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.788 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.76 124.95 35.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 10.6 m-85 -143.04 136.29 28.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.366 168.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.996 ' HD3' HG21 ' A' ' 40' ' ' ILE . 27.5 mtmt -134.0 120.3 20.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.809 HD22 ' H ' ' A' ' 5' ' ' PHE . 4.7 mt -93.11 162.22 14.12 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.646 -167.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.19 108.63 21.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -61.14 -14.42 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.451 -175.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.87 -39.12 93.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -99.68 -32.14 11.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.99 47.25 1.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.588 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.9 -42.13 17.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.789 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 31.1 t70 -65.27 -44.17 88.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 110.956 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -63.7 -39.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.204 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.79 77.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.5 mm-40 -71.51 -34.34 70.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.928 0.394 . . . . 0.0 110.438 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 40.1 mtmt -61.25 -38.73 87.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.648 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -95.08 15.29 19.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.884 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.6 40.94 26.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.812 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' A' ' 25' ' ' PHE . 86.4 t -88.9 113.38 25.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.15 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -116.06 -11.41 11.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.37 165.25 12.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.618 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.11 141.71 17.54 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.859 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.501 ' HG3' HD12 ' A' ' 36' ' ' ILE . 60.8 Cg_endo -75.28 163.41 90.62 Favored 'Cis proline' 0 C--O 1.234 0.301 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.795 -10.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.8 m -126.65 118.79 25.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.616 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.3 mt -110.34 107.65 17.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.379 0.609 . . . . 0.0 111.6 -172.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.67 HD22 ' HG3' ' A' ' 86' ' ' LYS . 18.9 mt -123.72 113.36 18.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.265 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.611 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.33 129.15 43.73 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.841 178.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 59.8 m-85 -112.27 154.09 26.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.441 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -136.52 117.54 14.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.393 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.55 43.83 2.4 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.065 0.853 . . . . 0.0 112.67 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.73 11.12 59.72 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.399 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -111.97 -0.32 15.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 32.9 tt0 69.79 172.77 0.3 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.137 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.554 HG11 HD21 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.46 -33.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.239 172.527 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.11 161.44 40.37 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.67 ' HG3' HD22 ' A' ' 76' ' ' LEU . 41.3 tttp -141.83 110.99 6.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.868 177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 t -123.58 135.1 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.23 82.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.951 0.881 . . . . 0.0 111.654 -168.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.5 64.27 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.235 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 54.78 83.85 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.021 0.438 . . . . 0.0 111.943 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 12.7 p-10 -125.02 83.99 59.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' O ' HG22 ' A' ' 95' ' ' ILE . 10.8 Cg_exo -74.15 -36.95 2.94 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.753 1.635 . . . . 0.0 111.654 168.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.3 -41.84 12.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 111.104 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.89 -17.37 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.639 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.5 tp -59.63 -38.16 74.28 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.284 171.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 99' ' ' ILE . 26.7 mmmt -59.53 -32.99 70.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.725 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -54.67 -61.24 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -71.25 -39.2 71.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.403 0.62 . . . . 0.0 111.649 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.648 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -68.74 -43.23 83.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.707 -171.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.17 10.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.909 0.385 . . . . 0.0 111.567 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.11 74.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.485 -175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.8 m-80 -92.65 -63.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.003 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.945 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.711 -0.661 . . . . 0.0 111.502 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.574 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.34 0 CA-C-O 121.323 0.582 . . . . 0.0 110.758 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -98.53 147.83 24.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.072 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -102.52 126.6 49.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.681 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 15.7 m-85 -80.42 157.39 26.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -113.05 -13.96 13.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.227 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -137.27 151.24 48.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.766 0.317 . . . . 0.0 111.126 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.496 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.15 -31.64 67.42 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 172.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -63.58 -38.13 89.96 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.231 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.427 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 27.4 mm-40 -61.58 -43.14 99.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.468 0.652 . . . . 0.0 109.772 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.42 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 4.4 t80 -68.15 -49.16 62.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.373 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' HG12 ' A' ' 15' ' ' ILE . 24.4 t70 -59.78 -46.06 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 0.0 111.438 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 m -68.68 -25.78 64.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -75.11 -51.6 13.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.826 0.346 . . . . 0.0 110.555 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.479 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.4 pt -65.22 -19.32 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.617 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.18 59.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.623 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -71.43 160.22 33.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.975 0.417 . . . . 0.0 110.861 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.496 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 4.8 m-20 -81.28 34.46 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.169 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -145.32 170.61 15.97 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.194 -174.399 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -72.16 105.44 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.02 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 14' ' ' ALA . 81.6 t -109.25 106.79 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.736 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.749 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.73 111.14 31.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.309 0.575 . . . . 0.0 111.116 175.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.668 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 44.8 t -110.69 131.15 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.294 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -109.32 110.82 22.09 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CD2' HD12 ' A' ' 55' ' ' LEU . 72.0 m-85 -70.77 107.72 4.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -162.93 151.37 14.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.298 0.571 . . . . 0.0 112.32 -178.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -120.03 158.66 26.34 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.0 p -81.11 -3.41 51.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -77.11 -16.63 59.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -172.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -98.26 -176.33 3.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.01 -60.19 1.98 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.153 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.621 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 82.0 Cg_exo -50.58 -49.22 17.32 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.968 2.445 . . . . 0.0 112.445 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.0 p -50.77 -36.94 39.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.692 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.737 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 39.8 ttpt -66.09 -54.32 27.22 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.06 0.225 . . . . 0.0 110.602 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.49 -45.99 91.91 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.808 HG13 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.25 -18.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.289 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.0 -56.38 31.31 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.128 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 33.4 Cg_endo -66.41 -32.16 41.13 Favored 'Trans proline' 0 C--N 1.359 1.127 0 CA-C-N 120.287 1.138 . . . . 0.0 112.492 171.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.534 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 33.2 mmt -64.27 -61.2 2.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.129 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.808 HD12 HG13 ' A' ' 36' ' ' ILE . 61.0 mt -64.41 -21.93 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.233 0.469 . . . . 0.0 111.647 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -61.96 -43.78 98.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 109.675 168.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -65.6 -40.63 92.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.531 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.711 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 15.2 m-85 -68.09 -17.95 64.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.177 0.513 . . . . 0.0 110.854 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 p -87.24 -11.48 49.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -83.23 -31.11 27.18 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.711 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 28.2 pt20 -109.27 33.24 4.41 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.234 -176.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.444 ' H ' ' HD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -100.1 76.6 0.13 Allowed Pre-proline 0 CA--C 1.556 1.207 0 CA-C-O 121.496 0.665 . . . . 0.0 112.711 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 32.2 Cg_exo -58.21 -46.07 27.44 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.115 1.877 . . . . 0.0 114.242 -170.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.82 16.51 19.5 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -124.23 165.89 16.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.954 0.406 . . . . 0.0 111.486 -171.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 6.2 m-20 -115.59 131.89 56.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 1.6 m-85 -114.28 124.71 52.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.464 -173.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 m-85 -139.85 151.54 45.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.733 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 38.1 mtmt -140.06 121.25 14.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 70.6 mt -78.42 141.02 38.63 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.506 -171.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.74 91.08 0.8 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 27' ' ' ALA . 2.3 p -59.53 -6.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -172.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.95 -32.97 15.77 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.48 -36.17 26.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.246 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.0 52.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.547 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.72 -40.29 22.59 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.04 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.4 m-20 -69.79 -38.53 76.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.455 0.169 . . . . 0.0 110.995 -177.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -68.96 -37.53 77.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.435 . . . . 0.0 110.41 176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.8 73.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.029 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.4 mt-30 -70.91 -34.75 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 52.7 mttp -59.46 -43.99 93.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.553 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -91.55 10.52 27.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.146 -174.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 58.27 48.68 12.22 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.498 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.513 HG13 ' OG1' ' A' ' 74' ' ' THR . 71.8 t -78.64 118.58 26.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.83 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -124.25 -58.83 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.19 127.63 32.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.333 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.5 134.91 19.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.334 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 64.9 Cg_endo -83.31 171.25 51.57 Favored 'Cis proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.855 -1.31 . . . . 0.0 112.035 -1.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.513 ' OG1' HG13 ' A' ' 69' ' ' VAL . 27.7 m -117.93 114.76 23.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.2 mm? -105.23 107.46 18.45 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.323 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.493 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.2 mt -126.25 112.7 16.04 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -87.14 116.89 25.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 70.3 m-85 -104.45 145.99 29.5 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.665 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mtpt -143.83 120.96 11.46 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.969 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 38.8 m-80 61.14 21.85 12.22 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.715 0.634 . . . . 0.0 110.809 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.06 12.3 65.07 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -111.59 5.57 19.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.57 ' HG2' ' H ' ' A' ' 84' ' ' VAL . 27.4 tt0 70.36 177.17 0.27 Allowed 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.123 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.576 HG21 ' HD3' ' A' ' 79' ' ' LYS . 1.4 p -157.12 -31.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.32 164.29 34.94 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.82 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.493 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 66.7 tttt -148.61 122.88 9.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.594 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.49 132.24 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.78 79.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.299 0.571 . . . . 0.0 111.065 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.09 -172.86 35.88 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -67.36 100.98 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.4 p-10 -124.07 63.55 32.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 90' ' ' ALA . 8.7 Cg_exo -70.75 -31.35 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 120.963 1.109 . . . . 0.0 110.098 172.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.65 -47.12 8.15 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.257 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -69.43 -16.31 63.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -177.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.696 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.1 tp -53.56 -38.29 33.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.114 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 169.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.686 ' HA ' HG22 ' A' ' 99' ' ' ILE . 36.0 mmtt -55.07 -41.7 71.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.937 0.773 . . . . 0.0 110.798 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 23.0 tm0? -51.17 -53.72 32.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.523 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -80.49 -30.56 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 111.762 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -76.05 -39.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.982 -172.056 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.86 -41.4 14.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.708 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.93 75.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.621 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 35.4 m-80 -107.26 -73.1 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.879 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.883 0 O-C-N 123.983 0.802 . . . . 0.0 112.632 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 52' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.138 0.494 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.43 HG22 ' HD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -84.12 148.43 26.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.087 -175.331 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -108.29 122.68 47.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.317 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.673 ' H ' HD22 ' A' ' 55' ' ' LEU . 12.4 m-85 -76.16 164.06 26.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.193 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -121.61 -20.26 6.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 61.1 p -131.63 155.12 48.12 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.296 -0.253 . . . . 0.0 111.312 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.29 -36.09 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 t -57.71 -41.15 81.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.572 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 19.6 mm-40 -59.59 -43.53 93.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.125 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.467 ' HD1' HG21 ' A' ' 23' ' ' VAL . 7.4 t80 -67.07 -53.2 33.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.465 ' HA ' HG12 ' A' ' 15' ' ' ILE . 10.9 m-20 -61.49 -37.19 82.76 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 111.781 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.822 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -69.14 -48.55 62.09 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.0 110.579 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 12' ' ' ASP . 34.2 pt -67.02 -20.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.97 -8.6 59.43 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.084 0.468 . . . . 0.0 111.306 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -75.73 152.58 37.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.889 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 2.3 m-20 -80.37 35.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.102 0.477 . . . . 0.0 111.634 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 4.4 ptpt -134.7 -179.06 5.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 0.0 111.346 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.3 tm? -84.36 108.26 17.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.445 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.763 HG13 ' CE1' ' A' ' 53' ' ' TYR . 78.3 t -112.88 106.92 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.019 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.698 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.34 106.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.341 0.591 . . . . 0.0 110.952 176.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 53' ' ' TYR . 59.3 t -106.23 136.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.634 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -118.1 115.45 24.85 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.161 0.505 . . . . 0.0 110.249 170.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.5 m-85 -70.06 109.96 4.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.544 ' CZ ' HD12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.78 159.24 31.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -163.035 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -147.53 135.88 21.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.159 173.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -83.88 -5.7 59.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -170.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 1.1 p90 -89.28 57.59 4.1 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.9 p -157.41 -176.72 6.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.26 -53.04 3.22 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.205 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' O ' ' HG2' ' A' ' 35' ' ' MET . 87.9 Cg_exo -49.07 -43.0 37.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.561 2.174 . . . . 0.0 112.075 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -58.13 -35.17 71.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -62.4 -46.55 88.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.628 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.624 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.7 ptm -77.26 -45.92 24.8 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.635 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -75.79 -23.31 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.439 -176.562 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.06 -49.53 91.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.092 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.624 ' HD2' ' O ' ' A' ' 35' ' ' MET . 23.3 Cg_exo -66.67 -38.3 18.81 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.498 1.465 . . . . 0.0 112.442 171.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -63.94 -58.29 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CG1' HG12 ' A' ' 36' ' ' ILE . 12.9 mm -56.21 -33.61 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.91 -49.17 78.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.248 0.547 . . . . 0.0 110.328 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -62.93 -47.33 83.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.262 0.553 . . . . 0.0 110.144 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.0 m-30 -64.52 -17.57 64.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.842 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.3 p -86.49 -13.37 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.873 0.844 . . . . 0.0 108.828 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -88.77 -19.35 26.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.328 169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -125.26 33.1 5.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.764 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -110.26 82.94 2.86 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-O 121.752 0.787 . . . . 0.0 111.659 169.505 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.13 -46.29 29.15 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.864 2.376 . . . . 0.0 114.561 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -112.71 6.33 18.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -105.63 165.08 11.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.954 -0.466 . . . . 0.0 110.743 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.45 123.23 27.67 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.71 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.764 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.2 m-85 -92.24 131.74 37.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.763 ' CE1' HG13 ' A' ' 21' ' ' VAL . 7.4 m-85 -130.82 135.3 47.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.298 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.617 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.57 120.78 31.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.18 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.673 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.9 mt -99.99 168.42 9.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.383 -171.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.69 104.08 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.991 0.9 . . . . 0.0 108.824 169.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -10.73 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.243 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.03 -33.84 65.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.081 0.467 . . . . 0.0 109.993 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -94.61 -36.39 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.903 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mm? -97.97 47.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.058 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.17 -39.12 27.94 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.886 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.44 -45.24 88.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 5.3 p -66.91 -37.76 80.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' A' ' 69' ' ' VAL . . . -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.112 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.3 mt-30 -62.8 -34.03 76.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -72.1 -24.97 61.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.7 9.54 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.998 0.428 . . . . 0.0 110.84 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 59.06 45.28 14.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.653 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 25' ' ' PHE . 72.5 t -74.74 117.3 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.908 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -133.24 -0.05 3.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.408 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.69 164.86 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 111.056 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 36.9 mtm -124.21 111.47 28.5 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.012 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.535 ' CB ' ' HE1' ' A' ' 26' ' ' TYR . 4.0 Cg_exo -77.63 170.32 71.27 Favored 'Cis proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.583 -5.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.42 ' OG1' HG13 ' A' ' 69' ' ' VAL . 77.1 m -115.29 112.38 22.32 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 158.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.602 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 6.0 mt -118.63 107.94 14.32 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.741 -167.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.466 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 5.4 mt -125.26 112.46 16.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.197 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.92 130.21 38.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.631 176.117 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 46.1 m-85 -111.11 154.15 24.69 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.143 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 27.8 ttpp -137.4 113.88 10.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.824 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 43.62 46.27 6.06 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.17 0.918 . . . . 0.0 111.941 -177.705 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 7.09 52.49 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.647 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.73 9.4 16.38 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 122.436 -0.449 . . . . 0.0 110.612 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.8 tt0 66.8 173.0 0.25 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.776 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.5 p -146.96 -32.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.728 0.299 . . . . 0.0 110.36 172.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -158.16 162.04 37.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.131 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.3 tmtp? -143.33 107.8 4.82 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.77 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.68 143.91 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -155.71 84.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.614 0.721 . . . . 0.0 111.74 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.09 81.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.644 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.526 ' HA ' ' CD ' ' A' ' 73' ' ' PRO . . . 45.13 74.76 0.12 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.05 0.54 . . . . 0.0 111.867 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 20.0 p-10 -123.59 75.53 54.69 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -171.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.577 ' O ' ' HE2' ' A' ' 43' ' ' PHE . 7.7 Cg_exo -74.07 -37.01 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.358 1.372 . . . . 0.0 110.4 166.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -87.4 -41.65 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.03 -17.78 60.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.517 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.603 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -63.14 -36.08 74.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 118.697 -1.201 . . . . 0.0 108.17 170.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.655 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 1.8 mmmp? -58.62 -33.73 70.36 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.389 0.431 . . . . 0.0 110.634 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.23 -54.95 40.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.63 173.313 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -71.81 -47.23 54.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.671 . . . . 0.0 111.229 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -61.44 -49.03 86.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.737 -172.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.35 -33.96 17.78 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -170.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.2 38.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.749 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -88.63 -54.65 4.06 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.195 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.582 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.535 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.624 HG21 ' HE3' ' A' ' 54' ' ' LYS . 1.2 m . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.525 ' CG2' ' HD2' ' A' ' 53' ' ' TYR . 1.3 m -74.03 144.76 44.96 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.463 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -111.63 118.56 36.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.595 172.002 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.682 ' H ' HD22 ' A' ' 55' ' ' LEU . 12.6 m-85 -71.22 163.37 27.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 110.063 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -112.33 -25.01 9.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.762 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.613 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 27.1 p -138.58 159.37 42.25 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -54.42 -39.29 67.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -53.67 -38.82 64.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.141 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.613 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 70.8 mm-40 -64.83 -50.46 66.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.519 0.675 . . . . 0.0 109.951 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.28 -48.1 81.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.497 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.546 ' HA ' HG12 ' A' ' 15' ' ' ILE . 7.2 m-20 -58.87 -35.34 72.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.349 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -74.64 -29.27 61.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.52 -39.56 24.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.172 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.818 HG22 HG11 ' A' ' 21' ' ' VAL . 43.8 pt -66.99 -22.28 29.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.698 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.77 -9.8 59.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.977 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.97 149.4 49.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.324 . . . . 0.0 110.507 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.31 39.19 0.31 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.214 0.53 . . . . 0.0 110.87 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.0 ptmt -147.32 173.75 12.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.817 -177.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.653 ' CD2' HG11 ' A' ' 84' ' ' VAL . 1.3 tm? -76.43 110.89 11.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.286 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.818 HG11 HG22 ' A' ' 15' ' ' ILE . 3.8 p -95.29 130.7 43.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.8 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -122.63 101.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.71 0.766 . . . . 0.0 109.71 169.212 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.637 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 57.7 t -109.12 143.28 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.874 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.28 120.51 32.41 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 83.7 m-85 -71.03 121.61 18.54 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.293 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.794 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 2.3 m-85 -119.99 177.78 4.86 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.127 0.489 . . . . 0.0 110.837 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.16 130.03 9.36 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 167.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -7.53 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 111.873 -174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -107.57 11.43 28.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.179 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.943 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -111.53 136.98 49.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.647 0.737 . . . . 0.0 111.649 -176.289 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.66 -41.46 50.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.589 -1.187 . . . . 0.0 114.325 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.943 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 16.5 Cg_exo -67.5 -27.96 38.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 CA-C-N 120.302 2.051 . . . . 0.0 110.441 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 58.9 m -55.26 -44.39 75.54 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.378 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.715 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 66.0 mttm -64.25 -51.33 64.12 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.561 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.675 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -62.05 -49.34 76.37 Favored 'General case' 0 C--O 1.252 1.185 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.04 -14.63 15.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.035 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.12 -49.68 92.26 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.971 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 24.5 Cg_exo -67.44 -35.1 24.46 Favored 'Trans proline' 0 C--N 1.36 1.156 0 CA-C-N 120.377 1.17 . . . . 0.0 111.645 169.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.433 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 97.1 mmm -62.36 -60.95 2.82 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.474 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.595 HG21 ' HD3' ' A' ' 54' ' ' LYS . 61.9 mt -65.07 -22.52 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.013 -0.429 . . . . 0.0 111.615 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 39.4 tt0 -63.36 -46.67 85.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.522 0.677 . . . . 0.0 109.474 169.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 14.6 tptm -60.88 -37.17 81.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.694 0.759 . . . . 0.0 109.532 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.673 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 2.6 m-30 -76.76 -14.66 59.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.751 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.815 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 46.1 p -74.62 -16.13 60.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.48 -24.1 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.023 171.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.673 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 12.8 mm100 -76.35 -38.66 55.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.073 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.604 ' CE1' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -104.03 101.9 28.62 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.0 Cg_endo -83.89 -19.07 5.1 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.077 2.518 . . . . 0.0 111.599 169.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.46 -22.22 19.73 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 111.161 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -109.07 140.21 42.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.672 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.1 117.52 29.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.586 0.708 . . . . 0.0 111.643 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.815 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.3 p90 -89.11 115.04 26.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.698 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.672 ' CE1' ' HB3' ' A' ' 51' ' ' ASP . 4.3 m-85 -133.41 150.7 51.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 171.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.659 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 9.7 mtmp? -143.99 119.39 10.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 6.8 mt -97.37 158.58 15.39 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -168.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.02 113.22 26.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.203 0.525 . . . . 0.0 110.009 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.727 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.76 -14.53 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.3 -29.17 62.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.12 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -105.72 -18.96 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.721 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.9 mm? -106.87 45.28 0.99 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.28 0.562 . . . . 0.0 110.417 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -76.85 -34.01 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.415 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 2.9 m-20 -71.17 -43.53 67.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.51 0.195 . . . . 0.0 110.802 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 8' ' ' ALA . 3.7 p -62.2 -39.74 85.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.76 81.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.161 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 55.1 mt-30 -71.46 -36.0 71.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.078 0.466 . . . . 0.0 110.496 -175.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 44.2 mtmt -62.45 -36.84 83.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.792 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.49 15.59 25.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.368 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 60.32 38.04 19.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.514 172.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.56 110.05 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.473 . . . . 0.0 111.008 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -109.6 -44.74 3.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.932 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.12 153.98 38.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.556 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.43 140.18 18.58 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.755 0.312 . . . . 0.0 110.317 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 72.9 Cg_endo -79.87 160.66 86.74 Favored 'Cis proline' 0 C--O 1.236 0.38 0 C-N-CA 123.276 -1.552 . . . . 0.0 112.629 -3.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 22.6 m -129.67 119.8 24.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.11 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.583 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.06 108.4 19.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.664 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -120.99 114.3 21.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.679 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.8 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -94.21 133.47 37.69 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.883 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.676 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 4.1 m-85 -117.53 156.03 28.76 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.436 -175.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.566 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 65.3 tttm -144.29 116.83 8.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.173 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.566 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 3.0 p-10 45.66 36.22 2.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.198 0.999 . . . . 0.0 112.664 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.93 5.93 76.96 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.254 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -115.58 14.61 16.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.742 0.271 . . . . 0.0 110.849 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.6 tt0 67.67 173.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.414 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.653 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.6 p -148.99 -33.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.932 0.396 . . . . 0.0 110.039 172.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.567 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -155.82 162.86 40.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.596 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -146.29 110.89 5.16 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.032 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.1 t -122.51 125.92 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.79 84.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.697 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.1 78.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.743 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 51.29 80.86 0.08 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.7 p-10 -124.47 87.24 54.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.439 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.7 Cg_exo -77.76 -38.89 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.523 1.482 . . . . 0.0 111.373 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.51 -44.55 10.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.913 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -68.68 -17.08 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.273 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.716 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.1 tp -58.69 -38.3 70.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 99' ' ' ILE . 12.8 mmmm -59.57 -36.25 75.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.162 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -51.91 -59.65 4.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.792 173.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -72.69 -36.22 67.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.345 0.593 . . . . 0.0 111.356 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.803 -171.125 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.21 -32.75 19.62 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.852 0.358 . . . . 0.0 111.327 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.53 48.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.792 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.567 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 66.9 m-80 -86.29 -53.99 4.7 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.621 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.802 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m -98.1 141.04 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.075 0.464 . . . . 0.0 109.916 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.9 148.08 25.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.905 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -111.92 120.08 40.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.817 174.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.618 ' H ' HD22 ' A' ' 55' ' ' LEU . 20.8 m-85 -73.43 164.41 26.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.219 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -116.23 -17.28 10.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.665 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.62 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 41.2 p -133.67 153.41 51.7 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.494 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.62 -31.37 66.17 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -60.91 -42.31 97.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.99 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.62 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.9 mm-40 -64.71 -42.68 95.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.391 0.615 . . . . 0.0 110.293 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 15' ' ' ILE . 5.3 t80 -66.42 -47.45 73.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.868 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.12 -47.7 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.408 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 20.1 m -68.93 -26.93 65.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.609 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.21 -54.57 7.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 27.4 pt -67.07 -19.71 25.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.23 -8.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.356 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.445 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.9 mt-30 -74.24 160.36 31.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.47 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 p-10 -77.5 19.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.481 0.657 . . . . 0.0 111.427 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.5 ptmt -118.7 166.15 13.12 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.249 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.612 ' CD2' HG11 ' A' ' 84' ' ' VAL . 2.4 tm? -78.72 112.16 15.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 HG23 ' A' ' 23' ' ' VAL . 88.7 t -117.94 108.18 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.654 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.25 108.42 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.822 0.82 . . . . 0.0 111.015 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.624 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 59.9 t -104.56 142.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.526 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.872 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -122.12 119.7 32.1 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' A' ' 69' ' ' VAL . 56.2 m-85 -71.41 125.43 26.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.352 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.774 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -120.98 -174.28 2.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.077 -173.095 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.2 155.12 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.151 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.08 -5.41 59.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -111.87 33.65 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -132.96 146.64 51.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.592 0.711 . . . . 0.0 112.135 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.562 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -85.17 -42.37 7.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.991 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 23.0 Cg_endo -61.34 -40.11 51.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 CA-C-N 119.817 1.808 . . . . 0.0 111.417 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 12.5 p -57.57 -31.6 66.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.792 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tptt -66.19 -53.6 35.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.789 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.707 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 21.5 ptm -63.09 -44.55 95.4 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.684 ' CG1' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -74.82 -18.83 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.39 -48.66 96.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.6 Cg_exo -70.92 -31.03 16.04 Favored 'Trans proline' 0 C--N 1.36 1.149 0 CA-C-N 120.537 1.228 . . . . 0.0 112.004 171.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 35' ' ' MET . 20.1 mmt -66.61 -56.37 11.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.582 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.717 HG23 ' CE2' ' A' ' 52' ' ' PHE . 6.5 mt -59.66 -27.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 31.8 tt0 -53.94 -48.64 70.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 16.0 tppt? -65.95 -47.77 73.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.945 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.635 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 3.4 m-30 -62.66 -26.55 68.7 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.777 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 92.3 p -85.1 -15.25 44.55 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 42.5 tt0 -79.66 -25.99 41.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.174 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.635 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -96.22 8.43 43.89 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.66 ' HE2' ' CD2' ' A' ' 52' ' ' PHE . 5.1 m-85 -103.52 100.0 17.36 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.729 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.54 -43.01 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.758 2.305 . . . . 0.0 112.677 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.27 -14.87 17.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.763 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB2' ' HB1' ' A' ' 103' ' ' ALA . . . -104.68 165.04 11.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.48 137.37 51.76 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.717 ' CE2' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -109.12 131.03 55.46 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.187 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 42.8 m-85 -136.65 151.93 49.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.872 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 10.0 mtmp? -139.57 120.54 14.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.624 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.7 mt -100.32 161.11 13.82 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 5.7 m-20 -94.22 107.5 19.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -13.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -172.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 5.5 p-10 -77.72 -25.23 49.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 109.59 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -93.97 -40.3 10.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.816 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -98.21 53.98 1.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.764 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.621 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.21 -45.89 10.91 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.86 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.7 t70 -61.11 -44.64 97.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.508 0.194 . . . . 0.0 111.189 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.586 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.5 p -65.1 -38.65 83.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.169 0.509 . . . . 0.0 110.611 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.63 78.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.909 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 13.4 mm100 -72.56 -31.62 65.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.702 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.41 -41.84 90.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.804 0.811 . . . . 0.0 110.223 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -98.44 21.49 11.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.381 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 38.2 50.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.936 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.618 HG21 ' CD2' ' A' ' 25' ' ' PHE . 76.2 t -81.18 115.87 24.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.945 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 p -122.42 17.54 10.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.294 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.04 157.97 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -138.58 122.29 11.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 36' ' ' ILE . 98.2 Cg_endo -83.79 166.2 64.04 Favored 'Cis proline' 0 C--O 1.235 0.349 0 C-N-CA 123.751 -1.354 . . . . 0.0 112.505 -5.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 78.2 m -123.75 122.73 38.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.634 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -105.42 109.66 21.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -173.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 21.5 mt -125.52 115.86 20.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.859 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.579 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.58 125.32 39.16 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 174.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.9 m-85 -108.05 154.48 21.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.468 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 50.7 tptt -143.37 116.57 8.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.198 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.47 ' ND2' ' HA ' ' A' ' 18' ' ' ASP . 23.4 m120 56.26 27.15 11.34 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 123.424 0.452 . . . . 0.0 111.527 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.54 10.06 59.72 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.002 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 47.6 pttt -109.88 1.9 19.5 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.632 0.73 . . . . 0.0 109.354 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.4 tt0 78.47 172.6 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.612 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -144.2 -31.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 109.847 173.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.454 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.37 162.37 30.74 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.842 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.6 tttt -139.82 124.64 18.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.603 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.5 t -131.02 137.97 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.8 83.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.893 0.854 . . . . 0.0 111.609 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.12 53.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.833 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.89 81.84 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 111.324 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 11.3 p-10 -117.67 90.82 36.86 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 95' ' ' ILE . 3.9 Cg_exo -77.2 -43.15 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.441 1.427 . . . . 0.0 110.897 169.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.3 16.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.094 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -74.61 -17.57 60.69 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.053 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.729 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.43 -38.77 76.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.618 ' HA ' HG22 ' A' ' 99' ' ' ILE . 31.2 mmmt -61.87 -29.66 70.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.357 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -56.39 -57.88 10.39 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 174.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.431 ' C ' HD11 ' A' ' 77' ' ' LEU . . . -74.86 -37.87 62.1 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -72.61 -39.14 60.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.009 -170.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.0 -32.41 21.52 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.361 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.83 70.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.14 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 52.5 m-80 -96.83 -62.33 1.28 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.603 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.695 0.283 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.87 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -90.4 141.73 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.255 0.55 . . . . 0.0 110.86 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 146.02 37.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.555 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 2.5 pp0? -104.95 136.23 44.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.261 171.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.572 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.7 m-85 -90.82 161.53 15.23 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.996 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -119.0 -18.54 8.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.284 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 58.7 p -133.08 151.57 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 111.121 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -60.44 -27.58 67.62 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -62.74 -43.73 98.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.387 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 9.4 mm-40 -60.46 -46.21 90.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.321 0.582 . . . . 0.0 110.251 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.43 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 9.5 t80 -64.85 -47.9 76.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.241 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HA ' HG12 ' A' ' 15' ' ' ILE . 31.3 t70 -62.69 -33.69 75.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.608 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 m -73.43 -36.84 66.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.242 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.73 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.507 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.2 pt -67.78 -24.84 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.23 -15.68 60.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.084 0.468 . . . . 0.0 111.36 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.59 ' HB2' ' NZ ' ' A' ' 19' ' ' LYS . 98.2 mt-30 -76.46 156.47 33.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.802 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 17.9 t70 -48.38 -38.15 18.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -167.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.668 ' HE2' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -109.1 -178.96 3.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -162.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.669 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -59.58 116.04 3.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.02 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.2 t -119.72 107.2 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.967 170.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.664 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.86 103.4 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.737 0.779 . . . . 0.0 111.008 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 3.5 t -108.14 144.23 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.99 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -128.64 128.97 45.2 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CE2' HD12 ' A' ' 55' ' ' LEU . 80.9 m-85 -70.67 121.11 17.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.392 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.52 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 m-30 -120.19 176.1 5.62 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.251 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.65 16.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.889 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -84.48 -5.6 59.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -113.55 24.56 12.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 8.2 p -130.83 127.56 38.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.564 0.697 . . . . 0.0 111.65 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.04 -44.88 75.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.901 -1.045 . . . . 0.0 114.208 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 51.3 Cg_exo -57.6 -44.56 40.6 Favored 'Trans proline' 0 C--N 1.358 1.033 0 CA-C-N 119.98 1.89 . . . . 0.0 111.928 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 3.6 m -54.48 -37.19 64.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.391 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 38.6 ttpt -66.31 -47.04 74.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.149 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.435 ' O ' ' HG2' ' A' ' 39' ' ' MET . 24.8 ptt? -68.95 -45.25 71.22 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.665 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.32 -16.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.637 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.4 -55.41 44.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.508 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.7 Cg_endo -67.99 -27.85 35.98 Favored 'Trans proline' 0 C--N 1.358 1.032 0 CA-C-N 120.573 1.24 . . . . 0.0 111.993 172.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 35' ' ' MET . 96.6 mmm -67.08 -58.66 4.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.871 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.566 HG21 ' NZ ' ' A' ' 54' ' ' LYS . 65.0 mt -66.65 -20.39 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.994 -0.441 . . . . 0.0 111.794 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.87 -50.14 73.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.627 0.727 . . . . 0.0 109.531 164.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 43.3 tptt -60.19 -37.01 78.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.462 0.649 . . . . 0.0 109.83 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.691 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.8 m-30 -76.31 -15.07 60.06 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.379 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.758 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 24.2 p -73.58 -16.21 61.26 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 32.0 tt0 -87.6 -25.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.924 171.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.691 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 25.9 mm-40 -78.12 -30.03 49.2 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.729 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 4.1 p90 -120.39 83.6 33.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.25 -12.74 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.431 2.087 . . . . 0.0 111.438 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -6.11 49.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.602 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -127.87 165.55 19.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.557 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 12.4 m-20 -101.83 117.53 35.05 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.876 0.846 . . . . 0.0 112.617 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.2 p90 -98.02 113.66 25.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.545 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.695 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 32.7 m-85 -137.49 153.49 50.04 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.91 -0.494 . . . . 0.0 111.317 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.87 ' HG2' HG21 ' A' ' 2' ' ' VAL . 10.3 mmtt -128.3 142.95 50.99 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 72.7 mt -99.59 143.66 29.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.034 -0.416 . . . . 0.0 111.646 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 15.5 m-20 -86.51 100.66 12.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 166.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -59.01 -14.68 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 12.2 p-10 -71.76 -36.05 70.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 109.91 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.29 -15.08 16.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.386 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.593 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -109.22 44.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.91 -33.35 41.77 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.57 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.85 -45.85 80.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.702 0.287 . . . . 0.0 110.404 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -66.65 -36.91 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.492 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . . . -57.87 -50.17 74.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.358 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -63.77 -31.83 73.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.263 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -26.0 61.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.005 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -97.14 4.79 51.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.642 0.258 . . . . 0.0 110.975 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 62.82 43.75 6.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.847 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -88.33 121.66 38.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.889 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 p -123.67 -7.75 7.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.25 159.0 29.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.901 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -129.8 133.94 25.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.74 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.9 Cg_endo -86.05 171.05 41.6 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.903 -1.29 . . . . 0.0 111.199 -2.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.8 m -129.39 117.02 19.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -101.4 109.59 21.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 -175.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.593 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 23.9 mt -124.25 113.05 17.76 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.664 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.44 127.26 43.25 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.593 174.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 32.7 m-85 -108.66 159.71 16.52 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.646 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 61.0 tttp -142.46 118.01 10.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.847 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.625 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 2.3 p-10 40.34 43.99 1.56 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.951 0.782 . . . . 0.0 112.912 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.71 1.41 58.46 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 114.073 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.99 10.93 18.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.291 0.546 . . . . 0.0 110.558 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.86 175.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.116 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.97 -35.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 173.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.483 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.69 165.18 36.98 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.411 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.593 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.8 tttt -148.9 115.98 6.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.556 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.29 139.25 48.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.21 89.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.503 0.668 . . . . 0.0 111.711 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.97 -174.78 31.68 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.469 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -72.91 93.15 1.69 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.883 0.373 . . . . 0.0 110.278 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 23.6 p-10 -119.49 69.21 11.37 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.0 -32.98 20.54 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.063 1.175 . . . . 0.0 111.002 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.96 -44.22 10.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.703 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.47 -17.13 61.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.2 tp -55.72 -39.51 55.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 99' ' ' ILE . 20.2 tptm -62.96 -32.44 73.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.368 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -54.18 -58.18 8.32 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.467 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -70.98 -36.67 72.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.539 0.685 . . . . 0.0 110.649 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -74.69 -42.04 47.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.178 -169.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -87.15 -39.42 15.53 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.961 0.41 . . . . 0.0 110.886 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.53 70.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.504 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 61.0 m-80 -89.04 -52.98 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.669 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.911 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.652 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -121.29 135.39 61.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.655 0.74 . . . . 0.0 111.734 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.27 147.85 23.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.325 -175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 4' ' ' GLN . 4.9 pt20 -99.85 120.31 39.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.114 169.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.588 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 16.7 m-85 -73.17 133.6 44.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.665 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -86.14 -16.85 36.61 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 74.5 p -131.79 151.86 51.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 111.432 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.549 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -60.32 -30.8 69.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.792 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -64.14 -37.09 86.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.79 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.489 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 25.3 mm-40 -62.01 -47.76 83.35 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.237 0.541 . . . . 0.0 110.04 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -47.03 87.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.967 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.09 -46.15 68.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.634 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 17.7 m -71.85 -32.66 67.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.568 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.02 -49.83 47.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.595 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.0 pt -67.99 -18.6 23.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.323 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.19 -10.03 59.69 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.282 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 13' ' ' SER . 78.2 mt-30 -79.62 150.72 30.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.46 56.23 2.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.926 0.87 . . . . 0.0 111.033 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 5.5 ptmt -150.72 169.22 22.14 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.042 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.939 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -74.62 108.01 7.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.037 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 84.6 t -116.45 107.37 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.794 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.717 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.89 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.568 0.699 . . . . 0.0 111.173 176.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 90.9 t -102.85 135.23 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.267 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -117.63 106.63 13.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE2' HD12 ' A' ' 55' ' ' LEU . 81.2 m-85 -71.42 107.57 4.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.866 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -162.77 152.23 15.48 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -178.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -129.04 141.65 51.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 p -68.25 -4.35 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -73.94 6.4 3.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.2 p -122.56 -172.89 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.979 0.418 . . . . 0.0 111.893 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.59 -59.23 2.14 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.95 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 51.2 Cg_exo -53.86 -49.33 17.55 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.609 2.206 . . . . 0.0 111.944 -176.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.2 p -49.82 -37.92 32.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.803 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.791 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 8.0 ttpm? -66.41 -56.46 10.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.536 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 39' ' ' MET . 22.8 ptm -59.54 -45.87 90.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.695 HG13 HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -74.48 -22.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.524 -177.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -54.5 -57.06 20.5 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.222 -177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.791 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 20.9 Cg_endo -63.99 -35.01 56.97 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.294 1.329 . . . . 0.0 112.797 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 35' ' ' MET . 94.0 mmm -62.2 -56.36 19.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.695 HD12 HG13 ' A' ' 36' ' ' ILE . 23.6 mt -62.6 -23.81 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 120.782 0.325 . . . . 0.0 111.638 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.58 -43.94 79.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HG3' HE21 ' A' ' 46' ' ' GLN . 2.5 tppp? -62.18 -45.17 94.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.251 0.548 . . . . 0.0 110.239 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.66 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.9 m-30 -67.92 -15.32 63.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 13.5 p -87.11 -14.41 41.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.133 0.968 . . . . 0.0 108.697 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -86.68 -14.6 42.08 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.992 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.66 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -129.37 36.14 4.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.844 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -115.74 74.24 4.74 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.91 -36.09 90.93 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.337 2.024 . . . . 0.0 113.946 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -107.21 24.45 12.82 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.557 0.694 . . . . 0.0 111.54 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' HB2' ' CB ' ' A' ' 103' ' ' ALA . . . -138.95 165.6 26.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.337 -0.852 . . . . 0.0 111.803 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 117.67 19.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.89 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.844 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -93.2 129.57 39.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.575 -174.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 36.1 m-85 -137.49 135.56 36.9 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.841 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 30.1 mtmt -125.08 121.7 35.06 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.057 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.588 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 54.6 mt -85.66 125.11 32.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.455 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.693 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.0 p-10 -70.95 105.61 3.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -58.23 -12.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.404 -175.345 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.53 -44.95 85.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.729 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.11 -18.14 17.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.164 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -106.8 51.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 110.825 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -78.22 -41.17 18.01 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.25 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.74 -41.49 83.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 7.7 p -65.51 -38.68 83.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.0 110.221 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.51 77.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.994 0.426 . . . . 0.0 110.796 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 78.3 mm-40 -70.66 -27.16 63.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.753 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -75.26 -25.09 57.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.266 0.555 . . . . 0.0 110.412 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -100.25 12.29 37.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.245 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.17 42.87 9.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG13 ' OG1' ' A' ' 74' ' ' THR . 85.0 t -91.71 124.63 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -138.03 17.75 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.109 0.481 . . . . 0.0 110.908 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -138.88 146.85 41.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.03 124.13 27.07 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.382 . . . . 0.0 110.194 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 58.0 Cg_endo -85.78 170.33 44.24 Favored 'Cis proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.55 -2.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 98.3 m -124.67 115.76 21.28 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -105.63 108.51 20.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.98 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.8 mt -127.57 114.4 17.36 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.85 130.07 41.59 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.63 0.729 . . . . 0.0 110.259 174.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.651 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 88.7 m-85 -111.0 156.71 20.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.359 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.4 ttmt -141.63 116.13 9.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.349 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.55 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 42.33 43.81 3.13 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.769 0.828 . . . . 0.0 112.529 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.08 53.69 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.572 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.31 8.61 18.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.071 0.463 . . . . 0.0 110.183 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.651 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 45.8 mt-10 64.77 178.48 0.18 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.619 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.7 p -148.86 -33.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 170.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.408 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.41 163.66 35.26 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 88' ' ' VAL . 30.4 tttm -146.41 120.52 9.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.497 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.9 t -127.05 131.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG21 ' HE2' ' A' ' 86' ' ' LYS . 2.5 t -125.89 79.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.024 0.44 . . . . 0.0 111.248 -171.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.5 -168.81 38.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -69.65 93.39 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.3 p-10 -123.74 63.4 28.31 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.453 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.1 Cg_exo -67.35 -37.76 16.91 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.038 1.159 . . . . 0.0 110.579 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.8 -40.36 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.939 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.26 -17.21 61.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.272 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.71 -37.15 69.72 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.612 ' HA ' HG22 ' A' ' 99' ' ' ILE . 29.2 mmtt -57.63 -34.79 69.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.538 0.524 . . . . 0.0 110.623 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -54.33 -56.4 18.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -73.43 -44.09 59.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.478 0.656 . . . . 0.0 111.204 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.678 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -65.26 -41.43 91.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.858 -171.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.11 -42.06 11.92 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.826 0.346 . . . . 0.0 111.762 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.8 -39.1 73.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.408 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.3 m-80 -85.85 -56.73 3.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.072 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.402 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 tmm? . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.821 HG21 ' HE2' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -88.33 144.66 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 145.76 55.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 112.504 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -112.9 127.14 56.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.597 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.7 ' H ' HD22 ' A' ' 55' ' ' LEU . 18.4 m-85 -74.7 163.04 28.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.875 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -119.83 -13.83 9.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.523 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.641 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 82.2 p -135.05 152.29 51.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.882 0.372 . . . . 0.0 111.098 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.81 -30.53 67.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -64.06 -39.17 93.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.901 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.641 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 15.8 mm-40 -60.8 -42.3 97.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.996 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -64.94 -49.15 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.739 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.36 -43.23 83.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.759 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -70.8 -36.06 72.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.72 -52.16 40.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.519 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 28.4 pt -65.03 -21.04 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.191 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.03 -6.99 57.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.749 0.309 . . . . 0.0 111.687 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' A' ' 19' ' ' LYS . 93.1 mt-30 -81.56 159.05 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.876 0.369 . . . . 0.0 110.325 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.73 18.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.237 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 17' ' ' GLN . 30.3 mtpt -107.75 174.61 5.81 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.906 0.86 . . . . 0.0 112.68 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.646 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tm? -91.2 107.06 18.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.355 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 67.3 t -106.0 115.45 47.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.547 HG22 HD22 ' A' ' 77' ' ' LEU . 21.6 t -92.3 102.39 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.211 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.576 HG23 HG12 ' A' ' 21' ' ' VAL . 44.2 t -108.39 136.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.473 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' CG ' ' A' ' 54' ' ' LYS . . . -128.92 141.55 51.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 120.764 0.316 . . . . 0.0 111.821 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.666 ' CD2' HG21 ' A' ' 69' ' ' VAL . 59.0 m-85 -95.11 122.52 37.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.336 0.589 . . . . 0.0 110.55 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.733 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.5 m-85 -119.98 -175.28 2.94 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.243 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.61 165.76 20.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -84.92 -5.55 59.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.317 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -122.88 34.59 5.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.776 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.673 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 6.9 p -132.11 121.82 24.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.527 0.68 . . . . 0.0 111.834 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.39 -42.12 97.79 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.923 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.611 ' O ' HG23 ' A' ' 36' ' ' ILE . 50.3 Cg_exo -57.47 -44.3 43.57 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.021 1.91 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 9.2 m -53.32 -41.35 65.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.718 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 37.5 ttpt -63.06 -56.36 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.6 ptp -60.65 -47.79 84.68 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.34 -13.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.014 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.67 -53.64 63.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.291 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.9 Cg_endo -65.53 -33.19 47.08 Favored 'Trans proline' 0 C--N 1.357 1.003 0 CA-C-N 120.281 1.136 . . . . 0.0 112.448 169.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 mmt -65.02 -58.92 4.85 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.969 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.521 HG12 HG21 ' A' ' 95' ' ' ILE . 51.6 mt -64.42 -23.04 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 122.107 -0.371 . . . . 0.0 111.399 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 42.6 tt0 -63.12 -41.51 99.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.66 0.743 . . . . 0.0 110.133 170.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 19.7 ttmt -64.56 -38.94 92.75 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.087 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.68 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.4 m-30 -69.63 -23.82 63.56 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.267 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 2.0 p -73.81 -14.67 61.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.71 -23.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.68 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 53.5 mt-30 -80.65 -33.38 35.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.063 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 5.8 p90 -108.43 92.13 9.44 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.2 Cg_endo -84.39 -12.79 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.132 2.555 . . . . 0.0 111.37 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 50' ' ' ALA . 3.3 pt20 -88.2 -22.95 23.73 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.354 0.597 . . . . 0.0 110.385 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -113.68 148.16 36.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 7.0 m-20 -91.12 116.73 29.04 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.402 0.62 . . . . 0.0 111.523 -174.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.686 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 2.8 p90 -87.7 114.55 24.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.946 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 22.1 m-85 -130.78 164.85 24.22 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.238 170.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.821 ' HE2' HG21 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -153.29 119.9 5.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 5.4 mt -99.31 159.52 14.94 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.255 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.42 118.77 37.59 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -63.34 -11.48 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.636 -174.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.24 -37.48 78.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.975 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.21 -31.02 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.458 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.579 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.0 mm? -107.73 48.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.004 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.598 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.92 -41.78 17.89 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.117 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 4.5 m-20 -66.7 -44.1 82.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.509 0.195 . . . . 0.0 110.839 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.0 p -62.74 -38.03 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.202 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.89 85.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.167 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 88.7 mm-40 -71.37 -32.13 68.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.901 0.382 . . . . 0.0 110.464 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.42 -42.63 92.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.6 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -94.81 14.74 20.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.044 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 58.86 43.79 17.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.602 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.666 HG21 ' CD2' ' A' ' 25' ' ' PHE . 94.8 t -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.979 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 p -125.87 22.43 7.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.156 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 88' ' ' VAL . . . -142.91 151.01 40.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.673 ' SD ' ' HB3' ' A' ' 30' ' ' CYS . 16.2 ptt? -121.45 123.15 27.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.202 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 6.1 Cg_endo -86.88 172.35 35.47 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.428 -1.072 . . . . 0.0 111.511 -3.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 55.1 m -138.82 116.78 11.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.698 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.5 mp -107.13 142.53 36.67 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.093 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 86' ' ' LYS . 21.8 mt -134.28 110.6 9.61 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.094 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.45 124.08 34.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.758 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 31.5 m-85 -109.68 154.65 22.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.955 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.611 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 58.5 tttp -142.95 115.06 8.34 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.961 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.603 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 9.6 p30 44.69 38.11 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.965 0.906 . . . . 0.0 112.45 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.43 3.93 63.42 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.697 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 16.8 ptmt -103.59 -3.7 24.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 109.412 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 29.3 tt0 77.23 -179.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.593 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.602 HG11 ' CD2' ' A' ' 20' ' ' LEU . 2.1 p -152.2 -32.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.884 0.374 . . . . 0.0 110.04 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.25 162.13 40.17 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.129 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.434 ' HG3' HD22 ' A' ' 76' ' ' LEU . 35.0 tttp -138.17 122.49 18.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.029 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.616 HG11 ' ND2' ' A' ' 91' ' ' ASN . 10.1 p -128.98 131.22 68.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.302 0.572 . . . . 0.0 110.277 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.0 t -131.11 80.41 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.672 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.36 -175.12 38.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.926 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.42 94.72 2.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.941 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 22.8 p-10 -124.45 68.95 51.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 95' ' ' ILE . 18.7 Cg_exo -64.68 -43.65 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 120.614 0.876 . . . . 0.0 110.991 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.88 -32.43 18.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.941 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.88 -18.76 59.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.429 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.0 tp -59.9 -38.12 75.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.589 ' HA ' HG22 ' A' ' 99' ' ' ILE . 19.3 tptm -64.27 -26.82 68.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.168 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.4 tm0? -58.83 -59.26 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 170.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 -38.36 78.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.7 . . . . 0.0 110.741 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -71.63 -42.37 71.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.146 -170.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.19 -40.45 14.57 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.99 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.76 -40.4 66.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.572 -175.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.8 m-80 -85.55 -56.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.469 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.646 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.581 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.661 0.267 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.958 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -121.59 140.08 46.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.302 0.572 . . . . 0.0 110.483 177.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.73 148.25 33.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.899 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.483 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -112.46 118.49 35.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.391 172.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.611 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -69.9 163.06 26.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 110.68 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -115.59 -18.34 10.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.176 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.61 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 28.5 p -138.0 155.49 48.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.501 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.64 -34.85 73.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 m -57.24 -37.77 72.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.991 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.61 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 34.4 mm-40 -63.36 -45.03 93.07 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.307 0.575 . . . . 0.0 109.961 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HD2' HG21 ' A' ' 23' ' ' VAL . 1.9 t80 -66.75 -50.36 62.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.747 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.53 -39.73 80.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.396 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.1 m -69.45 -37.05 77.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -66.62 -49.6 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.858 0.361 . . . . 0.0 110.814 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.5 pt -66.69 -24.26 32.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.649 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 -5.76 48.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.42 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 26.0 mt-30 -75.94 157.04 33.64 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.985 0.421 . . . . 0.0 110.302 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . 26.6 t70 -66.45 -1.78 3.91 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.73 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 11.1 ptmt -115.47 173.86 6.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.21 0.528 . . . . 0.0 111.812 -167.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.574 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.41 113.69 11.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -122.12 107.86 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.766 0.317 . . . . 0.0 110.641 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.587 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.93 109.2 26.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.867 0.842 . . . . 0.0 111.588 176.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 98.9 t -104.28 142.54 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.151 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.856 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -129.43 138.35 51.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 69' ' ' VAL . 70.1 m-85 -88.51 126.6 35.33 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.25 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.2 m-30 -120.82 -172.06 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.637 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -169.9 162.51 9.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.227 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 p -83.98 -4.85 59.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -122.8 35.0 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 -176.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -130.95 143.88 51.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.814 0.816 . . . . 0.0 111.911 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.48 -45.43 6.49 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.276 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 50.9 Cg_exo -57.11 -50.63 10.73 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.903 1.735 . . . . 0.0 112.17 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 28.5 p -53.5 -34.37 57.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.71 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 4.6 ttmp? -68.55 -45.17 72.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.064 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 24.9 ptt? -72.86 -41.52 64.67 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.277 0.561 . . . . 0.0 112.444 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.664 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.91 -17.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.44 177.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.03 -49.22 94.89 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.8 Cg_endo -69.84 -29.44 23.5 Favored 'Trans proline' 0 C--N 1.358 1.066 0 CA-C-N 120.56 1.236 . . . . 0.0 112.592 169.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.6 mmt -67.68 -52.21 40.57 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.958 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.786 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -55.8 -35.2 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 173.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 12.7 tp10 -55.45 -49.88 71.3 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.149 0.5 . . . . 0.0 110.254 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -61.63 -48.04 82.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.097 0.475 . . . . 0.0 110.493 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.661 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 m-30 -63.02 -22.36 66.8 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.981 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.471 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 34.9 p -82.03 -19.59 40.08 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.726 0.774 . . . . 0.0 108.949 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -77.48 -29.91 52.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.673 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.661 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -100.39 26.31 6.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.251 175.097 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.747 ' CE1' HD11 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -100.12 89.34 1.08 Allowed Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.889 170.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 83.0 Cg_endo -84.99 -45.18 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.125 1.883 . . . . 0.0 114.075 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.69 -24.19 14.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.226 0.536 . . . . 0.0 111.845 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.36 164.38 11.68 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.577 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.0 128.32 55.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.786 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.52 120.87 43.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.642 ' HA ' HG23 ' A' ' 2' ' ' VAL . 29.6 m-85 -132.39 142.03 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.737 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.958 ' HG2' HG21 ' A' ' 2' ' ' VAL . 7.8 mmtt -127.93 120.0 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.654 HD13 ' HG ' ' A' ' 60' ' ' LEU . 6.0 mt -100.67 167.73 10.14 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.53 120.41 40.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -15.96 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.281 -174.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.65 -51.04 46.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.913 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.16 -29.7 31.42 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.469 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.9 mm? -96.14 57.59 1.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 0.0 111.22 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.545 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.97 -45.43 10.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.375 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 33.3 t70 -61.25 -45.42 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.649 0.262 . . . . 0.0 111.165 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.9 p -64.82 -38.04 81.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.384 . . . . 0.0 110.557 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.05 74.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.0 110.81 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 88.8 mm-40 -75.02 -28.79 60.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.607 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 87.7 mttt -61.84 -41.31 97.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.462 0.649 . . . . 0.0 110.549 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -92.2 7.75 41.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.125 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 55.16 46.61 23.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.058 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 25' ' ' PHE . 93.3 t -77.89 109.44 12.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.41 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.51 -2.57 11.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.357 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.03 23.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.994 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.89 145.6 32.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.629 0.252 . . . . 0.0 110.695 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 90.5 Cg_endo -82.04 171.24 56.4 Favored 'Cis proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.355 -1.519 . . . . 0.0 112.046 -3.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.594 HG22 HD11 ' A' ' 76' ' ' LEU . 19.2 m -127.11 119.0 25.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -108.24 106.23 16.31 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.002 0.429 . . . . 0.0 111.016 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.594 HD11 HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -118.84 119.06 33.27 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.117 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -94.91 119.01 32.74 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.2 m-85 -105.37 160.25 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.86 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 65.8 tttp -150.68 125.5 9.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.014 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 18' ' ' ASP . 29.0 m120 53.9 33.76 17.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 111.882 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.19 60.91 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.719 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 47.3 mmtm -102.06 -73.55 0.65 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 9.5 pt-20 165.41 -170.98 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 124.724 1.265 . . . . 0.0 108.511 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 77' ' ' LEU . 1.5 p -156.62 -30.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.446 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -163.02 161.96 25.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.411 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.573 ' HG3' HD12 ' A' ' 76' ' ' LEU . 71.5 tttt -146.61 124.38 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.184 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.47 132.95 70.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.26 78.67 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.124 0.488 . . . . 0.0 110.853 -171.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.42 -171.79 40.02 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.609 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.38 93.57 2.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.0 p-10 -118.93 71.87 11.09 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 95' ' ' ILE . 7.3 Cg_exo -73.65 -31.75 8.33 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.264 1.309 . . . . 0.0 109.833 166.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.59 -44.1 10.32 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.432 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.91 -16.9 61.09 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.424 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.715 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -57.09 -37.68 56.62 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 169.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.683 ' HA ' HG22 ' A' ' 99' ' ' ILE . 13.9 mmmm -56.96 -32.77 66.37 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.743 0.652 . . . . 0.0 110.37 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.99 -56.65 19.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.605 174.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -77.9 -28.33 49.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.747 HD11 ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -74.43 -44.7 47.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.654 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 -32.44 22.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.279 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.88 82.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 17.9 m-80 -114.22 -77.21 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.192 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.917 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -171.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 ttp . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.903 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -114.63 135.75 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.575 0.702 . . . . 0.0 111.708 -177.349 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.437 ' CG2' ' HD1' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -81.33 148.66 29.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.428 -177.098 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.5 141.08 35.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 170.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.545 ' HB2' HD22 ' A' ' 55' ' ' LEU . 14.3 m-85 -98.77 157.15 16.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.044 0.449 . . . . 0.0 110.021 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -123.71 -17.42 6.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 50.0 p -130.08 150.88 51.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.952 0.406 . . . . 0.0 111.025 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -60.35 -30.39 69.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.396 175.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -67.77 -33.58 75.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.479 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 22.1 mm-40 -61.73 -47.16 86.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.264 0.554 . . . . 0.0 110.07 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.6 -45.98 81.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.059 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.99 -48.51 81.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.371 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -69.36 -26.74 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -70.66 -53.25 16.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.427 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 pt -65.35 -21.97 30.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.332 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.88 -2.75 48.77 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 19' ' ' LYS . 28.3 mt-30 -76.09 158.55 31.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.646 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . 33.9 t70 -80.16 28.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.104 0.954 . . . . 0.0 110.026 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 7.8 ptmt -134.75 169.12 17.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.506 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.811 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tm? -82.53 116.92 22.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.896 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.6 t -115.32 107.63 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.742 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.72 103.69 15.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 122.164 0.983 . . . . 0.0 111.209 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 21' ' ' VAL . 18.0 t -100.47 139.92 20.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.27 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -130.33 138.57 50.5 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.664 0.269 . . . . 0.0 111.698 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CD2' HG21 ' A' ' 69' ' ' VAL . 49.7 m-85 -88.59 128.17 35.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.92 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.4 m-30 -120.45 -170.93 2.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.04 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.24 172.39 12.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.252 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -20.74 65.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.225 0.536 . . . . 0.0 110.868 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 23.1 p90 -101.39 -147.45 0.36 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.254 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.9 p 56.73 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.408 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.86 -41.45 76.13 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 114.319 -1.309 . . . . 0.0 114.178 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.677 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 46.4 Cg_exo -58.82 -43.73 41.57 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 120.25 2.025 . . . . 0.0 112.154 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.4 m -53.21 -40.0 64.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.383 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.758 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 96.1 mttt -65.56 -53.34 43.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.499 -178.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.8 ptm -62.8 -45.36 92.99 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.649 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.62 -18.43 15.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.924 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.4 -48.16 97.78 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.758 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.9 Cg_exo -70.74 -32.53 14.34 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.174 1.249 . . . . 0.0 112.008 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.1 mmm -64.26 -51.02 65.65 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.614 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.57 HD13 ' CG1' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -53.85 -36.94 31.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-O 120.624 0.249 . . . . 0.0 110.341 172.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.92 -44.49 97.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.721 0.296 . . . . 0.0 111.195 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.92 -50.13 75.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.577 0.703 . . . . 0.0 109.408 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.704 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 14.1 m-30 -63.7 -17.17 62.7 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.482 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 9.6 p -86.15 -14.05 45.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.978 0.894 . . . . 0.0 108.921 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -88.14 -16.63 32.91 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.704 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -128.77 29.92 5.17 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.809 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -108.58 100.83 40.45 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-O 122.193 0.997 . . . . 0.0 112.623 172.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.85 -44.12 10.9 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.826 2.35 . . . . 0.0 114.375 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.5 -13.45 17.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 111.349 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -103.33 158.19 16.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.786 0.803 . . . . 0.0 112.002 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -126.38 119.13 26.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.173 171.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.809 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -87.64 130.58 34.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 -175.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.572 ' CE2' HG13 ' A' ' 21' ' ' VAL . 37.9 m-85 -133.32 133.07 42.06 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.356 168.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.903 ' HG2' HG21 ' A' ' 2' ' ' VAL . 8.0 mmpt? -117.0 118.96 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 1.3 mt -102.4 175.22 5.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.017 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -115.88 121.46 42.42 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -67.89 -10.58 12.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.198 -175.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.64 -35.64 52.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.58 -27.49 21.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.706 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.657 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.0 mt -117.85 54.09 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.367 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.25 -39.16 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.112 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.6 t70 -68.07 -46.99 69.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.644 0.259 . . . . 0.0 110.632 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.657 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.6 p -62.18 -38.45 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.402 . . . . 0.0 110.35 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.31 77.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.918 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 95.2 mt-30 -76.42 -30.85 57.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.461 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 39.1 mtmt -58.62 -39.95 81.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.51 0.671 . . . . 0.0 110.056 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -91.26 9.44 31.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.691 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 56.44 45.62 22.27 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.348 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 25' ' ' PHE . 62.3 t -85.96 123.72 39.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.508 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -134.67 -35.56 0.88 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.53 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.32 119.84 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.979 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.57 136.93 19.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.417 . . . . 0.0 110.872 -175.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 85.2 Cg_endo -83.98 169.88 52.84 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.124 -1.615 . . . . 0.0 111.714 -4.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.489 ' OG1' HG13 ' A' ' 69' ' ' VAL . 55.9 m -117.06 116.88 28.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.579 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.34 108.65 20.15 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.172 0.511 . . . . 0.0 111.084 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.538 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.4 mt -126.63 116.08 20.47 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.606 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.742 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.81 125.98 41.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.933 173.244 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 25.7 m-85 -108.73 154.28 22.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.381 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -139.99 111.6 7.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.536 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.646 ' ND2' ' HA ' ' A' ' 18' ' ' ASP . 17.9 m120 57.32 31.75 20.64 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.652 0.595 . . . . 0.0 111.508 -176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.36 11.19 51.77 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.51 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -106.01 0.3 25.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.764 0.792 . . . . 0.0 109.097 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 72.05 175.51 0.28 Allowed 'General case' 0 CA--C 1.524 -0.049 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.246 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.76 HG11 HD21 ' A' ' 20' ' ' LEU . 1.1 p -148.61 -30.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.006 0.431 . . . . 0.0 109.917 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . . . -161.61 164.54 29.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.645 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.1 tttt -146.4 118.37 8.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.167 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.17 131.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.17 76.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.204 0.526 . . . . 0.0 111.376 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.47 -167.51 35.71 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.226 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.99 96.99 3.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 110.094 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.1 p-10 -122.27 67.17 25.77 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.1 -34.63 27.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.173 1.248 . . . . 0.0 110.944 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.21 -43.26 11.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.143 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.4 -17.75 60.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.624 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.684 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.8 tp -58.85 -37.57 67.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 170.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.592 ' HA ' HG22 ' A' ' 99' ' ' ILE . 21.4 tptm -60.65 -32.76 71.92 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.049 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -56.17 -55.83 28.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 173.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.74 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -73.53 -36.04 65.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.542 0.687 . . . . 0.0 111.106 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -71.71 -45.11 67.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.645 -171.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.498 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -89.1 -40.81 12.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.917 0.389 . . . . 0.0 111.706 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.93 83.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.295 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 85' ' ' ALA . 18.9 m120 -93.25 -56.88 2.79 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.629 -172.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.811 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.165 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.651 HG11 ' HG2' ' A' ' 54' ' ' LYS . 35.9 t -103.34 128.38 56.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.041 0.448 . . . . 0.0 110.34 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 146.6 51.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.889 0.852 . . . . 0.0 112.397 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -103.38 141.52 35.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.804 -1.543 . . . . 0.0 109.463 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.729 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.7 m-85 -94.5 158.03 15.73 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -119.86 -15.08 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.704 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 37.2 p -135.07 151.5 50.82 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.41 -29.76 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.6 t -59.88 -46.89 87.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.063 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.2 mm-40 -60.38 -42.94 96.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.414 0.626 . . . . 0.0 110.143 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 19.7 t80 -67.58 -47.28 70.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.087 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' HA ' HG12 ' A' ' 15' ' ' ILE . 25.3 t70 -60.96 -42.85 99.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.597 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 22.6 t -67.16 -39.33 86.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.713 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -65.49 -50.84 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.981 0.419 . . . . 0.0 110.722 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 11' ' ' PHE . 35.5 pt -67.41 -18.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.632 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.62 -14.12 52.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 13' ' ' SER . 54.7 mt-30 -69.16 150.19 47.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 39.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.482 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 10.5 ptmt -136.75 167.38 21.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.588 HD21 HG11 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -77.6 108.01 10.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.475 HG12 HG23 ' A' ' 23' ' ' VAL . 53.0 t -110.02 107.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.209 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.693 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.93 103.12 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 122.062 0.934 . . . . 0.0 110.84 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 70.8 t -102.35 143.18 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.866 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -127.9 117.53 21.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -70.51 129.1 38.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.525 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.581 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 7.6 m-30 -118.5 -177.45 3.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . . . -152.23 130.21 11.8 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -58.26 -24.74 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.716 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -96.75 8.99 43.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.797 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.942 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -107.07 138.29 43.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.307 0.575 . . . . 0.0 111.786 -177.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -81.72 -37.65 16.11 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.904 -1.044 . . . . 0.0 114.546 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.942 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.1 Cg_exo -66.25 -29.33 46.92 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 120.359 2.08 . . . . 0.0 110.378 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 58.5 m -51.12 -39.62 56.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.732 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.931 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 13.5 mptt -67.79 -57.37 6.43 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.801 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 23.4 ptp -54.19 -50.22 67.57 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.692 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.41 -21.19 16.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.931 -177.297 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.96 -60.06 10.7 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.01 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.931 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 9.3 Cg_endo -56.37 -36.22 96.96 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 121.268 1.312 . . . . 0.0 112.792 169.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.597 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 26.1 mmt -62.75 -51.58 66.56 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.371 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.594 ' CG2' HG21 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -52.51 -32.73 17.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 122.672 0.389 . . . . 0.0 111.509 176.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 44.8 mt-10 -59.64 -48.57 81.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.351 0.596 . . . . 0.0 110.479 173.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 18.5 tptm -61.22 -47.62 85.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.685 0.755 . . . . 0.0 109.874 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.664 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 34.0 m-85 -67.42 -20.55 65.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.78 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 84.9 p -77.09 -15.96 59.39 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 108.85 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 37.1 tt0 -80.38 -20.7 43.46 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.537 171.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.664 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 7.3 mm100 -83.46 -7.05 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.984 175.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.715 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 7.5 p90 -134.68 85.44 36.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.36 0.6 . . . . 0.0 112.46 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.56 -21.9 4.05 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.218 2.612 . . . . 0.0 112.423 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.72 -1.0 50.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.438 0.637 . . . . 0.0 110.527 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -119.12 165.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -108.84 117.59 34.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.297 0.57 . . . . 0.0 111.997 -175.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 1.6 p90 -83.55 121.48 27.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.048 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 31.5 m-85 -136.74 142.59 43.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.335 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.866 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 10.9 mmtt -126.91 124.13 38.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.729 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.8 mt -100.67 -178.24 3.72 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.169 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 11.5 t0 -133.89 131.32 38.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.34 -8.7 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.316 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -31.62 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 109.971 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.61 -27.05 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.046 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.595 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.87 52.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.0 -39.81 22.81 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.487 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -44.0 73.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.775 0.322 . . . . 0.0 110.694 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.595 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -65.39 -38.82 83.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.048 0.451 . . . . 0.0 110.394 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.36 69.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.6 mt-30 -72.89 -36.83 67.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.962 0.411 . . . . 0.0 110.245 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -91.66 10.17 29.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.82 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 56.47 44.15 24.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.423 HG13 ' OG1' ' A' ' 74' ' ' THR . 74.2 t -73.7 109.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.489 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -117.54 -25.92 6.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.541 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.78 117.57 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.036 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -100.63 150.41 36.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 14.1 Cg_exo -71.21 171.47 59.51 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 123.872 -1.303 . . . . 0.0 111.834 -6.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 19.9 m -131.07 115.52 16.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.596 HD13 HD13 ' A' ' 95' ' ' ILE . 3.8 mt -105.7 108.67 20.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.503 0.668 . . . . 0.0 111.115 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.602 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 25.5 mt -123.23 114.4 20.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.014 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.693 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -93.75 125.02 38.13 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.168 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 m-85 -107.37 155.64 19.79 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.431 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -141.04 131.94 25.99 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 36.02 44.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 19.02 60.0 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.579 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 14.7 tttp -126.39 0.92 6.99 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.338 0.59 . . . . 0.0 110.215 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 39.2 mt-10 73.14 -179.1 0.2 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.951 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.588 HG11 HD21 ' A' ' 20' ' ' LEU . 1.3 p -153.31 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.754 174.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.599 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . . . -157.71 163.0 38.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.119 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 77.0 tttt -144.26 116.69 8.55 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.944 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 t -123.89 133.88 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.13 78.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.283 0.563 . . . . 0.0 110.927 -170.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.59 -175.67 39.78 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 96.48 1.87 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 19.1 p-10 -119.41 78.8 20.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 3.4 Cg_exo -74.91 -29.94 7.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.469 1.446 . . . . 0.0 110.319 167.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -90.25 -51.03 5.64 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.618 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -67.68 -16.59 64.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.518 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -55.74 -37.59 47.49 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.726 ' HA ' HG22 ' A' ' 99' ' ' ILE . 11.7 mmmm -58.39 -34.52 70.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.023 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -54.01 -58.66 6.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.37 55.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.784 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -80.49 -40.02 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.471 -172.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.19 17.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.666 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.19 70.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 85' ' ' ALA . 20.3 m120 -101.14 -68.92 0.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.273 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.727 0.298 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.419 HG11 ' HE3' ' A' ' 54' ' ' LYS . 39.4 t -121.46 109.6 25.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.961 0.41 . . . . 0.0 110.365 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -70.18 149.24 47.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.065 -176.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 3.2 pp0? -109.14 134.08 52.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.492 175.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.674 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.3 m-85 -86.75 164.4 16.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.164 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -123.22 -13.72 7.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.709 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 71.2 p -137.32 155.35 49.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.724 0.297 . . . . 0.0 111.017 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.553 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.85 -31.22 69.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 t -61.23 -42.09 98.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.7 mm-40 -59.0 -43.93 91.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.32 0.581 . . . . 0.0 109.992 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 15' ' ' ILE . 1.4 t80 -63.65 -49.18 74.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.843 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.1 -44.44 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.925 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 34.5 t -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.974 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -49.74 42.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.906 0.384 . . . . 0.0 110.666 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 29.3 pt -66.99 -21.71 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.548 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.67 -8.62 59.33 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.884 0.374 . . . . 0.0 111.371 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 13' ' ' SER . 27.6 mt-30 -75.63 158.99 31.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.733 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.04 36.24 0.34 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.42 0.628 . . . . 0.0 110.347 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' GLN . 29.1 mmmt -126.71 160.27 31.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.651 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.74 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.7 tm? -77.57 105.56 8.8 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 53.3 t -110.23 107.12 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.024 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.744 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.73 108.99 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.684 0.754 . . . . 0.0 110.818 175.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 85.1 t -103.53 142.72 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.117 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.711 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -126.72 113.68 16.98 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.81 106.48 7.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.063 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.708 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.2 m-85 -133.28 175.82 9.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 112.143 -171.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.07 163.56 39.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.49 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -85.49 -8.64 58.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -108.02 27.65 9.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -129.26 128.11 42.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.441 0.639 . . . . 0.0 111.306 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.14 97.49 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 114.713 -1.131 . . . . 0.0 114.107 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.572 ' O ' HG22 ' A' ' 36' ' ' ILE . 38.7 Cg_exo -58.15 -39.41 85.46 Favored 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 119.714 1.757 . . . . 0.0 110.674 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 39.0 m -58.57 -34.08 70.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.2 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 29.1 mtpp -63.87 -55.65 21.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.423 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 26.0 ptt? -61.03 -44.56 97.22 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.708 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.23 -24.15 18.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.796 -178.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -53.85 -51.36 77.46 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.619 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 35.6 Cg_endo -68.12 -32.46 27.5 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 120.215 1.113 . . . . 0.0 112.603 169.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.422 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.6 mmt -64.66 -57.59 8.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.597 HD12 ' CG1' ' A' ' 36' ' ' ILE . 36.5 mt -66.46 -23.12 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.45 0.568 . . . . 0.0 111.39 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.94 -47.29 85.61 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.53 0.681 . . . . 0.0 109.46 168.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -63.41 -48.53 77.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.145 0.498 . . . . 0.0 110.516 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.642 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 11.7 m-30 -65.6 -15.56 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.975 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 p -87.21 -14.9 39.8 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 121.555 0.693 . . . . 0.0 109.274 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.27 -23.2 40.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 168.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.642 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -120.87 34.08 5.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -104.59 85.11 1.07 Allowed Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 122.016 0.912 . . . . 0.0 112.298 172.568 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 24.3 Cg_exo -64.02 -45.68 9.82 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.005 1.803 . . . . 0.0 113.916 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -107.81 24.65 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 103' ' ' ALA . . . -128.98 156.38 43.88 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.798 -0.564 . . . . 0.0 111.914 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.76 120.26 40.2 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.24 169.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.613 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -103.35 116.74 33.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.5 -171.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CD2' HG13 ' A' ' 21' ' ' VAL . 23.2 m-85 -129.17 136.26 49.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.711 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -121.18 119.06 31.25 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.675 HD13 ' HG ' ' A' ' 60' ' ' LEU . 5.2 mt -100.96 160.55 14.28 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.776 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.48 114.56 26.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -11.25 9.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.44 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.02 -51.09 27.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.548 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -86.96 -25.68 24.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.438 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.675 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.6 mm? -99.99 45.06 0.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 111.316 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.05 -37.03 30.07 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.848 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.1 -42.41 94.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.695 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 8' ' ' ALA . 3.1 p -67.19 -39.09 82.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.81 76.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.72 -33.08 72.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.204 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -27.73 64.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.667 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -95.18 10.83 34.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.88 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 60.09 41.33 17.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.791 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.5 t -99.95 110.53 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.571 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 p -110.73 -19.22 12.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.85 0.357 . . . . 0.0 110.727 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.15 168.39 10.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.13 148.53 35.47 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.66 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 18.8 Cg_exo -70.77 173.35 48.61 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.839 -0.901 . . . . 0.0 112.581 -6.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 87.6 m -147.23 117.32 7.28 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.839 0.352 . . . . 0.0 110.496 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.463 ' HG ' HD13 ' A' ' 95' ' ' ILE . 4.0 mm? -110.76 111.23 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.326 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.413 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 35.8 mt -125.87 115.39 19.9 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -96.86 128.82 44.19 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.018 174.344 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 29.0 m-85 -110.72 155.53 22.34 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.131 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.641 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.3 tttt -142.28 116.83 9.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.829 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.641 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.52 38.4 7.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.787 0.835 . . . . 0.0 111.847 -177.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.15 8.63 55.06 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.34 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -109.39 4.05 22.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 109.997 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 24.2 tt0 67.92 174.6 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.025 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.4 p -144.31 -32.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.933 0.396 . . . . 0.0 110.117 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.411 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -157.93 161.33 38.2 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.979 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.413 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 1.7 ttmp? -139.72 117.48 11.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.245 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.08 125.71 73.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.05 87.0 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 111.296 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 -173.63 33.63 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.027 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 73' ' ' PRO . . . -71.91 103.62 3.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.5 p-10 -127.22 65.65 65.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 10.1 Cg_exo -69.21 -34.07 17.23 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 120.867 1.045 . . . . 0.0 110.871 174.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.53 -45.34 9.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -70.92 -17.24 62.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.58 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.652 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.7 tp -56.96 -38.45 59.77 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HA ' HG22 ' A' ' 99' ' ' ILE . 30.5 mmtt -59.58 -35.37 74.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.761 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 23.0 tm0? -54.14 -54.01 45.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -76.7 -39.77 50.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.629 0.728 . . . . 0.0 111.3 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -69.57 -41.0 80.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.678 -171.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 -38.57 14.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.635 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.11 -31.13 55.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 45.5 m-80 -95.65 -60.07 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.33 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.74 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.245 0.867 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.463 170.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.94 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -107.2 146.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.597 0.713 . . . . 0.0 112.025 -172.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.54 148.44 27.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.204 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -105.3 133.33 50.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.061 170.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.634 ' H ' HD22 ' A' ' 55' ' ' LEU . 15.3 m-85 -84.38 164.32 19.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -117.79 -16.91 9.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.444 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 40.1 p -134.89 153.64 51.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.42 -33.71 68.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -64.29 -32.09 73.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.474 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.625 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 23.4 mm-40 -67.42 -44.09 79.62 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.093 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -44.38 94.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.633 176.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.33 -44.42 88.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.447 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -71.14 -25.7 62.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.788 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' HG11 ' A' ' 21' ' ' VAL . . . -77.14 -50.02 13.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.684 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 pt -66.53 -17.83 23.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.286 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.05 59.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.893 0.377 . . . . 0.0 111.586 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.463 ' C ' ' H ' ' A' ' 19' ' ' LYS . 28.4 mt-30 -71.55 150.77 44.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.343 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.68 28.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.41 0.624 . . . . 0.0 110.975 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 17' ' ' GLN . 15.0 ptmt -135.94 174.65 10.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.46 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.552 ' CD1' HG11 ' A' ' 84' ' ' VAL . 8.0 tt -85.62 134.64 33.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.413 0.625 . . . . 0.0 111.199 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.438 HG11 ' HB1' ' A' ' 14' ' ' ALA . 55.9 t -134.98 109.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.963 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.63 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -103.17 107.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.147 0.975 . . . . 0.0 111.164 177.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 99.2 t -100.19 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.499 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -127.6 122.58 33.52 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CD2' HG21 ' A' ' 69' ' ' VAL . 95.8 m-85 -73.83 124.79 26.77 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.335 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.4 m-30 -118.66 179.25 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.29 144.54 27.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -3.81 28.15 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.05 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -122.16 13.32 10.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 3.7 p -109.43 156.06 20.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.571 0.7 . . . . 0.0 112.617 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.53 -52.36 3.57 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.639 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 72.0 Cg_exo -53.96 -48.44 21.68 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.249 1.966 . . . . 0.0 112.621 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 7.8 p -51.17 -35.51 36.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.188 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.9 tptm -65.2 -53.1 49.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.161 0.288 . . . . 0.0 110.532 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 39' ' ' MET . 26.5 ptt? -66.66 -43.34 84.83 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.49 -18.19 16.75 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.09 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.77 -53.22 67.13 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.825 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 34.2 Cg_endo -67.13 -28.2 41.09 Favored 'Trans proline' 0 C--N 1.359 1.107 0 CA-C-N 120.567 1.238 . . . . 0.0 112.428 170.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.541 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.9 mmm -65.91 -56.32 12.35 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.183 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.495 ' CG2' HG11 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -52.86 -31.09 16.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 122.495 0.318 . . . . 0.0 110.74 176.186 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -61.33 -50.77 71.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.305 0.574 . . . . 0.0 109.599 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 1.4 tmtp? -61.53 -44.49 96.97 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.611 0.719 . . . . 0.0 109.781 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.666 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 76.5 m-85 -66.06 -23.23 66.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.624 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.66 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 83.5 p -74.1 -19.03 60.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -78.16 -23.64 47.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.666 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 5.3 mm100 -87.69 5.54 39.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.338 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 0.6 OUTLIER -99.46 102.14 15.48 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.012 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.4 Cg_exo -76.5 -45.93 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.686 1.591 . . . . 0.0 112.692 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.97 1.25 15.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -113.55 153.28 29.03 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.02 129.26 46.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.2 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.4 OUTLIER -105.06 121.45 43.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.677 -175.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.763 ' HA ' HG23 ' A' ' 2' ' ' VAL . 30.1 m-85 -135.5 144.64 46.45 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.519 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.96 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 11.9 mmtt -128.87 122.51 30.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD13 ' HG ' ' A' ' 60' ' ' LEU . 6.4 mt -98.48 170.75 8.61 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.136 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.08 120.5 34.48 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.41 -8.52 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.16 -28.65 61.41 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.762 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG2' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -110.42 -35.65 5.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 169.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.655 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.7 mm? -87.28 52.21 2.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.851 0.358 . . . . 0.0 111.006 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.48 -37.5 30.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.152 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.648 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 13.6 p-10 -66.99 -43.99 81.57 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.046 -0.09 . . . . 0.0 110.766 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.6 p -66.44 -34.85 72.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 110.614 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.7 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.622 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 33.7 mm-40 -77.47 -30.08 52.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.907 0.384 . . . . 0.0 110.422 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 74.5 mmtt -57.32 -47.95 80.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.289 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -94.26 15.85 16.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.328 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 48.89 52.88 13.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.818 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 25' ' ' PHE . 97.7 t -81.42 113.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.731 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.7 p -118.55 1.07 11.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.9 154.21 45.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.776 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.94 128.86 20.87 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.773 178.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 84.9 Cg_endo -82.3 171.7 53.63 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.932 -5.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 68.2 m -124.74 116.69 22.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.716 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.78 111.66 24.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.185 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.9 mt -127.49 113.52 16.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.47 127.57 38.01 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.554 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 m-85 -112.59 157.45 21.17 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.122 -176.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.6 tttt -143.26 118.68 10.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.021 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.542 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.51 44.77 2.63 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.825 0.85 . . . . 0.0 112.509 -178.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.41 10.09 52.16 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.148 -0.478 . . . . 0.0 113.512 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -109.3 0.06 19.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.033 0.444 . . . . 0.0 110.288 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 28.1 tt0 66.83 179.75 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.554 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.561 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -152.83 -33.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.746 0.308 . . . . 0.0 110.705 173.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.4 164.49 32.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.79 0.329 . . . . 0.0 111.023 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.3 tttt -145.92 123.81 12.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.568 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.31 133.45 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.76 78.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.196 0.522 . . . . 0.0 111.344 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.83 -172.3 37.11 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.684 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -73.04 97.02 2.25 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.3 p-10 -121.77 66.14 19.94 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.485 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 15.3 Cg_exo -66.03 -37.18 27.0 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.092 1.195 . . . . 0.0 110.946 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 96' ' ' LYS . . . -88.92 -41.68 12.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.235 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.03 -17.09 61.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.459 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.711 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.7 tp -56.25 -38.14 53.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.616 ' HD3' HG22 ' A' ' 99' ' ' ILE . 17.5 tppt? -61.5 -31.39 71.38 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.187 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 20.1 tm0? -56.54 -55.61 31.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 174.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.65 -32.67 62.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.419 0.628 . . . . 0.0 110.751 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.76 -43.17 70.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.613 -172.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.59 -39.22 16.36 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.801 0.334 . . . . 0.0 110.802 -175.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.47 77.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.966 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 42.0 m-80 -104.12 -66.39 0.96 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.554 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.607 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.649 -0.691 . . . . 0.0 111.271 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.706 0.288 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.515 HG21 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -101.92 136.11 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.132 0.491 . . . . 0.0 110.05 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.56 147.43 33.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.976 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -107.14 122.54 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.214 171.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.633 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 13.4 m-85 -76.4 152.67 36.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.215 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.62 -19.55 15.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.364 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 81.2 p -135.39 156.61 48.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.241 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -59.07 -31.88 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -62.91 -38.67 91.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.99 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.0 mm-40 -60.37 -51.98 67.19 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.355 0.598 . . . . 0.0 110.193 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 2.1 t80 -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.727 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.97 -45.43 78.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.455 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 37.4 t -67.84 -42.1 81.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -61.39 -49.93 74.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.556 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 42.0 pt -67.27 -20.86 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.502 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.25 -2.56 58.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.733 0.302 . . . . 0.0 111.672 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 13' ' ' SER . 99.1 mt-30 -81.86 162.68 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.088 0.471 . . . . 0.0 111.08 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.1 26.04 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.687 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 9.0 ptmt -132.14 165.24 24.52 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.78 HD21 HG11 ' A' ' 84' ' ' VAL . 2.7 tm? -76.57 117.28 18.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG12 HG23 ' A' ' 23' ' ' VAL . 59.7 t -114.25 107.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.723 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.13 106.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.527 0.68 . . . . 0.0 110.343 175.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.637 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 34.5 t -108.4 143.36 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.551 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.915 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -122.32 120.83 35.21 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.338 0.59 . . . . 0.0 112.515 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CE2' HD12 ' A' ' 55' ' ' LEU . 95.4 m-85 -69.89 118.98 13.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.366 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.495 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -127.34 176.48 7.4 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.95 -164.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.29 146.87 14.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.165 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 p -84.48 -4.46 58.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -116.35 51.63 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -151.7 171.07 18.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.92 -54.16 2.83 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.632 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' A' ' 35' ' ' MET . 74.9 Cg_exo -53.11 -35.0 70.98 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.321 2.014 . . . . 0.0 112.406 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 p -65.6 -32.23 73.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.948 0.404 . . . . 0.0 111.027 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -68.39 -34.46 76.07 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.205 -0.309 . . . . 0.0 110.927 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -80.7 -49.78 10.76 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -76.75 -22.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.181 -0.949 . . . . 0.0 111.352 -175.106 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.77 -49.09 95.69 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.411 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 35' ' ' MET . 32.8 Cg_exo -63.47 -37.42 48.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.34 1.36 . . . . 0.0 111.806 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mmm -65.61 -61.6 1.99 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 36' ' ' ILE . 57.7 mt -66.33 -19.1 25.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 118.58 0.627 . . . . 0.0 111.377 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.2 tt0 -60.84 -46.06 92.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.697 0.76 . . . . 0.0 109.471 167.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 23.1 ttmt -66.12 -42.09 89.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.601 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.596 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.1 m-30 -71.65 -17.42 62.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.312 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.823 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 96.9 p -77.67 -16.89 58.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -83.86 -19.05 35.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.405 168.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.609 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 10.0 mm100 -95.18 -1.08 52.53 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.59 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 9.0 m-30 -100.51 101.48 15.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.263 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.9 Cg_exo -80.61 -43.98 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.659 2.239 . . . . 0.0 112.438 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -107.84 7.23 28.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.882 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -123.81 143.41 50.34 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.47 46.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.949 0.88 . . . . 0.0 111.014 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.823 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.6 OUTLIER -106.7 119.15 38.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.535 -169.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.504 ' HB2' HG22 ' A' ' 23' ' ' VAL . 29.0 m-85 -135.77 155.11 50.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.915 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -132.19 130.07 40.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.637 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 76.8 mt -95.34 128.42 42.17 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.128 -0.358 . . . . 0.0 111.128 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -70.91 97.53 1.44 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 168.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -56.52 -19.7 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.53 -35.86 72.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.091 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HG3' HD22 ' A' ' 60' ' ' LEU . 9.3 pt-20 -110.05 -38.59 5.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.462 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.606 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mm? -78.19 50.74 0.93 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.98 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.33 -42.05 24.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.7 p-10 -62.76 -46.71 86.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.315 0.103 . . . . 0.0 110.936 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.606 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -63.17 -38.56 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 110.254 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.91 70.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 22.1 mm-40 -75.95 -40.06 54.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.153 0.501 . . . . 0.0 109.748 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.657 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 58.4 mttm -59.34 -40.69 87.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.626 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -89.89 6.17 43.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.544 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 57.72 52.06 8.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.516 HG13 ' OG1' ' A' ' 74' ' ' THR . 57.1 t -75.52 116.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.856 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -113.93 -62.41 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.875 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.17 116.55 29.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.999 0.428 . . . . 0.0 110.568 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.68 145.95 30.79 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.464 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.06 162.03 92.58 Favored 'Cis proline' 0 C--O 1.235 0.359 0 C-N-CA 123.106 -1.623 . . . . 0.0 112.513 -5.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.516 ' OG1' HG13 ' A' ' 69' ' ' VAL . 52.5 m -118.45 117.24 28.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -102.2 108.62 20.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 31.3 mt -122.12 113.13 19.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.587 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -99.2 128.34 45.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.055 177.015 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 34.4 m-85 -112.09 153.71 26.51 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.3 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.454 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 24.1 tptm -135.97 115.0 12.27 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.389 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 2.6 p-10 44.15 38.24 2.25 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.134 0.974 . . . . 0.0 112.731 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.69 7.05 73.61 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.292 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -105.2 -7.12 19.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 77.77 173.29 0.19 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.673 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.78 HG11 HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -147.28 -29.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.699 0.285 . . . . 0.0 110.789 173.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.501 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . . . -161.69 162.68 29.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.21 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 1.8 tmtp? -142.82 108.99 5.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.33 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.5 t -119.56 143.43 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.17 86.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.761 0.791 . . . . 0.0 111.478 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 50.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.144 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.25 84.83 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.004 0.43 . . . . 0.0 111.005 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.3 p-10 -121.1 83.64 38.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 6.0 Cg_exo -75.14 -38.96 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.58 1.52 . . . . 0.0 111.03 168.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.31 -39.93 13.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.428 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -73.05 -17.29 61.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.078 0.466 . . . . 0.0 111.238 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.675 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -57.81 -36.72 56.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 99' ' ' ILE . 31.5 mmmt -56.34 -40.11 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.831 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.627 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 4.0 tp60 -46.48 -60.22 2.49 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 123.346 0.403 . . . . 0.0 110.349 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -77.37 -29.24 53.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.475 0.655 . . . . 0.0 111.436 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -80.01 -41.37 21.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.956 -170.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.97 -35.65 18.74 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.796 -176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.35 -39.18 78.29 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 85' ' ' ALA . 22.4 m120 -96.16 -60.31 1.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 50' ' ' ALA . . . . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.546 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.621 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 26.3 ptt? . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.948 0.404 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.609 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -97.91 145.14 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 -179.073 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.52 149.83 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.064 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -99.65 133.25 44.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.691 170.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.683 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.9 m-85 -86.98 164.35 16.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.16 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -117.2 -23.32 7.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.919 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.666 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 39.9 p -132.4 157.4 44.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 112.035 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.68 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -61.43 -35.6 78.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.771 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.0 mm-40 -61.3 -49.65 76.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.311 0.577 . . . . 0.0 110.345 177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -47.9 80.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.498 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.37 -44.42 95.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -67.61 -36.65 81.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.987 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.34 -49.26 61.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 pt -66.36 -20.74 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.94 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HA ' ' N ' ' A' ' 81' ' ' GLY . . . -80.84 -8.83 59.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -72.19 150.38 43.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.43 53.57 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.692 0.758 . . . . 0.0 110.221 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 10.0 ptmt -153.08 173.75 15.07 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.332 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.555 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -75.5 111.28 10.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.1 t -122.62 107.67 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.868 0.366 . . . . 0.0 110.442 169.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.13 115.36 47.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.56 0.695 . . . . 0.0 111.271 175.024 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.606 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 84.3 t -103.26 140.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.964 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.845 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.09 138.33 54.45 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 69' ' ' VAL . 71.5 m-85 -90.2 128.04 36.27 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.436 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.618 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 3.0 m-85 -120.68 -171.72 2.24 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.555 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.02 169.7 16.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.524 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.76 -30.34 69.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.591 0.71 . . . . 0.0 110.309 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -91.37 -138.84 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.5 p 56.3 110.41 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.73 1.212 . . . . 0.0 113.942 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.49 98.68 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.266 -1.334 . . . . 0.0 114.176 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.671 ' O ' HG23 ' A' ' 36' ' ' ILE . 31.5 Cg_exo -60.14 -41.76 49.06 Favored 'Trans proline' 0 C--N 1.36 1.139 0 CA-C-N 120.221 2.011 . . . . 0.0 111.663 -178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 29.3 m -51.37 -43.21 61.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.466 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.661 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.3 mmtt -62.87 -55.54 25.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -63.87 -48.0 78.42 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -75.51 -11.59 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.897 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.21 -57.49 25.73 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.292 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 28.1 Cg_endo -64.91 -34.01 50.09 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 120.025 1.044 . . . . 0.0 111.958 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.491 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.8 mtt -64.7 -60.94 2.53 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.892 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.647 HG21 ' HD3' ' A' ' 54' ' ' LYS . 17.4 mt -58.56 -25.47 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 118.228 0.467 . . . . 0.0 112.109 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.621 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 8.3 tp10 -61.31 -41.01 96.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 172.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.96 -46.04 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.826 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.684 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 66.0 m-85 -65.09 -24.38 67.43 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.267 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.625 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 33.9 t -85.57 -14.45 45.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.857 0.837 . . . . 0.0 109.232 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -84.27 -19.84 33.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.684 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 18.1 pt20 -104.66 26.01 9.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.869 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.579 ' HD1' ' O ' ' A' ' 43' ' ' PHE . 2.4 m-85 -97.97 89.95 0.85 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.44 166.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.22 -46.17 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.91 1.74 . . . . 0.0 112.714 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -11.45 14.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 149.27 24.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.98 126.87 50.33 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.637 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.629 ' CE2' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -110.15 125.5 53.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.54 -177.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 27.5 m-85 -130.96 143.4 50.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.845 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 31.6 mtmt -133.02 119.9 20.66 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.7 mt -97.54 163.9 12.66 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.729 -173.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -102.67 111.74 24.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.208 0.528 . . . . 0.0 109.788 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -66.58 -15.4 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.481 -171.63 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 56' ' ' ASP . 5.9 p-10 -70.34 -26.62 63.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -106.89 -39.28 5.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.356 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.0 mm? -88.09 41.65 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.366 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -70.2 -35.29 70.18 Favored Glycine 0 CA--C 1.504 -0.616 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.45 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 29.7 m-20 -63.36 -40.61 97.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 109.951 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 60' ' ' LEU . 86.0 t -63.2 -42.42 96.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.246 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.28 83.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.126 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 96.6 mt-30 -71.72 -33.06 68.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.526 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 69.0 mttm -57.17 -40.9 78.25 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.438 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -96.44 10.34 38.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.101 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 55.91 40.7 30.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.625 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 25' ' ' PHE . 49.2 t -83.0 127.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.347 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.4 t -134.14 -26.67 1.47 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.283 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.86 114.94 29.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 0.0 110.04 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 147.09 32.94 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.002 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.6 Cg_endo -84.23 161.98 68.23 Favored 'Cis proline' 0 N--CA 1.461 -0.424 0 C-N-CA 124.17 -1.179 . . . . 0.0 111.497 -8.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 m -119.64 121.32 39.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.664 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -107.83 109.93 21.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.607 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.614 HD22 ' HG2' ' A' ' 86' ' ' LYS . 7.6 mt -125.31 114.86 19.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -90.8 122.52 33.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.99 174.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.3 m-85 -106.31 162.19 13.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.36 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 24.7 ttmm -150.51 133.45 16.02 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.346 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 82' ' ' LYS . 1.8 p-10 48.02 29.79 1.85 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.056 0.942 . . . . 0.0 112.618 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.532 ' N ' ' HA ' ' A' ' 16' ' ' ALA . . . 74.69 9.38 82.61 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.855 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 13.4 tttp -107.25 -65.41 1.1 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 18.0 tt0 161.42 -178.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 123.976 0.798 . . . . 0.0 109.064 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 77' ' ' LEU . 2.2 p -154.53 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.532 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.45 165.1 31.64 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.906 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.614 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.7 tmtp? -142.7 119.52 11.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.257 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 t -131.55 144.1 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.74 91.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.888 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.8 53.59 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.643 172.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.492 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.31 86.76 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 111.303 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.2 p-10 -122.39 85.34 47.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.496 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.7 Cg_exo -77.34 -39.46 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.218 1.279 . . . . 0.0 110.308 166.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.47 -36.11 16.65 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.276 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.39 -17.33 60.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.136 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.8 tp -58.06 -37.95 64.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 170.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 19.4 mmtp -55.41 -37.37 67.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.914 0.758 . . . . 0.0 110.647 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.3 tm0? -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 176.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -77.16 -24.81 51.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.304 0.573 . . . . 0.0 111.352 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.731 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -78.01 -42.81 28.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.916 -173.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.45 -32.39 22.32 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.703 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.44 -41.62 93.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.274 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 41.2 m-80 -110.86 -90.39 0.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.859 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.547 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.713 -168.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.695 0.283 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -121.14 131.65 72.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.16 0.505 . . . . 0.0 110.913 178.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -81.83 147.92 29.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.918 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -103.67 130.17 51.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.953 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.699 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.0 m-85 -84.52 159.72 20.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -117.07 -19.06 9.9 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.57 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 25.7 p -135.01 153.65 52.01 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.779 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.96 -33.69 70.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 m -59.07 -36.34 74.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.106 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 39.4 mm-40 -65.99 -47.73 73.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.492 0.663 . . . . 0.0 110.062 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HD1' HG21 ' A' ' 23' ' ' VAL . 1.6 t80 -62.15 -44.14 97.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.079 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -55.33 -49.53 71.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.893 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -67.46 -37.58 83.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.205 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.95 58.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.04 -19.99 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.227 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 -13.8 59.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.975 0.417 . . . . 0.0 110.945 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -75.57 145.08 41.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.04 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.43 47.45 0.93 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.453 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 6.8 ptmt -138.96 168.35 20.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.064 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.552 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -74.92 105.84 6.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.214 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.469 HG13 ' CD2' ' A' ' 53' ' ' TYR . 53.5 t -114.58 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 173.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.747 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.86 109.41 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.642 0.734 . . . . 0.0 110.74 175.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 66.2 t -103.17 135.19 41.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.052 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -121.63 111.44 17.21 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 121.072 0.463 . . . . 0.0 112.093 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 69' ' ' VAL . 96.3 m-85 -69.05 112.56 5.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.227 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.03 177.44 5.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.11 147.45 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.454 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 p -84.62 -4.72 59.14 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -117.24 53.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.63 173.08 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.77 2.56 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.238 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 36' ' ' ILE . 75.5 Cg_exo -51.56 -40.86 63.06 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.461 2.108 . . . . 0.0 112.142 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 8.5 p -66.04 -29.7 70.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.231 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -68.64 -35.91 77.9 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.943 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.546 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptm -80.84 -46.93 14.54 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.691 HD11 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.93 -22.8 16.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.924 -175.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.503 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -58.46 -46.73 99.6 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.352 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 35' ' ' MET . 45.6 Cg_exo -59.96 -40.59 60.65 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.692 1.594 . . . . 0.0 112.395 167.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -65.02 -53.75 41.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -58.86 -35.71 57.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.223 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 9.5 tp10 -54.48 -47.45 72.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.503 0.668 . . . . 0.0 109.883 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -62.54 -48.89 77.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.631 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 12.1 m-30 -67.08 -17.27 64.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.452 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 29.0 p -87.25 -11.87 48.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.63 -24.18 29.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 168.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -119.36 36.38 4.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.722 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.475 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -99.55 90.66 1.27 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 122.039 0.924 . . . . 0.0 111.746 171.204 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 18.0 Cg_exo -65.35 -46.39 5.75 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.051 1.834 . . . . 0.0 113.359 -170.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -111.35 -7.7 14.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.91 163.18 12.36 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 111.656 -167.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.6 126.27 51.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.245 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 3.4 m-30 -99.57 121.69 41.55 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.689 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 29.9 m-85 -129.08 134.94 48.3 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.703 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 10.7 ttpp -127.45 117.43 22.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.699 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.9 mt -96.13 156.99 16.1 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -165.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -91.25 99.15 12.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -18.65 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.271 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.76 -37.49 84.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.083 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.96 -38.49 10.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.036 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.09 49.55 1.65 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.643 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.35 34.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.659 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 12.5 p-10 -66.02 -40.73 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.523 0.202 . . . . 0.0 111.118 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -72.98 -35.08 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.47 -36.99 74.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.125 0.488 . . . . 0.0 110.308 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 14.9 mm-40 -73.4 -29.8 62.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.416 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 30.0 mtpp -61.91 -40.95 97.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -95.77 12.94 28.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.397 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 59.79 40.56 19.4 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.096 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 25' ' ' PHE . 75.0 t -76.95 110.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.857 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 p -113.57 -1.64 14.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.37 143.05 43.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.473 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.33 128.0 26.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 89.1 Cg_endo -84.1 170.57 50.34 Favored 'Cis proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.514 -5.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.7 m -121.89 122.75 40.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.946 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.476 ' HB3' HD13 ' A' ' 95' ' ' ILE . 3.9 mm? -107.65 110.47 22.35 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.71 HD22 ' HG2' ' A' ' 86' ' ' LYS . 36.7 mt -126.81 119.37 26.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.356 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.747 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.881 173.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 26.1 m-85 -108.86 158.97 17.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.603 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.445 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 36.3 ttmt -143.44 116.03 8.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.338 173.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.445 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 1.8 p-10 47.6 31.48 2.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.399 1.079 . . . . 0.0 112.816 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 10.07 79.0 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.851 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 12.4 tptm -106.22 -2.61 22.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.989 0.899 . . . . 0.0 108.629 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 40.7 mt-10 71.75 -178.47 0.21 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.888 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.3 p -152.06 -29.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.976 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.78 161.29 36.96 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.632 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.71 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.4 tmtp? -143.24 115.84 8.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.971 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t -132.21 143.51 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 109.935 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.65 90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.686 0.755 . . . . 0.0 111.305 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.38 54.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.005 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 56.03 86.68 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.51 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.577 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 16.6 p-10 -125.13 89.41 52.66 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.446 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.2 Cg_endo -82.55 -29.68 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.965 1.777 . . . . 0.0 110.217 165.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 -49.07 6.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -72.61 -18.4 61.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.442 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.66 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -61.33 -37.67 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.739 ' HA ' HG22 ' A' ' 99' ' ' ILE . 24.3 tptp -60.94 -30.57 70.3 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.132 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -60.13 -53.24 60.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.952 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.596 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.11 -33.98 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.587 0.708 . . . . 0.0 111.422 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -74.62 -37.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.414 -171.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.62 -44.42 11.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.054 0.454 . . . . 0.0 110.831 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.8 80.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.72 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.2 -61.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.791 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.369 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.621 HG21 ' HE3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -80.5 132.28 32.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.4 0.619 . . . . 0.0 110.417 -178.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.4 148.13 43.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.818 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.501 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -114.39 114.26 25.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.146 174.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.574 ' H ' HD22 ' A' ' 55' ' ' LEU . 20.0 m-85 -67.68 163.74 20.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.036 0.446 . . . . 0.0 110.076 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -130.23 -13.09 3.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.259 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.719 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 70.6 p -135.48 152.68 51.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.56 -27.22 68.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.615 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 p -68.8 -36.73 78.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.061 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 24.7 mm-40 -63.03 -46.72 86.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 109.778 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 3.8 t80 -63.16 -45.92 89.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.127 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.98 -49.33 76.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.858 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -66.68 -36.48 82.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.415 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.39 -52.16 55.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.792 0.329 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.79 -19.9 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.09 -9.02 59.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.708 0.289 . . . . 0.0 111.625 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -75.88 146.52 39.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.643 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 38.2 t70 -72.98 8.97 1.3 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.293 0.568 . . . . 0.0 111.827 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -111.53 178.34 4.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.026 0.441 . . . . 0.0 111.065 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.591 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -76.06 108.07 8.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.768 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 14' ' ' ALA . 65.7 t -111.06 106.84 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.504 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.939 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.22 109.23 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.616 0.722 . . . . 0.0 111.128 175.263 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 21' ' ' VAL . 92.9 t -102.47 143.48 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.747 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB1' ' CE1' ' A' ' 26' ' ' TYR . . . -127.12 138.1 53.11 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.196 0.522 . . . . 0.0 111.715 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -101.04 103.38 14.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.516 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.671 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.5 m-85 -128.22 178.4 6.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.759 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -154.97 137.73 15.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.274 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -72.36 -6.04 40.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 13.7 p-90 -106.29 19.56 20.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.299 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.935 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -122.69 132.97 54.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.629 0.728 . . . . 0.0 110.965 178.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.46 88.84 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.628 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.935 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 22.2 Cg_exo -65.44 -31.81 50.94 Favored 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 120.29 2.045 . . . . 0.0 109.868 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 63.7 m -54.3 -41.13 68.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.154 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.706 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -62.98 -57.03 12.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.923 -178.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 ptm -55.55 -48.14 75.24 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -173.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.671 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.89 -23.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.99 -177.516 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 41' ' ' GLU . . . -55.19 -49.63 91.22 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.91 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 11.0 Cg_exo -72.98 -29.74 11.68 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 120.718 1.292 . . . . 0.0 111.849 171.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.7 mmt -66.49 -60.32 2.84 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.462 HD12 ' CG1' ' A' ' 36' ' ' ILE . 51.2 mt -62.68 -30.68 49.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.156 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 27.9 tt0 -50.03 -48.22 52.86 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.066 0.46 . . . . 0.0 110.361 172.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -65.5 -41.97 92.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.598 0.714 . . . . 0.0 110.023 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.689 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 7.3 m-30 -63.89 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.302 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 1.026 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 4.0 m -74.47 -23.16 58.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 41.4 mt-10 -78.36 -20.51 51.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.554 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 17.2 pt20 -112.9 22.89 13.98 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.573 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 8.4 m-30 -100.44 100.29 11.77 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 163.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 14.1 Cg_exo -70.04 -44.72 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.769 1.646 . . . . 0.0 111.891 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -2.71 15.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . . . -106.08 142.85 35.09 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.885 -0.509 . . . . 0.0 110.795 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.32 126.12 42.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.502 0.668 . . . . 0.0 111.301 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 1.026 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.7 OUTLIER -105.36 114.18 28.2 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.782 -173.213 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.6 142.09 50.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 110.74 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.621 ' HE3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -125.99 119.55 27.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.574 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.1 mt -101.73 161.81 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.273 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -102.8 115.05 29.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.628 0.728 . . . . 0.0 109.093 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -13.62 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.296 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.14 -35.12 79.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.185 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -96.84 -35.64 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.682 172.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.62 HD12 HG21 ' A' ' 63' ' ' VAL . 1.9 mm? -97.83 42.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.761 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -74.72 -40.81 36.42 Favored Glycine 0 CA--C 1.504 -0.628 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.694 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.65 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 9.7 p-10 -64.3 -34.59 78.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.62 HG21 HD12 ' A' ' 60' ' ' LEU . 87.8 t -65.31 -43.18 95.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.127 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.991 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 83.2 mm-40 -72.76 -36.31 67.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.3 mttm -61.6 -34.72 76.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.69 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -100.82 16.97 23.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 54.34 47.3 23.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.86 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.5 t -98.61 116.4 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.132 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 p -118.87 0.41 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.93 124.63 35.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 154.91 42.16 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.36 168.82 71.05 Favored 'Cis proline' 0 CA--C 1.533 0.43 0 C-N-CA 124.018 -1.243 . . . . 0.0 111.88 -6.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 m -137.26 128.35 27.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.511 -169.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' HB2' HD21 ' A' ' 91' ' ' ASN . 3.8 mm? -115.98 108.61 16.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.077 0.465 . . . . 0.0 110.357 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 20.1 mt -123.95 113.69 18.8 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.939 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.26 125.42 35.49 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.31 177.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 83.8 m-85 -110.47 148.11 32.73 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.119 -177.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.515 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 8.5 mtpm? -146.2 126.16 13.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 10.8 p30 45.7 29.2 0.64 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.451 1.1 . . . . 0.0 112.733 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.03 17.03 73.31 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.188 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 31.6 pttt -114.75 -1.26 13.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.414 0.626 . . . . 0.0 109.531 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 42.6 mt-10 75.48 -172.55 0.11 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.356 -175.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.564 HG12 ' HB2' ' A' ' 77' ' ' LEU . 1.4 p -162.3 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.619 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -153.26 162.42 41.32 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.796 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.474 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.2 tmtp? -144.64 109.18 4.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.937 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.2 t -121.51 143.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.31 89.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.686 0.755 . . . . 0.0 111.596 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.0 62.96 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.923 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 50.68 81.27 0.07 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.639 0.376 . . . . 0.0 111.582 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 17.4 p-10 -117.71 88.0 28.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -172.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.403 ' O ' HG22 ' A' ' 95' ' ' ILE . 2.6 Cg_endo -79.53 -34.42 1.04 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.762 1.641 . . . . 0.0 110.543 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.11 -44.63 10.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.39 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.48 -17.02 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.455 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.724 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.0 tp -56.16 -39.4 58.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.622 ' HA ' HG22 ' A' ' 99' ' ' ILE . 15.6 mmtt -59.71 -36.79 77.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.664 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -52.16 -57.36 9.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.859 174.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HB1' ' CB ' ' A' ' 85' ' ' ALA . . . -75.35 -30.1 60.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.55 -39.63 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.679 -170.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.59 21.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.971 0.415 . . . . 0.0 110.452 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.83 62.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.209 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.7 m-80 -98.06 -67.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.704 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.591 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.718 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HA ' ' HG3' ' A' ' 41' ' ' GLU . 12.8 tpt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.875 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m -109.51 147.65 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 0.0 111.072 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.86 147.81 28.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.152 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -98.68 134.42 41.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.905 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.647 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.0 m-85 -90.95 141.85 28.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -97.16 -14.84 21.22 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.715 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.523 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 62.6 p -132.58 153.13 51.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.94 0.4 . . . . 0.0 111.241 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.5 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -62.33 -28.66 69.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 172.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 t -66.19 -37.73 86.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.378 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.523 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.4 mm-40 -58.54 -49.15 78.44 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.424 0.631 . . . . 0.0 110.257 176.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' HD1' HG21 ' A' ' 23' ' ' VAL . 2.1 t80 -64.9 -44.9 88.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.992 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.81 -46.57 84.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -65.43 -33.69 76.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.147 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.14 -49.51 43.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 31.5 pt -67.93 -15.09 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.595 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.27 -8.33 58.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 0.0 111.171 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -76.35 153.89 35.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.571 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 20.2 t70 -68.47 2.56 2.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.554 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 4.0 ptpt -109.45 -179.51 3.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.638 0.732 . . . . 0.0 111.507 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.3 tm? -86.53 114.15 23.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.659 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.1 t -118.77 111.17 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.1 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.714 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -105.64 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.558 0.694 . . . . 0.0 111.058 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.629 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 22.6 t -111.4 143.45 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.329 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -120.49 123.94 44.19 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.2 m-85 -70.47 130.43 41.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.679 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -136.45 -178.19 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.349 -164.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -167.91 157.19 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.102 173.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -84.9 -5.34 59.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 111.256 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -117.31 42.28 2.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.93 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -144.07 123.47 13.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.575 0.702 . . . . 0.0 112.002 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.46 -44.13 98.0 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.438 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.441 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 44.0 Cg_exo -58.26 -40.06 79.22 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 119.868 1.834 . . . . 0.0 111.232 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 22.9 m -56.86 -37.83 71.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.754 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 60.2 tttm -63.2 -53.54 51.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.897 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.666 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptp -60.34 -48.07 83.35 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.601 ' CG1' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.6 -18.6 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.435 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.48 -48.82 96.63 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.189 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.754 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.3 Cg_exo -72.55 -30.15 12.48 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.225 1.283 . . . . 0.0 111.878 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' MET . 24.8 mmt -64.47 -60.0 3.67 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.755 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.601 HD12 ' CG1' ' A' ' 36' ' ' ILE . 30.4 mt -65.4 -20.8 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 111.297 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 29.4 tt0 -59.68 -46.93 87.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.494 0.664 . . . . 0.0 109.692 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -64.98 -45.88 83.8 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.773 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.701 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.6 m-30 -63.71 -25.03 68.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.67 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.827 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 87.4 p -76.36 -19.67 57.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -83.08 -16.1 48.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.982 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.701 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -120.36 28.24 8.13 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.58 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 14.0 m-30 -101.07 100.44 13.11 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.493 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.28 -43.41 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 121.944 1.763 . . . . 0.0 112.623 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -95.93 -22.94 17.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 111.947 -173.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -102.74 149.55 24.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.439 0.638 . . . . 0.0 110.879 -172.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.485 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.9 m-20 -104.3 133.27 49.48 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.752 176.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.827 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.7 p90 -110.39 116.28 31.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.628 -169.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 20.4 m-85 -137.33 158.47 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.18 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.875 ' HG3' HG21 ' A' ' 2' ' ' VAL . 10.4 mtmp? -141.36 127.38 19.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.718 0.294 . . . . 0.0 110.75 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.647 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 56.8 mt -95.49 129.14 42.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.218 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.69 119.25 18.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 166.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.27 -11.87 12.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.573 -173.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.22 -46.32 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.486 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.97 -31.8 31.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.062 0.458 . . . . 0.0 110.16 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.61 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.2 mm? -103.0 52.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.651 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.96 -40.83 20.02 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.414 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.587 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 26.4 t70 -64.35 -49.08 73.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.537 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -60.59 -38.25 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.392 . . . . 0.0 110.27 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.97 85.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.139 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -74.13 -34.94 64.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.421 . . . . 0.0 110.546 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 45.3 mtmt -61.99 -35.63 79.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.906 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -97.87 14.16 28.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.45 38.47 25.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.967 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.411 HG21 ' CD2' ' A' ' 25' ' ' PHE . 84.7 t -82.68 127.03 40.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.3 p -125.06 -56.56 1.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.406 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 159.75 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.659 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.96 144.8 42.76 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 111.493 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 63.3 Cg_endo -75.84 167.71 79.44 Favored 'Cis proline' 0 C--O 1.237 0.467 0 C-N-CA 123.03 -1.654 . . . . 0.0 111.694 -10.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 46.9 m -124.25 116.86 23.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -103.47 108.98 20.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.264 -174.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.516 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 33.3 mt -124.05 113.95 19.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.714 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.39 130.24 40.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.627 174.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 47.7 m-85 -111.2 160.05 17.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.605 -175.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.422 ' HG3' ' OD1' ' A' ' 80' ' ' ASN . 14.6 tppt? -144.04 124.11 13.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.592 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' OD1' ' HG3' ' A' ' 79' ' ' LYS . 8.7 p30 35.39 48.74 0.43 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 18.59 59.88 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.691 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -125.37 7.38 7.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.976 0.388 . . . . 0.0 110.785 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.36 176.51 0.25 Allowed 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.774 0.671 . . . . 0.0 109.572 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -146.28 -34.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.942 0.401 . . . . 0.0 110.422 172.124 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -158.86 161.18 36.82 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.6 tttt -140.97 122.22 14.81 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.13 136.51 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.2 88.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.752 0.787 . . . . 0.0 111.504 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.89 62.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.767 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . 58.81 94.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.937 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.9 p-10 -132.93 80.12 61.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.426 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 2.8 Cg_exo -73.82 -41.08 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.367 1.378 . . . . 0.0 111.149 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.19 -39.72 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.113 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.0 -17.57 62.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.269 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.724 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.1 tp -57.62 -38.1 62.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 20.4 mmtp -57.56 -36.95 72.32 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.796 0.685 . . . . 0.0 110.621 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -53.29 -57.05 11.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.88 175.257 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.39 -36.59 63.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.553 0.692 . . . . 0.0 110.818 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.37 -40.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.853 -171.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.09 -34.94 18.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.814 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.22 -35.29 68.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 50.5 m-80 -98.44 -59.82 1.67 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.507 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.047 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.3 m -97.43 145.69 8.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.419 0.628 . . . . 0.0 111.237 -174.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.62 145.44 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.917 -176.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -103.44 122.9 45.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.592 174.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.826 ' HB2' HD21 ' A' ' 55' ' ' LEU . 7.2 m-85 -76.07 165.84 24.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.009 0.433 . . . . 0.0 110.168 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -116.89 -30.0 5.85 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.528 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 19.4 p -127.2 145.27 50.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.004 0.43 . . . . 0.0 111.805 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.629 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -53.18 -40.41 64.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.766 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -61.03 -38.75 87.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.988 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.479 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 19.4 pt-20 -81.06 -22.03 39.58 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.817 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.483 ' HD1' HG21 ' A' ' 23' ' ' VAL . 3.3 t80 -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 168.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' A' ' 15' ' ' ILE . 4.8 m-20 -59.23 -38.66 80.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.151 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 t -66.46 -37.93 86.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -50.27 62.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 110.659 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 33.4 pt -69.97 -14.76 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.573 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.07 -6.19 59.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.95 0.405 . . . . 0.0 111.408 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 19' ' ' LYS . 77.9 mt-30 -88.39 161.11 17.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.082 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 5.4 m-20 -76.44 27.81 0.12 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 17' ' ' GLN . 23.4 mtpp -108.05 178.06 4.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 122.069 0.938 . . . . 0.0 112.756 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.609 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -94.8 104.93 16.84 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.885 172.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.9 t -114.01 107.67 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.896 0.379 . . . . 0.0 110.96 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.706 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -104.72 107.49 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.472 0.653 . . . . 0.0 110.728 175.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 53' ' ' TYR . 27.0 t -108.95 133.02 55.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.793 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.82 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -108.54 122.41 47.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CD2' HG21 ' A' ' 69' ' ' VAL . 68.8 m-85 -74.12 127.84 33.97 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.118 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.659 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 2.3 m-85 -120.02 -171.46 2.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.145 -175.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.02 31.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.055 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.9 p -79.99 -4.81 54.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.166 0.508 . . . . 0.0 110.993 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -131.93 54.17 1.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.7 p -145.56 116.76 7.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.475 0.655 . . . . 0.0 112.257 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -66.47 -37.94 93.08 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.234 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 31.6 Cg_exo -61.52 -35.32 82.66 Favored 'Trans proline' 0 C--N 1.36 1.18 0 CA-C-N 120.233 2.016 . . . . 0.0 111.408 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 57.1 m -54.6 -38.81 67.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.242 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.751 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.1 tptm -63.75 -54.81 29.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.683 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.0 ptp -59.98 -48.63 80.93 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.697 HG13 HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -76.07 -16.29 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.207 -178.365 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.62 -50.31 88.62 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.787 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.751 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.4 Cg_exo -71.83 -31.4 12.92 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.1 1.2 . . . . 0.0 111.871 171.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.431 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 94.6 mmm -63.91 -59.46 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.161 -0.615 . . . . 0.0 112.006 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 36' ' ' ILE . 53.4 mt -67.18 -19.4 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.03 -0.419 . . . . 0.0 111.428 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.3 tt0 -64.48 -43.29 94.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.478 0.656 . . . . 0.0 109.39 168.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 15.5 tttm -63.6 -39.76 95.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.2 m-30 -74.45 -15.16 60.91 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.741 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.823 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 25.1 p -74.71 -18.14 60.55 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -84.86 -21.75 29.67 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.899 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.672 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 6.5 mt-30 -95.98 5.48 51.1 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.484 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 3.8 m-30 -104.17 98.61 14.35 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.642 172.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 6.6 Cg_exo -73.83 -43.8 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.28 1.986 . . . . 0.0 112.201 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -108.52 -13.61 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.3 163.45 12.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.125 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.23 135.82 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.046 0.927 . . . . 0.0 112.568 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.823 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.8 p90 -115.02 116.94 29.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.468 -171.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.583 ' HB2' HG22 ' A' ' 23' ' ' VAL . 22.0 m-85 -136.33 158.64 43.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.82 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 10.3 mtmp? -142.58 129.49 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 110.969 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' A' ' 5' ' ' PHE . 18.2 mt -107.01 176.91 5.02 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.525 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 6.7 p-10 -131.24 130.49 42.95 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 26' ' ' TYR . 32.7 m -69.29 -8.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.71 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.06 -40.91 74.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.333 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -101.24 -28.11 12.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.666 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HG ' HD22 ' A' ' 55' ' ' LEU . 3.9 mm? -101.11 53.66 0.84 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.01 -43.07 23.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.127 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 13.2 t70 -66.3 -45.61 79.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.861 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.646 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -61.42 -39.22 82.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.112 0.482 . . . . 0.0 110.142 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.62 -36.93 72.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.103 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 12.0 mm-40 -79.02 -31.51 44.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 38.5 mtmt -62.56 -37.4 86.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.0 110.458 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -96.0 8.17 44.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.21 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 55.44 45.96 24.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.892 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.492 HG13 ' OG1' ' A' ' 74' ' ' THR . 69.6 t -69.71 124.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.814 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -139.33 31.29 2.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.044 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.08 152.62 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.5 112.43 32.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.06 172.72 30.95 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.921 -0.866 . . . . 0.0 112.275 -0.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.492 ' OG1' HG13 ' A' ' 69' ' ' VAL . 92.3 m -120.31 115.89 24.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.554 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -102.39 108.65 20.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.826 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.516 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 30.7 mt -125.43 113.05 17.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.706 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.16 122.06 36.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.022 174.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 42.2 m-85 -106.85 152.89 23.28 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.457 -174.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 87.1 tttt -138.71 122.05 17.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.801 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.68 44.28 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.146 0.979 . . . . 0.0 112.67 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 17.41 57.46 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.206 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 2.8 tttp -116.43 -5.33 11.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.089 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 22.9 tt0 75.06 168.85 0.29 Allowed 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.648 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.601 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.2 p -136.66 -33.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.84 163.91 34.06 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.74 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.3 tttt -143.13 125.1 15.21 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.401 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.5 t -131.13 130.5 63.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.97 82.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.44 -170.44 35.1 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.791 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -70.31 93.83 0.88 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.676 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.8 p-10 -121.77 67.33 21.91 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.5 -35.21 13.85 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 120.915 1.077 . . . . 0.0 110.743 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.62 -39.87 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.074 177.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -76.25 -17.86 59.29 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.462 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.715 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.3 tp -57.3 -40.06 71.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HA ' HG22 ' A' ' 99' ' ' ILE . 12.3 mmmm -57.94 -34.76 70.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.799 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -54.47 -58.14 8.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.21 64.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.635 0.731 . . . . 0.0 110.952 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -81.16 -38.94 17.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.483 -169.253 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.46 -36.78 18.86 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.377 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.84 68.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.277 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.9 m-80 -92.7 -65.05 1.03 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.574 -0.85 . . . . 0.0 112.477 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.787 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.877 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -121.52 141.03 43.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.33 0.586 . . . . 0.0 111.094 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.99 147.56 26.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.313 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.1 pp0? -99.97 137.34 38.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.111 171.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.658 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 9.7 m-85 -90.71 137.96 31.95 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.222 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -90.74 -24.95 20.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.394 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.1 p -131.67 153.3 50.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.764 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.63 -34.42 71.16 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 t -62.81 -34.04 76.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.741 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 20.0 mm-40 -62.58 -49.18 76.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.353 0.596 . . . . 0.0 109.884 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.464 ' HD1' HG21 ' A' ' 23' ' ' VAL . 1.7 t80 -62.91 -47.06 84.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.107 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.06 -44.1 78.58 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.346 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 m -70.1 -40.44 74.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.46 67.99 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.821 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.14 -20.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.174 -176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.34 61.53 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.917 0.389 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 19' ' ' LYS . 59.6 mt-30 -68.24 150.99 47.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.073 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.9 32.89 0.26 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.82 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.7 ptmt -135.57 173.62 11.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.29 -176.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.747 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -75.13 112.71 11.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.598 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.37 107.97 20.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.752 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.31 109.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.047 0.927 . . . . 0.0 111.622 176.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 39.5 t -105.02 144.31 14.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.072 177.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.72 ' HB2' HD13 ' A' ' 75' ' ' LEU . . . -129.51 122.64 29.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 55' ' ' LEU . 72.9 m-85 -72.89 115.91 12.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.414 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.72 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 8.5 m-30 -121.91 -178.34 3.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 123.369 0.418 . . . . 0.0 110.358 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.62 34.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.689 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.48 -4.43 58.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.214 0.531 . . . . 0.0 111.139 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -126.16 47.2 2.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.077 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 p -143.1 126.39 16.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.53 0.681 . . . . 0.0 111.728 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.9 -40.44 98.35 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.21 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.75 ' O ' HG23 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -63.08 -38.65 44.46 Favored 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 120.272 2.036 . . . . 0.0 110.921 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 20.5 m -58.46 -31.22 67.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.581 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 87.2 tttt -67.94 -57.03 6.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.491 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 ptp -64.95 -44.38 89.62 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.235 0.54 . . . . 0.0 112.431 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.96 -13.73 14.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 C-N-CA 118.441 -1.304 . . . . 0.0 110.401 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.5 -52.35 74.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.085 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 19.8 Cg_endo -64.63 -32.63 57.75 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 120.955 1.103 . . . . 0.0 112.574 169.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 23.5 mmt -66.92 -55.57 14.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.014 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.808 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -49.0 -38.56 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.599 0.36 . . . . 0.0 110.529 175.243 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.35 -48.1 79.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 110.692 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -60.0 -51.77 68.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.975 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.0 m-85 -64.09 -19.57 65.34 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.17 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.1 p -83.6 -22.13 32.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -83.82 -20.99 32.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.656 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.676 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -107.85 16.38 23.59 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.75 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 13.9 m-30 -100.62 101.81 16.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.486 167.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.14 -40.88 2.94 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 121.88 1.72 . . . . 0.0 112.851 174.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -107.73 -16.0 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.09 146.74 27.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 110.88 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -101.01 135.51 42.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.859 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.808 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -113.52 124.52 52.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.607 -177.219 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.656 ' HA ' HG23 ' A' ' 2' ' ' VAL . 42.1 m-85 -135.79 147.58 48.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.877 ' HG2' HG21 ' A' ' 2' ' ' VAL . 8.2 mmpt? -117.23 142.43 47.06 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.658 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 60.6 mt -107.13 142.49 36.73 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.149 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.32 102.48 14.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 167.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -60.26 -15.23 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -171.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.44 -21.8 57.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -108.65 -31.24 7.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.923 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.598 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -96.77 52.19 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.818 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.21 -40.73 19.22 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.061 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.619 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 6.3 m-20 -60.56 -49.74 76.34 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.419 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.7 p -62.83 -38.69 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.313 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.44 -35.03 73.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.071 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 55.7 mt-30 -76.27 -37.85 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.38 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 66.0 mttm -57.24 -39.46 75.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.812 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -95.0 6.55 48.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.912 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.84 48.78 17.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.925 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.09 121.13 35.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.688 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -123.27 -16.08 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.732 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.57 161.86 15.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 142.96 26.83 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.519 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 2.9 Cg_exo -78.33 165.31 83.05 Favored 'Cis proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.862 -1.308 . . . . 0.0 111.75 -8.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 86.8 m -123.38 116.84 23.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.2 mm? -108.13 108.61 19.74 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -174.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.609 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 18.2 mt -125.71 116.13 21.16 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.814 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -91.53 122.42 34.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.054 173.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 33.5 m-85 -105.46 156.48 18.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.808 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.3 ttpt -142.44 120.09 11.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.378 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.5 37.11 5.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.8 0.84 . . . . 0.0 111.901 -177.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.16 12.55 50.38 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.746 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 61.7 mttp -120.83 19.47 11.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.553 0.341 . . . . 0.0 110.142 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 10.2 pt-20 61.66 175.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.869 1.356 . . . . 0.0 112.128 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.532 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -148.75 -32.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.832 174.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.79 166.92 25.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.081 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.609 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.9 tttt -144.34 126.51 15.61 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.2 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 19.3 t -131.96 138.84 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 87.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.796 0.807 . . . . 0.0 111.593 -170.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.66 63.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.061 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.28 86.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.111 0.482 . . . . 0.0 111.78 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.609 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.5 p-10 -126.41 78.57 71.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.519 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.5 Cg_exo -68.14 -45.39 2.91 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.448 1.432 . . . . 0.0 110.955 168.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.44 -35.43 18.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.096 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -76.59 -17.55 59.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.46 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.751 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.0 tp -59.18 -38.94 77.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HD2' HG22 ' A' ' 99' ' ' ILE . 54.5 tptt -61.83 -27.37 68.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.995 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 18.3 tm0? -59.6 -59.66 5.08 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -71.67 -29.2 64.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.712 0.768 . . . . 0.0 110.503 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -77.62 -39.44 26.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.321 -171.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.2 -34.45 20.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.043 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.24 89.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.63 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 51.2 m-80 -97.33 -63.06 1.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.747 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.79 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.4 mmm . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.858 0.361 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.688 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 0.3 OUTLIER -79.59 125.85 38.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.637 0.732 . . . . 0.0 109.709 177.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.2 145.84 55.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.659 -168.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -108.56 136.35 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.655 170.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.809 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.6 m-85 -88.13 166.13 14.62 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -124.52 -10.29 7.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 60.1 p -134.44 150.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.68 0.276 . . . . 0.0 110.912 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.513 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.49 -33.68 70.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.3 t -65.73 -36.38 83.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.747 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 51.0 mm-40 -61.29 -44.74 96.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 7.5 t80 -67.55 -49.21 64.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.947 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -59.75 -37.55 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.69 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.4 t -68.29 -40.71 81.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.819 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -64.77 -50.48 66.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.43 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.51 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 35.3 pt -66.83 -18.82 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.499 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.44 -10.4 59.05 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.745 0.307 . . . . 0.0 111.589 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 54.8 mt-30 -76.09 153.3 36.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.344 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.4 37.75 0.34 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.86 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.9 ptmt -140.21 167.92 21.01 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.064 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.945 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -71.71 107.94 4.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.436 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.55 HG13 ' CD2' ' A' ' 53' ' ' TYR . 70.2 t -107.55 107.08 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 110.35 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.611 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -99.0 105.55 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.412 0.625 . . . . 0.0 110.294 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 53.5 t -107.01 139.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.371 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.749 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -128.39 122.4 31.34 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' HG21 ' A' ' 69' ' ' VAL . 52.4 m-85 -70.6 124.1 23.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.537 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.697 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.9 m-85 -120.01 -176.86 3.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.612 -174.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -161.77 156.68 23.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.144 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -84.09 -4.33 58.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.771 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -120.73 21.97 11.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 3.8 p -119.55 150.99 39.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.515 0.674 . . . . 0.0 112.253 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.75 -48.61 4.89 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.803 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 35' ' ' MET . 50.7 Cg_exo -55.25 -47.5 25.83 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.253 1.969 . . . . 0.0 112.307 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.9 p -51.07 -36.8 41.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.257 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.731 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 67.4 mttm -66.46 -50.31 63.76 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 123.212 0.32 . . . . 0.0 111.247 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 22.6 ptp -64.88 -44.7 88.81 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.424 0.631 . . . . 0.0 112.311 -175.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.686 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.0 -16.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.605 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.09 -55.26 47.14 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.909 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.731 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.7 Cg_endo -63.96 -30.42 67.0 Favored 'Trans proline' 0 C--N 1.358 1.054 0 CA-C-N 120.424 1.187 . . . . 0.0 112.1 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 25.4 mmt -65.98 -55.37 17.12 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.291 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.996 HG21 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -57.11 -38.08 58.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.87 175.175 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -52.48 -47.34 66.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.0 0.429 . . . . 0.0 109.958 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.33 -47.88 83.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.696 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 7.9 m-30 -67.05 -15.34 63.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.075 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.788 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 5.7 m -86.62 -13.71 44.87 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.23 -15.21 31.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.681 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.696 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -126.59 35.66 4.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.23 177.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -104.31 72.52 0.19 Allowed Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 172.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 88.9 Cg_exo -45.88 -45.64 16.88 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.945 2.43 . . . . 0.0 115.161 -166.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.69 8.53 19.02 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -103.16 165.09 11.23 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.82 -0.55 . . . . 0.0 111.573 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.98 123.37 41.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.788 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.76 124.95 35.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 10.6 m-85 -143.04 136.29 28.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.366 168.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.996 ' HD3' HG21 ' A' ' 40' ' ' ILE . 27.5 mtmt -134.0 120.3 20.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.809 HD22 ' H ' ' A' ' 5' ' ' PHE . 4.7 mt -93.11 162.22 14.12 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.646 -167.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.19 108.63 21.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -61.14 -14.42 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.451 -175.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.87 -39.12 93.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -99.68 -32.14 11.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.99 47.25 1.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.588 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.9 -42.13 17.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.789 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 31.1 t70 -65.27 -44.17 88.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 110.956 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -63.7 -39.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.204 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.79 77.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.5 mm-40 -71.51 -34.34 70.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.928 0.394 . . . . 0.0 110.438 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 40.1 mtmt -61.25 -38.73 87.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.648 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -95.08 15.29 19.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.884 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.6 40.94 26.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.812 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' A' ' 25' ' ' PHE . 86.4 t -88.9 113.38 25.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.15 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -116.06 -11.41 11.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.37 165.25 12.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.618 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.11 141.71 17.54 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.859 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.501 ' HG3' HD12 ' A' ' 36' ' ' ILE . 60.8 Cg_endo -75.28 163.41 90.62 Favored 'Cis proline' 0 C--O 1.234 0.301 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.795 -10.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.8 m -126.65 118.79 25.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.616 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.3 mt -110.34 107.65 17.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.379 0.609 . . . . 0.0 111.6 -172.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.67 HD22 ' HG3' ' A' ' 86' ' ' LYS . 18.9 mt -123.72 113.36 18.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.265 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.611 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.33 129.15 43.73 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.841 178.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 59.8 m-85 -112.27 154.09 26.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.441 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -136.52 117.54 14.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.393 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.55 43.83 2.4 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.065 0.853 . . . . 0.0 112.67 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.73 11.12 59.72 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.399 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -111.97 -0.32 15.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 32.9 tt0 69.79 172.77 0.3 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.137 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.554 HG11 HD21 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.46 -33.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.239 172.527 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.11 161.44 40.37 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.67 ' HG3' HD22 ' A' ' 76' ' ' LEU . 41.3 tttp -141.83 110.99 6.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.868 177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 t -123.58 135.1 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.23 82.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.951 0.881 . . . . 0.0 111.654 -168.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.5 64.27 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.235 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 54.78 83.85 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.021 0.438 . . . . 0.0 111.943 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 12.7 p-10 -125.02 83.99 59.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' O ' HG22 ' A' ' 95' ' ' ILE . 10.8 Cg_exo -74.15 -36.95 2.94 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.753 1.635 . . . . 0.0 111.654 168.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.3 -41.84 12.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 111.104 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.89 -17.37 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.639 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.5 tp -59.63 -38.16 74.28 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.284 171.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 99' ' ' ILE . 26.7 mmmt -59.53 -32.99 70.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.725 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -54.67 -61.24 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -71.25 -39.2 71.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.403 0.62 . . . . 0.0 111.649 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.648 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -68.74 -43.23 83.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.707 -171.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.17 10.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.909 0.385 . . . . 0.0 111.567 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.11 74.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.485 -175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.8 m-80 -92.65 -63.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.003 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.945 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.711 -0.661 . . . . 0.0 111.502 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.693 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 51.8 ttm . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -83.21 143.53 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.323 0.582 . . . . 0.0 110.758 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -98.53 147.83 24.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.072 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -102.52 126.6 49.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.681 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 15.7 m-85 -80.42 157.39 26.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -113.05 -13.96 13.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.227 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -137.27 151.24 48.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.766 0.317 . . . . 0.0 111.126 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.496 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.15 -31.64 67.42 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 172.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -63.58 -38.13 89.96 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.231 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.427 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 27.4 mm-40 -61.58 -43.14 99.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.468 0.652 . . . . 0.0 109.772 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.42 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 4.4 t80 -68.15 -49.16 62.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.373 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' HG12 ' A' ' 15' ' ' ILE . 24.4 t70 -59.78 -46.06 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 0.0 111.438 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 m -68.68 -25.78 64.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -75.11 -51.6 13.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.826 0.346 . . . . 0.0 110.555 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.479 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.4 pt -65.22 -19.32 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.617 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.18 59.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.623 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -71.43 160.22 33.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.975 0.417 . . . . 0.0 110.861 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.496 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 4.8 m-20 -81.28 34.46 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.169 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -145.32 170.61 15.97 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.194 -174.399 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -72.16 105.44 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.02 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 14' ' ' ALA . 81.6 t -109.25 106.79 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.736 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.749 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.73 111.14 31.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.309 0.575 . . . . 0.0 111.116 175.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.668 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 44.8 t -110.69 131.15 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.294 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -109.32 110.82 22.09 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CD2' HD12 ' A' ' 55' ' ' LEU . 72.0 m-85 -70.77 107.72 4.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -162.93 151.37 14.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.298 0.571 . . . . 0.0 112.32 -178.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -120.03 158.66 26.34 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.0 p -81.11 -3.41 51.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -77.11 -16.63 59.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -172.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -98.26 -176.33 3.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.01 -60.19 1.98 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.153 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.621 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 82.0 Cg_exo -50.58 -49.22 17.32 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.968 2.445 . . . . 0.0 112.445 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.0 p -50.77 -36.94 39.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.692 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.737 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 39.8 ttpt -66.09 -54.32 27.22 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.06 0.225 . . . . 0.0 110.602 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.49 -45.99 91.91 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.808 HG13 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.25 -18.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.289 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.0 -56.38 31.31 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.128 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 33.4 Cg_endo -66.41 -32.16 41.13 Favored 'Trans proline' 0 C--N 1.359 1.127 0 CA-C-N 120.287 1.138 . . . . 0.0 112.492 171.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.534 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 33.2 mmt -64.27 -61.2 2.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.129 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.808 HD12 HG13 ' A' ' 36' ' ' ILE . 61.0 mt -64.41 -21.93 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.233 0.469 . . . . 0.0 111.647 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.693 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 11.2 tp10 -61.96 -43.78 98.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 109.675 168.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -65.6 -40.63 92.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.531 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.711 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 15.2 m-85 -68.09 -17.95 64.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.177 0.513 . . . . 0.0 110.854 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 p -87.24 -11.48 49.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -83.23 -31.11 27.18 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.711 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 28.2 pt20 -109.27 33.24 4.41 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.234 -176.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.444 ' H ' ' HD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -100.1 76.6 0.13 Allowed Pre-proline 0 CA--C 1.556 1.207 0 CA-C-O 121.496 0.665 . . . . 0.0 112.711 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 32.2 Cg_exo -58.21 -46.07 27.44 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.115 1.877 . . . . 0.0 114.242 -170.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.82 16.51 19.5 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -124.23 165.89 16.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.954 0.406 . . . . 0.0 111.486 -171.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 6.2 m-20 -115.59 131.89 56.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 1.6 m-85 -114.28 124.71 52.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.464 -173.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 m-85 -139.85 151.54 45.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.733 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 38.1 mtmt -140.06 121.25 14.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 70.6 mt -78.42 141.02 38.63 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.506 -171.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.74 91.08 0.8 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 27' ' ' ALA . 2.3 p -59.53 -6.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -172.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.95 -32.97 15.77 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.48 -36.17 26.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.246 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.0 52.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.547 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.72 -40.29 22.59 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.04 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.4 m-20 -69.79 -38.53 76.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.455 0.169 . . . . 0.0 110.995 -177.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -68.96 -37.53 77.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.435 . . . . 0.0 110.41 176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.8 73.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.029 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.4 mt-30 -70.91 -34.75 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 52.7 mttp -59.46 -43.99 93.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.553 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -91.55 10.52 27.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.146 -174.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 58.27 48.68 12.22 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.498 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.513 HG13 ' OG1' ' A' ' 74' ' ' THR . 71.8 t -78.64 118.58 26.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.83 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -124.25 -58.83 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.19 127.63 32.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.333 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.5 134.91 19.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.334 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 64.9 Cg_endo -83.31 171.25 51.57 Favored 'Cis proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.855 -1.31 . . . . 0.0 112.035 -1.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.513 ' OG1' HG13 ' A' ' 69' ' ' VAL . 27.7 m -117.93 114.76 23.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.2 mm? -105.23 107.46 18.45 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.323 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.493 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.2 mt -126.25 112.7 16.04 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -87.14 116.89 25.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 70.3 m-85 -104.45 145.99 29.5 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.665 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mtpt -143.83 120.96 11.46 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.969 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 38.8 m-80 61.14 21.85 12.22 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.715 0.634 . . . . 0.0 110.809 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.06 12.3 65.07 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -111.59 5.57 19.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.57 ' HG2' ' H ' ' A' ' 84' ' ' VAL . 27.4 tt0 70.36 177.17 0.27 Allowed 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.123 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.576 HG21 ' HD3' ' A' ' 79' ' ' LYS . 1.4 p -157.12 -31.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.32 164.29 34.94 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.82 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.493 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 66.7 tttt -148.61 122.88 9.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.594 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.49 132.24 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.78 79.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.299 0.571 . . . . 0.0 111.065 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.09 -172.86 35.88 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -67.36 100.98 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.4 p-10 -124.07 63.55 32.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 90' ' ' ALA . 8.7 Cg_exo -70.75 -31.35 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 120.963 1.109 . . . . 0.0 110.098 172.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.65 -47.12 8.15 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.257 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -69.43 -16.31 63.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -177.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.696 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.1 tp -53.56 -38.29 33.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.114 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 169.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.686 ' HA ' HG22 ' A' ' 99' ' ' ILE . 36.0 mmtt -55.07 -41.7 71.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.937 0.773 . . . . 0.0 110.798 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 23.0 tm0? -51.17 -53.72 32.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.523 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -80.49 -30.56 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 111.762 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -76.05 -39.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.982 -172.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.86 -41.4 14.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.708 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.93 75.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.621 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 35.4 m-80 -107.26 -73.1 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.879 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.883 0 O-C-N 123.983 0.802 . . . . 0.0 112.632 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.905 0.383 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 52' ' ' PHE . 0.2 OUTLIER -122.63 135.6 62.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 177.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.43 HG22 ' HD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -84.12 148.43 26.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.087 -175.331 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -108.29 122.68 47.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.317 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.673 ' H ' HD22 ' A' ' 55' ' ' LEU . 12.4 m-85 -76.16 164.06 26.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.193 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -121.61 -20.26 6.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 61.1 p -131.63 155.12 48.12 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.296 -0.253 . . . . 0.0 111.312 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.29 -36.09 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 t -57.71 -41.15 81.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.572 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 19.6 mm-40 -59.59 -43.53 93.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.125 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.467 ' HD1' HG21 ' A' ' 23' ' ' VAL . 7.4 t80 -67.07 -53.2 33.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.465 ' HA ' HG12 ' A' ' 15' ' ' ILE . 10.9 m-20 -61.49 -37.19 82.76 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 111.781 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.822 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -69.14 -48.55 62.09 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.0 110.579 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 12' ' ' ASP . 34.2 pt -67.02 -20.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.97 -8.6 59.43 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.084 0.468 . . . . 0.0 111.306 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -75.73 152.58 37.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.889 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.413 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 2.3 m-20 -80.37 35.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.102 0.477 . . . . 0.0 111.634 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 4.4 ptpt -134.7 -179.06 5.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 0.0 111.346 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.3 tm? -84.36 108.26 17.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.445 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.763 HG13 ' CE1' ' A' ' 53' ' ' TYR . 78.3 t -112.88 106.92 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.019 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.698 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.34 106.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.341 0.591 . . . . 0.0 110.952 176.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 53' ' ' TYR . 59.3 t -106.23 136.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.634 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -118.1 115.45 24.85 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.161 0.505 . . . . 0.0 110.249 170.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.5 m-85 -70.06 109.96 4.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.544 ' CZ ' HD12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.78 159.24 31.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -163.035 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -147.53 135.88 21.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.159 173.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -83.88 -5.7 59.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -170.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 1.1 p90 -89.28 57.59 4.1 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.9 p -157.41 -176.72 6.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.26 -53.04 3.22 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.205 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' O ' ' HG2' ' A' ' 35' ' ' MET . 87.9 Cg_exo -49.07 -43.0 37.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.561 2.174 . . . . 0.0 112.075 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -58.13 -35.17 71.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -62.4 -46.55 88.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.628 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.624 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.7 ptm -77.26 -45.92 24.8 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.635 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -75.79 -23.31 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.439 -176.562 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.06 -49.53 91.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.092 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.624 ' HD2' ' O ' ' A' ' 35' ' ' MET . 23.3 Cg_exo -66.67 -38.3 18.81 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.498 1.465 . . . . 0.0 112.442 171.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -63.94 -58.29 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CG1' HG12 ' A' ' 36' ' ' ILE . 12.9 mm -56.21 -33.61 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.91 -49.17 78.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.248 0.547 . . . . 0.0 110.328 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -62.93 -47.33 83.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.262 0.553 . . . . 0.0 110.144 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.0 m-30 -64.52 -17.57 64.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.842 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.3 p -86.49 -13.37 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.873 0.844 . . . . 0.0 108.828 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -88.77 -19.35 26.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.328 169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -125.26 33.1 5.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.764 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -110.26 82.94 2.86 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-O 121.752 0.787 . . . . 0.0 111.659 169.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.13 -46.29 29.15 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.864 2.376 . . . . 0.0 114.561 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -112.71 6.33 18.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -105.63 165.08 11.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.954 -0.466 . . . . 0.0 110.743 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.45 123.23 27.67 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.71 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.764 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.2 m-85 -92.24 131.74 37.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.763 ' CE1' HG13 ' A' ' 21' ' ' VAL . 7.4 m-85 -130.82 135.3 47.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.298 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.617 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.57 120.78 31.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.18 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.673 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.9 mt -99.99 168.42 9.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.383 -171.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.69 104.08 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.991 0.9 . . . . 0.0 108.824 169.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -10.73 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.243 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.03 -33.84 65.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.081 0.467 . . . . 0.0 109.993 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -94.61 -36.39 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.903 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mm? -97.97 47.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.058 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.17 -39.12 27.94 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.886 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.44 -45.24 88.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 5.3 p -66.91 -37.76 80.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' A' ' 69' ' ' VAL . . . -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.112 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.3 mt-30 -62.8 -34.03 76.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -72.1 -24.97 61.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.7 9.54 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.998 0.428 . . . . 0.0 110.84 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 59.06 45.28 14.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.653 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 25' ' ' PHE . 72.5 t -74.74 117.3 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.908 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -133.24 -0.05 3.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.408 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.69 164.86 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 111.056 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 36.9 mtm -124.21 111.47 28.5 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.012 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.535 ' CB ' ' HE1' ' A' ' 26' ' ' TYR . 4.0 Cg_exo -77.63 170.32 71.27 Favored 'Cis proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.583 -5.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.42 ' OG1' HG13 ' A' ' 69' ' ' VAL . 77.1 m -115.29 112.38 22.32 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 158.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.602 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 6.0 mt -118.63 107.94 14.32 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.741 -167.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.466 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 5.4 mt -125.26 112.46 16.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.197 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.92 130.21 38.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.631 176.117 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 46.1 m-85 -111.11 154.15 24.69 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.143 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 27.8 ttpp -137.4 113.88 10.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.824 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 43.62 46.27 6.06 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.17 0.918 . . . . 0.0 111.941 -177.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 7.09 52.49 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.647 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.73 9.4 16.38 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 122.436 -0.449 . . . . 0.0 110.612 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.8 tt0 66.8 173.0 0.25 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.776 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.5 p -146.96 -32.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.728 0.299 . . . . 0.0 110.36 172.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -158.16 162.04 37.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.131 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.3 tmtp? -143.33 107.8 4.82 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.77 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.68 143.91 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -155.71 84.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.614 0.721 . . . . 0.0 111.74 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.09 81.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.644 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.526 ' HA ' ' CD ' ' A' ' 73' ' ' PRO . . . 45.13 74.76 0.12 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.05 0.54 . . . . 0.0 111.867 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 20.0 p-10 -123.59 75.53 54.69 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -171.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.577 ' O ' ' HE2' ' A' ' 43' ' ' PHE . 7.7 Cg_exo -74.07 -37.01 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.358 1.372 . . . . 0.0 110.4 166.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -87.4 -41.65 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.03 -17.78 60.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.517 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.603 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -63.14 -36.08 74.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 118.697 -1.201 . . . . 0.0 108.17 170.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.655 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 1.8 mmmp? -58.62 -33.73 70.36 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.389 0.431 . . . . 0.0 110.634 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.23 -54.95 40.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.63 173.313 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -71.81 -47.23 54.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.671 . . . . 0.0 111.229 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -61.44 -49.03 86.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.737 -172.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.35 -33.96 17.78 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -170.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.2 38.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.749 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -88.63 -54.65 4.06 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.195 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.582 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.535 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG21 ' HE3' ' A' ' 54' ' ' LYS . 1.2 m -93.82 145.11 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 173.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.525 ' CG2' ' HD2' ' A' ' 53' ' ' TYR . 1.3 m -74.03 144.76 44.96 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.463 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -111.63 118.56 36.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.595 172.002 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.682 ' H ' HD22 ' A' ' 55' ' ' LEU . 12.6 m-85 -71.22 163.37 27.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 110.063 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -112.33 -25.01 9.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.762 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.613 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 27.1 p -138.58 159.37 42.25 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -54.42 -39.29 67.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -53.67 -38.82 64.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.141 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.613 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 70.8 mm-40 -64.83 -50.46 66.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.519 0.675 . . . . 0.0 109.951 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.28 -48.1 81.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.497 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.546 ' HA ' HG12 ' A' ' 15' ' ' ILE . 7.2 m-20 -58.87 -35.34 72.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.349 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -74.64 -29.27 61.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.52 -39.56 24.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.172 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.818 HG22 HG11 ' A' ' 21' ' ' VAL . 43.8 pt -66.99 -22.28 29.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.698 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.77 -9.8 59.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.977 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.97 149.4 49.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.324 . . . . 0.0 110.507 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.31 39.19 0.31 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.214 0.53 . . . . 0.0 110.87 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.0 ptmt -147.32 173.75 12.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.817 -177.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.653 ' CD2' HG11 ' A' ' 84' ' ' VAL . 1.3 tm? -76.43 110.89 11.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.286 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.818 HG11 HG22 ' A' ' 15' ' ' ILE . 3.8 p -95.29 130.7 43.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.8 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -122.63 101.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.71 0.766 . . . . 0.0 109.71 169.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.637 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 57.7 t -109.12 143.28 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.874 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.28 120.51 32.41 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 83.7 m-85 -71.03 121.61 18.54 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.293 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.794 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 2.3 m-85 -119.99 177.78 4.86 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.127 0.489 . . . . 0.0 110.837 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.16 130.03 9.36 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 167.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -7.53 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 111.873 -174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -107.57 11.43 28.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.179 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.943 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -111.53 136.98 49.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.647 0.737 . . . . 0.0 111.649 -176.289 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.66 -41.46 50.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.589 -1.187 . . . . 0.0 114.325 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.943 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 16.5 Cg_exo -67.5 -27.96 38.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 CA-C-N 120.302 2.051 . . . . 0.0 110.441 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 58.9 m -55.26 -44.39 75.54 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.378 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.715 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 66.0 mttm -64.25 -51.33 64.12 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.561 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.675 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -62.05 -49.34 76.37 Favored 'General case' 0 C--O 1.252 1.185 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.04 -14.63 15.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.035 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.12 -49.68 92.26 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.971 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 24.5 Cg_exo -67.44 -35.1 24.46 Favored 'Trans proline' 0 C--N 1.36 1.156 0 CA-C-N 120.377 1.17 . . . . 0.0 111.645 169.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.433 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 97.1 mmm -62.36 -60.95 2.82 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.474 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.595 HG21 ' HD3' ' A' ' 54' ' ' LYS . 61.9 mt -65.07 -22.52 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.013 -0.429 . . . . 0.0 111.615 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 39.4 tt0 -63.36 -46.67 85.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.522 0.677 . . . . 0.0 109.474 169.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 14.6 tptm -60.88 -37.17 81.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.694 0.759 . . . . 0.0 109.532 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.673 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 2.6 m-30 -76.76 -14.66 59.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.751 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.815 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 46.1 p -74.62 -16.13 60.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.48 -24.1 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.023 171.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.673 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 12.8 mm100 -76.35 -38.66 55.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.073 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.604 ' CE1' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -104.03 101.9 28.62 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.0 Cg_endo -83.89 -19.07 5.1 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.077 2.518 . . . . 0.0 111.599 169.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.46 -22.22 19.73 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 111.161 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -109.07 140.21 42.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.672 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.1 117.52 29.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.586 0.708 . . . . 0.0 111.643 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.815 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.3 p90 -89.11 115.04 26.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.698 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.672 ' CE1' ' HB3' ' A' ' 51' ' ' ASP . 4.3 m-85 -133.41 150.7 51.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 171.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.659 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 9.7 mtmp? -143.99 119.39 10.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 6.8 mt -97.37 158.58 15.39 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -168.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.02 113.22 26.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.203 0.525 . . . . 0.0 110.009 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.727 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.76 -14.53 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.3 -29.17 62.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.12 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -105.72 -18.96 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.721 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.9 mm? -106.87 45.28 0.99 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.28 0.562 . . . . 0.0 110.417 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -76.85 -34.01 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.415 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 2.9 m-20 -71.17 -43.53 67.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.51 0.195 . . . . 0.0 110.802 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 8' ' ' ALA . 3.7 p -62.2 -39.74 85.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.76 81.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.161 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 55.1 mt-30 -71.46 -36.0 71.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.078 0.466 . . . . 0.0 110.496 -175.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 44.2 mtmt -62.45 -36.84 83.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.792 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.49 15.59 25.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.368 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 60.32 38.04 19.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.514 172.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.56 110.05 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.473 . . . . 0.0 111.008 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -109.6 -44.74 3.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.932 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.12 153.98 38.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.556 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.43 140.18 18.58 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.755 0.312 . . . . 0.0 110.317 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 72.9 Cg_endo -79.87 160.66 86.74 Favored 'Cis proline' 0 C--O 1.236 0.38 0 C-N-CA 123.276 -1.552 . . . . 0.0 112.629 -3.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 22.6 m -129.67 119.8 24.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.11 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.583 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.06 108.4 19.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.664 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -120.99 114.3 21.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.679 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.8 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -94.21 133.47 37.69 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.883 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.676 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 4.1 m-85 -117.53 156.03 28.76 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.436 -175.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.566 ' HG2' ' OD1' ' A' ' 80' ' ' ASN . 65.3 tttm -144.29 116.83 8.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.173 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.566 ' OD1' ' HG2' ' A' ' 79' ' ' LYS . 3.0 p-10 45.66 36.22 2.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.198 0.999 . . . . 0.0 112.664 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.93 5.93 76.96 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.254 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -115.58 14.61 16.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.742 0.271 . . . . 0.0 110.849 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.6 tt0 67.67 173.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.414 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.653 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.6 p -148.99 -33.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.932 0.396 . . . . 0.0 110.039 172.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.567 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -155.82 162.86 40.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.596 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -146.29 110.89 5.16 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.032 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.1 t -122.51 125.92 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.79 84.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.697 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.1 78.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.743 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 51.29 80.86 0.08 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.7 p-10 -124.47 87.24 54.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.439 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.7 Cg_exo -77.76 -38.89 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.523 1.482 . . . . 0.0 111.373 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.51 -44.55 10.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.913 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -68.68 -17.08 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.273 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.716 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.1 tp -58.69 -38.3 70.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 99' ' ' ILE . 12.8 mmmm -59.57 -36.25 75.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.162 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -51.91 -59.65 4.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.792 173.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -72.69 -36.22 67.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.345 0.593 . . . . 0.0 111.356 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.803 -171.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.21 -32.75 19.62 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.852 0.358 . . . . 0.0 111.327 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.53 48.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.792 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.567 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 66.9 m-80 -86.29 -53.99 4.7 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.621 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.802 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 121.075 0.464 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.9 148.08 25.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.905 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.452 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -111.92 120.08 40.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.817 174.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.618 ' H ' ' CD2' ' A' ' 55' ' ' LEU . 20.8 m-85 -73.43 164.41 26.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.219 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -116.23 -17.28 10.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.665 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.62 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 41.2 p -133.67 153.41 51.7 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.494 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.62 -31.37 66.17 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -60.91 -42.31 97.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.99 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.62 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.9 mm-40 -64.71 -42.68 95.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.391 0.615 . . . . 0.0 110.293 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 15' ' ' ILE . 5.3 t80 -66.42 -47.45 73.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.868 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.12 -47.7 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.408 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 20.1 m -68.93 -26.93 65.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.609 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -74.21 -54.57 7.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 27.4 pt -67.07 -19.71 25.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.23 -8.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.356 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.445 ' C ' ' H ' ' A' ' 19' ' ' LYS . 76.2 mt-30 -74.24 160.36 31.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.5 19.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.481 0.657 . . . . 0.0 111.427 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.5 ptmt -118.7 166.15 13.12 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.249 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.612 ' CD2' HG11 ' A' ' 84' ' ' VAL . 2.4 tm? -78.72 112.16 15.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 HG23 ' A' ' 23' ' ' VAL . 88.7 t -117.94 108.18 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.654 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.25 108.42 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.822 0.82 . . . . 0.0 111.015 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.624 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 59.9 t -104.56 142.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.526 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.872 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -122.12 119.7 32.1 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' A' ' 69' ' ' VAL . 56.2 m-85 -71.41 125.43 26.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.352 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.774 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -120.98 -174.28 2.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.077 -173.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.2 155.12 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.151 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.08 -5.41 59.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -111.87 33.65 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -132.96 146.64 51.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.592 0.711 . . . . 0.0 112.135 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.562 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -85.17 -42.37 7.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.991 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 23.0 Cg_endo -61.34 -40.11 51.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 CA-C-N 119.817 1.808 . . . . 0.0 111.417 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 12.5 p -57.57 -31.6 66.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.792 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tptt -66.19 -53.6 35.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.789 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.707 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 21.5 ptm -63.09 -44.55 95.4 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.684 ' CG1' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -74.82 -18.83 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.39 -48.66 96.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.6 Cg_exo -70.92 -31.03 16.04 Favored 'Trans proline' 0 C--N 1.36 1.149 0 CA-C-N 120.537 1.228 . . . . 0.0 112.004 171.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 35' ' ' MET . 20.1 mmt -66.61 -56.37 11.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.582 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.717 HG23 ' CE2' ' A' ' 52' ' ' PHE . 6.5 mt -59.66 -27.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 31.8 tt0 -53.94 -48.64 70.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 16.0 tppt? -65.95 -47.77 73.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.945 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.635 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 3.4 m-30 -62.66 -26.55 68.7 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.777 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 92.3 p -85.1 -15.25 44.55 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 42.5 tt0 -79.66 -25.99 41.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.174 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.635 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -96.22 8.43 43.89 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.66 ' HE2' ' CD2' ' A' ' 52' ' ' PHE . 5.1 m-85 -103.52 100.0 17.36 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.729 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.54 -43.01 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.758 2.305 . . . . 0.0 112.677 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.27 -14.87 17.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.763 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB2' ' HB1' ' A' ' 103' ' ' ALA . . . -104.68 165.04 11.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.48 137.37 51.76 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.717 ' CE2' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -109.12 131.03 55.46 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.187 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 42.8 m-85 -136.65 151.93 49.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.872 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 10.0 mtmp? -139.57 120.54 14.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.624 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.7 mt -100.32 161.11 13.82 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 5.7 m-20 -94.22 107.5 19.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -13.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -172.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 5.5 p-10 -77.72 -25.23 49.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 109.59 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -93.97 -40.3 10.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.816 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -98.21 53.98 1.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.764 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.621 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.21 -45.89 10.91 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.86 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.7 t70 -61.11 -44.64 97.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.508 0.194 . . . . 0.0 111.189 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.586 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.5 p -65.1 -38.65 83.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.169 0.509 . . . . 0.0 110.611 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.63 78.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.909 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 13.4 mm100 -72.56 -31.62 65.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.702 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.41 -41.84 90.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.804 0.811 . . . . 0.0 110.223 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -98.44 21.49 11.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.381 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 38.2 50.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.936 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.618 HG21 ' CD2' ' A' ' 25' ' ' PHE . 76.2 t -81.18 115.87 24.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.945 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 p -122.42 17.54 10.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.294 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.04 157.97 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -138.58 122.29 11.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 36' ' ' ILE . 98.2 Cg_endo -83.79 166.2 64.04 Favored 'Cis proline' 0 C--O 1.235 0.349 0 C-N-CA 123.751 -1.354 . . . . 0.0 112.505 -5.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 78.2 m -123.75 122.73 38.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.634 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -105.42 109.66 21.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -173.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 21.5 mt -125.52 115.86 20.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.859 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.579 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.58 125.32 39.16 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 174.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.9 m-85 -108.05 154.48 21.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.468 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 50.7 tptt -143.37 116.57 8.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.198 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.533 HD22 ' HG3' ' A' ' 79' ' ' LYS . 43.0 m-80 56.26 27.15 11.34 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 123.424 0.452 . . . . 0.0 111.527 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.54 10.06 59.72 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.002 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 47.6 pttt -109.88 1.9 19.5 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.632 0.73 . . . . 0.0 109.354 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.4 tt0 78.47 172.6 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.612 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -144.2 -31.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 109.847 173.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.454 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.37 162.37 30.74 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.842 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.6 tttt -139.82 124.64 18.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.603 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.5 t -131.02 137.97 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.8 83.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.893 0.854 . . . . 0.0 111.609 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.12 53.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.833 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.89 81.84 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 111.324 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 11.3 p-10 -117.67 90.82 36.86 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 95' ' ' ILE . 3.9 Cg_exo -77.2 -43.15 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.441 1.427 . . . . 0.0 110.897 169.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.3 16.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.094 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -74.61 -17.57 60.69 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.053 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.729 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.43 -38.77 76.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.618 ' HA ' HG22 ' A' ' 99' ' ' ILE . 31.2 mmmt -61.87 -29.66 70.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.357 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -56.39 -57.88 10.39 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 174.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.431 ' C ' HD11 ' A' ' 77' ' ' LEU . . . -74.86 -37.87 62.1 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -72.61 -39.14 60.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.009 -170.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.0 -32.41 21.52 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.361 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.83 70.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.14 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 52.5 m-80 -96.83 -62.33 1.28 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.603 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.87 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.302 0 CA-C-O 121.255 0.55 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 146.02 37.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.555 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -104.95 136.23 44.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.261 171.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.572 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.7 m-85 -90.82 161.53 15.23 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.996 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -119.0 -18.54 8.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.284 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 58.7 p -133.08 151.57 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 111.121 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -60.44 -27.58 67.62 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -62.74 -43.73 98.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.387 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 9.4 mm-40 -60.46 -46.21 90.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.321 0.582 . . . . 0.0 110.251 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.43 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 9.5 t80 -64.85 -47.9 76.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.241 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HA ' HG12 ' A' ' 15' ' ' ILE . 31.3 t70 -62.69 -33.69 75.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.608 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 m -73.43 -36.84 66.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.242 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.73 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.507 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.2 pt -67.78 -24.84 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.23 -15.68 60.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.084 0.468 . . . . 0.0 111.36 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.59 ' HB2' ' NZ ' ' A' ' 19' ' ' LYS . 98.2 mt-30 -76.46 156.47 33.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.802 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 17.9 t70 -48.38 -38.15 18.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -167.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.668 ' HE2' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -109.1 -178.96 3.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -162.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.669 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -59.58 116.04 3.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.02 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.2 t -119.72 107.2 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.967 170.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.664 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.86 103.4 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.737 0.779 . . . . 0.0 111.008 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 3.5 t -108.14 144.23 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.99 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -128.64 128.97 45.2 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CE2' HD12 ' A' ' 55' ' ' LEU . 80.9 m-85 -70.67 121.11 17.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.392 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.52 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 m-30 -120.19 176.1 5.62 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.251 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.65 16.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.889 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -84.48 -5.6 59.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -113.55 24.56 12.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 8.2 p -130.83 127.56 38.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.564 0.697 . . . . 0.0 111.65 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.04 -44.88 75.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.901 -1.045 . . . . 0.0 114.208 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 51.3 Cg_exo -57.6 -44.56 40.6 Favored 'Trans proline' 0 C--N 1.358 1.033 0 CA-C-N 119.98 1.89 . . . . 0.0 111.928 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 3.6 m -54.48 -37.19 64.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.391 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 38.6 ttpt -66.31 -47.04 74.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.149 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.435 ' O ' ' HG2' ' A' ' 39' ' ' MET . 24.8 ptt? -68.95 -45.25 71.22 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.665 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.32 -16.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.637 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.4 -55.41 44.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.508 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.7 Cg_endo -67.99 -27.85 35.98 Favored 'Trans proline' 0 C--N 1.358 1.032 0 CA-C-N 120.573 1.24 . . . . 0.0 111.993 172.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 35' ' ' MET . 96.6 mmm -67.08 -58.66 4.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.871 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.566 HG21 ' NZ ' ' A' ' 54' ' ' LYS . 65.0 mt -66.65 -20.39 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.994 -0.441 . . . . 0.0 111.794 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.87 -50.14 73.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.627 0.727 . . . . 0.0 109.531 164.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 43.3 tptt -60.19 -37.01 78.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.462 0.649 . . . . 0.0 109.83 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.691 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.8 m-30 -76.31 -15.07 60.06 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.379 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.758 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 24.2 p -73.58 -16.21 61.26 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 32.0 tt0 -87.6 -25.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.924 171.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.691 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 25.9 mm-40 -78.12 -30.03 49.2 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.729 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 4.1 p90 -120.39 83.6 33.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.25 -12.74 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.431 2.087 . . . . 0.0 111.438 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -6.11 49.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.602 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -127.87 165.55 19.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.557 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 12.4 m-20 -101.83 117.53 35.05 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.876 0.846 . . . . 0.0 112.617 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.2 p90 -98.02 113.66 25.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.545 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.695 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 32.7 m-85 -137.49 153.49 50.04 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.91 -0.494 . . . . 0.0 111.317 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.87 ' HG2' HG21 ' A' ' 2' ' ' VAL . 10.3 mmtt -128.3 142.95 50.99 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.572 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 72.7 mt -99.59 143.66 29.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.034 -0.416 . . . . 0.0 111.646 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 15.5 m-20 -86.51 100.66 12.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 166.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -59.01 -14.68 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 12.2 p-10 -71.76 -36.05 70.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 109.91 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.29 -15.08 16.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.386 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.593 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -109.22 44.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.91 -33.35 41.77 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.57 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.85 -45.85 80.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.702 0.287 . . . . 0.0 110.404 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -66.65 -36.91 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.492 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . . . -57.87 -50.17 74.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.358 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -63.77 -31.83 73.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.263 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -26.0 61.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.005 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -97.14 4.79 51.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.642 0.258 . . . . 0.0 110.975 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 62.82 43.75 6.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.847 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -88.33 121.66 38.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.889 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 p -123.67 -7.75 7.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.25 159.0 29.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.901 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -129.8 133.94 25.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.74 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.9 Cg_endo -86.05 171.05 41.6 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.903 -1.29 . . . . 0.0 111.199 -2.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.8 m -129.39 117.02 19.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -101.4 109.59 21.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 -175.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.593 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 23.9 mt -124.25 113.05 17.76 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.664 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.44 127.26 43.25 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.593 174.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 32.7 m-85 -108.66 159.71 16.52 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.646 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.774 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 61.0 tttp -142.46 118.01 10.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.847 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.774 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 5.9 p30 40.34 43.99 1.56 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.951 0.782 . . . . 0.0 112.912 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.71 1.41 58.46 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 114.073 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.99 10.93 18.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.291 0.546 . . . . 0.0 110.558 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.86 175.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.116 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.97 -35.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 173.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.483 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.69 165.18 36.98 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.411 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.593 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.8 tttt -148.9 115.98 6.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.556 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.29 139.25 48.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.21 89.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.503 0.668 . . . . 0.0 111.711 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.97 -174.78 31.68 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.469 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -72.91 93.15 1.69 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.883 0.373 . . . . 0.0 110.278 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 23.6 p-10 -119.49 69.21 11.37 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.0 -32.98 20.54 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.063 1.175 . . . . 0.0 111.002 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.96 -44.22 10.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.703 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.47 -17.13 61.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.2 tp -55.72 -39.51 55.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 99' ' ' ILE . 20.2 tptm -62.96 -32.44 73.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.368 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.18 -58.18 8.32 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.467 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -70.98 -36.67 72.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.539 0.685 . . . . 0.0 110.649 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -74.69 -42.04 47.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.178 -169.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -87.15 -39.42 15.53 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.961 0.41 . . . . 0.0 110.886 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.53 70.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.504 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 61.0 m-80 -89.04 -52.98 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.669 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.911 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.652 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.655 0.74 . . . . 0.0 111.734 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.27 147.85 23.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.325 -175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 4.9 pt20 -99.85 120.31 39.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.114 169.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.588 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 16.7 m-85 -73.17 133.6 44.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.665 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -86.14 -16.85 36.61 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 74.5 p -131.79 151.86 51.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 111.432 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.549 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -60.32 -30.8 69.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.792 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -64.14 -37.09 86.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.79 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.489 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 25.3 mm-40 -62.01 -47.76 83.35 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.237 0.541 . . . . 0.0 110.04 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -47.03 87.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.967 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.09 -46.15 68.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.634 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 17.7 m -71.85 -32.66 67.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.568 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.02 -49.83 47.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.595 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.0 pt -67.99 -18.6 23.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.323 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.19 -10.03 59.69 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.282 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 13' ' ' SER . 78.2 mt-30 -79.62 150.72 30.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.46 56.23 2.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.926 0.87 . . . . 0.0 111.033 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 5.5 ptmt -150.72 169.22 22.14 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.042 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.939 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -74.62 108.01 7.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.037 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 84.6 t -116.45 107.37 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.794 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.717 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.89 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.568 0.699 . . . . 0.0 111.173 176.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 90.9 t -102.85 135.23 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.267 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -117.63 106.63 13.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE2' HD12 ' A' ' 55' ' ' LEU . 81.2 m-85 -71.42 107.57 4.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.866 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -162.77 152.23 15.48 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -178.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -129.04 141.65 51.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 p -68.25 -4.35 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -73.94 6.4 3.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.2 p -122.56 -172.89 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.979 0.418 . . . . 0.0 111.893 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.59 -59.23 2.14 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.95 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 51.2 Cg_exo -53.86 -49.33 17.55 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.609 2.206 . . . . 0.0 111.944 -176.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.2 p -49.82 -37.92 32.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.803 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.791 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 8.0 ttpm? -66.41 -56.46 10.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.536 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 39' ' ' MET . 22.8 ptm -59.54 -45.87 90.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.695 HG13 HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -74.48 -22.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.524 -177.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -54.5 -57.06 20.5 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.222 -177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.791 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 20.9 Cg_endo -63.99 -35.01 56.97 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.294 1.329 . . . . 0.0 112.797 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 35' ' ' MET . 94.0 mmm -62.2 -56.36 19.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.695 HD12 HG13 ' A' ' 36' ' ' ILE . 23.6 mt -62.6 -23.81 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 120.782 0.325 . . . . 0.0 111.638 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.58 -43.94 79.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HG3' HE21 ' A' ' 46' ' ' GLN . 2.5 tppp? -62.18 -45.17 94.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.251 0.548 . . . . 0.0 110.239 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.66 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.9 m-30 -67.92 -15.32 63.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 13.5 p -87.11 -14.41 41.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.133 0.968 . . . . 0.0 108.697 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -86.68 -14.6 42.08 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.992 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.66 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -129.37 36.14 4.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.844 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -115.74 74.24 4.74 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.91 -36.09 90.93 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.337 2.024 . . . . 0.0 113.946 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -107.21 24.45 12.82 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.557 0.694 . . . . 0.0 111.54 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' HB2' ' CB ' ' A' ' 103' ' ' ALA . . . -138.95 165.6 26.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.337 -0.852 . . . . 0.0 111.803 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 117.67 19.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.89 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.844 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -93.2 129.57 39.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.575 -174.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 36.1 m-85 -137.49 135.56 36.9 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.841 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 30.1 mtmt -125.08 121.7 35.06 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.057 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.588 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 54.6 mt -85.66 125.11 32.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.455 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.693 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.0 p-10 -70.95 105.61 3.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -58.23 -12.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.404 -175.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.53 -44.95 85.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.729 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.11 -18.14 17.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.164 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -106.8 51.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 110.825 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -78.22 -41.17 18.01 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.25 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.74 -41.49 83.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 7.7 p -65.51 -38.68 83.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.0 110.221 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.51 77.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.994 0.426 . . . . 0.0 110.796 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 78.3 mm-40 -70.66 -27.16 63.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.753 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -75.26 -25.09 57.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.266 0.555 . . . . 0.0 110.412 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -100.25 12.29 37.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.245 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.17 42.87 9.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG13 ' OG1' ' A' ' 74' ' ' THR . 85.0 t -91.71 124.63 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -138.03 17.75 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.109 0.481 . . . . 0.0 110.908 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -138.88 146.85 41.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.03 124.13 27.07 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.382 . . . . 0.0 110.194 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 58.0 Cg_endo -85.78 170.33 44.24 Favored 'Cis proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.55 -2.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 98.3 m -124.67 115.76 21.28 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -105.63 108.51 20.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.98 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.8 mt -127.57 114.4 17.36 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.85 130.07 41.59 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.63 0.729 . . . . 0.0 110.259 174.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.651 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 88.7 m-85 -111.0 156.71 20.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.359 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.4 ttmt -141.63 116.13 9.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.349 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.55 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 42.33 43.81 3.13 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.769 0.828 . . . . 0.0 112.529 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.08 53.69 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.572 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.31 8.61 18.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.071 0.463 . . . . 0.0 110.183 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.651 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 45.8 mt-10 64.77 178.48 0.18 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.619 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.571 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.7 p -148.86 -33.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 170.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.408 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.41 163.66 35.26 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 88' ' ' VAL . 30.4 tttm -146.41 120.52 9.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.497 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.9 t -127.05 131.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.411 HG21 ' HE2' ' A' ' 86' ' ' LYS . 2.5 t -125.89 79.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.024 0.44 . . . . 0.0 111.248 -171.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.5 -168.81 38.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -69.65 93.39 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.3 p-10 -123.74 63.4 28.31 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.453 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.1 Cg_exo -67.35 -37.76 16.91 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.038 1.159 . . . . 0.0 110.579 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.8 -40.36 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.939 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.26 -17.21 61.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.272 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.71 -37.15 69.72 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.612 ' HA ' HG22 ' A' ' 99' ' ' ILE . 29.2 mmtt -57.63 -34.79 69.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.538 0.524 . . . . 0.0 110.623 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -54.33 -56.4 18.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -73.43 -44.09 59.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.478 0.656 . . . . 0.0 111.204 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.678 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -65.26 -41.43 91.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.858 -171.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.11 -42.06 11.92 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.826 0.346 . . . . 0.0 111.762 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.8 -39.1 73.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.408 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.3 m-80 -85.85 -56.73 3.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.072 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.402 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.821 HG21 ' HE2' ' A' ' 54' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 145.76 55.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 112.504 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.14 56.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.597 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.7 ' H ' HD22 ' A' ' 55' ' ' LEU . 18.4 m-85 -74.7 163.04 28.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.875 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -119.83 -13.83 9.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.523 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.641 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 82.2 p -135.05 152.29 51.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.882 0.372 . . . . 0.0 111.098 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.81 -30.53 67.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -64.06 -39.17 93.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.901 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.641 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 15.8 mm-40 -60.8 -42.3 97.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.996 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -64.94 -49.15 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.739 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.36 -43.23 83.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.759 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -70.8 -36.06 72.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.72 -52.16 40.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.519 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 28.4 pt -65.03 -21.04 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.191 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.03 -6.99 57.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.749 0.309 . . . . 0.0 111.687 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.9 mt-30 -81.56 159.05 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.876 0.369 . . . . 0.0 110.325 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.73 18.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.237 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 17' ' ' GLN . 30.3 mtpt -107.75 174.61 5.81 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.906 0.86 . . . . 0.0 112.68 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.646 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tm? -91.2 107.06 18.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.355 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 67.3 t -106.0 115.45 47.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.547 HG22 HD22 ' A' ' 77' ' ' LEU . 21.6 t -92.3 102.39 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.211 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.576 HG23 HG12 ' A' ' 21' ' ' VAL . 44.2 t -108.39 136.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.473 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' CG ' ' A' ' 54' ' ' LYS . . . -128.92 141.55 51.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 120.764 0.316 . . . . 0.0 111.821 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.666 ' CD2' HG21 ' A' ' 69' ' ' VAL . 59.0 m-85 -95.11 122.52 37.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.336 0.589 . . . . 0.0 110.55 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.733 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.5 m-85 -119.98 -175.28 2.94 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.243 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.61 165.76 20.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -84.92 -5.55 59.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.317 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -122.88 34.59 5.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.776 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.673 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 6.9 p -132.11 121.82 24.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.527 0.68 . . . . 0.0 111.834 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.39 -42.12 97.79 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.923 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.611 ' O ' HG23 ' A' ' 36' ' ' ILE . 50.3 Cg_exo -57.47 -44.3 43.57 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.021 1.91 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 9.2 m -53.32 -41.35 65.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.718 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 37.5 ttpt -63.06 -56.36 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.6 ptp -60.65 -47.79 84.68 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.34 -13.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.014 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.67 -53.64 63.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.291 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.9 Cg_endo -65.53 -33.19 47.08 Favored 'Trans proline' 0 C--N 1.357 1.003 0 CA-C-N 120.281 1.136 . . . . 0.0 112.448 169.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 mmt -65.02 -58.92 4.85 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.969 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.521 HG12 HG21 ' A' ' 95' ' ' ILE . 51.6 mt -64.42 -23.04 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 122.107 -0.371 . . . . 0.0 111.399 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 42.6 tt0 -63.12 -41.51 99.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.66 0.743 . . . . 0.0 110.133 170.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 19.7 ttmt -64.56 -38.94 92.75 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.087 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.68 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.4 m-30 -69.63 -23.82 63.56 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.267 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 2.0 p -73.81 -14.67 61.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.71 -23.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.68 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 53.5 mt-30 -80.65 -33.38 35.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.063 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 5.8 p90 -108.43 92.13 9.44 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.2 Cg_endo -84.39 -12.79 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.132 2.555 . . . . 0.0 111.37 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 50' ' ' ALA . 3.3 pt20 -88.2 -22.95 23.73 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.354 0.597 . . . . 0.0 110.385 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -113.68 148.16 36.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 7.0 m-20 -91.12 116.73 29.04 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.402 0.62 . . . . 0.0 111.523 -174.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.686 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 2.8 p90 -87.7 114.55 24.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.946 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 22.1 m-85 -130.78 164.85 24.22 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.238 170.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.821 ' HE2' HG21 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -153.29 119.9 5.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 5.4 mt -99.31 159.52 14.94 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.255 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.42 118.77 37.59 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -63.34 -11.48 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.636 -174.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.24 -37.48 78.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.975 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.21 -31.02 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.458 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.579 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.0 mm? -107.73 48.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.004 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.598 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.92 -41.78 17.89 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.117 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 4.5 m-20 -66.7 -44.1 82.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.509 0.195 . . . . 0.0 110.839 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.0 p -62.74 -38.03 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.202 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.89 85.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.167 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 17.1 mm100 -71.37 -32.13 68.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.901 0.382 . . . . 0.0 110.464 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.42 -42.63 92.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.6 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -94.81 14.74 20.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.044 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 58.86 43.79 17.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.602 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.666 HG21 ' CD2' ' A' ' 25' ' ' PHE . 94.8 t -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.979 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 p -125.87 22.43 7.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.156 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 88' ' ' VAL . . . -142.91 151.01 40.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.673 ' SD ' ' HB3' ' A' ' 30' ' ' CYS . 16.2 ptt? -121.45 123.15 27.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.202 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 6.1 Cg_endo -86.88 172.35 35.47 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.428 -1.072 . . . . 0.0 111.511 -3.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 55.1 m -138.82 116.78 11.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.698 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.5 mp -107.13 142.53 36.67 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.093 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 86' ' ' LYS . 21.8 mt -134.28 110.6 9.61 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.094 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.45 124.08 34.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.758 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 31.5 m-85 -109.68 154.65 22.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.955 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.611 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 58.5 tttp -142.95 115.06 8.34 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.961 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.603 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 9.6 p30 44.69 38.11 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.965 0.906 . . . . 0.0 112.45 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.43 3.93 63.42 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.697 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 16.8 ptmt -103.59 -3.7 24.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 109.412 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 29.3 tt0 77.23 -179.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.593 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.602 HG11 ' CD2' ' A' ' 20' ' ' LEU . 2.1 p -152.2 -32.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.884 0.374 . . . . 0.0 110.04 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.25 162.13 40.17 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.129 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.434 ' HG3' HD22 ' A' ' 76' ' ' LEU . 35.0 tttp -138.17 122.49 18.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.029 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.616 HG11 ' ND2' ' A' ' 91' ' ' ASN . 10.1 p -128.98 131.22 68.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.302 0.572 . . . . 0.0 110.277 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.0 t -131.11 80.41 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.672 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.36 -175.12 38.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.926 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.42 94.72 2.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.941 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 22.8 p-10 -124.45 68.95 51.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 95' ' ' ILE . 18.7 Cg_exo -64.68 -43.65 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 120.614 0.876 . . . . 0.0 110.991 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.88 -32.43 18.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.941 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.88 -18.76 59.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.429 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.0 tp -59.9 -38.12 75.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.589 ' HA ' HG22 ' A' ' 99' ' ' ILE . 19.3 tptm -64.27 -26.82 68.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.168 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.4 tm0? -58.83 -59.26 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 170.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 -38.36 78.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.7 . . . . 0.0 110.741 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -71.63 -42.37 71.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.146 -170.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.19 -40.45 14.57 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.99 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.76 -40.4 66.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.572 -175.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.8 m-80 -85.55 -56.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.469 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.646 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.581 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.958 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.302 0.572 . . . . 0.0 110.483 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.73 148.25 33.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.899 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.483 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -112.46 118.49 35.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.391 172.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.611 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -69.9 163.06 26.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 110.68 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -115.59 -18.34 10.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.176 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.61 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 28.5 p -138.0 155.49 48.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.501 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.64 -34.85 73.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 m -57.24 -37.77 72.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.991 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.61 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 34.4 mm-40 -63.36 -45.03 93.07 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.307 0.575 . . . . 0.0 109.961 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HD2' HG21 ' A' ' 23' ' ' VAL . 1.9 t80 -66.75 -50.36 62.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.747 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.53 -39.73 80.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.396 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.1 m -69.45 -37.05 77.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -66.62 -49.6 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.858 0.361 . . . . 0.0 110.814 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.5 pt -66.69 -24.26 32.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.649 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 -5.76 48.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.42 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 26.0 mt-30 -75.94 157.04 33.64 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.985 0.421 . . . . 0.0 110.302 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.45 -1.78 3.91 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.73 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 11.1 ptmt -115.47 173.86 6.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.21 0.528 . . . . 0.0 111.812 -167.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.574 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.41 113.69 11.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -122.12 107.86 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.766 0.317 . . . . 0.0 110.641 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.587 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.93 109.2 26.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.867 0.842 . . . . 0.0 111.588 176.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 98.9 t -104.28 142.54 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.151 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.856 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -129.43 138.35 51.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 69' ' ' VAL . 70.1 m-85 -88.51 126.6 35.33 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.25 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.2 m-30 -120.82 -172.06 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.637 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -169.9 162.51 9.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.227 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 p -83.98 -4.85 59.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -122.8 35.0 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 -176.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -130.95 143.88 51.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.814 0.816 . . . . 0.0 111.911 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.48 -45.43 6.49 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.276 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 50.9 Cg_exo -57.11 -50.63 10.73 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.903 1.735 . . . . 0.0 112.17 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 28.5 p -53.5 -34.37 57.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.71 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 4.6 ttmp? -68.55 -45.17 72.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.064 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 24.9 ptt? -72.86 -41.52 64.67 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.277 0.561 . . . . 0.0 112.444 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.664 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.91 -17.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.44 177.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.03 -49.22 94.89 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.8 Cg_endo -69.84 -29.44 23.5 Favored 'Trans proline' 0 C--N 1.358 1.066 0 CA-C-N 120.56 1.236 . . . . 0.0 112.592 169.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.6 mmt -67.68 -52.21 40.57 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.958 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.786 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -55.8 -35.2 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 173.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 12.7 tp10 -55.45 -49.88 71.3 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.149 0.5 . . . . 0.0 110.254 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -61.63 -48.04 82.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.097 0.475 . . . . 0.0 110.493 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.661 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 m-30 -63.02 -22.36 66.8 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.981 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.471 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 34.9 p -82.03 -19.59 40.08 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.726 0.774 . . . . 0.0 108.949 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -77.48 -29.91 52.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.673 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.661 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -100.39 26.31 6.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.251 175.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.747 ' CE1' HD11 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -100.12 89.34 1.08 Allowed Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.889 170.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 83.0 Cg_endo -84.99 -45.18 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.125 1.883 . . . . 0.0 114.075 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.69 -24.19 14.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.226 0.536 . . . . 0.0 111.845 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.36 164.38 11.68 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.577 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.0 128.32 55.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.786 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.52 120.87 43.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.642 ' HA ' HG23 ' A' ' 2' ' ' VAL . 29.6 m-85 -132.39 142.03 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.737 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.958 ' HG2' HG21 ' A' ' 2' ' ' VAL . 7.8 mmtt -127.93 120.0 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.654 HD13 ' HG ' ' A' ' 60' ' ' LEU . 6.0 mt -100.67 167.73 10.14 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.53 120.41 40.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -15.96 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.281 -174.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.65 -51.04 46.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.913 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.16 -29.7 31.42 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.469 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.9 mm? -96.14 57.59 1.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 0.0 111.22 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.545 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.97 -45.43 10.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.375 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 33.3 t70 -61.25 -45.42 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.649 0.262 . . . . 0.0 111.165 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.9 p -64.82 -38.04 81.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.384 . . . . 0.0 110.557 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.05 74.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.0 110.81 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 16.9 mm100 -75.02 -28.79 60.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.607 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 87.7 mttt -61.84 -41.31 97.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.462 0.649 . . . . 0.0 110.549 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -92.2 7.75 41.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.125 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 55.16 46.61 23.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.058 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 25' ' ' PHE . 93.3 t -77.89 109.44 12.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.41 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.51 -2.57 11.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.357 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.03 23.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.994 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.89 145.6 32.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.629 0.252 . . . . 0.0 110.695 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 90.5 Cg_endo -82.04 171.24 56.4 Favored 'Cis proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.355 -1.519 . . . . 0.0 112.046 -3.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.594 HG22 HD11 ' A' ' 76' ' ' LEU . 19.2 m -127.11 119.0 25.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -108.24 106.23 16.31 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.002 0.429 . . . . 0.0 111.016 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.594 HD11 HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -118.84 119.06 33.27 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.117 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -94.91 119.01 32.74 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.2 m-85 -105.37 160.25 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.86 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' HD22 ' A' ' 80' ' ' ASN . 65.8 tttp -150.68 125.5 9.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.014 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.55 HD22 ' HG2' ' A' ' 79' ' ' LYS . 55.2 m-80 53.9 33.76 17.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 111.882 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.19 60.91 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.719 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 47.3 mmtm -102.06 -73.55 0.65 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 9.5 pt-20 165.41 -170.98 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 124.724 1.265 . . . . 0.0 108.511 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 77' ' ' LEU . 1.5 p -156.62 -30.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.446 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -163.02 161.96 25.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.411 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.573 ' HG3' HD12 ' A' ' 76' ' ' LEU . 71.5 tttt -146.61 124.38 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.184 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.47 132.95 70.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.26 78.67 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.124 0.488 . . . . 0.0 110.853 -171.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.42 -171.79 40.02 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.609 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.38 93.57 2.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.0 p-10 -118.93 71.87 11.09 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 95' ' ' ILE . 7.3 Cg_exo -73.65 -31.75 8.33 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.264 1.309 . . . . 0.0 109.833 166.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.59 -44.1 10.32 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.432 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.91 -16.9 61.09 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.424 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.715 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -57.09 -37.68 56.62 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 169.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.683 ' HA ' HG22 ' A' ' 99' ' ' ILE . 13.9 mmmm -56.96 -32.77 66.37 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.743 0.652 . . . . 0.0 110.37 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -57.99 -56.65 19.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.605 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -77.9 -28.33 49.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.747 HD11 ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -74.43 -44.7 47.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.654 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 -32.44 22.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.279 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.88 82.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 17.9 m-80 -114.22 -77.21 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.192 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.917 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -171.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.903 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.575 0.702 . . . . 0.0 111.708 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.437 ' CG2' ' HD1' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -81.33 148.66 29.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.428 -177.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.5 141.08 35.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 170.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.545 ' HB2' HD22 ' A' ' 55' ' ' LEU . 14.3 m-85 -98.77 157.15 16.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.044 0.449 . . . . 0.0 110.021 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -123.71 -17.42 6.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 50.0 p -130.08 150.88 51.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.952 0.406 . . . . 0.0 111.025 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -60.35 -30.39 69.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.396 175.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -67.77 -33.58 75.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.479 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 22.1 mm-40 -61.73 -47.16 86.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.264 0.554 . . . . 0.0 110.07 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.6 -45.98 81.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.059 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.99 -48.51 81.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.371 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -69.36 -26.74 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.49 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -70.66 -53.25 16.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.427 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 pt -65.35 -21.97 30.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.332 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.88 -2.75 48.77 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.49 ' NE2' ' HA ' ' A' ' 14' ' ' ALA . 78.1 mt-30 -76.09 158.55 31.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.506 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 33.9 t70 -80.16 28.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.104 0.954 . . . . 0.0 110.026 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 7.8 ptmt -134.75 169.12 17.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.506 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.811 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tm? -82.53 116.92 22.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.896 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.6 t -115.32 107.63 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.742 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.72 103.69 15.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 122.164 0.983 . . . . 0.0 111.209 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 21' ' ' VAL . 18.0 t -100.47 139.92 20.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.27 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -130.33 138.57 50.5 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.664 0.269 . . . . 0.0 111.698 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CD2' HG21 ' A' ' 69' ' ' VAL . 49.7 m-85 -88.59 128.17 35.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.92 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.4 m-30 -120.45 -170.93 2.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.04 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.24 172.39 12.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.252 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -20.74 65.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.225 0.536 . . . . 0.0 110.868 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 23.1 p90 -101.39 -147.45 0.36 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.254 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.9 p 56.73 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.408 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.86 -41.45 76.13 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 114.319 -1.309 . . . . 0.0 114.178 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.677 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 46.4 Cg_exo -58.82 -43.73 41.57 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 120.25 2.025 . . . . 0.0 112.154 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.4 m -53.21 -40.0 64.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.383 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.758 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 96.1 mttt -65.56 -53.34 43.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.499 -178.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.8 ptm -62.8 -45.36 92.99 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.649 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.62 -18.43 15.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.924 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.4 -48.16 97.78 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.758 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.9 Cg_exo -70.74 -32.53 14.34 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.174 1.249 . . . . 0.0 112.008 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.1 mmm -64.26 -51.02 65.65 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.614 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.57 HD13 ' CG1' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -53.85 -36.94 31.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-O 120.624 0.249 . . . . 0.0 110.341 172.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.92 -44.49 97.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.721 0.296 . . . . 0.0 111.195 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.92 -50.13 75.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.577 0.703 . . . . 0.0 109.408 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.704 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 14.1 m-30 -63.7 -17.17 62.7 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.482 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 9.6 p -86.15 -14.05 45.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.978 0.894 . . . . 0.0 108.921 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -88.14 -16.63 32.91 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.704 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -128.77 29.92 5.17 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.809 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -108.58 100.83 40.45 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-O 122.193 0.997 . . . . 0.0 112.623 172.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.85 -44.12 10.9 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.826 2.35 . . . . 0.0 114.375 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.5 -13.45 17.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 111.349 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -103.33 158.19 16.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.786 0.803 . . . . 0.0 112.002 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -126.38 119.13 26.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.173 171.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.809 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -87.64 130.58 34.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 -175.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.572 ' CE2' HG13 ' A' ' 21' ' ' VAL . 37.9 m-85 -133.32 133.07 42.06 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.356 168.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.903 ' HG2' HG21 ' A' ' 2' ' ' VAL . 8.0 mmpt? -117.0 118.96 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 1.3 mt -102.4 175.22 5.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.017 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -115.88 121.46 42.42 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -67.89 -10.58 12.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.198 -175.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.64 -35.64 52.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.58 -27.49 21.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.706 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.657 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.0 mt -117.85 54.09 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.367 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.25 -39.16 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.112 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.6 t70 -68.07 -46.99 69.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.644 0.259 . . . . 0.0 110.632 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.657 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.6 p -62.18 -38.45 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.402 . . . . 0.0 110.35 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.31 77.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.918 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 27.5 mt-30 -76.42 -30.85 57.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.461 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 39.1 mtmt -58.62 -39.95 81.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.51 0.671 . . . . 0.0 110.056 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -91.26 9.44 31.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.691 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 56.44 45.62 22.27 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.348 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 25' ' ' PHE . 62.3 t -85.96 123.72 39.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.508 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -134.67 -35.56 0.88 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.53 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.32 119.84 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.979 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.57 136.93 19.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.417 . . . . 0.0 110.872 -175.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 85.2 Cg_endo -83.98 169.88 52.84 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.124 -1.615 . . . . 0.0 111.714 -4.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.489 ' OG1' HG13 ' A' ' 69' ' ' VAL . 55.9 m -117.06 116.88 28.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.579 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.34 108.65 20.15 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.172 0.511 . . . . 0.0 111.084 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.538 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.4 mt -126.63 116.08 20.47 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.606 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.742 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.81 125.98 41.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.933 173.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 25.7 m-85 -108.73 154.28 22.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.381 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' HG2' HD22 ' A' ' 80' ' ' ASN . 22.5 ttmm -139.99 111.6 7.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.536 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.555 HD22 ' HG2' ' A' ' 79' ' ' LYS . 30.8 m-80 57.32 31.75 20.64 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.652 0.595 . . . . 0.0 111.508 -176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.36 11.19 51.77 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.51 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -106.01 0.3 25.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.764 0.792 . . . . 0.0 109.097 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 72.05 175.51 0.28 Allowed 'General case' 0 CA--C 1.524 -0.049 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.246 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.76 HG11 HD21 ' A' ' 20' ' ' LEU . 1.1 p -148.61 -30.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.006 0.431 . . . . 0.0 109.917 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.638 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.61 164.54 29.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.645 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.1 tttt -146.4 118.37 8.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.167 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.17 131.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.17 76.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.204 0.526 . . . . 0.0 111.376 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.47 -167.51 35.71 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.226 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.99 96.99 3.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 110.094 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.1 p-10 -122.27 67.17 25.77 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.1 -34.63 27.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.173 1.248 . . . . 0.0 110.944 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.21 -43.26 11.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.143 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.4 -17.75 60.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.624 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.684 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.8 tp -58.85 -37.57 67.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 170.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.592 ' HA ' HG22 ' A' ' 99' ' ' ILE . 21.4 tptm -60.65 -32.76 71.92 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.049 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -56.17 -55.83 28.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 173.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.74 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -73.53 -36.04 65.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.542 0.687 . . . . 0.0 111.106 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -71.71 -45.11 67.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.645 -171.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.498 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -89.1 -40.81 12.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.917 0.389 . . . . 0.0 111.706 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.93 83.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.295 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.638 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 79.1 m-20 -93.25 -56.88 2.79 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.629 -172.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.811 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.165 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.651 HG11 ' HG2' ' A' ' 54' ' ' LYS . 35.9 t . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.041 0.448 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 146.6 51.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.889 0.852 . . . . 0.0 112.397 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -103.38 141.52 35.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.804 -1.543 . . . . 0.0 109.463 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.729 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.7 m-85 -94.5 158.03 15.73 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -119.86 -15.08 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.704 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 37.2 p -135.07 151.5 50.82 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.41 -29.76 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.6 t -59.88 -46.89 87.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.063 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.2 mm-40 -60.38 -42.94 96.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.414 0.626 . . . . 0.0 110.143 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 19.7 t80 -67.58 -47.28 70.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.087 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' HA ' HG12 ' A' ' 15' ' ' ILE . 25.3 t70 -60.96 -42.85 99.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.597 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 22.6 t -67.16 -39.33 86.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.713 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -65.49 -50.84 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.981 0.419 . . . . 0.0 110.722 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 11' ' ' PHE . 35.5 pt -67.41 -18.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.632 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.62 -14.12 52.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 13' ' ' SER . 54.7 mt-30 -69.16 150.19 47.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 39.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.482 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 10.5 ptmt -136.75 167.38 21.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.588 HD21 HG11 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -77.6 108.01 10.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.475 HG12 HG23 ' A' ' 23' ' ' VAL . 53.0 t -110.02 107.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.209 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.693 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.93 103.12 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 122.062 0.934 . . . . 0.0 110.84 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 70.8 t -102.35 143.18 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.866 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -127.9 117.53 21.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -70.51 129.1 38.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.525 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.581 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 7.6 m-30 -118.5 -177.45 3.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . . . -152.23 130.21 11.8 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -58.26 -24.74 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.716 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -96.75 8.99 43.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.797 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.942 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -107.07 138.29 43.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.307 0.575 . . . . 0.0 111.786 -177.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -81.72 -37.65 16.11 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.904 -1.044 . . . . 0.0 114.546 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.942 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.1 Cg_exo -66.25 -29.33 46.92 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 120.359 2.08 . . . . 0.0 110.378 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 58.5 m -51.12 -39.62 56.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.732 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.931 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 13.5 mptt -67.79 -57.37 6.43 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.801 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 23.4 ptp -54.19 -50.22 67.57 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.692 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.41 -21.19 16.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.931 -177.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.96 -60.06 10.7 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.01 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.931 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 9.3 Cg_endo -56.37 -36.22 96.96 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 121.268 1.312 . . . . 0.0 112.792 169.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.597 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 26.1 mmt -62.75 -51.58 66.56 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.371 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.594 ' CG2' HG21 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -52.51 -32.73 17.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 122.672 0.389 . . . . 0.0 111.509 176.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 44.8 mt-10 -59.64 -48.57 81.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.351 0.596 . . . . 0.0 110.479 173.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 18.5 tptm -61.22 -47.62 85.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.685 0.755 . . . . 0.0 109.874 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.664 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 34.0 m-85 -67.42 -20.55 65.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.78 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 84.9 p -77.09 -15.96 59.39 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 108.85 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 37.1 tt0 -80.38 -20.7 43.46 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.537 171.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.664 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 7.3 mm100 -83.46 -7.05 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.984 175.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.715 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 7.5 p90 -134.68 85.44 36.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.36 0.6 . . . . 0.0 112.46 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.56 -21.9 4.05 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.218 2.612 . . . . 0.0 112.423 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.72 -1.0 50.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.438 0.637 . . . . 0.0 110.527 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -119.12 165.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -108.84 117.59 34.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.297 0.57 . . . . 0.0 111.997 -175.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 1.6 p90 -83.55 121.48 27.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.048 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 31.5 m-85 -136.74 142.59 43.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.335 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.866 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 10.9 mmtt -126.91 124.13 38.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.729 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.8 mt -100.67 -178.24 3.72 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.169 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 11.5 t0 -133.89 131.32 38.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.34 -8.7 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.316 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -31.62 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 109.971 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.61 -27.05 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.046 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.595 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.87 52.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.0 -39.81 22.81 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.487 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -44.0 73.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.775 0.322 . . . . 0.0 110.694 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.595 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -65.39 -38.82 83.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.048 0.451 . . . . 0.0 110.394 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.36 69.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.6 mt-30 -72.89 -36.83 67.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.962 0.411 . . . . 0.0 110.245 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -91.66 10.17 29.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.82 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 56.47 44.15 24.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.423 HG13 ' OG1' ' A' ' 74' ' ' THR . 74.2 t -73.7 109.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.489 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -117.54 -25.92 6.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.541 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.78 117.57 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.036 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -100.63 150.41 36.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 14.1 Cg_exo -71.21 171.47 59.51 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 123.872 -1.303 . . . . 0.0 111.834 -6.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 19.9 m -131.07 115.52 16.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.596 HD13 HD13 ' A' ' 95' ' ' ILE . 3.8 mt -105.7 108.67 20.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.503 0.668 . . . . 0.0 111.115 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.602 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 25.5 mt -123.23 114.4 20.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.014 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.693 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -93.75 125.02 38.13 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.168 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 m-85 -107.37 155.64 19.79 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.431 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -141.04 131.94 25.99 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.02 44.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 19.02 60.0 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.579 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 14.7 tttp -126.39 0.92 6.99 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.338 0.59 . . . . 0.0 110.215 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 39.2 mt-10 73.14 -179.1 0.2 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.951 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.588 HG11 HD21 ' A' ' 20' ' ' LEU . 1.3 p -153.31 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.754 174.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.745 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -157.71 163.0 38.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.119 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 77.0 tttt -144.26 116.69 8.55 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.944 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 t -123.89 133.88 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.13 78.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.283 0.563 . . . . 0.0 110.927 -170.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.59 -175.67 39.78 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 96.48 1.87 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 19.1 p-10 -119.41 78.8 20.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 3.4 Cg_exo -74.91 -29.94 7.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.469 1.446 . . . . 0.0 110.319 167.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -90.25 -51.03 5.64 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.618 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -67.68 -16.59 64.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.518 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -55.74 -37.59 47.49 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.726 ' HA ' HG22 ' A' ' 99' ' ' ILE . 11.7 mmmm -58.39 -34.52 70.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.023 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.01 -58.66 6.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.37 55.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.784 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -80.49 -40.02 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.471 -172.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.19 17.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.666 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.19 70.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.745 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 89.0 m-20 -101.14 -68.92 0.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.273 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.419 HG11 ' HE3' ' A' ' 54' ' ' LYS . 39.4 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 120.961 0.41 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -70.18 149.24 47.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.065 -176.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -109.14 134.08 52.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.492 175.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.674 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.3 m-85 -86.75 164.4 16.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.164 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -123.22 -13.72 7.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.709 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 71.2 p -137.32 155.35 49.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.724 0.297 . . . . 0.0 111.017 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.553 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.85 -31.22 69.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 t -61.23 -42.09 98.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.7 mm-40 -59.0 -43.93 91.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.32 0.581 . . . . 0.0 109.992 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 15' ' ' ILE . 1.4 t80 -63.65 -49.18 74.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.843 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.1 -44.44 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.925 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 34.5 t -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.974 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -49.74 42.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.906 0.384 . . . . 0.0 110.666 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 29.3 pt -66.99 -21.71 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.548 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.67 -8.62 59.33 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.884 0.374 . . . . 0.0 111.371 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 13' ' ' SER . 27.6 mt-30 -75.63 158.99 31.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.733 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.04 36.24 0.34 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.42 0.628 . . . . 0.0 110.347 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' GLN . 29.1 mmmt -126.71 160.27 31.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.651 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.74 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.7 tm? -77.57 105.56 8.8 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 53.3 t -110.23 107.12 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.024 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.744 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.73 108.99 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.684 0.754 . . . . 0.0 110.818 175.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 85.1 t -103.53 142.72 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.117 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.711 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -126.72 113.68 16.98 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.81 106.48 7.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.063 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.708 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.2 m-85 -133.28 175.82 9.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 112.143 -171.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.07 163.56 39.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.49 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -85.49 -8.64 58.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -108.02 27.65 9.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -129.26 128.11 42.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.441 0.639 . . . . 0.0 111.306 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.14 97.49 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 114.713 -1.131 . . . . 0.0 114.107 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.572 ' O ' HG22 ' A' ' 36' ' ' ILE . 38.7 Cg_exo -58.15 -39.41 85.46 Favored 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 119.714 1.757 . . . . 0.0 110.674 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 39.0 m -58.57 -34.08 70.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.2 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 29.1 mtpp -63.87 -55.65 21.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.423 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 26.0 ptt? -61.03 -44.56 97.22 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.708 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.23 -24.15 18.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.796 -178.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -53.85 -51.36 77.46 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.619 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 35.6 Cg_endo -68.12 -32.46 27.5 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 120.215 1.113 . . . . 0.0 112.603 169.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.422 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.6 mmt -64.66 -57.59 8.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.597 HD12 ' CG1' ' A' ' 36' ' ' ILE . 36.5 mt -66.46 -23.12 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.45 0.568 . . . . 0.0 111.39 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.94 -47.29 85.61 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.53 0.681 . . . . 0.0 109.46 168.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -63.41 -48.53 77.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.145 0.498 . . . . 0.0 110.516 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.642 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 11.7 m-30 -65.6 -15.56 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.975 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 p -87.21 -14.9 39.8 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 121.555 0.693 . . . . 0.0 109.274 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.27 -23.2 40.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 168.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.642 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -120.87 34.08 5.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -104.59 85.11 1.07 Allowed Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 122.016 0.912 . . . . 0.0 112.298 172.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 24.3 Cg_exo -64.02 -45.68 9.82 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.005 1.803 . . . . 0.0 113.916 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -107.81 24.65 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 103' ' ' ALA . . . -128.98 156.38 43.88 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.798 -0.564 . . . . 0.0 111.914 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.76 120.26 40.2 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.24 169.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.613 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -103.35 116.74 33.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.5 -171.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CD2' HG13 ' A' ' 21' ' ' VAL . 23.2 m-85 -129.17 136.26 49.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.711 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -121.18 119.06 31.25 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.675 HD13 ' HG ' ' A' ' 60' ' ' LEU . 5.2 mt -100.96 160.55 14.28 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.776 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.48 114.56 26.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -11.25 9.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.44 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.02 -51.09 27.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.548 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -86.96 -25.68 24.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.438 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.675 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.6 mm? -99.99 45.06 0.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 111.316 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.05 -37.03 30.07 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.848 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.1 -42.41 94.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.695 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 8' ' ' ALA . 3.1 p -67.19 -39.09 82.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.81 76.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.72 -33.08 72.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.204 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -27.73 64.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.667 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -95.18 10.83 34.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.88 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 60.09 41.33 17.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.791 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.5 t -99.95 110.53 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.571 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 p -110.73 -19.22 12.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.85 0.357 . . . . 0.0 110.727 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.15 168.39 10.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.13 148.53 35.47 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.66 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 18.8 Cg_exo -70.77 173.35 48.61 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.839 -0.901 . . . . 0.0 112.581 -6.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 87.6 m -147.23 117.32 7.28 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.839 0.352 . . . . 0.0 110.496 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.463 ' HG ' HD13 ' A' ' 95' ' ' ILE . 4.0 mm? -110.76 111.23 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.326 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.413 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 35.8 mt -125.87 115.39 19.9 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -96.86 128.82 44.19 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.018 174.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 29.0 m-85 -110.72 155.53 22.34 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.131 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.641 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.3 tttt -142.28 116.83 9.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.829 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.641 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.52 38.4 7.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.787 0.835 . . . . 0.0 111.847 -177.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.15 8.63 55.06 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.34 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -109.39 4.05 22.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 109.997 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 24.2 tt0 67.92 174.6 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.025 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.4 p -144.31 -32.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.933 0.396 . . . . 0.0 110.117 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.411 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -157.93 161.33 38.2 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.979 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.413 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 1.7 ttmp? -139.72 117.48 11.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.245 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.08 125.71 73.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.05 87.0 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 111.296 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 -173.63 33.63 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.027 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 73' ' ' PRO . . . -71.91 103.62 3.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.5 p-10 -127.22 65.65 65.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 10.1 Cg_exo -69.21 -34.07 17.23 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 120.867 1.045 . . . . 0.0 110.871 174.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.53 -45.34 9.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -70.92 -17.24 62.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.58 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.652 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.7 tp -56.96 -38.45 59.77 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HA ' HG22 ' A' ' 99' ' ' ILE . 30.5 mmtt -59.58 -35.37 74.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.761 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.14 -54.01 45.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -76.7 -39.77 50.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.629 0.728 . . . . 0.0 111.3 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -69.57 -41.0 80.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.678 -171.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 -38.57 14.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.635 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.11 -31.13 55.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 45.5 m-80 -95.65 -60.07 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.33 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.74 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.245 0.867 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.463 170.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.94 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.597 0.713 . . . . 0.0 112.025 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.54 148.44 27.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.204 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 133.33 50.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.061 170.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.634 ' H ' HD22 ' A' ' 55' ' ' LEU . 15.3 m-85 -84.38 164.32 19.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -117.79 -16.91 9.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.444 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 40.1 p -134.89 153.64 51.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.42 -33.71 68.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -64.29 -32.09 73.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.474 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.625 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 23.4 mm-40 -67.42 -44.09 79.62 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.093 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -44.38 94.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.633 176.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.33 -44.42 88.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.447 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -71.14 -25.7 62.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.788 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.522 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -77.14 -50.02 13.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.684 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 pt -66.53 -17.83 23.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.286 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.05 59.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.893 0.377 . . . . 0.0 111.586 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' A' ' 14' ' ' ALA . 77.3 mt-30 -71.55 150.77 44.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.343 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.68 28.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.41 0.624 . . . . 0.0 110.975 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 17' ' ' GLN . 15.0 ptmt -135.94 174.65 10.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.46 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.552 ' CD1' HG11 ' A' ' 84' ' ' VAL . 8.0 tt -85.62 134.64 33.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.413 0.625 . . . . 0.0 111.199 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.438 HG11 ' HB1' ' A' ' 14' ' ' ALA . 55.9 t -134.98 109.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.963 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.63 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -103.17 107.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.147 0.975 . . . . 0.0 111.164 177.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 99.2 t -100.19 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.499 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -127.6 122.58 33.52 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CD2' HG21 ' A' ' 69' ' ' VAL . 95.8 m-85 -73.83 124.79 26.77 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.335 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.4 m-30 -118.66 179.25 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.29 144.54 27.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -3.81 28.15 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.05 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -122.16 13.32 10.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 3.7 p -109.43 156.06 20.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.571 0.7 . . . . 0.0 112.617 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.53 -52.36 3.57 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.639 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 72.0 Cg_exo -53.96 -48.44 21.68 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.249 1.966 . . . . 0.0 112.621 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 7.8 p -51.17 -35.51 36.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.188 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.9 tptm -65.2 -53.1 49.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.161 0.288 . . . . 0.0 110.532 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 39' ' ' MET . 26.5 ptt? -66.66 -43.34 84.83 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.629 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.49 -18.19 16.75 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.09 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.77 -53.22 67.13 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.825 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 34.2 Cg_endo -67.13 -28.2 41.09 Favored 'Trans proline' 0 C--N 1.359 1.107 0 CA-C-N 120.567 1.238 . . . . 0.0 112.428 170.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.541 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.9 mmm -65.91 -56.32 12.35 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.183 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.495 ' CG2' HG11 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -52.86 -31.09 16.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 122.495 0.318 . . . . 0.0 110.74 176.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -61.33 -50.77 71.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.305 0.574 . . . . 0.0 109.599 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 1.4 tmtp? -61.53 -44.49 96.97 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.611 0.719 . . . . 0.0 109.781 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.666 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 76.5 m-85 -66.06 -23.23 66.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.624 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.66 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 83.5 p -74.1 -19.03 60.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -78.16 -23.64 47.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.666 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 5.3 mm100 -87.69 5.54 39.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.338 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 0.6 OUTLIER -99.46 102.14 15.48 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.4 Cg_exo -76.5 -45.93 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.686 1.591 . . . . 0.0 112.692 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -112.97 1.25 15.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -172.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB2' HE21 ' A' ' 49' ' ' GLN . . . -113.55 153.28 29.03 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.02 129.26 46.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.2 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.4 OUTLIER -105.06 121.45 43.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.677 -175.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.763 ' HA ' HG23 ' A' ' 2' ' ' VAL . 30.1 m-85 -135.5 144.64 46.45 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.519 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.96 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 11.9 mmtt -128.87 122.51 30.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.655 HD13 ' HG ' ' A' ' 60' ' ' LEU . 6.4 mt -98.48 170.75 8.61 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.136 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.08 120.5 34.48 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.41 -8.52 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.16 -28.65 61.41 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.762 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG2' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -110.42 -35.65 5.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 169.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.655 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.7 mm? -87.28 52.21 2.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.851 0.358 . . . . 0.0 111.006 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.48 -37.5 30.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.152 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.648 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 13.6 p-10 -66.99 -43.99 81.57 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.046 -0.09 . . . . 0.0 110.766 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.6 p -66.44 -34.85 72.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 110.614 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.7 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.622 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 33.7 mm-40 -77.47 -30.08 52.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.907 0.384 . . . . 0.0 110.422 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 74.5 mmtt -57.32 -47.95 80.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.289 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -94.26 15.85 16.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.328 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 48.89 52.88 13.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.818 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 25' ' ' PHE . 97.7 t -81.42 113.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.731 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.7 p -118.55 1.07 11.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.9 154.21 45.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.776 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.94 128.86 20.87 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.773 178.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 84.9 Cg_endo -82.3 171.7 53.63 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.932 -5.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 68.2 m -124.74 116.69 22.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.716 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.78 111.66 24.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.185 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.9 mt -127.49 113.52 16.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.47 127.57 38.01 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.554 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 m-85 -112.59 157.45 21.17 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.122 -176.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.6 tttt -143.26 118.68 10.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.021 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.542 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.51 44.77 2.63 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.825 0.85 . . . . 0.0 112.509 -178.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.41 10.09 52.16 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.148 -0.478 . . . . 0.0 113.512 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -109.3 0.06 19.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.033 0.444 . . . . 0.0 110.288 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 28.1 tt0 66.83 179.75 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.554 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.561 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -152.83 -33.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.746 0.308 . . . . 0.0 110.705 173.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.4 164.49 32.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.79 0.329 . . . . 0.0 111.023 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.3 tttt -145.92 123.81 12.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.568 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.31 133.45 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.76 78.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.196 0.522 . . . . 0.0 111.344 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.83 -172.3 37.11 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.684 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -73.04 97.02 2.25 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.3 p-10 -121.77 66.14 19.94 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.485 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 15.3 Cg_exo -66.03 -37.18 27.0 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.092 1.195 . . . . 0.0 110.946 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 96' ' ' LYS . . . -88.92 -41.68 12.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.235 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.03 -17.09 61.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.459 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.711 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.7 tp -56.25 -38.14 53.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.616 ' HD3' HG22 ' A' ' 99' ' ' ILE . 17.5 tppt? -61.5 -31.39 71.38 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.187 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -56.54 -55.61 31.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 174.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.65 -32.67 62.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.419 0.628 . . . . 0.0 110.751 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.76 -43.17 70.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.613 -172.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.59 -39.22 16.36 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.801 0.334 . . . . 0.0 110.802 -175.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.47 77.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.966 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 42.0 m-80 -104.12 -66.39 0.96 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.554 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.607 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.649 -0.691 . . . . 0.0 111.271 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.515 HG21 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.132 0.491 . . . . 0.0 110.05 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.56 147.43 33.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.976 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -107.14 122.54 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.214 171.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.633 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 13.4 m-85 -76.4 152.67 36.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.215 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.62 -19.55 15.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.364 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 81.2 p -135.39 156.61 48.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.241 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -59.07 -31.88 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -62.91 -38.67 91.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.99 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.0 mm-40 -60.37 -51.98 67.19 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.355 0.598 . . . . 0.0 110.193 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 2.1 t80 -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.727 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.97 -45.43 78.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.455 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 37.4 t -67.84 -42.1 81.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -61.39 -49.93 74.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.556 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 42.0 pt -67.27 -20.86 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.502 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.25 -2.56 58.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.733 0.302 . . . . 0.0 111.672 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.6 mt-30 -81.86 162.68 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.088 0.471 . . . . 0.0 111.08 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.1 26.04 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.687 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 9.0 ptmt -132.14 165.24 24.52 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.78 HD21 HG11 ' A' ' 84' ' ' VAL . 2.7 tm? -76.57 117.28 18.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG12 HG23 ' A' ' 23' ' ' VAL . 59.7 t -114.25 107.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.723 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.13 106.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.527 0.68 . . . . 0.0 110.343 175.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.637 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 34.5 t -108.4 143.36 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.551 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.915 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -122.32 120.83 35.21 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.338 0.59 . . . . 0.0 112.515 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CE2' HD12 ' A' ' 55' ' ' LEU . 95.4 m-85 -69.89 118.98 13.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.366 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.495 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -127.34 176.48 7.4 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.95 -164.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.29 146.87 14.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.165 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 p -84.48 -4.46 58.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -116.35 51.63 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -151.7 171.07 18.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.92 -54.16 2.83 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.632 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' A' ' 35' ' ' MET . 74.9 Cg_exo -53.11 -35.0 70.98 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.321 2.014 . . . . 0.0 112.406 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 p -65.6 -32.23 73.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.948 0.404 . . . . 0.0 111.027 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -68.39 -34.46 76.07 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.205 -0.309 . . . . 0.0 110.927 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -80.7 -49.78 10.76 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -76.75 -22.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.181 -0.949 . . . . 0.0 111.352 -175.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.77 -49.09 95.69 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.411 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 35' ' ' MET . 32.8 Cg_exo -63.47 -37.42 48.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.34 1.36 . . . . 0.0 111.806 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mmm -65.61 -61.6 1.99 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 36' ' ' ILE . 57.7 mt -66.33 -19.1 25.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 118.58 0.627 . . . . 0.0 111.377 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.2 tt0 -60.84 -46.06 92.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.697 0.76 . . . . 0.0 109.471 167.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 23.1 ttmt -66.12 -42.09 89.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.601 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.596 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.1 m-30 -71.65 -17.42 62.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.312 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.823 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 96.9 p -77.67 -16.89 58.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -83.86 -19.05 35.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.405 168.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.609 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 10.0 mm100 -95.18 -1.08 52.53 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.59 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 9.0 m-30 -100.51 101.48 15.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.263 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.9 Cg_exo -80.61 -43.98 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.659 2.239 . . . . 0.0 112.438 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -107.84 7.23 28.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.882 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -123.81 143.41 50.34 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.47 46.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.949 0.88 . . . . 0.0 111.014 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.823 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.6 OUTLIER -106.7 119.15 38.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.535 -169.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.504 ' HB2' HG22 ' A' ' 23' ' ' VAL . 29.0 m-85 -135.77 155.11 50.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.915 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -132.19 130.07 40.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.637 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 76.8 mt -95.34 128.42 42.17 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.128 -0.358 . . . . 0.0 111.128 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -70.91 97.53 1.44 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 168.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -56.52 -19.7 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.53 -35.86 72.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.091 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HG3' HD22 ' A' ' 60' ' ' LEU . 9.3 pt-20 -110.05 -38.59 5.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.462 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.606 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mm? -78.19 50.74 0.93 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.98 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.33 -42.05 24.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.7 p-10 -62.76 -46.71 86.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.315 0.103 . . . . 0.0 110.936 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.606 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -63.17 -38.56 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 110.254 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.91 70.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.609 ' HA ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -75.95 -40.06 54.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.153 0.501 . . . . 0.0 109.748 -177.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.657 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 58.4 mttm -59.34 -40.69 87.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.626 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -89.89 6.17 43.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.544 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 57.72 52.06 8.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.516 HG13 ' OG1' ' A' ' 74' ' ' THR . 57.1 t -75.52 116.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.856 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -113.93 -62.41 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.875 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.17 116.55 29.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.999 0.428 . . . . 0.0 110.568 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.68 145.95 30.79 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.464 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.06 162.03 92.58 Favored 'Cis proline' 0 C--O 1.235 0.359 0 C-N-CA 123.106 -1.623 . . . . 0.0 112.513 -5.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.516 ' OG1' HG13 ' A' ' 69' ' ' VAL . 52.5 m -118.45 117.24 28.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -102.2 108.62 20.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 31.3 mt -122.12 113.13 19.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.587 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -99.2 128.34 45.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.055 177.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 34.4 m-85 -112.09 153.71 26.51 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.3 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.607 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 24.1 tptm -135.97 115.0 12.27 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.389 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.607 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 9.8 p30 44.15 38.24 2.25 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.134 0.974 . . . . 0.0 112.731 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.69 7.05 73.61 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.292 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -105.2 -7.12 19.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 77.77 173.29 0.19 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.673 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.78 HG11 HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -147.28 -29.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.699 0.285 . . . . 0.0 110.789 173.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.69 162.68 29.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.21 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 1.8 tmtp? -142.82 108.99 5.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.33 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.5 t -119.56 143.43 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.17 86.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.761 0.791 . . . . 0.0 111.478 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 50.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.144 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.25 84.83 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.004 0.43 . . . . 0.0 111.005 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.3 p-10 -121.1 83.64 38.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 6.0 Cg_exo -75.14 -38.96 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.58 1.52 . . . . 0.0 111.03 168.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.31 -39.93 13.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.428 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -73.05 -17.29 61.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.078 0.466 . . . . 0.0 111.238 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.675 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -57.81 -36.72 56.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 99' ' ' ILE . 31.5 mmmt -56.34 -40.11 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.831 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.627 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 4.0 tp60 -46.48 -60.22 2.49 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 123.346 0.403 . . . . 0.0 110.349 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -77.37 -29.24 53.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.475 0.655 . . . . 0.0 111.436 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -80.01 -41.37 21.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.956 -170.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.97 -35.65 18.74 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.796 -176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.35 -39.18 78.29 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.651 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 83.7 m-20 -96.16 -60.31 1.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 50' ' ' ALA . . . . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.546 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.609 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.52 149.83 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.064 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.65 133.25 44.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.691 170.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.683 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.9 m-85 -86.98 164.35 16.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.16 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -117.2 -23.32 7.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.919 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.666 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 39.9 p -132.4 157.4 44.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 112.035 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.68 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -61.43 -35.6 78.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.771 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.0 mm-40 -61.3 -49.65 76.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.311 0.577 . . . . 0.0 110.345 177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -47.9 80.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.498 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.37 -44.42 95.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -67.61 -36.65 81.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.987 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.34 -49.26 61.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 pt -66.36 -20.74 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.94 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HA ' ' N ' ' A' ' 81' ' ' GLY . . . -80.84 -8.83 59.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -72.19 150.38 43.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.43 53.57 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.692 0.758 . . . . 0.0 110.221 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 10.0 ptmt -153.08 173.75 15.07 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.332 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.555 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -75.5 111.28 10.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.1 t -122.62 107.67 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.868 0.366 . . . . 0.0 110.442 169.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.13 115.36 47.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.56 0.695 . . . . 0.0 111.271 175.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.606 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 84.3 t -103.26 140.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.964 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.845 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.09 138.33 54.45 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 69' ' ' VAL . 71.5 m-85 -90.2 128.04 36.27 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.436 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.618 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 3.0 m-85 -120.68 -171.72 2.24 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.555 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.02 169.7 16.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.524 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.76 -30.34 69.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.591 0.71 . . . . 0.0 110.309 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -91.37 -138.84 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.5 p 56.3 110.41 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.73 1.212 . . . . 0.0 113.942 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.49 98.68 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.266 -1.334 . . . . 0.0 114.176 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.671 ' O ' HG23 ' A' ' 36' ' ' ILE . 31.5 Cg_exo -60.14 -41.76 49.06 Favored 'Trans proline' 0 C--N 1.36 1.139 0 CA-C-N 120.221 2.011 . . . . 0.0 111.663 -178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 29.3 m -51.37 -43.21 61.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.466 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.661 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.3 mmtt -62.87 -55.54 25.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -63.87 -48.0 78.42 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -75.51 -11.59 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.897 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.21 -57.49 25.73 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.292 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 28.1 Cg_endo -64.91 -34.01 50.09 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 120.025 1.044 . . . . 0.0 111.958 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.491 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.8 mtt -64.7 -60.94 2.53 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.892 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.647 HG21 ' HD3' ' A' ' 54' ' ' LYS . 17.4 mt -58.56 -25.47 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 118.228 0.467 . . . . 0.0 112.109 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.31 -41.01 96.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 172.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.96 -46.04 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.826 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.684 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 66.0 m-85 -65.09 -24.38 67.43 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.267 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.625 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 33.9 t -85.57 -14.45 45.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.857 0.837 . . . . 0.0 109.232 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -84.27 -19.84 33.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.684 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 18.1 pt20 -104.66 26.01 9.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.869 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.579 ' HD1' ' O ' ' A' ' 43' ' ' PHE . 2.4 m-85 -97.97 89.95 0.85 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.44 166.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.22 -46.17 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.91 1.74 . . . . 0.0 112.714 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -11.45 14.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 149.27 24.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.98 126.87 50.33 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.637 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.629 ' CE2' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -110.15 125.5 53.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.54 -177.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 27.5 m-85 -130.96 143.4 50.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.845 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 31.6 mtmt -133.02 119.9 20.66 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.7 mt -97.54 163.9 12.66 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.729 -173.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.41 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -102.67 111.74 24.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.208 0.528 . . . . 0.0 109.788 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -66.58 -15.4 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.481 -171.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 56' ' ' ASP . 5.9 p-10 -70.34 -26.62 63.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -106.89 -39.28 5.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.356 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.0 mm? -88.09 41.65 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.366 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -70.2 -35.29 70.18 Favored Glycine 0 CA--C 1.504 -0.616 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.45 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 29.7 m-20 -63.36 -40.61 97.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 109.951 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 60' ' ' LEU . 86.0 t -63.2 -42.42 96.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.246 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.28 83.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.126 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 24.0 mt-30 -71.72 -33.06 68.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.526 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 69.0 mttm -57.17 -40.9 78.25 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.438 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -96.44 10.34 38.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.101 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 55.91 40.7 30.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.625 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 25' ' ' PHE . 49.2 t -83.0 127.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.347 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.4 t -134.14 -26.67 1.47 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.283 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.86 114.94 29.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 0.0 110.04 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 147.09 32.94 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.002 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.6 Cg_endo -84.23 161.98 68.23 Favored 'Cis proline' 0 N--CA 1.461 -0.424 0 C-N-CA 124.17 -1.179 . . . . 0.0 111.497 -8.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 m -119.64 121.32 39.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.664 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -107.83 109.93 21.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.607 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.614 HD22 ' HG2' ' A' ' 86' ' ' LYS . 7.6 mt -125.31 114.86 19.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -90.8 122.52 33.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.99 174.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.3 m-85 -106.31 162.19 13.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.36 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.571 ' HG2' HD22 ' A' ' 80' ' ' ASN . 24.7 ttmm -150.51 133.45 16.02 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.346 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.571 HD22 ' HG2' ' A' ' 79' ' ' LYS . 11.5 p30 48.02 29.79 1.85 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.056 0.942 . . . . 0.0 112.618 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.532 ' N ' ' HA ' ' A' ' 16' ' ' ALA . . . 74.69 9.38 82.61 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.855 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 13.4 tttp -107.25 -65.41 1.1 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 18.0 tt0 161.42 -178.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 123.976 0.798 . . . . 0.0 109.064 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 77' ' ' LEU . 2.2 p -154.53 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.532 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.45 165.1 31.64 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.906 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.614 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.7 tmtp? -142.7 119.52 11.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.257 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 t -131.55 144.1 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.74 91.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.888 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.8 53.59 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.643 172.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.492 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.31 86.76 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 111.303 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.2 p-10 -122.39 85.34 47.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.496 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.7 Cg_exo -77.34 -39.46 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.218 1.279 . . . . 0.0 110.308 166.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.47 -36.11 16.65 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.276 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.39 -17.33 60.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.136 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.8 tp -58.06 -37.95 64.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 170.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 19.4 mmtp -55.41 -37.37 67.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.914 0.758 . . . . 0.0 110.647 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.3 tm0? -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 176.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -77.16 -24.81 51.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.304 0.573 . . . . 0.0 111.352 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.731 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -78.01 -42.81 28.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.916 -173.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.45 -32.39 22.32 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.703 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.44 -41.62 93.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.274 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 41.2 m-80 -110.86 -90.39 0.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.859 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.547 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.713 -168.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.16 0.505 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -81.83 147.92 29.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.918 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.67 130.17 51.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.953 172.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.699 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.0 m-85 -84.52 159.72 20.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -117.07 -19.06 9.9 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.57 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 25.7 p -135.01 153.65 52.01 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.779 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.96 -33.69 70.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 m -59.07 -36.34 74.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.106 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 39.4 mm-40 -65.99 -47.73 73.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.492 0.663 . . . . 0.0 110.062 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HD1' HG21 ' A' ' 23' ' ' VAL . 1.6 t80 -62.15 -44.14 97.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.079 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -55.33 -49.53 71.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.893 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -67.46 -37.58 83.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.205 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.95 58.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.04 -19.99 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.227 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 -13.8 59.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.975 0.417 . . . . 0.0 110.945 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -75.57 145.08 41.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.04 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.43 47.45 0.93 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.453 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 6.8 ptmt -138.96 168.35 20.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.064 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.552 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -74.92 105.84 6.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.214 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.469 HG13 ' CD2' ' A' ' 53' ' ' TYR . 53.5 t -114.58 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 173.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.747 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.86 109.41 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.642 0.734 . . . . 0.0 110.74 175.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 66.2 t -103.17 135.19 41.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.052 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -121.63 111.44 17.21 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 121.072 0.463 . . . . 0.0 112.093 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 69' ' ' VAL . 96.3 m-85 -69.05 112.56 5.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.227 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.03 177.44 5.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.11 147.45 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.454 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 p -84.62 -4.72 59.14 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -117.24 53.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.63 173.08 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.77 2.56 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.238 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 36' ' ' ILE . 75.5 Cg_exo -51.56 -40.86 63.06 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.461 2.108 . . . . 0.0 112.142 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 8.5 p -66.04 -29.7 70.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.231 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -68.64 -35.91 77.9 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.943 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.546 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptm -80.84 -46.93 14.54 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.691 HD11 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.93 -22.8 16.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.924 -175.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.503 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -58.46 -46.73 99.6 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.352 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 35' ' ' MET . 45.6 Cg_exo -59.96 -40.59 60.65 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.692 1.594 . . . . 0.0 112.395 167.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -65.02 -53.75 41.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -58.86 -35.71 57.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 9.5 tp10 -54.48 -47.45 72.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.503 0.668 . . . . 0.0 109.883 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -62.54 -48.89 77.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.631 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 12.1 m-30 -67.08 -17.27 64.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.452 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 29.0 p -87.25 -11.87 48.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.63 -24.18 29.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 168.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -119.36 36.38 4.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.722 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.475 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -99.55 90.66 1.27 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 122.039 0.924 . . . . 0.0 111.746 171.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 18.0 Cg_exo -65.35 -46.39 5.75 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.051 1.834 . . . . 0.0 113.359 -170.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -111.35 -7.7 14.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.91 163.18 12.36 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 111.656 -167.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.6 126.27 51.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.245 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 3.4 m-30 -99.57 121.69 41.55 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.689 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 29.9 m-85 -129.08 134.94 48.3 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.703 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 10.7 ttpp -127.45 117.43 22.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.699 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.9 mt -96.13 156.99 16.1 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -165.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -91.25 99.15 12.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -18.65 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.271 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.76 -37.49 84.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.083 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.96 -38.49 10.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.036 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.09 49.55 1.65 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.643 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.35 34.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.659 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 12.5 p-10 -66.02 -40.73 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.523 0.202 . . . . 0.0 111.118 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -72.98 -35.08 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.47 -36.99 74.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.125 0.488 . . . . 0.0 110.308 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 14.9 mm-40 -73.4 -29.8 62.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.416 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 30.0 mtpp -61.91 -40.95 97.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -95.77 12.94 28.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.397 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 59.79 40.56 19.4 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.096 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 25' ' ' PHE . 75.0 t -76.95 110.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.857 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 p -113.57 -1.64 14.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.37 143.05 43.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.473 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.33 128.0 26.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 89.1 Cg_endo -84.1 170.57 50.34 Favored 'Cis proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.514 -5.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.7 m -121.89 122.75 40.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.946 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.476 ' HB3' HD13 ' A' ' 95' ' ' ILE . 3.9 mm? -107.65 110.47 22.35 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.71 HD22 ' HG2' ' A' ' 86' ' ' LYS . 36.7 mt -126.81 119.37 26.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.356 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.747 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.881 173.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 26.1 m-85 -108.86 158.97 17.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.603 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.595 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 36.3 ttmt -143.44 116.03 8.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.338 173.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.595 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 10.9 p30 47.6 31.48 2.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.399 1.079 . . . . 0.0 112.816 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 10.07 79.0 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.851 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 12.4 tptm -106.22 -2.61 22.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.989 0.899 . . . . 0.0 108.629 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 40.7 mt-10 71.75 -178.47 0.21 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.888 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.3 p -152.06 -29.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.976 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.78 161.29 36.96 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.632 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.71 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.4 tmtp? -143.24 115.84 8.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.971 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t -132.21 143.51 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 109.935 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.65 90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.686 0.755 . . . . 0.0 111.305 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.38 54.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.005 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 56.03 86.68 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.51 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.577 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 16.6 p-10 -125.13 89.41 52.66 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.446 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.2 Cg_endo -82.55 -29.68 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.965 1.777 . . . . 0.0 110.217 165.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 -49.07 6.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -72.61 -18.4 61.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.442 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.66 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -61.33 -37.67 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.739 ' HA ' HG22 ' A' ' 99' ' ' ILE . 24.3 tptp -60.94 -30.57 70.3 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.132 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -60.13 -53.24 60.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.952 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.596 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.11 -33.98 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.587 0.708 . . . . 0.0 111.422 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -74.62 -37.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.414 -171.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.62 -44.42 11.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.054 0.454 . . . . 0.0 110.831 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.8 80.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.72 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.2 -61.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.791 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.369 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.621 HG21 ' HE3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.341 0 CA-C-O 121.4 0.619 . . . . 0.0 110.417 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.4 148.13 43.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.818 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.501 ' HG3' ' H ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -114.39 114.26 25.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.146 174.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.574 ' H ' HD22 ' A' ' 55' ' ' LEU . 20.0 m-85 -67.68 163.74 20.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.036 0.446 . . . . 0.0 110.076 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -130.23 -13.09 3.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.259 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.719 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 70.6 p -135.48 152.68 51.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.56 -27.22 68.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.615 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 p -68.8 -36.73 78.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.061 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 24.7 mm-40 -63.03 -46.72 86.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 109.778 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 3.8 t80 -63.16 -45.92 89.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.127 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.98 -49.33 76.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.858 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -66.68 -36.48 82.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.415 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.39 -52.16 55.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.792 0.329 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.79 -19.9 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.09 -9.02 59.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.708 0.289 . . . . 0.0 111.625 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -75.88 146.52 39.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.643 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 38.2 t70 -72.98 8.97 1.3 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.293 0.568 . . . . 0.0 111.827 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -111.53 178.34 4.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.026 0.441 . . . . 0.0 111.065 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.591 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -76.06 108.07 8.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.768 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 14' ' ' ALA . 65.7 t -111.06 106.84 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.504 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.939 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.22 109.23 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.616 0.722 . . . . 0.0 111.128 175.263 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 21' ' ' VAL . 92.9 t -102.47 143.48 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.747 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB1' ' CE1' ' A' ' 26' ' ' TYR . . . -127.12 138.1 53.11 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.196 0.522 . . . . 0.0 111.715 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -101.04 103.38 14.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.516 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.671 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.5 m-85 -128.22 178.4 6.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.759 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -154.97 137.73 15.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.274 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -72.36 -6.04 40.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 13.7 p-90 -106.29 19.56 20.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.299 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.935 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -122.69 132.97 54.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.629 0.728 . . . . 0.0 110.965 178.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.46 88.84 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.628 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.935 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 22.2 Cg_exo -65.44 -31.81 50.94 Favored 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 120.29 2.045 . . . . 0.0 109.868 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 63.7 m -54.3 -41.13 68.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.154 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.706 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -62.98 -57.03 12.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.923 -178.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 ptm -55.55 -48.14 75.24 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -173.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.671 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.89 -23.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.99 -177.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 41' ' ' GLU . . . -55.19 -49.63 91.22 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.91 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 11.0 Cg_exo -72.98 -29.74 11.68 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 120.718 1.292 . . . . 0.0 111.849 171.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.7 mmt -66.49 -60.32 2.84 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.462 HD12 ' CG1' ' A' ' 36' ' ' ILE . 51.2 mt -62.68 -30.68 49.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.156 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 27.9 tt0 -50.03 -48.22 52.86 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.066 0.46 . . . . 0.0 110.361 172.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -65.5 -41.97 92.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.598 0.714 . . . . 0.0 110.023 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.689 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 7.3 m-30 -63.89 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.302 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 1.026 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 4.0 m -74.47 -23.16 58.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 41.4 mt-10 -78.36 -20.51 51.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.554 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 17.2 pt20 -112.9 22.89 13.98 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.573 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 8.4 m-30 -100.44 100.29 11.77 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 163.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 14.1 Cg_exo -70.04 -44.72 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.769 1.646 . . . . 0.0 111.891 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -2.71 15.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . . . -106.08 142.85 35.09 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.885 -0.509 . . . . 0.0 110.795 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.32 126.12 42.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.502 0.668 . . . . 0.0 111.301 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 1.026 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.7 OUTLIER -105.36 114.18 28.2 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.782 -173.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.6 142.09 50.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 110.74 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.621 ' HE3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -125.99 119.55 27.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.574 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.1 mt -101.73 161.81 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.273 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -102.8 115.05 29.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.628 0.728 . . . . 0.0 109.093 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -13.62 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.296 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.14 -35.12 79.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.185 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -96.84 -35.64 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.682 172.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.62 HD12 HG21 ' A' ' 63' ' ' VAL . 1.9 mm? -97.83 42.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.761 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -74.72 -40.81 36.42 Favored Glycine 0 CA--C 1.504 -0.628 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.694 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.65 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 9.7 p-10 -64.3 -34.59 78.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.62 HG21 HD12 ' A' ' 60' ' ' LEU . 87.8 t -65.31 -43.18 95.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.127 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.991 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 83.2 mm-40 -72.76 -36.31 67.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.3 mttm -61.6 -34.72 76.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.69 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -100.82 16.97 23.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 54.34 47.3 23.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.86 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.5 t -98.61 116.4 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.132 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 p -118.87 0.41 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.93 124.63 35.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 154.91 42.16 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.36 168.82 71.05 Favored 'Cis proline' 0 CA--C 1.533 0.43 0 C-N-CA 124.018 -1.243 . . . . 0.0 111.88 -6.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 m -137.26 128.35 27.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.511 -169.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' HB2' HD21 ' A' ' 91' ' ' ASN . 3.8 mm? -115.98 108.61 16.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.077 0.465 . . . . 0.0 110.357 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 20.1 mt -123.95 113.69 18.8 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.939 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.26 125.42 35.49 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.31 177.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 83.8 m-85 -110.47 148.11 32.73 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.119 -177.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.515 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 8.5 mtpm? -146.2 126.16 13.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 10.8 p30 45.7 29.2 0.64 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.451 1.1 . . . . 0.0 112.733 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.03 17.03 73.31 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.188 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 31.6 pttt -114.75 -1.26 13.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.414 0.626 . . . . 0.0 109.531 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 42.6 mt-10 75.48 -172.55 0.11 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.356 -175.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.564 HG12 ' HB2' ' A' ' 77' ' ' LEU . 1.4 p -162.3 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.619 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -153.26 162.42 41.32 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.796 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.474 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.2 tmtp? -144.64 109.18 4.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.937 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.2 t -121.51 143.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.31 89.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.686 0.755 . . . . 0.0 111.596 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.0 62.96 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.923 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 50.68 81.27 0.07 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.639 0.376 . . . . 0.0 111.582 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 17.4 p-10 -117.71 88.0 28.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -172.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.403 ' O ' HG22 ' A' ' 95' ' ' ILE . 2.6 Cg_endo -79.53 -34.42 1.04 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.762 1.641 . . . . 0.0 110.543 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.11 -44.63 10.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.39 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.48 -17.02 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.455 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.724 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.0 tp -56.16 -39.4 58.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.622 ' HA ' HG22 ' A' ' 99' ' ' ILE . 15.6 mmtt -59.71 -36.79 77.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.664 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -52.16 -57.36 9.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.859 174.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HB1' ' CB ' ' A' ' 85' ' ' ALA . . . -75.35 -30.1 60.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.55 -39.63 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.679 -170.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.59 21.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.971 0.415 . . . . 0.0 110.452 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.83 62.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.209 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.7 m-80 -98.06 -67.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.704 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.591 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.718 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.875 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.247 0.546 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.86 147.81 28.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.152 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -98.68 134.42 41.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.905 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.647 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.0 m-85 -90.95 141.85 28.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -97.16 -14.84 21.22 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.715 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.523 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 62.6 p -132.58 153.13 51.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.94 0.4 . . . . 0.0 111.241 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.5 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -62.33 -28.66 69.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 172.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 t -66.19 -37.73 86.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.378 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.523 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.4 mm-40 -58.54 -49.15 78.44 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.424 0.631 . . . . 0.0 110.257 176.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.401 ' HD1' HG21 ' A' ' 23' ' ' VAL . 2.1 t80 -64.9 -44.9 88.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.992 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.81 -46.57 84.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -65.43 -33.69 76.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.147 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.14 -49.51 43.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 31.5 pt -67.93 -15.09 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.595 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.27 -8.33 58.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 0.0 111.171 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -76.35 153.89 35.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.571 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 20.2 t70 -68.47 2.56 2.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.554 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 4.0 ptpt -109.45 -179.51 3.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.638 0.732 . . . . 0.0 111.507 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.3 tm? -86.53 114.15 23.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.659 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.1 t -118.77 111.17 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.1 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.714 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -105.64 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.558 0.694 . . . . 0.0 111.058 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.629 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 22.6 t -111.4 143.45 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.329 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -120.49 123.94 44.19 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.2 m-85 -70.47 130.43 41.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.679 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -136.45 -178.19 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.349 -164.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -167.91 157.19 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.102 173.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -84.9 -5.34 59.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 111.256 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -117.31 42.28 2.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.93 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -144.07 123.47 13.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.575 0.702 . . . . 0.0 112.002 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.46 -44.13 98.0 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.438 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.441 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 44.0 Cg_exo -58.26 -40.06 79.22 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 119.868 1.834 . . . . 0.0 111.232 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 22.9 m -56.86 -37.83 71.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.754 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 60.2 tttm -63.2 -53.54 51.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.897 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.666 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptp -60.34 -48.07 83.35 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.601 ' CG1' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.6 -18.6 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.435 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.48 -48.82 96.63 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.189 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.754 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.3 Cg_exo -72.55 -30.15 12.48 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.225 1.283 . . . . 0.0 111.878 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' MET . 24.8 mmt -64.47 -60.0 3.67 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.755 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.601 HD12 ' CG1' ' A' ' 36' ' ' ILE . 30.4 mt -65.4 -20.8 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 111.297 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 29.4 tt0 -59.68 -46.93 87.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.494 0.664 . . . . 0.0 109.692 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -64.98 -45.88 83.8 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.773 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.701 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.6 m-30 -63.71 -25.03 68.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.67 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.827 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 87.4 p -76.36 -19.67 57.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -83.08 -16.1 48.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.982 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.701 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -120.36 28.24 8.13 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.58 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 14.0 m-30 -101.07 100.44 13.11 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.493 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.28 -43.41 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 121.944 1.763 . . . . 0.0 112.623 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -95.93 -22.94 17.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 111.947 -173.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -102.74 149.55 24.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.439 0.638 . . . . 0.0 110.879 -172.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.485 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.9 m-20 -104.3 133.27 49.48 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.752 176.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.827 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.7 p90 -110.39 116.28 31.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.628 -169.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 20.4 m-85 -137.33 158.47 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.18 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.875 ' HG3' HG21 ' A' ' 2' ' ' VAL . 10.4 mtmp? -141.36 127.38 19.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.718 0.294 . . . . 0.0 110.75 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.647 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 56.8 mt -95.49 129.14 42.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.218 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.69 119.25 18.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 166.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.27 -11.87 12.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.573 -173.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.22 -46.32 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.486 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.97 -31.8 31.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.062 0.458 . . . . 0.0 110.16 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.61 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.2 mm? -103.0 52.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.651 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.96 -40.83 20.02 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.414 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.587 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 26.4 t70 -64.35 -49.08 73.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.537 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -60.59 -38.25 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.392 . . . . 0.0 110.27 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.97 85.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.139 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -74.13 -34.94 64.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.421 . . . . 0.0 110.546 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 45.3 mtmt -61.99 -35.63 79.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.906 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -97.87 14.16 28.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.45 38.47 25.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.967 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.411 HG21 ' CD2' ' A' ' 25' ' ' PHE . 84.7 t -82.68 127.03 40.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.3 p -125.06 -56.56 1.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.406 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 159.75 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.659 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.96 144.8 42.76 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 111.493 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 63.3 Cg_endo -75.84 167.71 79.44 Favored 'Cis proline' 0 C--O 1.237 0.467 0 C-N-CA 123.03 -1.654 . . . . 0.0 111.694 -10.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 46.9 m -124.25 116.86 23.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -103.47 108.98 20.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.264 -174.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.516 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 33.3 mt -124.05 113.95 19.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.714 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.39 130.24 40.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.627 174.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 47.7 m-85 -111.2 160.05 17.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.605 -175.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.559 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 14.6 tppt? -144.04 124.11 13.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.592 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.559 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 0.3 OUTLIER 35.39 48.74 0.43 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 18.59 59.88 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.691 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -125.37 7.38 7.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.976 0.388 . . . . 0.0 110.785 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.36 176.51 0.25 Allowed 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.774 0.671 . . . . 0.0 109.572 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -146.28 -34.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.942 0.401 . . . . 0.0 110.422 172.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -158.86 161.18 36.82 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.6 tttt -140.97 122.22 14.81 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.13 136.51 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.2 88.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.752 0.787 . . . . 0.0 111.504 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.89 62.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.767 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . 58.81 94.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.937 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.9 p-10 -132.93 80.12 61.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.426 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 2.8 Cg_exo -73.82 -41.08 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.367 1.378 . . . . 0.0 111.149 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.19 -39.72 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.113 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.0 -17.57 62.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.269 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.724 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.1 tp -57.62 -38.1 62.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 20.4 mmtp -57.56 -36.95 72.32 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.796 0.685 . . . . 0.0 110.621 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -53.29 -57.05 11.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.88 175.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.39 -36.59 63.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.553 0.692 . . . . 0.0 110.818 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.37 -40.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.853 -171.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.09 -34.94 18.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.814 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.22 -35.29 68.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 50.5 m-80 -98.44 -59.82 1.67 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.507 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.047 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.596 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.419 0.628 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.62 145.44 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.917 -176.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -103.44 122.9 45.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.592 174.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.826 ' HB2' HD21 ' A' ' 55' ' ' LEU . 7.2 m-85 -76.07 165.84 24.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.009 0.433 . . . . 0.0 110.168 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -116.89 -30.0 5.85 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.528 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 19.4 p -127.2 145.27 50.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.004 0.43 . . . . 0.0 111.805 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.629 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -53.18 -40.41 64.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.766 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -61.03 -38.75 87.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.988 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.479 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 19.4 pt-20 -81.06 -22.03 39.58 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.817 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.483 ' HD1' HG21 ' A' ' 23' ' ' VAL . 3.3 t80 -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 168.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' A' ' 15' ' ' ILE . 4.8 m-20 -59.23 -38.66 80.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.151 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 t -66.46 -37.93 86.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -50.27 62.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 110.659 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 12' ' ' ASP . 33.4 pt -69.97 -14.76 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.573 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.07 -6.19 59.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.95 0.405 . . . . 0.0 111.408 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 19' ' ' LYS . 77.9 mt-30 -88.39 161.11 17.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.082 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 5.4 m-20 -76.44 27.81 0.12 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 17' ' ' GLN . 23.4 mtpp -108.05 178.06 4.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 122.069 0.938 . . . . 0.0 112.756 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.609 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -94.8 104.93 16.84 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.885 172.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.9 t -114.01 107.67 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.896 0.379 . . . . 0.0 110.96 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.706 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -104.72 107.49 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.472 0.653 . . . . 0.0 110.728 175.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 27.0 t -108.95 133.02 55.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.793 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.82 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -108.54 122.41 47.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CD2' HG21 ' A' ' 69' ' ' VAL . 68.8 m-85 -74.12 127.84 33.97 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.118 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.659 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 2.3 m-85 -120.02 -171.46 2.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.145 -175.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.02 31.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.055 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.9 p -79.99 -4.81 54.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.166 0.508 . . . . 0.0 110.993 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -131.93 54.17 1.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.7 p -145.56 116.76 7.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.475 0.655 . . . . 0.0 112.257 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -66.47 -37.94 93.08 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.234 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 31.6 Cg_exo -61.52 -35.32 82.66 Favored 'Trans proline' 0 C--N 1.36 1.18 0 CA-C-N 120.233 2.016 . . . . 0.0 111.408 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 57.1 m -54.6 -38.81 67.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.242 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.751 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.1 tptm -63.75 -54.81 29.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.683 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.0 ptp -59.98 -48.63 80.93 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.697 HG13 HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -76.07 -16.29 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.207 -178.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.62 -50.31 88.62 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.787 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.751 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.4 Cg_exo -71.83 -31.4 12.92 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.1 1.2 . . . . 0.0 111.871 171.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.431 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 94.6 mmm -63.91 -59.46 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.161 -0.615 . . . . 0.0 112.006 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 36' ' ' ILE . 53.4 mt -67.18 -19.4 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.03 -0.419 . . . . 0.0 111.428 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.3 tt0 -64.48 -43.29 94.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.478 0.656 . . . . 0.0 109.39 168.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 15.5 tttm -63.6 -39.76 95.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.2 m-30 -74.45 -15.16 60.91 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.741 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.823 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 25.1 p -74.71 -18.14 60.55 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -84.86 -21.75 29.67 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.899 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.672 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 6.5 mt-30 -95.98 5.48 51.1 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.484 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 3.8 m-30 -104.17 98.61 14.35 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.642 172.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 6.6 Cg_exo -73.83 -43.8 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.28 1.986 . . . . 0.0 112.201 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -108.52 -13.61 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.3 163.45 12.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.125 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.23 135.82 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.046 0.927 . . . . 0.0 112.568 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.823 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.8 p90 -115.02 116.94 29.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.468 -171.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 22.0 m-85 -136.33 158.64 43.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.82 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 10.3 mtmp? -142.58 129.49 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 110.969 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' A' ' 5' ' ' PHE . 18.2 mt -107.01 176.91 5.02 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.525 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 6.7 p-10 -131.24 130.49 42.95 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 26' ' ' TYR . 32.7 m -69.29 -8.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.71 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.06 -40.91 74.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.333 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -101.24 -28.11 12.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.666 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HG ' HD22 ' A' ' 55' ' ' LEU . 3.9 mm? -101.11 53.66 0.84 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.01 -43.07 23.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.127 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 13.2 t70 -66.3 -45.61 79.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.861 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.646 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -61.42 -39.22 82.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.112 0.482 . . . . 0.0 110.142 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.62 -36.93 72.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.103 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 12.0 mm-40 -79.02 -31.51 44.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 38.5 mtmt -62.56 -37.4 86.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.0 110.458 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -96.0 8.17 44.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.21 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 55.44 45.96 24.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.892 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.492 HG13 ' OG1' ' A' ' 74' ' ' THR . 69.6 t -69.71 124.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.814 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -139.33 31.29 2.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.044 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.08 152.62 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.5 112.43 32.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.06 172.72 30.95 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.921 -0.866 . . . . 0.0 112.275 -0.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.492 ' OG1' HG13 ' A' ' 69' ' ' VAL . 92.3 m -120.31 115.89 24.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.554 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -102.39 108.65 20.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.826 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.516 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 30.7 mt -125.43 113.05 17.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.706 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.16 122.06 36.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.022 174.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 42.2 m-85 -106.85 152.89 23.28 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.457 -174.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 87.1 tttt -138.71 122.05 17.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.801 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.68 44.28 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.146 0.979 . . . . 0.0 112.67 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 17.41 57.46 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.206 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 2.8 tttp -116.43 -5.33 11.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.089 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 22.9 tt0 75.06 168.85 0.29 Allowed 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.648 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.601 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.2 p -136.66 -33.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.84 163.91 34.06 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.74 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.3 tttt -143.13 125.1 15.21 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.401 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.5 t -131.13 130.5 63.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.97 82.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.44 -170.44 35.1 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.791 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -70.31 93.83 0.88 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.676 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.8 p-10 -121.77 67.33 21.91 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.5 -35.21 13.85 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 120.915 1.077 . . . . 0.0 110.743 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.62 -39.87 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.074 177.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -76.25 -17.86 59.29 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.462 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.715 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.3 tp -57.3 -40.06 71.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HA ' HG22 ' A' ' 99' ' ' ILE . 12.3 mmmm -57.94 -34.76 70.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.799 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.47 -58.14 8.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.21 64.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.635 0.731 . . . . 0.0 110.952 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -81.16 -38.94 17.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.483 -169.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.46 -36.78 18.86 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.377 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.84 68.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.277 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.9 m-80 -92.7 -65.05 1.03 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.574 -0.85 . . . . 0.0 112.477 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.609 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.787 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.877 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.33 0.586 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.99 147.56 26.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.313 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.97 137.34 38.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.111 171.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.658 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 9.7 m-85 -90.71 137.96 31.95 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.222 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -90.74 -24.95 20.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.394 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.1 p -131.67 153.3 50.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.764 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.63 -34.42 71.16 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 t -62.81 -34.04 76.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.741 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 20.0 mm-40 -62.58 -49.18 76.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.353 0.596 . . . . 0.0 109.884 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.464 ' HD1' HG21 ' A' ' 23' ' ' VAL . 1.7 t80 -62.91 -47.06 84.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.107 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.06 -44.1 78.58 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.346 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 m -70.1 -40.44 74.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.46 67.99 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.821 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.14 -20.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.174 -176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.34 61.53 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.917 0.389 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 19' ' ' LYS . 46.6 mt-30 -68.24 150.99 47.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.073 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.9 32.89 0.26 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.82 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.7 ptmt -135.57 173.62 11.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.29 -176.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.747 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -75.13 112.71 11.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.598 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.37 107.97 20.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.752 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.31 109.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.047 0.927 . . . . 0.0 111.622 176.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 39.5 t -105.02 144.31 14.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.072 177.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.72 ' HB2' HD13 ' A' ' 75' ' ' LEU . . . -129.51 122.64 29.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 55' ' ' LEU . 72.9 m-85 -72.89 115.91 12.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.414 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.72 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 8.5 m-30 -121.91 -178.34 3.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 123.369 0.418 . . . . 0.0 110.358 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.62 34.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.689 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.48 -4.43 58.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.214 0.531 . . . . 0.0 111.139 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -126.16 47.2 2.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.077 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 p -143.1 126.39 16.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.53 0.681 . . . . 0.0 111.728 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.9 -40.44 98.35 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.21 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.75 ' O ' HG23 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -63.08 -38.65 44.46 Favored 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 120.272 2.036 . . . . 0.0 110.921 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 20.5 m -58.46 -31.22 67.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.581 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 87.2 tttt -67.94 -57.03 6.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.491 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 ptp -64.95 -44.38 89.62 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.235 0.54 . . . . 0.0 112.431 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.96 -13.73 14.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 C-N-CA 118.441 -1.304 . . . . 0.0 110.401 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.5 -52.35 74.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.085 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 19.8 Cg_endo -64.63 -32.63 57.75 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 120.955 1.103 . . . . 0.0 112.574 169.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 23.5 mmt -66.92 -55.57 14.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.014 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.808 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -49.0 -38.56 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.599 0.36 . . . . 0.0 110.529 175.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.35 -48.1 79.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 110.692 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -60.0 -51.77 68.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.975 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.0 m-85 -64.09 -19.57 65.34 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.17 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.1 p -83.6 -22.13 32.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -83.82 -20.99 32.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.656 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.676 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -107.85 16.38 23.59 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.75 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 13.9 m-30 -100.62 101.81 16.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.486 167.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.14 -40.88 2.94 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 121.88 1.72 . . . . 0.0 112.851 174.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -107.73 -16.0 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.09 146.74 27.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 110.88 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -101.01 135.51 42.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.859 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.808 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -113.52 124.52 52.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.607 -177.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.656 ' HA ' HG23 ' A' ' 2' ' ' VAL . 42.1 m-85 -135.79 147.58 48.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.877 ' HG2' HG21 ' A' ' 2' ' ' VAL . 8.2 mmpt? -117.23 142.43 47.06 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.658 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 60.6 mt -107.13 142.49 36.73 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.149 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.32 102.48 14.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 167.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -60.26 -15.23 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -171.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.44 -21.8 57.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -108.65 -31.24 7.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.923 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.598 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -96.77 52.19 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.818 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.21 -40.73 19.22 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.061 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.619 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 6.3 m-20 -60.56 -49.74 76.34 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.419 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.7 p -62.83 -38.69 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.313 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.44 -35.03 73.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.071 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 55.7 mt-30 -76.27 -37.85 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.38 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 66.0 mttm -57.24 -39.46 75.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.812 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -95.0 6.55 48.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.912 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.84 48.78 17.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.925 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.09 121.13 35.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.688 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -123.27 -16.08 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.732 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.57 161.86 15.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 142.96 26.83 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.519 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 2.9 Cg_exo -78.33 165.31 83.05 Favored 'Cis proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.862 -1.308 . . . . 0.0 111.75 -8.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 86.8 m -123.38 116.84 23.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.2 mm? -108.13 108.61 19.74 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -174.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.609 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 18.2 mt -125.71 116.13 21.16 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.814 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -91.53 122.42 34.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.054 173.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 33.5 m-85 -105.46 156.48 18.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.808 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.3 ttpt -142.44 120.09 11.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.378 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.5 37.11 5.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.8 0.84 . . . . 0.0 111.901 -177.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.16 12.55 50.38 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.746 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 61.7 mttp -120.83 19.47 11.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.553 0.341 . . . . 0.0 110.142 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 10.2 pt-20 61.66 175.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.869 1.356 . . . . 0.0 112.128 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.532 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -148.75 -32.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.832 174.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.79 166.92 25.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.081 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.609 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.9 tttt -144.34 126.51 15.61 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.2 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 19.3 t -131.96 138.84 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 87.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.796 0.807 . . . . 0.0 111.593 -170.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.66 63.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.061 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.474 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.28 86.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.111 0.482 . . . . 0.0 111.78 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.609 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.5 p-10 -126.41 78.57 71.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.519 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.5 Cg_exo -68.14 -45.39 2.91 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.448 1.432 . . . . 0.0 110.955 168.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.44 -35.43 18.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.096 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -76.59 -17.55 59.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.46 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.751 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.0 tp -59.18 -38.94 77.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HD2' HG22 ' A' ' 99' ' ' ILE . 54.5 tptt -61.83 -27.37 68.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.995 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.2 tm0? -59.6 -59.66 5.08 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -71.67 -29.2 64.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.712 0.768 . . . . 0.0 110.503 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -77.62 -39.44 26.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.321 -171.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.2 -34.45 20.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.043 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.24 89.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.63 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 51.2 m-80 -97.33 -63.06 1.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.747 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.79 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.688 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.637 0.732 . . . . 0.0 109.709 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.2 145.84 55.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.659 -168.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.56 136.35 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.655 170.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.809 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.6 m-85 -88.13 166.13 14.62 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -124.52 -10.29 7.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 60.1 p -134.44 150.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.68 0.276 . . . . 0.0 110.912 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.513 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.49 -33.68 70.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.3 t -65.73 -36.38 83.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.747 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 51.0 mm-40 -61.29 -44.74 96.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 7.5 t80 -67.55 -49.21 64.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.947 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.449 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -59.75 -37.55 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.69 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.4 t -68.29 -40.71 81.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.819 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -64.77 -50.48 66.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.43 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.51 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 35.3 pt -66.83 -18.82 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.499 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.44 -10.4 59.05 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.745 0.307 . . . . 0.0 111.589 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 54.8 mt-30 -76.09 153.3 36.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.344 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.4 37.75 0.34 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.86 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.9 ptmt -140.21 167.92 21.01 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.064 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.945 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -71.71 107.94 4.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.436 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.55 HG13 ' CD2' ' A' ' 53' ' ' TYR . 70.2 t -107.55 107.08 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 110.35 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.611 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -99.0 105.55 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.412 0.625 . . . . 0.0 110.294 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 53.5 t -107.01 139.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.371 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.749 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -128.39 122.4 31.34 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' HG21 ' A' ' 69' ' ' VAL . 52.4 m-85 -70.6 124.1 23.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.537 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.697 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.9 m-85 -120.01 -176.86 3.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.612 -174.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -161.77 156.68 23.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.144 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -84.09 -4.33 58.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.771 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -120.73 21.97 11.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 3.8 p -119.55 150.99 39.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.515 0.674 . . . . 0.0 112.253 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.75 -48.61 4.89 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.803 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 35' ' ' MET . 50.7 Cg_exo -55.25 -47.5 25.83 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.253 1.969 . . . . 0.0 112.307 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.9 p -51.07 -36.8 41.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.257 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.731 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 67.4 mttm -66.46 -50.31 63.76 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 123.212 0.32 . . . . 0.0 111.247 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 22.6 ptp -64.88 -44.7 88.81 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.424 0.631 . . . . 0.0 112.311 -175.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.686 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.0 -16.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.605 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.09 -55.26 47.14 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.909 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.731 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.7 Cg_endo -63.96 -30.42 67.0 Favored 'Trans proline' 0 C--N 1.358 1.054 0 CA-C-N 120.424 1.187 . . . . 0.0 112.1 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 25.4 mmt -65.98 -55.37 17.12 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.291 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.996 HG21 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -57.11 -38.08 58.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.87 175.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -52.48 -47.34 66.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.0 0.429 . . . . 0.0 109.958 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.33 -47.88 83.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.696 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 7.9 m-30 -67.05 -15.34 63.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.075 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.788 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 5.7 m -86.62 -13.71 44.87 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.23 -15.21 31.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.681 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.696 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -126.59 35.66 4.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.23 177.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -104.31 72.52 0.19 Allowed Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 172.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 88.9 Cg_exo -45.88 -45.64 16.88 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.945 2.43 . . . . 0.0 115.161 -166.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.69 8.53 19.02 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -103.16 165.09 11.23 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.82 -0.55 . . . . 0.0 111.573 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.98 123.37 41.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.788 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.76 124.95 35.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 10.6 m-85 -143.04 136.29 28.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.366 168.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.996 ' HD3' HG21 ' A' ' 40' ' ' ILE . 27.5 mtmt -134.0 120.3 20.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.809 HD22 ' H ' ' A' ' 5' ' ' PHE . 4.7 mt -93.11 162.22 14.12 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.646 -167.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.19 108.63 21.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -61.14 -14.42 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.451 -175.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.87 -39.12 93.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -99.68 -32.14 11.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.99 47.25 1.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.588 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.9 -42.13 17.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.789 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 31.1 t70 -65.27 -44.17 88.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 110.956 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -63.7 -39.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.204 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.79 77.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.5 mm-40 -71.51 -34.34 70.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.928 0.394 . . . . 0.0 110.438 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 40.1 mtmt -61.25 -38.73 87.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.648 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -95.08 15.29 19.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.884 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.6 40.94 26.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.812 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' A' ' 25' ' ' PHE . 86.4 t -88.9 113.38 25.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.15 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -116.06 -11.41 11.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.37 165.25 12.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.618 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.11 141.71 17.54 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.859 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.501 ' HG3' HD12 ' A' ' 36' ' ' ILE . 60.8 Cg_endo -75.28 163.41 90.62 Favored 'Cis proline' 0 C--O 1.234 0.301 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.795 -10.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.8 m -126.65 118.79 25.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.616 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.3 mt -110.34 107.65 17.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.379 0.609 . . . . 0.0 111.6 -172.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.67 HD22 ' HG3' ' A' ' 86' ' ' LYS . 18.9 mt -123.72 113.36 18.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.265 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.611 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.33 129.15 43.73 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.841 178.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 59.8 m-85 -112.27 154.09 26.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.441 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -136.52 117.54 14.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.393 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.55 43.83 2.4 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.065 0.853 . . . . 0.0 112.67 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.73 11.12 59.72 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.399 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -111.97 -0.32 15.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 32.9 tt0 69.79 172.77 0.3 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.137 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.554 HG11 HD21 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.46 -33.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.239 172.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.11 161.44 40.37 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.67 ' HG3' HD22 ' A' ' 76' ' ' LEU . 41.3 tttp -141.83 110.99 6.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.868 177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 t -123.58 135.1 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.23 82.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.951 0.881 . . . . 0.0 111.654 -168.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.5 64.27 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.235 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 54.78 83.85 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.021 0.438 . . . . 0.0 111.943 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 12.7 p-10 -125.02 83.99 59.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' O ' HG22 ' A' ' 95' ' ' ILE . 10.8 Cg_exo -74.15 -36.95 2.94 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.753 1.635 . . . . 0.0 111.654 168.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.3 -41.84 12.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 111.104 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.89 -17.37 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.639 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.5 tp -59.63 -38.16 74.28 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.284 171.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 99' ' ' ILE . 26.7 mmmt -59.53 -32.99 70.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.725 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -54.67 -61.24 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -71.25 -39.2 71.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.403 0.62 . . . . 0.0 111.649 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.648 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -68.74 -43.23 83.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.707 -171.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.17 10.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.909 0.385 . . . . 0.0 111.567 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.11 74.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.485 -175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.8 m-80 -92.65 -63.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.003 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.945 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.711 -0.661 . . . . 0.0 111.502 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.574 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.34 0 CA-C-O 121.323 0.582 . . . . 0.0 110.758 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -98.53 147.83 24.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.072 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.52 126.6 49.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 171.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.681 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 15.7 m-85 -80.42 157.39 26.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -113.05 -13.96 13.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.227 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -137.27 151.24 48.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.766 0.317 . . . . 0.0 111.126 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.496 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.15 -31.64 67.42 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 172.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -63.58 -38.13 89.96 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.231 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.427 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 27.4 mm-40 -61.58 -43.14 99.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.468 0.652 . . . . 0.0 109.772 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.42 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 4.4 t80 -68.15 -49.16 62.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.373 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' HG12 ' A' ' 15' ' ' ILE . 24.4 t70 -59.78 -46.06 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 0.0 111.438 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 m -68.68 -25.78 64.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -75.11 -51.6 13.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.826 0.346 . . . . 0.0 110.555 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.479 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.4 pt -65.22 -19.32 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.617 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.18 59.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.623 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -71.43 160.22 33.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.975 0.417 . . . . 0.0 110.861 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.496 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 4.8 m-20 -81.28 34.46 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.169 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -145.32 170.61 15.97 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.194 -174.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -72.16 105.44 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.02 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 14' ' ' ALA . 81.6 t -109.25 106.79 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.736 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.749 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.73 111.14 31.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.309 0.575 . . . . 0.0 111.116 175.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.668 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 44.8 t -110.69 131.15 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.294 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -109.32 110.82 22.09 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CD2' HD12 ' A' ' 55' ' ' LEU . 72.0 m-85 -70.77 107.72 4.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -162.93 151.37 14.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.298 0.571 . . . . 0.0 112.32 -178.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -120.03 158.66 26.34 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.0 p -81.11 -3.41 51.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -77.11 -16.63 59.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -172.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -98.26 -176.33 3.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.01 -60.19 1.98 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.153 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.621 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 82.0 Cg_exo -50.58 -49.22 17.32 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.968 2.445 . . . . 0.0 112.445 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.0 p -50.77 -36.94 39.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.692 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.737 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 39.8 ttpt -66.09 -54.32 27.22 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.06 0.225 . . . . 0.0 110.602 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.49 -45.99 91.91 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.808 HG13 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.25 -18.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.289 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.0 -56.38 31.31 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.128 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 33.4 Cg_endo -66.41 -32.16 41.13 Favored 'Trans proline' 0 C--N 1.359 1.127 0 CA-C-N 120.287 1.138 . . . . 0.0 112.492 171.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.534 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 33.2 mmt -64.27 -61.2 2.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.129 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.808 HD12 HG13 ' A' ' 36' ' ' ILE . 61.0 mt -64.41 -21.93 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.233 0.469 . . . . 0.0 111.647 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -61.96 -43.78 98.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 109.675 168.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -65.6 -40.63 92.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.531 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.711 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 15.2 m-85 -68.09 -17.95 64.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.177 0.513 . . . . 0.0 110.854 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 p -87.24 -11.48 49.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -83.23 -31.11 27.18 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.711 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 28.2 pt20 -109.27 33.24 4.41 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.234 -176.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.444 ' H ' ' HD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -100.1 76.6 0.13 Allowed Pre-proline 0 CA--C 1.556 1.207 0 CA-C-O 121.496 0.665 . . . . 0.0 112.711 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 32.2 Cg_exo -58.21 -46.07 27.44 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.115 1.877 . . . . 0.0 114.242 -170.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.82 16.51 19.5 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -124.23 165.89 16.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.954 0.406 . . . . 0.0 111.486 -171.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 6.2 m-20 -115.59 131.89 56.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 1.6 m-85 -114.28 124.71 52.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.464 -173.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 m-85 -139.85 151.54 45.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.733 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 38.1 mtmt -140.06 121.25 14.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 70.6 mt -78.42 141.02 38.63 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.506 -171.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.74 91.08 0.8 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 27' ' ' ALA . 2.3 p -59.53 -6.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -172.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.95 -32.97 15.77 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.48 -36.17 26.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.246 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.0 52.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.547 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.72 -40.29 22.59 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.04 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.4 m-20 -69.79 -38.53 76.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.455 0.169 . . . . 0.0 110.995 -177.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -68.96 -37.53 77.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.435 . . . . 0.0 110.41 176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.8 73.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.029 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.4 mt-30 -70.91 -34.75 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 52.7 mttp -59.46 -43.99 93.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.553 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -91.55 10.52 27.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.146 -174.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 58.27 48.68 12.22 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.498 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.513 HG13 ' OG1' ' A' ' 74' ' ' THR . 71.8 t -78.64 118.58 26.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.83 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -124.25 -58.83 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.19 127.63 32.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.333 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.5 134.91 19.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.334 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 64.9 Cg_endo -83.31 171.25 51.57 Favored 'Cis proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.855 -1.31 . . . . 0.0 112.035 -1.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.513 ' OG1' HG13 ' A' ' 69' ' ' VAL . 27.7 m -117.93 114.76 23.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.2 mm? -105.23 107.46 18.45 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.323 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.493 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.2 mt -126.25 112.7 16.04 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -87.14 116.89 25.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 70.3 m-85 -104.45 145.99 29.5 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.665 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mtpt -143.83 120.96 11.46 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.969 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 38.8 m-80 61.14 21.85 12.22 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.715 0.634 . . . . 0.0 110.809 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.06 12.3 65.07 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -111.59 5.57 19.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.57 ' HG2' ' H ' ' A' ' 84' ' ' VAL . 27.4 tt0 70.36 177.17 0.27 Allowed 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.123 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.576 HG21 ' HD3' ' A' ' 79' ' ' LYS . 1.4 p -157.12 -31.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.32 164.29 34.94 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.82 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.493 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 66.7 tttt -148.61 122.88 9.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.594 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.49 132.24 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.78 79.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.299 0.571 . . . . 0.0 111.065 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.09 -172.86 35.88 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -67.36 100.98 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.4 p-10 -124.07 63.55 32.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 90' ' ' ALA . 8.7 Cg_exo -70.75 -31.35 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 120.963 1.109 . . . . 0.0 110.098 172.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.65 -47.12 8.15 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.257 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -69.43 -16.31 63.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -177.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.696 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.1 tp -53.56 -38.29 33.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.114 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 169.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.686 ' HA ' HG22 ' A' ' 99' ' ' ILE . 36.0 mmtt -55.07 -41.7 71.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.937 0.773 . . . . 0.0 110.798 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -51.17 -53.72 32.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.523 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -80.49 -30.56 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 111.762 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -76.05 -39.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.982 -172.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.86 -41.4 14.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.708 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.93 75.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.621 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 35.4 m-80 -107.26 -73.1 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.879 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.883 0 O-C-N 123.983 0.802 . . . . 0.0 112.632 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 52' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.138 0.494 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.43 HG22 ' HD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -84.12 148.43 26.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.087 -175.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.29 122.68 47.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.317 171.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.673 ' H ' HD22 ' A' ' 55' ' ' LEU . 12.4 m-85 -76.16 164.06 26.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.193 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -121.61 -20.26 6.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 61.1 p -131.63 155.12 48.12 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.296 -0.253 . . . . 0.0 111.312 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.29 -36.09 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 t -57.71 -41.15 81.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.572 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 19.6 mm-40 -59.59 -43.53 93.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.125 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.467 ' HD1' HG21 ' A' ' 23' ' ' VAL . 7.4 t80 -67.07 -53.2 33.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.465 ' HA ' HG12 ' A' ' 15' ' ' ILE . 10.9 m-20 -61.49 -37.19 82.76 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 111.781 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.822 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -69.14 -48.55 62.09 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.0 110.579 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 12' ' ' ASP . 34.2 pt -67.02 -20.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.97 -8.6 59.43 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.084 0.468 . . . . 0.0 111.306 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -75.73 152.58 37.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.889 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 2.3 m-20 -80.37 35.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.102 0.477 . . . . 0.0 111.634 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 4.4 ptpt -134.7 -179.06 5.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 0.0 111.346 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.3 tm? -84.36 108.26 17.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.445 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.763 HG13 ' CE1' ' A' ' 53' ' ' TYR . 78.3 t -112.88 106.92 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.019 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.698 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.34 106.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.341 0.591 . . . . 0.0 110.952 176.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 53' ' ' TYR . 59.3 t -106.23 136.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.634 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -118.1 115.45 24.85 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.161 0.505 . . . . 0.0 110.249 170.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.5 m-85 -70.06 109.96 4.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.544 ' CZ ' HD12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.78 159.24 31.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -163.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -147.53 135.88 21.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.159 173.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -83.88 -5.7 59.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -170.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 1.1 p90 -89.28 57.59 4.1 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.9 p -157.41 -176.72 6.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.26 -53.04 3.22 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.205 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' O ' ' HG2' ' A' ' 35' ' ' MET . 87.9 Cg_exo -49.07 -43.0 37.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.561 2.174 . . . . 0.0 112.075 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -58.13 -35.17 71.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -62.4 -46.55 88.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.628 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.624 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.7 ptm -77.26 -45.92 24.8 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.635 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -75.79 -23.31 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.439 -176.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.06 -49.53 91.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.092 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.624 ' HD2' ' O ' ' A' ' 35' ' ' MET . 23.3 Cg_exo -66.67 -38.3 18.81 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.498 1.465 . . . . 0.0 112.442 171.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -63.94 -58.29 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CG1' HG12 ' A' ' 36' ' ' ILE . 12.9 mm -56.21 -33.61 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.91 -49.17 78.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.248 0.547 . . . . 0.0 110.328 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -62.93 -47.33 83.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.262 0.553 . . . . 0.0 110.144 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.0 m-30 -64.52 -17.57 64.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.842 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.3 p -86.49 -13.37 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.873 0.844 . . . . 0.0 108.828 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -88.77 -19.35 26.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.328 169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -125.26 33.1 5.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.764 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -110.26 82.94 2.86 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-O 121.752 0.787 . . . . 0.0 111.659 169.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.13 -46.29 29.15 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.864 2.376 . . . . 0.0 114.561 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -112.71 6.33 18.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -105.63 165.08 11.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.954 -0.466 . . . . 0.0 110.743 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.45 123.23 27.67 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.71 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.764 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.2 m-85 -92.24 131.74 37.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.763 ' CE1' HG13 ' A' ' 21' ' ' VAL . 7.4 m-85 -130.82 135.3 47.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.298 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.617 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.57 120.78 31.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.673 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.9 mt -99.99 168.42 9.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.383 -171.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.69 104.08 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.991 0.9 . . . . 0.0 108.824 169.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -10.73 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.243 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.03 -33.84 65.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.081 0.467 . . . . 0.0 109.993 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -94.61 -36.39 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.903 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mm? -97.97 47.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.058 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.17 -39.12 27.94 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.886 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.44 -45.24 88.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 5.3 p -66.91 -37.76 80.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' A' ' 69' ' ' VAL . . . -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.112 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.3 mt-30 -62.8 -34.03 76.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -72.1 -24.97 61.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.7 9.54 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.998 0.428 . . . . 0.0 110.84 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 59.06 45.28 14.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.653 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 25' ' ' PHE . 72.5 t -74.74 117.3 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.908 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -133.24 -0.05 3.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.408 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.69 164.86 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 111.056 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 36.9 mtm -124.21 111.47 28.5 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.012 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.535 ' CB ' ' HE1' ' A' ' 26' ' ' TYR . 4.0 Cg_exo -77.63 170.32 71.27 Favored 'Cis proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.583 -5.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.42 ' OG1' HG13 ' A' ' 69' ' ' VAL . 77.1 m -115.29 112.38 22.32 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 158.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.602 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 6.0 mt -118.63 107.94 14.32 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.741 -167.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.466 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 5.4 mt -125.26 112.46 16.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.197 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.92 130.21 38.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.631 176.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 46.1 m-85 -111.11 154.15 24.69 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.143 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 27.8 ttpp -137.4 113.88 10.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.824 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 43.62 46.27 6.06 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.17 0.918 . . . . 0.0 111.941 -177.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 7.09 52.49 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.647 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.73 9.4 16.38 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 122.436 -0.449 . . . . 0.0 110.612 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.8 tt0 66.8 173.0 0.25 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.776 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.5 p -146.96 -32.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.728 0.299 . . . . 0.0 110.36 172.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -158.16 162.04 37.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.131 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.3 tmtp? -143.33 107.8 4.82 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.77 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.68 143.91 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -155.71 84.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.614 0.721 . . . . 0.0 111.74 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.09 81.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.644 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.526 ' HA ' ' CD ' ' A' ' 73' ' ' PRO . . . 45.13 74.76 0.12 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.05 0.54 . . . . 0.0 111.867 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 20.0 p-10 -123.59 75.53 54.69 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -171.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.577 ' O ' ' HE2' ' A' ' 43' ' ' PHE . 7.7 Cg_exo -74.07 -37.01 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.358 1.372 . . . . 0.0 110.4 166.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -87.4 -41.65 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.03 -17.78 60.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.517 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.603 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -63.14 -36.08 74.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 118.697 -1.201 . . . . 0.0 108.17 170.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.655 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 1.8 mmmp? -58.62 -33.73 70.36 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.389 0.431 . . . . 0.0 110.634 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -57.23 -54.95 40.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.63 173.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -71.81 -47.23 54.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.671 . . . . 0.0 111.229 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -61.44 -49.03 86.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.737 -172.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.35 -33.96 17.78 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -170.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.2 38.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.749 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -88.63 -54.65 4.06 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.195 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.582 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.535 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.624 HG21 ' HE3' ' A' ' 54' ' ' LYS . 1.2 m . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.525 ' CG2' ' HD2' ' A' ' 53' ' ' TYR . 1.3 m -74.03 144.76 44.96 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.463 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -111.63 118.56 36.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.595 172.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.682 ' H ' HD22 ' A' ' 55' ' ' LEU . 12.6 m-85 -71.22 163.37 27.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 110.063 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -112.33 -25.01 9.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.762 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.613 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 27.1 p -138.58 159.37 42.25 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -54.42 -39.29 67.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -53.67 -38.82 64.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.141 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.613 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 70.8 mm-40 -64.83 -50.46 66.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.519 0.675 . . . . 0.0 109.951 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.28 -48.1 81.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.497 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.546 ' HA ' HG12 ' A' ' 15' ' ' ILE . 7.2 m-20 -58.87 -35.34 72.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.349 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -74.64 -29.27 61.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.52 -39.56 24.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.172 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.818 HG22 HG11 ' A' ' 21' ' ' VAL . 43.8 pt -66.99 -22.28 29.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.698 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.77 -9.8 59.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.977 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.97 149.4 49.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.324 . . . . 0.0 110.507 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.31 39.19 0.31 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.214 0.53 . . . . 0.0 110.87 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.0 ptmt -147.32 173.75 12.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.817 -177.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.653 ' CD2' HG11 ' A' ' 84' ' ' VAL . 1.3 tm? -76.43 110.89 11.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.286 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.818 HG11 HG22 ' A' ' 15' ' ' ILE . 3.8 p -95.29 130.7 43.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.8 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -122.63 101.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.71 0.766 . . . . 0.0 109.71 169.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.637 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 57.7 t -109.12 143.28 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.874 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.28 120.51 32.41 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 83.7 m-85 -71.03 121.61 18.54 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.293 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.794 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 2.3 m-85 -119.99 177.78 4.86 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.127 0.489 . . . . 0.0 110.837 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.16 130.03 9.36 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 167.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -7.53 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 111.873 -174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -107.57 11.43 28.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.179 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.943 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -111.53 136.98 49.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.647 0.737 . . . . 0.0 111.649 -176.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.66 -41.46 50.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.589 -1.187 . . . . 0.0 114.325 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.943 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 16.5 Cg_exo -67.5 -27.96 38.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 CA-C-N 120.302 2.051 . . . . 0.0 110.441 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 58.9 m -55.26 -44.39 75.54 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.378 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.715 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 66.0 mttm -64.25 -51.33 64.12 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.561 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.675 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -62.05 -49.34 76.37 Favored 'General case' 0 C--O 1.252 1.185 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.04 -14.63 15.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.035 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.12 -49.68 92.26 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.971 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 24.5 Cg_exo -67.44 -35.1 24.46 Favored 'Trans proline' 0 C--N 1.36 1.156 0 CA-C-N 120.377 1.17 . . . . 0.0 111.645 169.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.433 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 97.1 mmm -62.36 -60.95 2.82 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.474 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.595 HG21 ' HD3' ' A' ' 54' ' ' LYS . 61.9 mt -65.07 -22.52 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.013 -0.429 . . . . 0.0 111.615 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 39.4 tt0 -63.36 -46.67 85.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.522 0.677 . . . . 0.0 109.474 169.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 14.6 tptm -60.88 -37.17 81.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.694 0.759 . . . . 0.0 109.532 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.673 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 2.6 m-30 -76.76 -14.66 59.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.751 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.815 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 46.1 p -74.62 -16.13 60.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.48 -24.1 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.023 171.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.673 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 12.8 mm100 -76.35 -38.66 55.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.073 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.604 ' CE1' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -104.03 101.9 28.62 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.0 Cg_endo -83.89 -19.07 5.1 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.077 2.518 . . . . 0.0 111.599 169.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.46 -22.22 19.73 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 111.161 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -109.07 140.21 42.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.672 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.1 117.52 29.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.586 0.708 . . . . 0.0 111.643 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.815 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.3 p90 -89.11 115.04 26.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.698 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.672 ' CE1' ' HB3' ' A' ' 51' ' ' ASP . 4.3 m-85 -133.41 150.7 51.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 171.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.659 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 9.7 mtmp? -143.99 119.39 10.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 6.8 mt -97.37 158.58 15.39 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -168.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.02 113.22 26.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.203 0.525 . . . . 0.0 110.009 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.727 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.76 -14.53 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.3 -29.17 62.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.12 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -105.72 -18.96 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.721 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.9 mm? -106.87 45.28 0.99 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.28 0.562 . . . . 0.0 110.417 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -76.85 -34.01 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.415 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 2.9 m-20 -71.17 -43.53 67.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.51 0.195 . . . . 0.0 110.802 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 8' ' ' ALA . 3.7 p -62.2 -39.74 85.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.76 81.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.161 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -71.46 -36.0 71.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.078 0.466 . . . . 0.0 110.496 -175.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 44.2 mtmt -62.45 -36.84 83.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.792 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.49 15.59 25.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.368 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 60.32 38.04 19.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.514 172.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.56 110.05 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.473 . . . . 0.0 111.008 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -109.6 -44.74 3.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.932 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.12 153.98 38.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.556 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.43 140.18 18.58 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.755 0.312 . . . . 0.0 110.317 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 72.9 Cg_endo -79.87 160.66 86.74 Favored 'Cis proline' 0 C--O 1.236 0.38 0 C-N-CA 123.276 -1.552 . . . . 0.0 112.629 -3.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 22.6 m -129.67 119.8 24.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.11 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.583 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.06 108.4 19.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.664 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -120.99 114.3 21.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.679 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.8 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -94.21 133.47 37.69 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.883 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.676 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 4.1 m-85 -117.53 156.03 28.76 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.436 -175.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.716 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 65.3 tttm -144.29 116.83 8.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.173 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.716 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.0 p30 45.66 36.22 2.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.198 0.999 . . . . 0.0 112.664 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.93 5.93 76.96 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.254 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -115.58 14.61 16.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.742 0.271 . . . . 0.0 110.849 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.6 tt0 67.67 173.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.414 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.653 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.6 p -148.99 -33.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.932 0.396 . . . . 0.0 110.039 172.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.567 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -155.82 162.86 40.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.596 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -146.29 110.89 5.16 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.032 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.1 t -122.51 125.92 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.79 84.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.697 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.1 78.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.743 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 51.29 80.86 0.08 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.7 p-10 -124.47 87.24 54.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.439 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.7 Cg_exo -77.76 -38.89 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.523 1.482 . . . . 0.0 111.373 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.51 -44.55 10.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.913 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -68.68 -17.08 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.273 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.716 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.1 tp -58.69 -38.3 70.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 99' ' ' ILE . 12.8 mmmm -59.57 -36.25 75.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.162 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -51.91 -59.65 4.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.792 173.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -72.69 -36.22 67.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.345 0.593 . . . . 0.0 111.356 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.803 -171.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.21 -32.75 19.62 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.852 0.358 . . . . 0.0 111.327 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.53 48.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.792 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.567 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 66.9 m-80 -86.29 -53.99 4.7 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.621 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.802 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m -98.1 141.04 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.075 0.464 . . . . 0.0 109.916 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.9 148.08 25.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.905 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -111.92 120.08 40.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.817 174.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.618 ' H ' ' CD2' ' A' ' 55' ' ' LEU . 20.8 m-85 -73.43 164.41 26.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.219 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -116.23 -17.28 10.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.665 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.62 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 41.2 p -133.67 153.41 51.7 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.494 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.62 -31.37 66.17 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 m -60.91 -42.31 97.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.99 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.62 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.9 mm-40 -64.71 -42.68 95.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.391 0.615 . . . . 0.0 110.293 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 15' ' ' ILE . 5.3 t80 -66.42 -47.45 73.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.868 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.12 -47.7 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.408 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 20.1 m -68.93 -26.93 65.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.609 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -74.21 -54.57 7.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 27.4 pt -67.07 -19.71 25.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.23 -8.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.356 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.445 ' C ' ' H ' ' A' ' 19' ' ' LYS . 76.2 mt-30 -74.24 160.36 31.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.5 19.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.481 0.657 . . . . 0.0 111.427 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.5 ptmt -118.7 166.15 13.12 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.249 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.612 ' CD2' HG11 ' A' ' 84' ' ' VAL . 2.4 tm? -78.72 112.16 15.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 HG23 ' A' ' 23' ' ' VAL . 88.7 t -117.94 108.18 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.654 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.25 108.42 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.822 0.82 . . . . 0.0 111.015 175.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.624 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 59.9 t -104.56 142.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.526 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.872 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -122.12 119.7 32.1 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' A' ' 69' ' ' VAL . 56.2 m-85 -71.41 125.43 26.98 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.352 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.774 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -120.98 -174.28 2.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.077 -173.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.2 155.12 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.151 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.08 -5.41 59.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -111.87 33.65 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -132.96 146.64 51.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.592 0.711 . . . . 0.0 112.135 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.562 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -85.17 -42.37 7.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.991 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 23.0 Cg_endo -61.34 -40.11 51.8 Favored 'Trans proline' 0 C--N 1.359 1.09 0 CA-C-N 119.817 1.808 . . . . 0.0 111.417 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 12.5 p -57.57 -31.6 66.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.67 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.792 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tptt -66.19 -53.6 35.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.789 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.707 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 21.5 ptm -63.09 -44.55 95.4 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.684 ' CG1' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -74.82 -18.83 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.977 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.39 -48.66 96.93 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.6 Cg_exo -70.92 -31.03 16.04 Favored 'Trans proline' 0 C--N 1.36 1.149 0 CA-C-N 120.537 1.228 . . . . 0.0 112.004 171.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 35' ' ' MET . 20.1 mmt -66.61 -56.37 11.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.582 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.717 HG23 ' CE2' ' A' ' 52' ' ' PHE . 6.5 mt -59.66 -27.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 31.8 tt0 -53.94 -48.64 70.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 16.0 tppt? -65.95 -47.77 73.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.945 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.635 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 3.4 m-30 -62.66 -26.55 68.7 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.777 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 92.3 p -85.1 -15.25 44.55 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 42.5 tt0 -79.66 -25.99 41.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.174 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.635 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -96.22 8.43 43.89 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.66 ' HE2' ' CD2' ' A' ' 52' ' ' PHE . 5.1 m-85 -103.52 100.0 17.36 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.729 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.54 -43.01 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.758 2.305 . . . . 0.0 112.677 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.27 -14.87 17.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.763 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB2' ' HB1' ' A' ' 103' ' ' ALA . . . -104.68 165.04 11.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.48 137.37 51.76 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.717 ' CE2' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -109.12 131.03 55.46 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.187 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 42.8 m-85 -136.65 151.93 49.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.872 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 10.0 mtmp? -139.57 120.54 14.55 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.624 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 6.7 mt -100.32 161.11 13.82 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 5.7 m-20 -94.22 107.5 19.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -13.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -172.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 5.5 p-10 -77.72 -25.23 49.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 109.59 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -93.97 -40.3 10.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.816 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -98.21 53.98 1.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.764 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.621 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.21 -45.89 10.91 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.86 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.7 t70 -61.11 -44.64 97.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.508 0.194 . . . . 0.0 111.189 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.586 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.5 p -65.1 -38.65 83.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.169 0.509 . . . . 0.0 110.611 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.63 78.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.909 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 13.4 mm100 -72.56 -31.62 65.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.702 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.41 -41.84 90.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.804 0.811 . . . . 0.0 110.223 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -98.44 21.49 11.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.381 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 38.2 50.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.936 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.618 HG21 ' CD2' ' A' ' 25' ' ' PHE . 76.2 t -81.18 115.87 24.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.945 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 p -122.42 17.54 10.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.294 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.04 157.97 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -138.58 122.29 11.27 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 36' ' ' ILE . 98.2 Cg_endo -83.79 166.2 64.04 Favored 'Cis proline' 0 C--O 1.235 0.349 0 C-N-CA 123.751 -1.354 . . . . 0.0 112.505 -5.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 78.2 m -123.75 122.73 38.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.634 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -105.42 109.66 21.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -173.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 21.5 mt -125.52 115.86 20.86 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.859 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.579 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.58 125.32 39.16 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 174.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.9 m-85 -108.05 154.48 21.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.468 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 50.7 tptt -143.37 116.57 8.97 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.198 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.533 HD22 ' HG3' ' A' ' 79' ' ' LYS . 43.0 m-80 56.26 27.15 11.34 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 123.424 0.452 . . . . 0.0 111.527 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.54 10.06 59.72 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.002 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 47.6 pttt -109.88 1.9 19.5 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.632 0.73 . . . . 0.0 109.354 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.4 tt0 78.47 172.6 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.612 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -144.2 -31.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 109.847 173.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.454 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.37 162.37 30.74 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.842 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.638 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.6 tttt -139.82 124.64 18.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.603 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.5 t -131.02 137.97 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.8 83.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.893 0.854 . . . . 0.0 111.609 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.12 53.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.833 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.89 81.84 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 111.324 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 11.3 p-10 -117.67 90.82 36.86 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 95' ' ' ILE . 3.9 Cg_exo -77.2 -43.15 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.441 1.427 . . . . 0.0 110.897 169.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.3 16.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.094 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -74.61 -17.57 60.69 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.053 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.729 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.43 -38.77 76.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.618 ' HA ' HG22 ' A' ' 99' ' ' ILE . 31.2 mmmt -61.87 -29.66 70.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.357 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -56.39 -57.88 10.39 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 174.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.431 ' C ' HD11 ' A' ' 77' ' ' LEU . . . -74.86 -37.87 62.1 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -72.61 -39.14 60.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.009 -170.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.0 -32.41 21.52 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.361 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.83 70.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.14 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 52.5 m-80 -96.83 -62.33 1.28 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.603 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.695 0.283 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.87 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -90.4 141.73 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.255 0.55 . . . . 0.0 110.86 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.28 146.02 37.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.555 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -104.95 136.23 44.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.261 171.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.572 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.7 m-85 -90.82 161.53 15.23 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.996 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -119.0 -18.54 8.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.284 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 58.7 p -133.08 151.57 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 111.121 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -60.44 -27.58 67.62 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 t -62.74 -43.73 98.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.387 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 9.4 mm-40 -60.46 -46.21 90.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.321 0.582 . . . . 0.0 110.251 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.43 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 9.5 t80 -64.85 -47.9 76.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.241 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HA ' HG12 ' A' ' 15' ' ' ILE . 31.3 t70 -62.69 -33.69 75.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.608 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 m -73.43 -36.84 66.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.242 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.73 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.507 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.2 pt -67.78 -24.84 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.23 -15.68 60.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.084 0.468 . . . . 0.0 111.36 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.59 ' HB2' ' NZ ' ' A' ' 19' ' ' LYS . 98.2 mt-30 -76.46 156.47 33.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.802 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 17.9 t70 -48.38 -38.15 18.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -167.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.668 ' HE2' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -109.1 -178.96 3.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -162.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.669 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -59.58 116.04 3.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.02 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.2 t -119.72 107.2 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.967 170.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.664 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.86 103.4 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.737 0.779 . . . . 0.0 111.008 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 3.5 t -108.14 144.23 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.99 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -128.64 128.97 45.2 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CE2' HD12 ' A' ' 55' ' ' LEU . 80.9 m-85 -70.67 121.11 17.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.392 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.52 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 4.2 m-30 -120.19 176.1 5.62 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.251 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.65 16.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.889 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -84.48 -5.6 59.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -113.55 24.56 12.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 8.2 p -130.83 127.56 38.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.564 0.697 . . . . 0.0 111.65 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.04 -44.88 75.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.901 -1.045 . . . . 0.0 114.208 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 51.3 Cg_exo -57.6 -44.56 40.6 Favored 'Trans proline' 0 C--N 1.358 1.033 0 CA-C-N 119.98 1.89 . . . . 0.0 111.928 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 3.6 m -54.48 -37.19 64.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.391 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 38.6 ttpt -66.31 -47.04 74.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.149 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.435 ' O ' ' HG2' ' A' ' 39' ' ' MET . 24.8 ptt? -68.95 -45.25 71.22 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.665 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.32 -16.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.637 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.4 -55.41 44.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.508 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.7 Cg_endo -67.99 -27.85 35.98 Favored 'Trans proline' 0 C--N 1.358 1.032 0 CA-C-N 120.573 1.24 . . . . 0.0 111.993 172.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 35' ' ' MET . 96.6 mmm -67.08 -58.66 4.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.871 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.566 HG21 ' NZ ' ' A' ' 54' ' ' LYS . 65.0 mt -66.65 -20.39 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 O-C-N 121.994 -0.441 . . . . 0.0 111.794 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.87 -50.14 73.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.627 0.727 . . . . 0.0 109.531 164.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 43.3 tptt -60.19 -37.01 78.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.462 0.649 . . . . 0.0 109.83 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.691 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.8 m-30 -76.31 -15.07 60.06 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.379 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.758 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 24.2 p -73.58 -16.21 61.26 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 32.0 tt0 -87.6 -25.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.924 171.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.691 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 25.9 mm-40 -78.12 -30.03 49.2 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.729 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 4.1 p90 -120.39 83.6 33.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.25 -12.74 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.431 2.087 . . . . 0.0 111.438 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -6.11 49.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.602 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -127.87 165.55 19.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.557 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 12.4 m-20 -101.83 117.53 35.05 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.876 0.846 . . . . 0.0 112.617 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.2 p90 -98.02 113.66 25.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.545 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.695 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 32.7 m-85 -137.49 153.49 50.04 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.91 -0.494 . . . . 0.0 111.317 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.87 ' HG2' HG21 ' A' ' 2' ' ' VAL . 10.3 mmtt -128.3 142.95 50.99 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 72.7 mt -99.59 143.66 29.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.034 -0.416 . . . . 0.0 111.646 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 15.5 m-20 -86.51 100.66 12.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 166.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -59.01 -14.68 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' OD1' ' HB3' ' A' ' 56' ' ' ASP . 12.2 p-10 -71.76 -36.05 70.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 109.91 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.29 -15.08 16.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.386 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.593 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.4 mm? -109.22 44.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.91 -33.35 41.77 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.57 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.85 -45.85 80.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.702 0.287 . . . . 0.0 110.404 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -66.65 -36.91 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.492 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . . . -57.87 -50.17 74.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.358 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -63.77 -31.83 73.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.263 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -26.0 61.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.005 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -97.14 4.79 51.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.642 0.258 . . . . 0.0 110.975 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 62.82 43.75 6.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.847 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -88.33 121.66 38.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.889 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 p -123.67 -7.75 7.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.25 159.0 29.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.901 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -129.8 133.94 25.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.74 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.9 Cg_endo -86.05 171.05 41.6 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.903 -1.29 . . . . 0.0 111.199 -2.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.8 m -129.39 117.02 19.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -101.4 109.59 21.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 -175.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.593 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 23.9 mt -124.25 113.05 17.76 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.664 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.44 127.26 43.25 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.593 174.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 32.7 m-85 -108.66 159.71 16.52 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.646 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.774 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 61.0 tttp -142.46 118.01 10.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.847 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.774 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 5.9 p30 40.34 43.99 1.56 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.951 0.782 . . . . 0.0 112.912 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.71 1.41 58.46 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 114.073 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.99 10.93 18.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.291 0.546 . . . . 0.0 110.558 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.86 175.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.116 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.97 -35.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 173.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.483 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.69 165.18 36.98 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.411 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.593 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.8 tttt -148.9 115.98 6.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.556 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.29 139.25 48.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.21 89.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.503 0.668 . . . . 0.0 111.711 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.97 -174.78 31.68 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.469 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -72.91 93.15 1.69 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.883 0.373 . . . . 0.0 110.278 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 23.6 p-10 -119.49 69.21 11.37 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.0 -32.98 20.54 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.063 1.175 . . . . 0.0 111.002 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.96 -44.22 10.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.703 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.47 -17.13 61.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.2 tp -55.72 -39.51 55.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 99' ' ' ILE . 20.2 tptm -62.96 -32.44 73.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.368 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.18 -58.18 8.32 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.467 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -70.98 -36.67 72.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.539 0.685 . . . . 0.0 110.649 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -74.69 -42.04 47.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.178 -169.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -87.15 -39.42 15.53 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.961 0.41 . . . . 0.0 110.886 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.53 70.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.504 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 61.0 m-80 -89.04 -52.98 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.669 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.911 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.652 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -121.29 135.39 61.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.655 0.74 . . . . 0.0 111.734 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.27 147.85 23.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.325 -175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 4.9 pt20 -99.85 120.31 39.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.114 169.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.588 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 16.7 m-85 -73.17 133.6 44.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.665 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -86.14 -16.85 36.61 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 74.5 p -131.79 151.86 51.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 111.432 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.549 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -60.32 -30.8 69.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.792 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -64.14 -37.09 86.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.79 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.489 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 25.3 mm-40 -62.01 -47.76 83.35 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.237 0.541 . . . . 0.0 110.04 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -47.03 87.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.967 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.09 -46.15 68.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.634 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 17.7 m -71.85 -32.66 67.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.568 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.02 -49.83 47.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.595 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.0 pt -67.99 -18.6 23.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.323 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.19 -10.03 59.69 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.282 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 13' ' ' SER . 78.2 mt-30 -79.62 150.72 30.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.46 56.23 2.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.926 0.87 . . . . 0.0 111.033 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 5.5 ptmt -150.72 169.22 22.14 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.042 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.939 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -74.62 108.01 7.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.037 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 84.6 t -116.45 107.37 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.794 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.717 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.89 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.568 0.699 . . . . 0.0 111.173 176.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 90.9 t -102.85 135.23 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.267 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -117.63 106.63 13.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE2' HD12 ' A' ' 55' ' ' LEU . 81.2 m-85 -71.42 107.57 4.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.866 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -162.77 152.23 15.48 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -178.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -129.04 141.65 51.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 p -68.25 -4.35 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -73.94 6.4 3.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.2 p -122.56 -172.89 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.979 0.418 . . . . 0.0 111.893 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.59 -59.23 2.14 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.95 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 51.2 Cg_exo -53.86 -49.33 17.55 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.609 2.206 . . . . 0.0 111.944 -176.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.2 p -49.82 -37.92 32.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.803 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.791 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 8.0 ttpm? -66.41 -56.46 10.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.536 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 39' ' ' MET . 22.8 ptm -59.54 -45.87 90.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.695 HG13 HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -74.48 -22.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.524 -177.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -54.5 -57.06 20.5 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.222 -177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.791 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 20.9 Cg_endo -63.99 -35.01 56.97 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.294 1.329 . . . . 0.0 112.797 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 35' ' ' MET . 94.0 mmm -62.2 -56.36 19.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.735 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.695 HD12 HG13 ' A' ' 36' ' ' ILE . 23.6 mt -62.6 -23.81 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 120.782 0.325 . . . . 0.0 111.638 176.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.58 -43.94 79.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HG3' HE21 ' A' ' 46' ' ' GLN . 2.5 tppp? -62.18 -45.17 94.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.251 0.548 . . . . 0.0 110.239 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.66 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.9 m-30 -67.92 -15.32 63.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 13.5 p -87.11 -14.41 41.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.133 0.968 . . . . 0.0 108.697 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -86.68 -14.6 42.08 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.992 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.66 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -129.37 36.14 4.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.844 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -115.74 74.24 4.74 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.91 -36.09 90.93 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.337 2.024 . . . . 0.0 113.946 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -107.21 24.45 12.82 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.557 0.694 . . . . 0.0 111.54 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' HB2' ' CB ' ' A' ' 103' ' ' ALA . . . -138.95 165.6 26.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.337 -0.852 . . . . 0.0 111.803 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 117.67 19.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.89 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.844 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -93.2 129.57 39.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.575 -174.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 36.1 m-85 -137.49 135.56 36.9 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.841 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 30.1 mtmt -125.08 121.7 35.06 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.057 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.588 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 54.6 mt -85.66 125.11 32.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.455 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.693 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 5.0 p-10 -70.95 105.61 3.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -58.23 -12.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.404 -175.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.53 -44.95 85.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.729 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.11 -18.14 17.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.164 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -106.8 51.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 110.825 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -78.22 -41.17 18.01 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.25 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.74 -41.49 83.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 7.7 p -65.51 -38.68 83.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.0 110.221 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.51 77.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.994 0.426 . . . . 0.0 110.796 174.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 78.3 mm-40 -70.66 -27.16 63.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.753 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -75.26 -25.09 57.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.266 0.555 . . . . 0.0 110.412 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -100.25 12.29 37.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.245 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 62.17 42.87 9.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG13 ' OG1' ' A' ' 74' ' ' THR . 85.0 t -91.71 124.63 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -138.03 17.75 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.109 0.481 . . . . 0.0 110.908 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -138.88 146.85 41.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.766 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.03 124.13 27.07 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.382 . . . . 0.0 110.194 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 58.0 Cg_endo -85.78 170.33 44.24 Favored 'Cis proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.55 -2.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 98.3 m -124.67 115.76 21.28 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -105.63 108.51 20.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.98 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.8 mt -127.57 114.4 17.36 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.85 130.07 41.59 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.63 0.729 . . . . 0.0 110.259 174.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.651 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 88.7 m-85 -111.0 156.71 20.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.359 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.4 ttmt -141.63 116.13 9.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.349 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.55 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 42.33 43.81 3.13 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.769 0.828 . . . . 0.0 112.529 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.08 53.69 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.572 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.31 8.61 18.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.071 0.463 . . . . 0.0 110.183 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.651 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 45.8 mt-10 64.77 178.48 0.18 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.619 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.7 p -148.86 -33.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.526 170.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.408 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.41 163.66 35.26 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 88' ' ' VAL . 30.4 tttm -146.41 120.52 9.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.497 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.9 t -127.05 131.51 70.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG21 ' HE2' ' A' ' 86' ' ' LYS . 2.5 t -125.89 79.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.024 0.44 . . . . 0.0 111.248 -171.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.5 -168.81 38.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -69.65 93.39 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.3 p-10 -123.74 63.4 28.31 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.453 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.1 Cg_exo -67.35 -37.76 16.91 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.038 1.159 . . . . 0.0 110.579 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.8 -40.36 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.939 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.26 -17.21 61.36 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.272 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.8 tp -59.71 -37.15 69.72 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.612 ' HA ' HG22 ' A' ' 99' ' ' ILE . 29.2 mmtt -57.63 -34.79 69.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.538 0.524 . . . . 0.0 110.623 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -54.33 -56.4 18.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -73.43 -44.09 59.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.478 0.656 . . . . 0.0 111.204 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.678 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -65.26 -41.43 91.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.858 -171.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.11 -42.06 11.92 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.826 0.346 . . . . 0.0 111.762 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.8 -39.1 73.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.408 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.3 m-80 -85.85 -56.73 3.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.072 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.402 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 tmm? . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.821 HG21 ' HE2' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -88.33 144.66 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 145.76 55.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 112.504 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.14 56.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.597 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.7 ' H ' HD22 ' A' ' 55' ' ' LEU . 18.4 m-85 -74.7 163.04 28.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.875 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -119.83 -13.83 9.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.523 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.641 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 82.2 p -135.05 152.29 51.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.882 0.372 . . . . 0.0 111.098 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.81 -30.53 67.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -64.06 -39.17 93.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.901 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.641 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 15.8 mm-40 -60.8 -42.3 97.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.996 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -64.94 -49.15 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.739 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.36 -43.23 83.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.759 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -70.8 -36.06 72.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.72 -52.16 40.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.519 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 28.4 pt -65.03 -21.04 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.191 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.03 -6.99 57.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.749 0.309 . . . . 0.0 111.687 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' A' ' 19' ' ' LYS . 27.9 mt-30 -81.56 159.05 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.876 0.369 . . . . 0.0 110.325 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.73 18.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.237 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 17' ' ' GLN . 30.3 mtpt -107.75 174.61 5.81 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.906 0.86 . . . . 0.0 112.68 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.646 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tm? -91.2 107.06 18.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.355 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 67.3 t -106.0 115.45 47.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.547 HG22 HD22 ' A' ' 77' ' ' LEU . 21.6 t -92.3 102.39 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.211 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.576 HG23 HG12 ' A' ' 21' ' ' VAL . 44.2 t -108.39 136.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.473 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' CG ' ' A' ' 54' ' ' LYS . . . -128.92 141.55 51.23 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 120.764 0.316 . . . . 0.0 111.821 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.666 ' CD2' HG21 ' A' ' 69' ' ' VAL . 59.0 m-85 -95.11 122.52 37.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.336 0.589 . . . . 0.0 110.55 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.733 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.5 m-85 -119.98 -175.28 2.94 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.243 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.61 165.76 20.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -84.92 -5.55 59.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.317 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -122.88 34.59 5.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.776 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.673 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 6.9 p -132.11 121.82 24.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.527 0.68 . . . . 0.0 111.834 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.39 -42.12 97.79 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.923 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.611 ' O ' HG23 ' A' ' 36' ' ' ILE . 50.3 Cg_exo -57.47 -44.3 43.57 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.021 1.91 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 9.2 m -53.32 -41.35 65.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.718 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 37.5 ttpt -63.06 -56.36 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.6 ptp -60.65 -47.79 84.68 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.34 -13.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.014 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -57.67 -53.64 63.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.291 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.9 Cg_endo -65.53 -33.19 47.08 Favored 'Trans proline' 0 C--N 1.357 1.003 0 CA-C-N 120.281 1.136 . . . . 0.0 112.448 169.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 mmt -65.02 -58.92 4.85 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.969 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.521 HG12 HG21 ' A' ' 95' ' ' ILE . 51.6 mt -64.42 -23.04 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 O-C-N 122.107 -0.371 . . . . 0.0 111.399 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 42.6 tt0 -63.12 -41.51 99.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.66 0.743 . . . . 0.0 110.133 170.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 19.7 ttmt -64.56 -38.94 92.75 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.087 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.68 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 9.4 m-30 -69.63 -23.82 63.56 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.267 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 2.0 p -73.81 -14.67 61.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.71 -23.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.68 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 53.5 mt-30 -80.65 -33.38 35.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.063 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 5.8 p90 -108.43 92.13 9.44 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.2 Cg_endo -84.39 -12.79 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.132 2.555 . . . . 0.0 111.37 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 50' ' ' ALA . 3.3 pt20 -88.2 -22.95 23.73 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.354 0.597 . . . . 0.0 110.385 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -113.68 148.16 36.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 7.0 m-20 -91.12 116.73 29.04 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.402 0.62 . . . . 0.0 111.523 -174.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.686 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 2.8 p90 -87.7 114.55 24.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.946 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 51' ' ' ASP . 22.1 m-85 -130.78 164.85 24.22 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.238 170.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.821 ' HE2' HG21 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -153.29 119.9 5.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 5.4 mt -99.31 159.52 14.94 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.255 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -102.42 118.77 37.59 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -63.34 -11.48 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.636 -174.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.24 -37.48 78.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.975 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.21 -31.02 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.458 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.579 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.0 mm? -107.73 48.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.004 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.598 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.92 -41.78 17.89 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.117 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 4.5 m-20 -66.7 -44.1 82.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.509 0.195 . . . . 0.0 110.839 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.0 p -62.74 -38.03 80.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.202 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.89 85.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.167 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 17.1 mm100 -71.37 -32.13 68.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.901 0.382 . . . . 0.0 110.464 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.9 mttm -59.42 -42.63 92.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.6 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -94.81 14.74 20.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.044 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 58.86 43.79 17.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.602 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.666 HG21 ' CD2' ' A' ' 25' ' ' PHE . 94.8 t -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.979 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 p -125.87 22.43 7.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.156 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 88' ' ' VAL . . . -142.91 151.01 40.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.673 ' SD ' ' HB3' ' A' ' 30' ' ' CYS . 16.2 ptt? -121.45 123.15 27.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.202 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 6.1 Cg_endo -86.88 172.35 35.47 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.428 -1.072 . . . . 0.0 111.511 -3.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 55.1 m -138.82 116.78 11.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.698 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.5 mp -107.13 142.53 36.67 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.093 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 86' ' ' LYS . 21.8 mt -134.28 110.6 9.61 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.094 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -89.45 124.08 34.17 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.758 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 31.5 m-85 -109.68 154.65 22.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.955 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.611 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 58.5 tttp -142.95 115.06 8.34 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.961 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.603 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 9.6 p30 44.69 38.11 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.965 0.906 . . . . 0.0 112.45 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.43 3.93 63.42 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.697 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 79' ' ' LYS . 16.8 ptmt -103.59 -3.7 24.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 109.412 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 29.3 tt0 77.23 -179.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.565 -1.652 . . . . 0.0 108.593 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.602 HG11 ' CD2' ' A' ' 20' ' ' LEU . 2.1 p -152.2 -32.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.884 0.374 . . . . 0.0 110.04 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.25 162.13 40.17 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.129 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.434 ' HG3' HD22 ' A' ' 76' ' ' LEU . 35.0 tttp -138.17 122.49 18.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.029 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.616 HG11 ' ND2' ' A' ' 91' ' ' ASN . 10.1 p -128.98 131.22 68.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.302 0.572 . . . . 0.0 110.277 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.0 t -131.11 80.41 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.672 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.36 -175.12 38.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.926 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.42 94.72 2.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.941 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 22.8 p-10 -124.45 68.95 51.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 95' ' ' ILE . 18.7 Cg_exo -64.68 -43.65 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 120.614 0.876 . . . . 0.0 110.991 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.88 -32.43 18.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.941 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.88 -18.76 59.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.429 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.682 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.0 tp -59.9 -38.12 75.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.589 ' HA ' HG22 ' A' ' 99' ' ' ILE . 19.3 tptm -64.27 -26.82 68.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.168 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.4 tm0? -58.83 -59.26 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 170.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 -38.36 78.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.7 . . . . 0.0 110.741 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -71.63 -42.37 71.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.146 -170.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.19 -40.45 14.57 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.99 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.76 -40.4 66.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.572 -175.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.8 m-80 -85.55 -56.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.469 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.646 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.581 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.661 0.267 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.958 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -121.59 140.08 46.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.302 0.572 . . . . 0.0 110.483 177.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.73 148.25 33.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.899 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.483 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -112.46 118.49 35.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.391 172.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.611 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -69.9 163.06 26.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.44 . . . . 0.0 110.68 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -115.59 -18.34 10.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.176 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.61 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 28.5 p -138.0 155.49 48.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.501 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.64 -34.85 73.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 m -57.24 -37.77 72.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.991 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.61 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 34.4 mm-40 -63.36 -45.03 93.07 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.307 0.575 . . . . 0.0 109.961 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HD2' HG21 ' A' ' 23' ' ' VAL . 1.9 t80 -66.75 -50.36 62.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.747 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.53 -39.73 80.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.396 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.1 m -69.45 -37.05 77.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -66.62 -49.6 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.858 0.361 . . . . 0.0 110.814 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.5 pt -66.69 -24.26 32.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.649 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.33 -5.76 48.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.42 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 26.0 mt-30 -75.94 157.04 33.64 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.985 0.421 . . . . 0.0 110.302 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.45 -1.78 3.91 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.73 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 11.1 ptmt -115.47 173.86 6.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.21 0.528 . . . . 0.0 111.812 -167.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.574 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.41 113.69 11.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -122.12 107.86 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.766 0.317 . . . . 0.0 110.641 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.587 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.93 109.2 26.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.867 0.842 . . . . 0.0 111.588 176.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 98.9 t -104.28 142.54 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.151 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.856 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -129.43 138.35 51.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 69' ' ' VAL . 70.1 m-85 -88.51 126.6 35.33 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.25 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.2 m-30 -120.82 -172.06 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.637 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -169.9 162.51 9.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.227 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 p -83.98 -4.85 59.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -122.8 35.0 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 -176.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -130.95 143.88 51.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.814 0.816 . . . . 0.0 111.911 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.48 -45.43 6.49 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.276 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 50.9 Cg_exo -57.11 -50.63 10.73 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.903 1.735 . . . . 0.0 112.17 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 28.5 p -53.5 -34.37 57.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.71 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 4.6 ttmp? -68.55 -45.17 72.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.064 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 24.9 ptt? -72.86 -41.52 64.67 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.277 0.561 . . . . 0.0 112.444 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.664 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.91 -17.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.44 177.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.03 -49.22 94.89 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 37.8 Cg_endo -69.84 -29.44 23.5 Favored 'Trans proline' 0 C--N 1.358 1.066 0 CA-C-N 120.56 1.236 . . . . 0.0 112.592 169.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.6 mmt -67.68 -52.21 40.57 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.958 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.786 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -55.8 -35.2 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 173.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 12.7 tp10 -55.45 -49.88 71.3 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.149 0.5 . . . . 0.0 110.254 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -61.63 -48.04 82.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.097 0.475 . . . . 0.0 110.493 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.661 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 m-30 -63.02 -22.36 66.8 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.981 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.471 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 34.9 p -82.03 -19.59 40.08 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.726 0.774 . . . . 0.0 108.949 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -77.48 -29.91 52.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.673 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.661 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -100.39 26.31 6.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.251 175.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.747 ' CE1' HD11 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -100.12 89.34 1.08 Allowed Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.889 170.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 83.0 Cg_endo -84.99 -45.18 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.125 1.883 . . . . 0.0 114.075 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.69 -24.19 14.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.226 0.536 . . . . 0.0 111.845 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.36 164.38 11.68 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.577 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.0 128.32 55.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.786 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.52 120.87 43.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.642 ' HA ' HG23 ' A' ' 2' ' ' VAL . 29.6 m-85 -132.39 142.03 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.737 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.958 ' HG2' HG21 ' A' ' 2' ' ' VAL . 7.8 mmtt -127.93 120.0 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.654 HD13 ' HG ' ' A' ' 60' ' ' LEU . 6.0 mt -100.67 167.73 10.14 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.53 120.41 40.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -15.96 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.281 -174.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.65 -51.04 46.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.913 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.16 -29.7 31.42 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.469 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.9 mm? -96.14 57.59 1.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 0.0 111.22 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.545 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.97 -45.43 10.44 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.375 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 33.3 t70 -61.25 -45.42 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.649 0.262 . . . . 0.0 111.165 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.9 p -64.82 -38.04 81.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.384 . . . . 0.0 110.557 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.05 74.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.0 110.81 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 16.9 mm100 -75.02 -28.79 60.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.607 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 87.7 mttt -61.84 -41.31 97.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.462 0.649 . . . . 0.0 110.549 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -92.2 7.75 41.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.125 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 55.16 46.61 23.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.058 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 25' ' ' PHE . 93.3 t -77.89 109.44 12.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.41 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.51 -2.57 11.48 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.357 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.03 23.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.994 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.89 145.6 32.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.629 0.252 . . . . 0.0 110.695 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 90.5 Cg_endo -82.04 171.24 56.4 Favored 'Cis proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.355 -1.519 . . . . 0.0 112.046 -3.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.594 HG22 HD11 ' A' ' 76' ' ' LEU . 19.2 m -127.11 119.0 25.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -108.24 106.23 16.31 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.002 0.429 . . . . 0.0 111.016 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.594 HD11 HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -118.84 119.06 33.27 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.117 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -94.91 119.01 32.74 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.2 m-85 -105.37 160.25 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.86 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' HD22 ' A' ' 80' ' ' ASN . 65.8 tttp -150.68 125.5 9.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.014 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.55 HD22 ' HG2' ' A' ' 79' ' ' LYS . 55.2 m-80 53.9 33.76 17.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 111.882 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.19 60.91 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.719 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 47.3 mmtm -102.06 -73.55 0.65 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 9.5 pt-20 165.41 -170.98 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 124.724 1.265 . . . . 0.0 108.511 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 77' ' ' LEU . 1.5 p -156.62 -30.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.446 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -163.02 161.96 25.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.411 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.573 ' HG3' HD12 ' A' ' 76' ' ' LEU . 71.5 tttt -146.61 124.38 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.184 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.47 132.95 70.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.26 78.67 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.124 0.488 . . . . 0.0 110.853 -171.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.42 -171.79 40.02 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.609 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.38 93.57 2.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.665 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.0 p-10 -118.93 71.87 11.09 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 95' ' ' ILE . 7.3 Cg_exo -73.65 -31.75 8.33 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.264 1.309 . . . . 0.0 109.833 166.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.59 -44.1 10.32 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.432 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.91 -16.9 61.09 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.424 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.715 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -57.09 -37.68 56.62 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 169.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.683 ' HA ' HG22 ' A' ' 99' ' ' ILE . 13.9 mmmm -56.96 -32.77 66.37 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.743 0.652 . . . . 0.0 110.37 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -57.99 -56.65 19.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.605 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -77.9 -28.33 49.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.747 HD11 ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -74.43 -44.7 47.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.654 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 -32.44 22.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.279 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.88 82.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 17.9 m-80 -114.22 -77.21 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.192 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.917 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -171.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 ttp . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.903 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -114.63 135.75 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.575 0.702 . . . . 0.0 111.708 -177.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.437 ' CG2' ' HD1' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -81.33 148.66 29.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.428 -177.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.5 141.08 35.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 170.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.545 ' HB2' HD22 ' A' ' 55' ' ' LEU . 14.3 m-85 -98.77 157.15 16.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.044 0.449 . . . . 0.0 110.021 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -123.71 -17.42 6.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 50.0 p -130.08 150.88 51.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.952 0.406 . . . . 0.0 111.025 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -60.35 -30.39 69.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.396 175.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -67.77 -33.58 75.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.479 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 22.1 mm-40 -61.73 -47.16 86.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.264 0.554 . . . . 0.0 110.07 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.6 -45.98 81.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.059 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.99 -48.51 81.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.371 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -69.36 -26.74 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.49 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -70.66 -53.25 16.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.427 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 pt -65.35 -21.97 30.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.332 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.88 -2.75 48.77 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.49 ' NE2' ' HA ' ' A' ' 14' ' ' ALA . 78.1 mt-30 -76.09 158.55 31.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.506 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 33.9 t70 -80.16 28.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.104 0.954 . . . . 0.0 110.026 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 7.8 ptmt -134.75 169.12 17.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.506 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.811 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tm? -82.53 116.92 22.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.896 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.6 t -115.32 107.63 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.742 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.72 103.69 15.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 122.164 0.983 . . . . 0.0 111.209 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 21' ' ' VAL . 18.0 t -100.47 139.92 20.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.27 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -130.33 138.57 50.5 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.664 0.269 . . . . 0.0 111.698 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CD2' HG21 ' A' ' 69' ' ' VAL . 49.7 m-85 -88.59 128.17 35.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.92 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 4.4 m-30 -120.45 -170.93 2.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.04 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.24 172.39 12.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.252 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -67.71 -20.74 65.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.225 0.536 . . . . 0.0 110.868 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 23.1 p90 -101.39 -147.45 0.36 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.254 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.9 p 56.73 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.408 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.86 -41.45 76.13 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 114.319 -1.309 . . . . 0.0 114.178 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.677 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 46.4 Cg_exo -58.82 -43.73 41.57 Favored 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 120.25 2.025 . . . . 0.0 112.154 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.4 m -53.21 -40.0 64.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.383 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.758 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 96.1 mttt -65.56 -53.34 43.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.499 -178.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.8 ptm -62.8 -45.36 92.99 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.649 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.62 -18.43 15.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.924 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.4 -48.16 97.78 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.758 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 16.9 Cg_exo -70.74 -32.53 14.34 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.174 1.249 . . . . 0.0 112.008 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.1 mmm -64.26 -51.02 65.65 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.614 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.57 HD13 ' CG1' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -53.85 -36.94 31.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-O 120.624 0.249 . . . . 0.0 110.341 172.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.92 -44.49 97.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.721 0.296 . . . . 0.0 111.195 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.92 -50.13 75.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.577 0.703 . . . . 0.0 109.408 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.704 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 14.1 m-30 -63.7 -17.17 62.7 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.482 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 9.6 p -86.15 -14.05 45.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.978 0.894 . . . . 0.0 108.921 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -88.14 -16.63 32.91 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.704 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -128.77 29.92 5.17 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.809 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -108.58 100.83 40.45 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-O 122.193 0.997 . . . . 0.0 112.623 172.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.85 -44.12 10.9 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.826 2.35 . . . . 0.0 114.375 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.5 -13.45 17.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 111.349 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -103.33 158.19 16.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.786 0.803 . . . . 0.0 112.002 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -126.38 119.13 26.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.173 171.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.809 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -87.64 130.58 34.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 -175.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.572 ' CE2' HG13 ' A' ' 21' ' ' VAL . 37.9 m-85 -133.32 133.07 42.06 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.356 168.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.903 ' HG2' HG21 ' A' ' 2' ' ' VAL . 8.0 mmpt? -117.0 118.96 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 1.3 mt -102.4 175.22 5.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.017 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -115.88 121.46 42.42 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -67.89 -10.58 12.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.198 -175.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.64 -35.64 52.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.58 -27.49 21.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.706 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.657 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.0 mt -117.85 54.09 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.367 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.25 -39.16 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.112 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.6 t70 -68.07 -46.99 69.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.644 0.259 . . . . 0.0 110.632 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.657 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 5.6 p -62.18 -38.45 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.402 . . . . 0.0 110.35 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.31 77.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.918 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 27.5 mt-30 -76.42 -30.85 57.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.461 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 39.1 mtmt -58.62 -39.95 81.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.51 0.671 . . . . 0.0 110.056 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -91.26 9.44 31.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.691 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 56.44 45.62 22.27 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.348 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 25' ' ' PHE . 62.3 t -85.96 123.72 39.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.508 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -134.67 -35.56 0.88 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.53 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.32 119.84 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.979 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.57 136.93 19.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.417 . . . . 0.0 110.872 -175.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 85.2 Cg_endo -83.98 169.88 52.84 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.124 -1.615 . . . . 0.0 111.714 -4.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.489 ' OG1' HG13 ' A' ' 69' ' ' VAL . 55.9 m -117.06 116.88 28.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.579 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.34 108.65 20.15 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.172 0.511 . . . . 0.0 111.084 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.538 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.4 mt -126.63 116.08 20.47 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.606 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.742 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.81 125.98 41.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.933 173.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 25.7 m-85 -108.73 154.28 22.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.381 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' HG2' HD22 ' A' ' 80' ' ' ASN . 22.5 ttmm -139.99 111.6 7.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.536 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.555 HD22 ' HG2' ' A' ' 79' ' ' LYS . 30.8 m-80 57.32 31.75 20.64 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.652 0.595 . . . . 0.0 111.508 -176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.36 11.19 51.77 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.51 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -106.01 0.3 25.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.764 0.792 . . . . 0.0 109.097 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 72.05 175.51 0.28 Allowed 'General case' 0 CA--C 1.524 -0.049 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.246 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.76 HG11 HD21 ' A' ' 20' ' ' LEU . 1.1 p -148.61 -30.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.006 0.431 . . . . 0.0 109.917 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.638 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.61 164.54 29.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.645 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 80.1 tttt -146.4 118.37 8.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.167 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.17 131.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.17 76.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.204 0.526 . . . . 0.0 111.376 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.47 -167.51 35.71 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.226 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -74.99 96.99 3.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 110.094 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 25.1 p-10 -122.27 67.17 25.77 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.1 -34.63 27.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.173 1.248 . . . . 0.0 110.944 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.21 -43.26 11.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.143 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.4 -17.75 60.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.624 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.684 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.8 tp -58.85 -37.57 67.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.119 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 170.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.592 ' HA ' HG22 ' A' ' 99' ' ' ILE . 21.4 tptm -60.65 -32.76 71.92 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.049 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -56.17 -55.83 28.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 173.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.74 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -73.53 -36.04 65.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.542 0.687 . . . . 0.0 111.106 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -71.71 -45.11 67.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.645 -171.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.498 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -89.1 -40.81 12.68 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.917 0.389 . . . . 0.0 111.706 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.93 83.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.295 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.638 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 79.1 m-20 -93.25 -56.88 2.79 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.629 -172.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.811 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.165 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.651 HG11 ' HG2' ' A' ' 54' ' ' LYS . 35.9 t -103.34 128.38 56.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.041 0.448 . . . . 0.0 110.34 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 146.6 51.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.889 0.852 . . . . 0.0 112.397 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -103.38 141.52 35.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.804 -1.543 . . . . 0.0 109.463 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.729 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.7 m-85 -94.5 158.03 15.73 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -119.86 -15.08 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.704 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 37.2 p -135.07 151.5 50.82 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.41 -29.76 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.6 t -59.88 -46.89 87.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.063 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.2 mm-40 -60.38 -42.94 96.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.414 0.626 . . . . 0.0 110.143 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 19.7 t80 -67.58 -47.28 70.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.087 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' HA ' HG12 ' A' ' 15' ' ' ILE . 25.3 t70 -60.96 -42.85 99.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.597 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 22.6 t -67.16 -39.33 86.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.713 -178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . . . -65.49 -50.84 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.981 0.419 . . . . 0.0 110.722 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 11' ' ' PHE . 35.5 pt -67.41 -18.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.632 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.62 -14.12 52.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 13' ' ' SER . 54.7 mt-30 -69.16 150.19 47.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 39.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.482 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 10.5 ptmt -136.75 167.38 21.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.588 HD21 HG11 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -77.6 108.01 10.49 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.475 HG12 HG23 ' A' ' 23' ' ' VAL . 53.0 t -110.02 107.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.209 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.693 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -101.93 103.12 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 122.062 0.934 . . . . 0.0 110.84 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 70.8 t -102.35 143.18 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.866 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -127.9 117.53 21.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -70.51 129.1 38.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.525 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.581 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 7.6 m-30 -118.5 -177.45 3.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . . . -152.23 130.21 11.8 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -58.26 -24.74 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.716 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -96.75 8.99 43.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.797 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.942 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -107.07 138.29 43.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.307 0.575 . . . . 0.0 111.786 -177.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -81.72 -37.65 16.11 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.904 -1.044 . . . . 0.0 114.546 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.942 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 17.1 Cg_exo -66.25 -29.33 46.92 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 120.359 2.08 . . . . 0.0 110.378 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 58.5 m -51.12 -39.62 56.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.732 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.931 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 13.5 mptt -67.79 -57.37 6.43 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.801 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 23.4 ptp -54.19 -50.22 67.57 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.692 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -75.41 -21.19 16.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.931 -177.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.96 -60.06 10.7 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.01 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.931 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 9.3 Cg_endo -56.37 -36.22 96.96 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 121.268 1.312 . . . . 0.0 112.792 169.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.597 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 26.1 mmt -62.75 -51.58 66.56 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.371 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.594 ' CG2' HG21 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -52.51 -32.73 17.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 122.672 0.389 . . . . 0.0 111.509 176.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 44.8 mt-10 -59.64 -48.57 81.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.351 0.596 . . . . 0.0 110.479 173.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 18.5 tptm -61.22 -47.62 85.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.685 0.755 . . . . 0.0 109.874 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.664 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 34.0 m-85 -67.42 -20.55 65.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.78 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 84.9 p -77.09 -15.96 59.39 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 108.85 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 37.1 tt0 -80.38 -20.7 43.46 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.537 171.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.664 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 7.3 mm100 -83.46 -7.05 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.984 175.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.715 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 7.5 p90 -134.68 85.44 36.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.36 0.6 . . . . 0.0 112.46 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.56 -21.9 4.05 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.218 2.612 . . . . 0.0 112.423 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.72 -1.0 50.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.438 0.637 . . . . 0.0 110.527 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -119.12 165.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -108.84 117.59 34.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.297 0.57 . . . . 0.0 111.997 -175.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 1.6 p90 -83.55 121.48 27.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.048 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 31.5 m-85 -136.74 142.59 43.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.335 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.866 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 10.9 mmtt -126.91 124.13 38.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.729 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.8 mt -100.67 -178.24 3.72 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.169 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' HA ' ' A' ' 27' ' ' ALA . 11.5 t0 -133.89 131.32 38.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.34 -8.7 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.316 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -31.62 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 109.971 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.61 -27.05 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.046 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.595 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.87 52.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.0 -39.81 22.81 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.487 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.07 -44.0 73.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.775 0.322 . . . . 0.0 110.694 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.595 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -65.39 -38.82 83.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.048 0.451 . . . . 0.0 110.394 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.36 69.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.6 mt-30 -72.89 -36.83 67.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.962 0.411 . . . . 0.0 110.245 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -91.66 10.17 29.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.82 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 56.47 44.15 24.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.423 HG13 ' OG1' ' A' ' 74' ' ' THR . 74.2 t -73.7 109.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.489 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -117.54 -25.92 6.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.541 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.78 117.57 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.036 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -100.63 150.41 36.96 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 14.1 Cg_exo -71.21 171.47 59.51 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 123.872 -1.303 . . . . 0.0 111.834 -6.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 19.9 m -131.07 115.52 16.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.596 HD13 HD13 ' A' ' 95' ' ' ILE . 3.8 mt -105.7 108.67 20.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.503 0.668 . . . . 0.0 111.115 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.602 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 25.5 mt -123.23 114.4 20.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.014 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.693 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -93.75 125.02 38.13 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.168 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 m-85 -107.37 155.64 19.79 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.431 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -141.04 131.94 25.99 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.02 44.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 19.02 60.0 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.579 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 14.7 tttp -126.39 0.92 6.99 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.338 0.59 . . . . 0.0 110.215 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 39.2 mt-10 73.14 -179.1 0.2 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.951 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.588 HG11 HD21 ' A' ' 20' ' ' LEU . 1.3 p -153.31 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.754 174.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.745 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -157.71 163.0 38.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.119 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.602 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 77.0 tttt -144.26 116.69 8.55 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.944 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 t -123.89 133.88 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.13 78.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.283 0.563 . . . . 0.0 110.927 -170.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.59 -175.67 39.78 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 96.48 1.87 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 19.1 p-10 -119.41 78.8 20.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 3.4 Cg_exo -74.91 -29.94 7.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.469 1.446 . . . . 0.0 110.319 167.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -90.25 -51.03 5.64 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.618 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -67.68 -16.59 64.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.518 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -55.74 -37.59 47.49 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 169.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.726 ' HA ' HG22 ' A' ' 99' ' ' ILE . 11.7 mmmm -58.39 -34.52 70.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.023 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.01 -58.66 6.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.37 55.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.784 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -80.49 -40.02 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.471 -172.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.63 -39.19 17.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.666 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.19 70.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.745 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 89.0 m-20 -101.14 -68.92 0.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.273 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.727 0.298 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.419 HG11 ' HE3' ' A' ' 54' ' ' LYS . 39.4 t -121.46 109.6 25.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.961 0.41 . . . . 0.0 110.365 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -70.18 149.24 47.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.065 -176.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -109.14 134.08 52.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.492 175.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.674 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.3 m-85 -86.75 164.4 16.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.164 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -123.22 -13.72 7.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.709 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 71.2 p -137.32 155.35 49.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.724 0.297 . . . . 0.0 111.017 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.553 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -59.85 -31.22 69.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 t -61.23 -42.09 98.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 16.7 mm-40 -59.0 -43.93 91.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.32 0.581 . . . . 0.0 109.992 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 15' ' ' ILE . 1.4 t80 -63.65 -49.18 74.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.843 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.1 -44.44 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.925 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 34.5 t -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.974 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -49.74 42.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.906 0.384 . . . . 0.0 110.666 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 29.3 pt -66.99 -21.71 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.548 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.67 -8.62 59.33 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.884 0.374 . . . . 0.0 111.371 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 13' ' ' SER . 27.6 mt-30 -75.63 158.99 31.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.733 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.04 36.24 0.34 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.42 0.628 . . . . 0.0 110.347 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' GLN . 29.1 mmmt -126.71 160.27 31.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.651 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.74 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.7 tm? -77.57 105.56 8.8 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 53.3 t -110.23 107.12 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.024 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.744 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.73 108.99 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.684 0.754 . . . . 0.0 110.818 175.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 85.1 t -103.53 142.72 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.117 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.711 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -126.72 113.68 16.98 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -75.81 106.48 7.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.063 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.708 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.2 m-85 -133.28 175.82 9.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 112.143 -171.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.07 163.56 39.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.49 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -85.49 -8.64 58.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -108.02 27.65 9.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -129.26 128.11 42.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.441 0.639 . . . . 0.0 111.306 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.14 97.49 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 114.713 -1.131 . . . . 0.0 114.107 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.572 ' O ' HG22 ' A' ' 36' ' ' ILE . 38.7 Cg_exo -58.15 -39.41 85.46 Favored 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 119.714 1.757 . . . . 0.0 110.674 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 39.0 m -58.57 -34.08 70.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.2 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 29.1 mtpp -63.87 -55.65 21.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.423 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 26.0 ptt? -61.03 -44.56 97.22 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.708 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.23 -24.15 18.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.796 -178.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -53.85 -51.36 77.46 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.619 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 35.6 Cg_endo -68.12 -32.46 27.5 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 120.215 1.113 . . . . 0.0 112.603 169.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.422 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.6 mmt -64.66 -57.59 8.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.597 HD12 ' CG1' ' A' ' 36' ' ' ILE . 36.5 mt -66.46 -23.12 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.45 0.568 . . . . 0.0 111.39 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.94 -47.29 85.61 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.53 0.681 . . . . 0.0 109.46 168.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -63.41 -48.53 77.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.145 0.498 . . . . 0.0 110.516 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.642 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 11.7 m-30 -65.6 -15.56 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.975 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 p -87.21 -14.9 39.8 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 121.555 0.693 . . . . 0.0 109.274 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.27 -23.2 40.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 168.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.642 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -120.87 34.08 5.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -104.59 85.11 1.07 Allowed Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 122.016 0.912 . . . . 0.0 112.298 172.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 24.3 Cg_exo -64.02 -45.68 9.82 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.005 1.803 . . . . 0.0 113.916 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -107.81 24.65 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 103' ' ' ALA . . . -128.98 156.38 43.88 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.798 -0.564 . . . . 0.0 111.914 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.76 120.26 40.2 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.24 169.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.613 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -103.35 116.74 33.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.5 -171.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CD2' HG13 ' A' ' 21' ' ' VAL . 23.2 m-85 -129.17 136.26 49.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.711 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -121.18 119.06 31.25 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.675 HD13 ' HG ' ' A' ' 60' ' ' LEU . 5.2 mt -100.96 160.55 14.28 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.776 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.48 114.56 26.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -11.25 9.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.44 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.02 -51.09 27.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.548 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -86.96 -25.68 24.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.438 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.675 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.6 mm? -99.99 45.06 0.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 111.316 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.05 -37.03 30.07 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.848 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.1 -42.41 94.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.85 0.357 . . . . 0.0 110.695 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 8' ' ' ALA . 3.1 p -67.19 -39.09 82.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.81 76.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.72 -33.08 72.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.204 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -27.73 64.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.667 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -95.18 10.83 34.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.88 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 60.09 41.33 17.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.791 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.5 t -99.95 110.53 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.571 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 p -110.73 -19.22 12.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.85 0.357 . . . . 0.0 110.727 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.15 168.39 10.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.13 148.53 35.47 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.66 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 18.8 Cg_exo -70.77 173.35 48.61 Favored 'Cis proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.839 -0.901 . . . . 0.0 112.581 -6.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 87.6 m -147.23 117.32 7.28 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.839 0.352 . . . . 0.0 110.496 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.463 ' HG ' HD13 ' A' ' 95' ' ' ILE . 4.0 mm? -110.76 111.23 22.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.326 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.413 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 35.8 mt -125.87 115.39 19.9 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -96.86 128.82 44.19 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.018 174.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 29.0 m-85 -110.72 155.53 22.34 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.131 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.641 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.3 tttt -142.28 116.83 9.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.829 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.641 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.52 38.4 7.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.787 0.835 . . . . 0.0 111.847 -177.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.15 8.63 55.06 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.34 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -109.39 4.05 22.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 109.997 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 24.2 tt0 67.92 174.6 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.025 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.4 p -144.31 -32.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.933 0.396 . . . . 0.0 110.117 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.411 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -157.93 161.33 38.2 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.979 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.413 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 1.7 ttmp? -139.72 117.48 11.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.245 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.08 125.71 73.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.05 87.0 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 111.296 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 -173.63 33.63 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.027 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 73' ' ' PRO . . . -71.91 103.62 3.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.5 p-10 -127.22 65.65 65.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 10.1 Cg_exo -69.21 -34.07 17.23 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 120.867 1.045 . . . . 0.0 110.871 174.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.53 -45.34 9.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -70.92 -17.24 62.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.58 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.652 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.7 tp -56.96 -38.45 59.77 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HA ' HG22 ' A' ' 99' ' ' ILE . 30.5 mmtt -59.58 -35.37 74.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.761 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.14 -54.01 45.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -76.7 -39.77 50.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.629 0.728 . . . . 0.0 111.3 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -69.57 -41.0 80.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.678 -171.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 -38.57 14.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.635 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.11 -31.13 55.61 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 45.5 m-80 -95.65 -60.07 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.33 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.74 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.245 0.867 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.463 170.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.94 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -107.2 146.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.597 0.713 . . . . 0.0 112.025 -172.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.54 148.44 27.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.204 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 133.33 50.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.061 170.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.634 ' H ' HD22 ' A' ' 55' ' ' LEU . 15.3 m-85 -84.38 164.32 19.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -117.79 -16.91 9.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.444 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 40.1 p -134.89 153.64 51.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -57.42 -33.71 68.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -64.29 -32.09 73.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.474 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.625 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 23.4 mm-40 -67.42 -44.09 79.62 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.093 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -44.38 94.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.633 176.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.33 -44.42 88.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.447 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -71.14 -25.7 62.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.788 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.522 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . . . -77.14 -50.02 13.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 110.684 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 pt -66.53 -17.83 23.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.286 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.05 59.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.893 0.377 . . . . 0.0 111.586 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' A' ' 14' ' ' ALA . 77.3 mt-30 -71.55 150.77 44.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.343 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.68 28.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.41 0.624 . . . . 0.0 110.975 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 17' ' ' GLN . 15.0 ptmt -135.94 174.65 10.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.46 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.552 ' CD1' HG11 ' A' ' 84' ' ' VAL . 8.0 tt -85.62 134.64 33.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.413 0.625 . . . . 0.0 111.199 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.438 HG11 ' HB1' ' A' ' 14' ' ' ALA . 55.9 t -134.98 109.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.963 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.63 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -103.17 107.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.147 0.975 . . . . 0.0 111.164 177.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 99.2 t -100.19 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.499 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 54' ' ' LYS . . . -127.6 122.58 33.52 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CD2' HG21 ' A' ' 69' ' ' VAL . 95.8 m-85 -73.83 124.79 26.77 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.335 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 6.4 m-30 -118.66 179.25 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.29 144.54 27.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.92 -3.81 28.15 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.05 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -122.16 13.32 10.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 3.7 p -109.43 156.06 20.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.571 0.7 . . . . 0.0 112.617 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.53 -52.36 3.57 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.639 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 72.0 Cg_exo -53.96 -48.44 21.68 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.249 1.966 . . . . 0.0 112.621 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 7.8 p -51.17 -35.51 36.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.188 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 23.9 tptm -65.2 -53.1 49.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.161 0.288 . . . . 0.0 110.532 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 39' ' ' MET . 26.5 ptt? -66.66 -43.34 84.83 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.49 -18.19 16.75 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.09 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.77 -53.22 67.13 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.825 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 34.2 Cg_endo -67.13 -28.2 41.09 Favored 'Trans proline' 0 C--N 1.359 1.107 0 CA-C-N 120.567 1.238 . . . . 0.0 112.428 170.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.541 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.9 mmm -65.91 -56.32 12.35 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.183 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.495 ' CG2' HG11 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -52.86 -31.09 16.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 122.495 0.318 . . . . 0.0 110.74 176.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -61.33 -50.77 71.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.305 0.574 . . . . 0.0 109.599 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 1.4 tmtp? -61.53 -44.49 96.97 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.611 0.719 . . . . 0.0 109.781 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.666 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 76.5 m-85 -66.06 -23.23 66.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.624 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.66 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 83.5 p -74.1 -19.03 60.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -78.16 -23.64 47.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.666 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 5.3 mm100 -87.69 5.54 39.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.338 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 52' ' ' PHE . 0.6 OUTLIER -99.46 102.14 15.48 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.4 Cg_exo -76.5 -45.93 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.686 1.591 . . . . 0.0 112.692 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -112.97 1.25 15.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -172.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB2' HE21 ' A' ' 49' ' ' GLN . . . -113.55 153.28 29.03 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.02 129.26 46.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.2 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.4 OUTLIER -105.06 121.45 43.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.677 -175.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.763 ' HA ' HG23 ' A' ' 2' ' ' VAL . 30.1 m-85 -135.5 144.64 46.45 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.519 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.96 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 11.9 mmtt -128.87 122.51 30.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD13 ' HG ' ' A' ' 60' ' ' LEU . 6.4 mt -98.48 170.75 8.61 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.136 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.08 120.5 34.48 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.41 -8.52 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.16 -28.65 61.41 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.762 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG2' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -110.42 -35.65 5.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 169.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.655 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.7 mm? -87.28 52.21 2.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.851 0.358 . . . . 0.0 111.006 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.48 -37.5 30.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.152 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.648 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 13.6 p-10 -66.99 -43.99 81.57 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.046 -0.09 . . . . 0.0 110.766 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.6 p -66.44 -34.85 72.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 110.614 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.7 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.622 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 33.7 mm-40 -77.47 -30.08 52.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.907 0.384 . . . . 0.0 110.422 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 74.5 mmtt -57.32 -47.95 80.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.656 0.741 . . . . 0.0 110.289 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -94.26 15.85 16.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.328 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 48.89 52.88 13.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.818 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 25' ' ' PHE . 97.7 t -81.42 113.81 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.731 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.7 p -118.55 1.07 11.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.9 154.21 45.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.776 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.94 128.86 20.87 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.773 178.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 84.9 Cg_endo -82.3 171.7 53.63 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.932 -5.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 68.2 m -124.74 116.69 22.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.716 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.78 111.66 24.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.185 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.9 mt -127.49 113.52 16.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.47 127.57 38.01 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.554 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 m-85 -112.59 157.45 21.17 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.122 -176.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 86.6 tttt -143.26 118.68 10.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.021 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.542 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.51 44.77 2.63 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.825 0.85 . . . . 0.0 112.509 -178.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.41 10.09 52.16 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.148 -0.478 . . . . 0.0 113.512 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -109.3 0.06 19.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.033 0.444 . . . . 0.0 110.288 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 28.1 tt0 66.83 179.75 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.554 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.561 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -152.83 -33.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.746 0.308 . . . . 0.0 110.705 173.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.4 164.49 32.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.79 0.329 . . . . 0.0 111.023 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.3 tttt -145.92 123.81 12.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.568 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.31 133.45 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.76 78.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.196 0.522 . . . . 0.0 111.344 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.83 -172.3 37.11 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.684 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -73.04 97.02 2.25 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.3 p-10 -121.77 66.14 19.94 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.485 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 15.3 Cg_exo -66.03 -37.18 27.0 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.092 1.195 . . . . 0.0 110.946 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 96' ' ' LYS . . . -88.92 -41.68 12.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.235 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -73.03 -17.09 61.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.459 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.711 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.7 tp -56.25 -38.14 53.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.616 ' HD3' HG22 ' A' ' 99' ' ' ILE . 17.5 tppt? -61.5 -31.39 71.38 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.187 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -56.54 -55.61 31.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 174.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.65 -32.67 62.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.419 0.628 . . . . 0.0 110.751 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.76 -43.17 70.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.613 -172.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.59 -39.22 16.36 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.801 0.334 . . . . 0.0 110.802 -175.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.47 77.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.966 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 42.0 m-80 -104.12 -66.39 0.96 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.554 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.607 ' HB3' HD13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.649 -0.691 . . . . 0.0 111.271 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.706 0.288 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.515 HG21 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -101.92 136.11 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.132 0.491 . . . . 0.0 110.05 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.56 147.43 33.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.976 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -107.14 122.54 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.214 171.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.633 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 13.4 m-85 -76.4 152.67 36.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.215 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -101.62 -19.55 15.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.364 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 81.2 p -135.39 156.61 48.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.241 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -59.07 -31.88 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -62.91 -38.67 91.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.99 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 8.0 mm-40 -60.37 -51.98 67.19 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.355 0.598 . . . . 0.0 110.193 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' HG12 ' A' ' 15' ' ' ILE . 2.1 t80 -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.727 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.97 -45.43 78.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.455 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 37.4 t -67.84 -42.1 81.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -61.39 -49.93 74.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.556 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 42.0 pt -67.27 -20.86 27.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.502 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.25 -2.56 58.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.733 0.302 . . . . 0.0 111.672 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.6 mt-30 -81.86 162.68 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.088 0.471 . . . . 0.0 111.08 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.1 26.04 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.687 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 9.0 ptmt -132.14 165.24 24.52 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.78 HD21 HG11 ' A' ' 84' ' ' VAL . 2.7 tm? -76.57 117.28 18.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG12 HG23 ' A' ' 23' ' ' VAL . 59.7 t -114.25 107.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.723 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.13 106.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.527 0.68 . . . . 0.0 110.343 175.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.637 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 34.5 t -108.4 143.36 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.551 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.915 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -122.32 120.83 35.21 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.338 0.59 . . . . 0.0 112.515 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CE2' HD12 ' A' ' 55' ' ' LEU . 95.4 m-85 -69.89 118.98 13.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.366 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.495 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -127.34 176.48 7.4 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.95 -164.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.29 146.87 14.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.165 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 p -84.48 -4.46 58.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -116.35 51.63 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -151.7 171.07 18.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.92 -54.16 2.83 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.632 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' A' ' 35' ' ' MET . 74.9 Cg_exo -53.11 -35.0 70.98 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.321 2.014 . . . . 0.0 112.406 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 p -65.6 -32.23 73.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.948 0.404 . . . . 0.0 111.027 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -68.39 -34.46 76.07 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.205 -0.309 . . . . 0.0 110.927 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -80.7 -49.78 10.76 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -76.75 -22.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 121.181 -0.949 . . . . 0.0 111.352 -175.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.77 -49.09 95.69 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.411 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 35' ' ' MET . 32.8 Cg_exo -63.47 -37.42 48.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.34 1.36 . . . . 0.0 111.806 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mmm -65.61 -61.6 1.99 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 36' ' ' ILE . 57.7 mt -66.33 -19.1 25.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 118.58 0.627 . . . . 0.0 111.377 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.2 tt0 -60.84 -46.06 92.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.697 0.76 . . . . 0.0 109.471 167.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 23.1 ttmt -66.12 -42.09 89.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.601 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.596 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 1.1 m-30 -71.65 -17.42 62.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.312 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.823 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 96.9 p -77.67 -16.89 58.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -83.86 -19.05 35.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.405 168.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.609 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 10.0 mm100 -95.18 -1.08 52.53 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.59 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 9.0 m-30 -100.51 101.48 15.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.263 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 4.9 Cg_exo -80.61 -43.98 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.659 2.239 . . . . 0.0 112.438 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -107.84 7.23 28.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.882 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -123.81 143.41 50.34 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.47 46.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.949 0.88 . . . . 0.0 111.014 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.823 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 0.6 OUTLIER -106.7 119.15 38.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.535 -169.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.504 ' HB2' HG22 ' A' ' 23' ' ' VAL . 29.0 m-85 -135.77 155.11 50.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.915 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -132.19 130.07 40.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.637 ' HG ' ' CG1' ' A' ' 23' ' ' VAL . 76.8 mt -95.34 128.42 42.17 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.128 -0.358 . . . . 0.0 111.128 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -70.91 97.53 1.44 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 168.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -56.52 -19.7 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.53 -35.86 72.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.091 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HG3' HD22 ' A' ' 60' ' ' LEU . 9.3 pt-20 -110.05 -38.59 5.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.462 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.606 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 2.5 mm? -78.19 50.74 0.93 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.98 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.33 -42.05 24.2 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.657 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.7 p-10 -62.76 -46.71 86.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.315 0.103 . . . . 0.0 110.936 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.606 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -63.17 -38.56 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 110.254 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.91 70.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.609 ' HA ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -75.95 -40.06 54.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.153 0.501 . . . . 0.0 109.748 -177.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.657 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 58.4 mttm -59.34 -40.69 87.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.626 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -89.89 6.17 43.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.544 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 57.72 52.06 8.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.516 HG13 ' OG1' ' A' ' 74' ' ' THR . 57.1 t -75.52 116.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.856 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -113.93 -62.41 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.875 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.17 116.55 29.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.999 0.428 . . . . 0.0 110.568 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.68 145.95 30.79 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.464 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.06 162.03 92.58 Favored 'Cis proline' 0 C--O 1.235 0.359 0 C-N-CA 123.106 -1.623 . . . . 0.0 112.513 -5.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.516 ' OG1' HG13 ' A' ' 69' ' ' VAL . 52.5 m -118.45 117.24 28.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -102.2 108.62 20.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 31.3 mt -122.12 113.13 19.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.587 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -99.2 128.34 45.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.055 177.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 34.4 m-85 -112.09 153.71 26.51 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.3 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.607 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 24.1 tptm -135.97 115.0 12.27 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.389 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.607 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 9.8 p30 44.15 38.24 2.25 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.134 0.974 . . . . 0.0 112.731 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.69 7.05 73.61 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.292 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -105.2 -7.12 19.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.0 tt0 77.77 173.29 0.19 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.673 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.78 HG11 HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -147.28 -29.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.699 0.285 . . . . 0.0 110.789 173.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.69 162.68 29.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.21 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 1.8 tmtp? -142.82 108.99 5.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.33 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.5 t -119.56 143.43 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.17 86.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.761 0.791 . . . . 0.0 111.478 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 50.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.144 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.25 84.83 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.004 0.43 . . . . 0.0 111.005 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.3 p-10 -121.1 83.64 38.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 6.0 Cg_exo -75.14 -38.96 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.58 1.52 . . . . 0.0 111.03 168.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.31 -39.93 13.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.428 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -73.05 -17.29 61.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.078 0.466 . . . . 0.0 111.238 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.675 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -57.81 -36.72 56.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 99' ' ' ILE . 31.5 mmmt -56.34 -40.11 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.831 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.627 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 4.0 tp60 -46.48 -60.22 2.49 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 123.346 0.403 . . . . 0.0 110.349 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -77.37 -29.24 53.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.475 0.655 . . . . 0.0 111.436 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -80.01 -41.37 21.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.956 -170.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.97 -35.65 18.74 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.796 -176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.35 -39.18 78.29 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.651 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 83.7 m-20 -96.16 -60.31 1.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 50' ' ' ALA . . . . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.546 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.621 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 26.3 ptt? . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.948 0.404 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.609 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -97.91 145.14 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 -179.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.52 149.83 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.064 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.65 133.25 44.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.691 170.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.683 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.9 m-85 -86.98 164.35 16.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.16 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -117.2 -23.32 7.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.919 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.666 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 39.9 p -132.4 157.4 44.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 112.035 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.68 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 m -61.43 -35.6 78.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.771 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.666 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.0 mm-40 -61.3 -49.65 76.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.311 0.577 . . . . 0.0 110.345 177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -47.9 80.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.498 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.37 -44.42 95.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -67.61 -36.65 81.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.987 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.34 -49.26 61.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 pt -66.36 -20.74 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.94 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HA ' ' N ' ' A' ' 81' ' ' GLY . . . -80.84 -8.83 59.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -72.19 150.38 43.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.43 53.57 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.692 0.758 . . . . 0.0 110.221 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 10.0 ptmt -153.08 173.75 15.07 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.332 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.555 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -75.5 111.28 10.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 53' ' ' TYR . 56.1 t -122.62 107.67 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.868 0.366 . . . . 0.0 110.442 169.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.13 115.36 47.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.56 0.695 . . . . 0.0 111.271 175.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.606 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 84.3 t -103.26 140.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.964 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.845 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.09 138.33 54.45 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 69' ' ' VAL . 71.5 m-85 -90.2 128.04 36.27 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.436 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.618 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 3.0 m-85 -120.68 -171.72 2.24 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.555 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.02 169.7 16.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.524 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.76 -30.34 69.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.591 0.71 . . . . 0.0 110.309 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -91.37 -138.84 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.5 p 56.3 110.41 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.73 1.212 . . . . 0.0 113.942 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.49 98.68 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.266 -1.334 . . . . 0.0 114.176 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.671 ' O ' HG23 ' A' ' 36' ' ' ILE . 31.5 Cg_exo -60.14 -41.76 49.06 Favored 'Trans proline' 0 C--N 1.36 1.139 0 CA-C-N 120.221 2.011 . . . . 0.0 111.663 -178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 29.3 m -51.37 -43.21 61.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.466 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.661 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.3 mmtt -62.87 -55.54 25.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -63.87 -48.0 78.42 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -75.51 -11.59 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.897 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.21 -57.49 25.73 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.292 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 28.1 Cg_endo -64.91 -34.01 50.09 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 120.025 1.044 . . . . 0.0 111.958 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.491 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.8 mtt -64.7 -60.94 2.53 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.892 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.647 HG21 ' HD3' ' A' ' 54' ' ' LYS . 17.4 mt -58.56 -25.47 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 118.228 0.467 . . . . 0.0 112.109 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.621 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 8.3 tp10 -61.31 -41.01 96.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 172.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.96 -46.04 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.826 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.684 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 66.0 m-85 -65.09 -24.38 67.43 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.267 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.625 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 33.9 t -85.57 -14.45 45.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.857 0.837 . . . . 0.0 109.232 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -84.27 -19.84 33.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.684 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 18.1 pt20 -104.66 26.01 9.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.869 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.579 ' HD1' ' O ' ' A' ' 43' ' ' PHE . 2.4 m-85 -97.97 89.95 0.85 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.44 166.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 5.9 Cg_exo -79.22 -46.17 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.91 1.74 . . . . 0.0 112.714 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.07 -11.45 14.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 149.27 24.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.98 126.87 50.33 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.637 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.629 ' CE2' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -110.15 125.5 53.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.54 -177.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 27.5 m-85 -130.96 143.4 50.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.845 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 31.6 mtmt -133.02 119.9 20.66 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.7 mt -97.54 163.9 12.66 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.729 -173.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -102.67 111.74 24.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.208 0.528 . . . . 0.0 109.788 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -66.58 -15.4 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.481 -171.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 56' ' ' ASP . 5.9 p-10 -70.34 -26.62 63.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -106.89 -39.28 5.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.356 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.0 mm? -88.09 41.65 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.366 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -70.2 -35.29 70.18 Favored Glycine 0 CA--C 1.504 -0.616 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.45 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 29.7 m-20 -63.36 -40.61 97.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 109.951 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 60' ' ' LEU . 86.0 t -63.2 -42.42 96.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.246 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.28 83.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.126 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 24.0 mt-30 -71.72 -33.06 68.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.526 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 69.0 mttm -57.17 -40.9 78.25 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.438 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -96.44 10.34 38.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.101 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 55.91 40.7 30.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.625 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 25' ' ' PHE . 49.2 t -83.0 127.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.347 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.4 t -134.14 -26.67 1.47 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.283 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.86 114.94 29.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 0.0 110.04 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 147.09 32.94 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.002 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 32' ' ' PRO . 2.6 Cg_endo -84.23 161.98 68.23 Favored 'Cis proline' 0 N--CA 1.461 -0.424 0 C-N-CA 124.17 -1.179 . . . . 0.0 111.497 -8.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 20.4 m -119.64 121.32 39.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.664 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -107.83 109.93 21.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.607 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.614 HD22 ' HG2' ' A' ' 86' ' ' LYS . 7.6 mt -125.31 114.86 19.46 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -90.8 122.52 33.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.99 174.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.3 m-85 -106.31 162.19 13.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.36 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.571 ' HG2' HD22 ' A' ' 80' ' ' ASN . 24.7 ttmm -150.51 133.45 16.02 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.346 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.571 HD22 ' HG2' ' A' ' 79' ' ' LYS . 11.5 p30 48.02 29.79 1.85 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.056 0.942 . . . . 0.0 112.618 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.532 ' N ' ' HA ' ' A' ' 16' ' ' ALA . . . 74.69 9.38 82.61 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.855 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 13.4 tttp -107.25 -65.41 1.1 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 18.0 tt0 161.42 -178.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 123.976 0.798 . . . . 0.0 109.064 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 77' ' ' LEU . 2.2 p -154.53 -31.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.532 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -160.45 165.1 31.64 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.906 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.614 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.7 tmtp? -142.7 119.52 11.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.257 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 t -131.55 144.1 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.74 91.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.888 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.8 53.59 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.643 172.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.492 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.31 86.76 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 111.303 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.2 p-10 -122.39 85.34 47.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.496 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.7 Cg_exo -77.34 -39.46 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.218 1.279 . . . . 0.0 110.308 166.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.47 -36.11 16.65 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.276 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -75.39 -17.33 60.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.136 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.8 tp -58.06 -37.95 64.53 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 170.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 19.4 mmtp -55.41 -37.37 67.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.914 0.758 . . . . 0.0 110.647 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 9.3 tm0? -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 176.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -77.16 -24.81 51.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.304 0.573 . . . . 0.0 111.352 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.731 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -78.01 -42.81 28.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.916 -173.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.45 -32.39 22.32 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.703 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.44 -41.62 93.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.274 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 41.2 m-80 -110.86 -90.39 0.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.859 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.547 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.713 -168.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.695 0.283 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -121.14 131.65 72.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.16 0.505 . . . . 0.0 110.913 178.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -81.83 147.92 29.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.918 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.67 130.17 51.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.953 172.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.699 ' H ' HD22 ' A' ' 55' ' ' LEU . 13.0 m-85 -84.52 159.72 20.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -117.07 -19.06 9.9 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.57 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 25.7 p -135.01 153.65 52.01 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.779 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.96 -33.69 70.94 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 m -59.07 -36.34 74.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.106 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 39.4 mm-40 -65.99 -47.73 73.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.492 0.663 . . . . 0.0 110.062 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HD1' HG21 ' A' ' 23' ' ' VAL . 1.6 t80 -62.15 -44.14 97.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.079 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -55.33 -49.53 71.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.893 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -67.46 -37.58 83.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.205 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.95 58.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.04 -19.99 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.227 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 -13.8 59.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.975 0.417 . . . . 0.0 110.945 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -75.57 145.08 41.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.04 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.43 47.45 0.93 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.453 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 6.8 ptmt -138.96 168.35 20.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.064 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.552 ' CD2' HG11 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -74.92 105.84 6.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.214 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.469 HG13 ' CD2' ' A' ' 53' ' ' TYR . 53.5 t -114.58 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 173.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.747 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -100.86 109.41 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.642 0.734 . . . . 0.0 110.74 175.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 66.2 t -103.17 135.19 41.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.052 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -121.63 111.44 17.21 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 121.072 0.463 . . . . 0.0 112.093 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 69' ' ' VAL . 96.3 m-85 -69.05 112.56 5.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.227 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' OH ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.03 177.44 5.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.11 147.45 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.454 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 p -84.62 -4.72 59.14 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -117.24 53.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.63 173.08 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.77 2.56 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.238 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 36' ' ' ILE . 75.5 Cg_exo -51.56 -40.86 63.06 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.461 2.108 . . . . 0.0 112.142 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 8.5 p -66.04 -29.7 70.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.231 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -68.64 -35.91 77.9 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.943 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.546 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptm -80.84 -46.93 14.54 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.691 HD11 HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.93 -22.8 16.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.924 -175.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.503 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -58.46 -46.73 99.6 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.352 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 35' ' ' MET . 45.6 Cg_exo -59.96 -40.59 60.65 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.692 1.594 . . . . 0.0 112.395 167.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -65.02 -53.75 41.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -58.86 -35.71 57.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 9.5 tp10 -54.48 -47.45 72.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.503 0.668 . . . . 0.0 109.883 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -62.54 -48.89 77.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.631 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 12.1 m-30 -67.08 -17.27 64.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.452 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 29.0 p -87.25 -11.87 48.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.63 -24.18 29.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 168.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -119.36 36.38 4.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.722 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.475 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -99.55 90.66 1.27 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 122.039 0.924 . . . . 0.0 111.746 171.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 18.0 Cg_exo -65.35 -46.39 5.75 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.051 1.834 . . . . 0.0 113.359 -170.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -111.35 -7.7 14.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.91 163.18 12.36 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 111.656 -167.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.6 126.27 51.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.245 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 3.4 m-30 -99.57 121.69 41.55 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.689 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 29.9 m-85 -129.08 134.94 48.3 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.703 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 10.7 ttpp -127.45 117.43 22.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.699 HD22 ' H ' ' A' ' 5' ' ' PHE . 3.9 mt -96.13 156.99 16.1 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -165.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -91.25 99.15 12.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -18.65 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.271 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.76 -37.49 84.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.083 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.96 -38.49 10.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.036 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.09 49.55 1.65 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.643 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.28 -38.35 34.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.659 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 12.5 p-10 -66.02 -40.73 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.523 0.202 . . . . 0.0 111.118 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.2 p -72.98 -35.08 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.47 -36.99 74.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.125 0.488 . . . . 0.0 110.308 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 14.9 mm-40 -73.4 -29.8 62.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.416 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 30.0 mtpp -61.91 -40.95 97.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -95.77 12.94 28.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.397 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 59.79 40.56 19.4 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.096 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 25' ' ' PHE . 75.0 t -76.95 110.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.857 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 p -113.57 -1.64 14.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.37 143.05 43.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.473 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.33 128.0 26.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 89.1 Cg_endo -84.1 170.57 50.34 Favored 'Cis proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.514 -5.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.7 m -121.89 122.75 40.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.946 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.476 ' HB3' HD13 ' A' ' 95' ' ' ILE . 3.9 mm? -107.65 110.47 22.35 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.71 HD22 ' HG2' ' A' ' 86' ' ' LYS . 36.7 mt -126.81 119.37 26.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.356 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.747 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.881 173.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 26.1 m-85 -108.86 158.97 17.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.603 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.595 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 36.3 ttmt -143.44 116.03 8.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.338 173.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.595 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 10.9 p30 47.6 31.48 2.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.399 1.079 . . . . 0.0 112.816 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 10.07 79.0 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.851 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 12.4 tptm -106.22 -2.61 22.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.989 0.899 . . . . 0.0 108.629 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 40.7 mt-10 71.75 -178.47 0.21 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.888 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.3 p -152.06 -29.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.976 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.78 161.29 36.96 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.632 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.71 ' HG2' HD22 ' A' ' 76' ' ' LEU . 1.4 tmtp? -143.24 115.84 8.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.971 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t -132.21 143.51 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 109.935 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.65 90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.686 0.755 . . . . 0.0 111.305 -173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.38 54.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.005 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 56.03 86.68 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 111.51 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.577 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 16.6 p-10 -125.13 89.41 52.66 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.446 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.2 Cg_endo -82.55 -29.68 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.965 1.777 . . . . 0.0 110.217 165.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 -49.07 6.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -72.61 -18.4 61.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.442 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.66 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.9 tp -61.33 -37.67 78.16 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.739 ' HA ' HG22 ' A' ' 99' ' ' ILE . 24.3 tptp -60.94 -30.57 70.3 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.132 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -60.13 -53.24 60.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.952 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.596 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.11 -33.98 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.587 0.708 . . . . 0.0 111.422 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -74.62 -37.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.414 -171.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.62 -44.42 11.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.054 0.454 . . . . 0.0 110.831 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.8 80.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.72 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.2 -61.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.791 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.369 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.621 HG21 ' HE3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -80.5 132.28 32.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.4 0.619 . . . . 0.0 110.417 -178.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.4 148.13 43.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.818 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.501 ' HG3' ' H ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -114.39 114.26 25.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.146 174.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.574 ' H ' HD22 ' A' ' 55' ' ' LEU . 20.0 m-85 -67.68 163.74 20.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.036 0.446 . . . . 0.0 110.076 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -130.23 -13.09 3.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.259 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.719 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 70.6 p -135.48 152.68 51.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.56 -27.22 68.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.615 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 p -68.8 -36.73 78.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.061 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 24.7 mm-40 -63.03 -46.72 86.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.53 0.681 . . . . 0.0 109.778 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 3.8 t80 -63.16 -45.92 89.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.127 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.98 -49.33 76.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.858 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -66.68 -36.48 82.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.415 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -65.39 -52.16 55.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.792 0.329 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.79 -19.9 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.09 -9.02 59.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.708 0.289 . . . . 0.0 111.625 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -75.88 146.52 39.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.643 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 38.2 t70 -72.98 8.97 1.3 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.293 0.568 . . . . 0.0 111.827 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -111.53 178.34 4.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.026 0.441 . . . . 0.0 111.065 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.591 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -76.06 108.07 8.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.768 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 14' ' ' ALA . 65.7 t -111.06 106.84 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.504 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.939 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.22 109.23 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.616 0.722 . . . . 0.0 111.128 175.263 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 21' ' ' VAL . 92.9 t -102.47 143.48 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.747 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB1' ' CE1' ' A' ' 26' ' ' TYR . . . -127.12 138.1 53.11 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.196 0.522 . . . . 0.0 111.715 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -101.04 103.38 14.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.516 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.671 ' CE2' HD12 ' A' ' 36' ' ' ILE . 7.5 m-85 -128.22 178.4 6.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.759 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -154.97 137.73 15.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.274 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -72.36 -6.04 40.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 13.7 p-90 -106.29 19.56 20.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.299 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.935 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -122.69 132.97 54.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.629 0.728 . . . . 0.0 110.965 178.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.46 88.84 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 114.695 -1.139 . . . . 0.0 114.628 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.935 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 22.2 Cg_exo -65.44 -31.81 50.94 Favored 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 120.29 2.045 . . . . 0.0 109.868 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 63.7 m -54.3 -41.13 68.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.154 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.706 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -62.98 -57.03 12.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.923 -178.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 ptm -55.55 -48.14 75.24 Favored 'General case' 0 C--O 1.25 1.117 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -173.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.671 HD12 ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -74.89 -23.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.99 -177.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 41' ' ' GLU . . . -55.19 -49.63 91.22 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.91 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 11.0 Cg_exo -72.98 -29.74 11.68 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 120.718 1.292 . . . . 0.0 111.849 171.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 24.7 mmt -66.49 -60.32 2.84 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.462 HD12 ' CG1' ' A' ' 36' ' ' ILE . 51.2 mt -62.68 -30.68 49.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.156 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 27.9 tt0 -50.03 -48.22 52.86 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.066 0.46 . . . . 0.0 110.361 172.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -65.5 -41.97 92.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.598 0.714 . . . . 0.0 110.023 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.689 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 7.3 m-30 -63.89 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.302 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 1.026 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 4.0 m -74.47 -23.16 58.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 41.4 mt-10 -78.36 -20.51 51.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.554 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 17.2 pt20 -112.9 22.89 13.98 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.573 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 8.4 m-30 -100.44 100.29 11.77 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 163.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 14.1 Cg_exo -70.04 -44.72 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.769 1.646 . . . . 0.0 111.891 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -2.71 15.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . . . -106.08 142.85 35.09 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.885 -0.509 . . . . 0.0 110.795 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.32 126.12 42.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.502 0.668 . . . . 0.0 111.301 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 1.026 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.7 OUTLIER -105.36 114.18 28.2 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.782 -173.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.6 142.09 50.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 0.0 110.74 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.621 ' HE3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -125.99 119.55 27.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.574 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.1 mt -101.73 161.81 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.273 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -102.8 115.05 29.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.628 0.728 . . . . 0.0 109.093 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -13.62 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.296 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.14 -35.12 79.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.185 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -96.84 -35.64 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.682 172.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.62 HD12 HG21 ' A' ' 63' ' ' VAL . 1.9 mm? -97.83 42.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.761 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -74.72 -40.81 36.42 Favored Glycine 0 CA--C 1.504 -0.628 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.694 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.65 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 9.7 p-10 -64.3 -34.59 78.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.62 HG21 HD12 ' A' ' 60' ' ' LEU . 87.8 t -65.31 -43.18 95.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.127 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.991 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 83.2 mm-40 -72.76 -36.31 67.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 68.3 mttm -61.6 -34.72 76.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.69 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -100.82 16.97 23.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 54.34 47.3 23.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.86 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.5 t -98.61 116.4 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.132 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 p -118.87 0.41 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.93 124.63 35.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.63 154.91 42.16 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.36 168.82 71.05 Favored 'Cis proline' 0 CA--C 1.533 0.43 0 C-N-CA 124.018 -1.243 . . . . 0.0 111.88 -6.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 1.1 m -137.26 128.35 27.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.511 -169.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' HB2' HD21 ' A' ' 91' ' ' ASN . 3.8 mm? -115.98 108.61 16.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.077 0.465 . . . . 0.0 110.357 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 20.1 mt -123.95 113.69 18.8 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.939 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.26 125.42 35.49 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.31 177.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 83.8 m-85 -110.47 148.11 32.73 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.119 -177.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.515 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 8.5 mtpm? -146.2 126.16 13.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 10.8 p30 45.7 29.2 0.64 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.451 1.1 . . . . 0.0 112.733 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.03 17.03 73.31 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.188 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 31.6 pttt -114.75 -1.26 13.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.414 0.626 . . . . 0.0 109.531 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 42.6 mt-10 75.48 -172.55 0.11 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.356 -175.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.564 HG12 ' HB2' ' A' ' 77' ' ' LEU . 1.4 p -162.3 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.619 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.621 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -153.26 162.42 41.32 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.796 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.474 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.2 tmtp? -144.64 109.18 4.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.937 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.2 t -121.51 143.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.31 89.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.686 0.755 . . . . 0.0 111.596 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.0 62.96 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.923 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 50.68 81.27 0.07 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.639 0.376 . . . . 0.0 111.582 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 17.4 p-10 -117.71 88.0 28.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -172.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.403 ' O ' HG22 ' A' ' 95' ' ' ILE . 2.6 Cg_endo -79.53 -34.42 1.04 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.762 1.641 . . . . 0.0 110.543 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.11 -44.63 10.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.39 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.48 -17.02 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.455 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.724 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.0 tp -56.16 -39.4 58.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.622 ' HA ' HG22 ' A' ' 99' ' ' ILE . 15.6 mmtt -59.71 -36.79 77.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.664 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -52.16 -57.36 9.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.859 174.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HB1' ' CB ' ' A' ' 85' ' ' ALA . . . -75.35 -30.1 60.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.55 -39.63 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.679 -170.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 -31.59 21.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.971 0.415 . . . . 0.0 110.452 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.83 62.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.209 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 58.7 m-80 -98.06 -67.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.704 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.591 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.718 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HA ' ' HG3' ' A' ' 41' ' ' GLU . 12.8 tpt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.875 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.5 m -109.51 147.65 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 0.0 111.072 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.86 147.81 28.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.152 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -98.68 134.42 41.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.905 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.647 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 12.0 m-85 -90.95 141.85 28.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -97.16 -14.84 21.22 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.715 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.523 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 62.6 p -132.58 153.13 51.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.94 0.4 . . . . 0.0 111.241 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.5 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -62.33 -28.66 69.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 172.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 t -66.19 -37.73 86.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.378 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.523 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 12.4 mm-40 -58.54 -49.15 78.44 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.424 0.631 . . . . 0.0 110.257 176.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' HD1' HG21 ' A' ' 23' ' ' VAL . 2.1 t80 -64.9 -44.9 88.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.992 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.81 -46.57 84.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m -65.43 -33.69 76.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.147 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.14 -49.51 43.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 31.5 pt -67.93 -15.09 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.595 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.27 -8.33 58.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 0.0 111.171 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -76.35 153.89 35.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.571 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 20.2 t70 -68.47 2.56 2.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.554 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 4.0 ptpt -109.45 -179.51 3.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.638 0.732 . . . . 0.0 111.507 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.3 tm? -86.53 114.15 23.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.659 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 71.1 t -118.77 111.17 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.1 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.714 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -105.64 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.558 0.694 . . . . 0.0 111.058 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.629 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 22.6 t -111.4 143.45 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.329 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -120.49 123.94 44.19 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.2 m-85 -70.47 130.43 41.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.679 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -136.45 -178.19 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.349 -164.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -167.91 157.19 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.102 173.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 p -84.9 -5.34 59.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 111.256 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -117.31 42.28 2.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.93 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 2.0 p -144.07 123.47 13.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.575 0.702 . . . . 0.0 112.002 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.46 -44.13 98.0 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.438 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.441 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 44.0 Cg_exo -58.26 -40.06 79.22 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 119.868 1.834 . . . . 0.0 111.232 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 22.9 m -56.86 -37.83 71.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.754 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 60.2 tttm -63.2 -53.54 51.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.897 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.666 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.1 ptp -60.34 -48.07 83.35 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.601 ' CG1' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.6 -18.6 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.435 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -57.48 -48.82 96.63 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.189 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.754 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.3 Cg_exo -72.55 -30.15 12.48 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.225 1.283 . . . . 0.0 111.878 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' MET . 24.8 mmt -64.47 -60.0 3.67 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.755 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.601 HD12 ' CG1' ' A' ' 36' ' ' ILE . 30.4 mt -65.4 -20.8 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 111.297 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 29.4 tt0 -59.68 -46.93 87.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.494 0.664 . . . . 0.0 109.692 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -64.98 -45.88 83.8 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.773 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.701 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.6 m-30 -63.71 -25.03 68.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.67 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.827 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 87.4 p -76.36 -19.67 57.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -83.08 -16.1 48.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.982 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.701 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -120.36 28.24 8.13 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.58 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 14.0 m-30 -101.07 100.44 13.11 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.493 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.28 -43.41 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 121.944 1.763 . . . . 0.0 112.623 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -95.93 -22.94 17.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 111.947 -173.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -102.74 149.55 24.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.439 0.638 . . . . 0.0 110.879 -172.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.485 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.9 m-20 -104.3 133.27 49.48 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.752 176.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.827 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.7 p90 -110.39 116.28 31.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.628 -169.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 20.4 m-85 -137.33 158.47 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.18 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.875 ' HG3' HG21 ' A' ' 2' ' ' VAL . 10.4 mtmp? -141.36 127.38 19.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.718 0.294 . . . . 0.0 110.75 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.647 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 56.8 mt -95.49 129.14 42.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.218 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.69 119.25 18.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 166.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.27 -11.87 12.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.573 -173.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.22 -46.32 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.486 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.97 -31.8 31.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.062 0.458 . . . . 0.0 110.16 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.61 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.2 mm? -103.0 52.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.651 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.96 -40.83 20.02 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.414 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.587 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 26.4 t70 -64.35 -49.08 73.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.537 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -60.59 -38.25 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.392 . . . . 0.0 110.27 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.97 85.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.139 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -74.13 -34.94 64.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.421 . . . . 0.0 110.546 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 45.3 mtmt -61.99 -35.63 79.09 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.906 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -97.87 14.16 28.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.45 38.47 25.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.967 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.411 HG21 ' CD2' ' A' ' 25' ' ' PHE . 84.7 t -82.68 127.03 40.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.3 p -125.06 -56.56 1.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.406 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 159.75 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.659 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.96 144.8 42.76 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 111.493 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 63.3 Cg_endo -75.84 167.71 79.44 Favored 'Cis proline' 0 C--O 1.237 0.467 0 C-N-CA 123.03 -1.654 . . . . 0.0 111.694 -10.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 46.9 m -124.25 116.86 23.34 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.1 mm? -103.47 108.98 20.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.264 -174.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.516 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 33.3 mt -124.05 113.95 19.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.714 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.39 130.24 40.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.627 174.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 47.7 m-85 -111.2 160.05 17.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.605 -175.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.559 ' HG3' ' ND2' ' A' ' 80' ' ' ASN . 14.6 tppt? -144.04 124.11 13.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.592 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.559 ' ND2' ' HG3' ' A' ' 79' ' ' LYS . 0.3 OUTLIER 35.39 48.74 0.43 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 18.59 59.88 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.691 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -125.37 7.38 7.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.976 0.388 . . . . 0.0 110.785 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 23.9 tt0 67.36 176.51 0.25 Allowed 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.774 0.671 . . . . 0.0 109.572 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -146.28 -34.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.942 0.401 . . . . 0.0 110.422 172.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -158.86 161.18 36.82 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.6 tttt -140.97 122.22 14.81 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.13 136.51 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.2 88.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.752 0.787 . . . . 0.0 111.504 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.89 62.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.767 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . 58.81 94.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.937 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.9 p-10 -132.93 80.12 61.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.426 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 2.8 Cg_exo -73.82 -41.08 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.367 1.378 . . . . 0.0 111.149 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.19 -39.72 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.113 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -72.0 -17.57 62.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.269 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.724 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 3.1 tp -57.62 -38.1 62.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 20.4 mmtp -57.56 -36.95 72.32 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.796 0.685 . . . . 0.0 110.621 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -53.29 -57.05 11.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.88 175.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -74.39 -36.59 63.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.553 0.692 . . . . 0.0 110.818 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -71.37 -40.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.853 -171.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.09 -34.94 18.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.814 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.22 -35.29 68.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 50.5 m-80 -98.44 -59.82 1.67 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.507 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.047 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG21 ' HG3' ' A' ' 54' ' ' LYS . 1.3 m -97.43 145.69 8.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.419 0.628 . . . . 0.0 111.237 -174.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.62 145.44 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.917 -176.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -103.44 122.9 45.84 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.592 174.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.826 ' HB2' HD21 ' A' ' 55' ' ' LEU . 7.2 m-85 -76.07 165.84 24.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.009 0.433 . . . . 0.0 110.168 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -116.89 -30.0 5.85 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.528 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 19.4 p -127.2 145.27 50.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.004 0.43 . . . . 0.0 111.805 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.629 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -53.18 -40.41 64.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.766 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -61.03 -38.75 87.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.988 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.479 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 19.4 pt-20 -81.06 -22.03 39.58 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.817 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.483 ' HD1' HG21 ' A' ' 23' ' ' VAL . 3.3 t80 -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 168.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' A' ' 15' ' ' ILE . 4.8 m-20 -59.23 -38.66 80.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.151 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 t -66.46 -37.93 86.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -50.27 62.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 110.659 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 12' ' ' ASP . 33.4 pt -69.97 -14.76 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.573 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.07 -6.19 59.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.95 0.405 . . . . 0.0 111.408 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 19' ' ' LYS . 77.9 mt-30 -88.39 161.11 17.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.082 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 5.4 m-20 -76.44 27.81 0.12 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 17' ' ' GLN . 23.4 mtpp -108.05 178.06 4.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 122.069 0.938 . . . . 0.0 112.756 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.609 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.2 tm? -94.8 104.93 16.84 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.885 172.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.9 t -114.01 107.67 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.896 0.379 . . . . 0.0 110.96 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.706 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -104.72 107.49 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.472 0.653 . . . . 0.0 110.728 175.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 27.0 t -108.95 133.02 55.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.793 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.82 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -108.54 122.41 47.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CD2' HG21 ' A' ' 69' ' ' VAL . 68.8 m-85 -74.12 127.84 33.97 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.118 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.659 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 2.3 m-85 -120.02 -171.46 2.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.145 -175.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.55 166.02 31.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.055 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.9 p -79.99 -4.81 54.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.166 0.508 . . . . 0.0 110.993 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -131.93 54.17 1.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.7 p -145.56 116.76 7.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.475 0.655 . . . . 0.0 112.257 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 32' ' ' PRO . . . -66.47 -37.94 93.08 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.985 -1.007 . . . . 0.0 114.234 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 31.6 Cg_exo -61.52 -35.32 82.66 Favored 'Trans proline' 0 C--N 1.36 1.18 0 CA-C-N 120.233 2.016 . . . . 0.0 111.408 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 57.1 m -54.6 -38.81 67.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.242 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.751 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 23.1 tptm -63.75 -54.81 29.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.683 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.0 ptp -59.98 -48.63 80.93 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.697 HG13 HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -76.07 -16.29 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.207 -178.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.62 -50.31 88.62 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.787 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.751 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 14.4 Cg_exo -71.83 -31.4 12.92 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.1 1.2 . . . . 0.0 111.871 171.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.431 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 94.6 mmm -63.91 -59.46 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.161 -0.615 . . . . 0.0 112.006 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 36' ' ' ILE . 53.4 mt -67.18 -19.4 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.03 -0.419 . . . . 0.0 111.428 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 34.3 tt0 -64.48 -43.29 94.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.478 0.656 . . . . 0.0 109.39 168.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 15.5 tttm -63.6 -39.76 95.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.2 m-30 -74.45 -15.16 60.91 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.741 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.823 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 25.1 p -74.71 -18.14 60.55 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -84.86 -21.75 29.67 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.899 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.672 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 6.5 mt-30 -95.98 5.48 51.1 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.484 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 3.8 m-30 -104.17 98.61 14.35 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.642 172.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 6.6 Cg_exo -73.83 -43.8 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.28 1.986 . . . . 0.0 112.201 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -108.52 -13.61 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.3 163.45 12.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.125 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.23 135.82 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.046 0.927 . . . . 0.0 112.568 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.823 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.8 p90 -115.02 116.94 29.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.468 -171.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 22.0 m-85 -136.33 158.64 43.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.82 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 10.3 mtmp? -142.58 129.49 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.373 . . . . 0.0 110.969 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' A' ' 5' ' ' PHE . 18.2 mt -107.01 176.91 5.02 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.525 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 6.7 p-10 -131.24 130.49 42.95 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 26' ' ' TYR . 32.7 m -69.29 -8.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.71 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.06 -40.91 74.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.333 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -101.24 -28.11 12.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.666 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HG ' HD22 ' A' ' 55' ' ' LEU . 3.9 mm? -101.11 53.66 0.84 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -76.01 -43.07 23.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.127 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 13.2 t70 -66.3 -45.61 79.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.861 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.646 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -61.42 -39.22 82.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.112 0.482 . . . . 0.0 110.142 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.62 -36.93 72.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.103 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 12.0 mm-40 -79.02 -31.51 44.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 38.5 mtmt -62.56 -37.4 86.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.0 110.458 175.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -96.0 8.17 44.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.21 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 55.44 45.96 24.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.892 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.492 HG13 ' OG1' ' A' ' 74' ' ' THR . 69.6 t -69.71 124.89 26.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.814 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -139.33 31.29 2.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.044 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.08 152.62 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.5 112.43 32.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.06 172.72 30.95 Favored 'Cis proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.921 -0.866 . . . . 0.0 112.275 -0.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.492 ' OG1' HG13 ' A' ' 69' ' ' VAL . 92.3 m -120.31 115.89 24.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.554 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.3 mm? -102.39 108.65 20.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.826 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.516 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 30.7 mt -125.43 113.05 17.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.706 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.16 122.06 36.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.022 174.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 42.2 m-85 -106.85 152.89 23.28 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.457 -174.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 87.1 tttt -138.71 122.05 17.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.801 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 41.68 44.28 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.146 0.979 . . . . 0.0 112.67 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.65 17.41 57.46 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.206 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 2.8 tttp -116.43 -5.33 11.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.089 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 22.9 tt0 75.06 168.85 0.29 Allowed 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.648 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.601 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.2 p -136.66 -33.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.84 163.91 34.06 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.74 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 79.3 tttt -143.13 125.1 15.21 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.401 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.5 t -131.13 130.5 63.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.97 82.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.44 -170.44 35.1 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.791 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -70.31 93.83 0.88 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.676 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.8 p-10 -121.77 67.33 21.91 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.5 -35.21 13.85 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 120.915 1.077 . . . . 0.0 110.743 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.62 -39.87 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.074 177.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -76.25 -17.86 59.29 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.462 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.715 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 4.3 tp -57.3 -40.06 71.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HA ' HG22 ' A' ' 99' ' ' ILE . 12.3 mmmm -57.94 -34.76 70.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.799 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -54.47 -58.14 8.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.21 64.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.635 0.731 . . . . 0.0 110.952 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -81.16 -38.94 17.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.483 -169.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.46 -36.78 18.86 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.377 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.84 68.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.277 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.9 m-80 -92.7 -65.05 1.03 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.574 -0.85 . . . . 0.0 112.477 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.787 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.877 HG21 ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -121.52 141.03 43.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.33 0.586 . . . . 0.0 111.094 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.99 147.56 26.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.313 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.97 137.34 38.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.111 171.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.658 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 9.7 m-85 -90.71 137.96 31.95 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.222 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -90.74 -24.95 20.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.394 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.1 p -131.67 153.3 50.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.764 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -58.63 -34.42 71.16 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 t -62.81 -34.04 76.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.741 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 20.0 mm-40 -62.58 -49.18 76.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.353 0.596 . . . . 0.0 109.884 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.464 ' HD1' HG21 ' A' ' 23' ' ' VAL . 1.7 t80 -62.91 -47.06 84.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.107 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.06 -44.1 78.58 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.346 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 m -70.1 -40.44 74.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.46 67.99 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.821 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 11' ' ' PHE . 25.6 pt -68.14 -20.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.174 -176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.34 61.53 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.917 0.389 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 19' ' ' LYS . 46.6 mt-30 -68.24 150.99 47.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.073 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.9 32.89 0.26 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.82 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.7 ptmt -135.57 173.62 11.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.29 -176.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.747 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -75.13 112.71 11.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.598 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.37 107.97 20.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.752 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -104.31 109.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.047 0.927 . . . . 0.0 111.622 176.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 39.5 t -105.02 144.31 14.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.072 177.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.72 ' HB2' HD13 ' A' ' 75' ' ' LEU . . . -129.51 122.64 29.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 55' ' ' LEU . 72.9 m-85 -72.89 115.91 12.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.414 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.72 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 8.5 m-30 -121.91 -178.34 3.82 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 123.369 0.418 . . . . 0.0 110.358 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.62 34.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.689 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.48 -4.43 58.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.214 0.531 . . . . 0.0 111.139 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -126.16 47.2 2.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.077 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 p -143.1 126.39 16.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.53 0.681 . . . . 0.0 111.728 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.9 -40.44 98.35 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.21 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.75 ' O ' HG23 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -63.08 -38.65 44.46 Favored 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 120.272 2.036 . . . . 0.0 110.921 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 20.5 m -58.46 -31.22 67.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.581 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 87.2 tttt -67.94 -57.03 6.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.491 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 ptp -64.95 -44.38 89.62 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.235 0.54 . . . . 0.0 112.431 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -76.96 -13.73 14.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 C-N-CA 118.441 -1.304 . . . . 0.0 110.401 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.5 -52.35 74.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.085 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 19.8 Cg_endo -64.63 -32.63 57.75 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 120.955 1.103 . . . . 0.0 112.574 169.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 23.5 mmt -66.92 -55.57 14.04 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.014 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.808 HG13 ' CZ ' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -49.0 -38.56 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.599 0.36 . . . . 0.0 110.529 175.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.35 -48.1 79.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 110.692 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -60.0 -51.77 68.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.975 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.0 m-85 -64.09 -19.57 65.34 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.17 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.1 p -83.6 -22.13 32.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -83.82 -20.99 32.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.656 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.676 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -107.85 16.38 23.59 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.75 ' CZ ' HG13 ' A' ' 99' ' ' ILE . 13.9 m-30 -100.62 101.81 16.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.486 167.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.14 -40.88 2.94 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 121.88 1.72 . . . . 0.0 112.851 174.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -107.73 -16.0 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.09 146.74 27.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.217 0.532 . . . . 0.0 110.88 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 2.2 m-20 -101.01 135.51 42.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.859 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.808 ' CZ ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -113.52 124.52 52.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.607 -177.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.656 ' HA ' HG23 ' A' ' 2' ' ' VAL . 42.1 m-85 -135.79 147.58 48.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.877 ' HG2' HG21 ' A' ' 2' ' ' VAL . 8.2 mmpt? -117.23 142.43 47.06 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.658 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 60.6 mt -107.13 142.49 36.73 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.149 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.32 102.48 14.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 167.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -60.26 -15.23 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -171.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.44 -21.8 57.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -108.65 -31.24 7.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.923 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.598 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.8 mm? -96.77 52.19 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.818 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -78.21 -40.73 19.22 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.061 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.619 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 6.3 m-20 -60.56 -49.74 76.34 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.419 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 3.7 p -62.83 -38.69 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.313 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.44 -35.03 73.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.071 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 55.7 mt-30 -76.27 -37.85 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.38 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 66.0 mttm -57.24 -39.46 75.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.812 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -95.0 6.55 48.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.912 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.84 48.78 17.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.925 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.09 121.13 35.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.688 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -123.27 -16.08 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.732 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.57 161.86 15.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 142.96 26.83 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.519 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 2.9 Cg_exo -78.33 165.31 83.05 Favored 'Cis proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.862 -1.308 . . . . 0.0 111.75 -8.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 86.8 m -123.38 116.84 23.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 24' ' ' ALA . 4.2 mm? -108.13 108.61 19.74 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -174.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.609 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 18.2 mt -125.71 116.13 21.16 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.814 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -91.53 122.42 34.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.054 173.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 33.5 m-85 -105.46 156.48 18.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.808 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 38.3 ttpt -142.44 120.09 11.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.378 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 47.5 37.11 5.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.8 0.84 . . . . 0.0 111.901 -177.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.16 12.55 50.38 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.746 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 61.7 mttp -120.83 19.47 11.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.553 0.341 . . . . 0.0 110.142 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 10.2 pt-20 61.66 175.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.869 1.356 . . . . 0.0 112.128 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.532 HG11 ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -148.75 -32.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.832 174.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -161.79 166.92 25.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.081 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.609 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 78.9 tttt -144.34 126.51 15.61 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.2 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' HB ' ' ND2' ' A' ' 91' ' ' ASN . 19.3 t -131.96 138.84 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 87.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.796 0.807 . . . . 0.0 111.593 -170.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.66 63.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.061 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' CA ' ' HD2' ' A' ' 73' ' ' PRO . . . 57.28 86.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.111 0.482 . . . . 0.0 111.78 176.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.609 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 14.5 p-10 -126.41 78.57 71.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.519 ' O ' HG22 ' A' ' 95' ' ' ILE . 14.5 Cg_exo -68.14 -45.39 2.91 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.448 1.432 . . . . 0.0 110.955 168.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.44 -35.43 18.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.096 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -76.59 -17.55 59.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.46 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.751 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 5.0 tp -59.18 -38.94 77.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HD2' HG22 ' A' ' 99' ' ' ILE . 54.5 tptt -61.83 -27.37 68.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.995 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.2 tm0? -59.6 -59.66 5.08 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -71.67 -29.2 64.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.712 0.768 . . . . 0.0 110.503 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -77.62 -39.44 26.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.321 -171.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.2 -34.45 20.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.043 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.24 89.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.63 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 51.2 m-80 -97.33 -63.06 1.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.747 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.79 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.4 mmm . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.858 0.361 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.688 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 0.3 OUTLIER -79.59 125.85 38.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.637 0.732 . . . . 0.0 109.709 177.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.2 145.84 55.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.659 -168.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.56 136.35 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.655 170.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.809 ' H ' HD22 ' A' ' 55' ' ' LEU . 16.6 m-85 -88.13 166.13 14.62 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -124.52 -10.29 7.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 60.1 p -134.44 150.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.68 0.276 . . . . 0.0 110.912 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.513 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.49 -33.68 70.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.3 t -65.73 -36.38 83.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.747 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 51.0 mm-40 -61.29 -44.74 96.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 7.5 t80 -67.55 -49.21 64.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.947 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' HA ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -59.75 -37.55 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.69 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.4 t -68.29 -40.71 81.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.819 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -64.77 -50.48 66.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.43 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.51 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 35.3 pt -66.83 -18.82 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.499 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.44 -10.4 59.05 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.745 0.307 . . . . 0.0 111.589 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 14' ' ' ALA . 54.8 mt-30 -76.09 153.3 36.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.344 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.4 37.75 0.34 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.86 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 8.9 ptmt -140.21 167.92 21.01 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.064 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.945 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -71.71 107.94 4.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.436 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.55 HG13 ' CD2' ' A' ' 53' ' ' TYR . 70.2 t -107.55 107.08 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 110.35 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.611 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -99.0 105.55 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.412 0.625 . . . . 0.0 110.294 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 53' ' ' TYR . 53.5 t -107.01 139.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.371 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.749 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -128.39 122.4 31.34 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' HG21 ' A' ' 69' ' ' VAL . 52.4 m-85 -70.6 124.1 23.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.537 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.697 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 1.9 m-85 -120.01 -176.86 3.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.612 -174.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . . . -161.77 156.68 23.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.144 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -84.09 -4.33 58.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.771 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -120.73 21.97 11.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 3.8 p -119.55 150.99 39.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.515 0.674 . . . . 0.0 112.253 -176.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.75 -48.61 4.89 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.803 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 35' ' ' MET . 50.7 Cg_exo -55.25 -47.5 25.83 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.253 1.969 . . . . 0.0 112.307 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 8.9 p -51.07 -36.8 41.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.257 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.731 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 67.4 mttm -66.46 -50.31 63.76 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 123.212 0.32 . . . . 0.0 111.247 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 22.6 ptp -64.88 -44.7 88.81 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.424 0.631 . . . . 0.0 112.311 -175.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.686 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -74.0 -16.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.605 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.09 -55.26 47.14 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.909 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.731 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 23.7 Cg_endo -63.96 -30.42 67.0 Favored 'Trans proline' 0 C--N 1.358 1.054 0 CA-C-N 120.424 1.187 . . . . 0.0 112.1 170.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 25.4 mmt -65.98 -55.37 17.12 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.291 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.996 HG21 ' HD3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -57.11 -38.08 58.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.87 175.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -52.48 -47.34 66.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.0 0.429 . . . . 0.0 109.958 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.33 -47.88 83.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.696 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 7.9 m-30 -67.05 -15.34 63.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.075 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.788 ' HB3' ' CD2' ' A' ' 52' ' ' PHE . 5.7 m -86.62 -13.71 44.87 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.23 -15.21 31.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.681 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.696 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -126.59 35.66 4.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.23 177.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -104.31 72.52 0.19 Allowed Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 172.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 88.9 Cg_exo -45.88 -45.64 16.88 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.945 2.43 . . . . 0.0 115.161 -166.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -112.69 8.53 19.02 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -103.16 165.09 11.23 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.82 -0.55 . . . . 0.0 111.573 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.98 123.37 41.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.788 ' CD2' ' HB3' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.76 124.95 35.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 10.6 m-85 -143.04 136.29 28.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.366 168.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.996 ' HD3' HG21 ' A' ' 40' ' ' ILE . 27.5 mtmt -134.0 120.3 20.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.809 HD22 ' H ' ' A' ' 5' ' ' PHE . 4.7 mt -93.11 162.22 14.12 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.646 -167.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.19 108.63 21.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -61.14 -14.42 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.451 -175.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.87 -39.12 93.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -99.68 -32.14 11.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mm? -91.99 47.25 1.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.588 ' O ' ' HG2' ' A' ' 65' ' ' GLN . . . -77.9 -42.13 17.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.789 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 31.1 t70 -65.27 -44.17 88.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 110.956 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -63.7 -39.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.204 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.79 77.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.5 mm-40 -71.51 -34.34 70.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.928 0.394 . . . . 0.0 110.438 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 40.1 mtmt -61.25 -38.73 87.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.648 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -95.08 15.29 19.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.884 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.6 40.94 26.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.812 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' A' ' 25' ' ' PHE . 86.4 t -88.9 113.38 25.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.15 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -116.06 -11.41 11.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.37 165.25 12.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.618 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.11 141.71 17.54 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.859 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.501 ' HG3' HD12 ' A' ' 36' ' ' ILE . 60.8 Cg_endo -75.28 163.41 90.62 Favored 'Cis proline' 0 C--O 1.234 0.301 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.795 -10.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 53.8 m -126.65 118.79 25.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.616 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 2.3 mt -110.34 107.65 17.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.379 0.609 . . . . 0.0 111.6 -172.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.67 HD22 ' HG3' ' A' ' 86' ' ' LYS . 18.9 mt -123.72 113.36 18.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.265 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.611 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -96.33 129.15 43.73 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.841 178.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 59.8 m-85 -112.27 154.09 26.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.441 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -136.52 117.54 14.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.393 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.55 43.83 2.4 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.065 0.853 . . . . 0.0 112.67 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.73 11.12 59.72 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.399 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -111.97 -0.32 15.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 32.9 tt0 69.79 172.77 0.3 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.137 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.554 HG11 HD21 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -145.46 -33.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.239 172.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -156.11 161.44 40.37 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.67 ' HG3' HD22 ' A' ' 76' ' ' LEU . 41.3 tttp -141.83 110.99 6.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.868 177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 t -123.58 135.1 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.23 82.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.951 0.881 . . . . 0.0 111.654 -168.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.5 64.27 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.235 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . 54.78 83.85 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.021 0.438 . . . . 0.0 111.943 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 12.7 p-10 -125.02 83.99 59.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' O ' HG22 ' A' ' 95' ' ' ILE . 10.8 Cg_exo -74.15 -36.95 2.94 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.753 1.635 . . . . 0.0 111.654 168.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.3 -41.84 12.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.93 0.395 . . . . 0.0 111.104 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.89 -17.37 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.639 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.5 tp -59.63 -38.16 74.28 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.284 171.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 99' ' ' ILE . 26.7 mmmt -59.53 -32.99 70.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.725 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -54.67 -61.24 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -71.25 -39.2 71.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.403 0.62 . . . . 0.0 111.649 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.648 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -68.74 -43.23 83.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.707 -171.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.17 10.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.909 0.385 . . . . 0.0 111.567 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.11 74.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.485 -175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 56.8 m-80 -92.65 -63.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.003 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.945 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.711 -0.661 . . . . 0.0 111.502 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.693 ' HA ' ' OE2' ' A' ' 41' ' ' GLU . 51.8 ttm . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -83.21 143.53 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.323 0.582 . . . . 0.0 110.758 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -98.53 147.83 24.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.072 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.52 126.6 49.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 171.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.681 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 15.7 m-85 -80.42 157.39 26.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -113.05 -13.96 13.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.227 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -137.27 151.24 48.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.766 0.317 . . . . 0.0 111.126 178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.496 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -58.15 -31.64 67.42 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 172.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -63.58 -38.13 89.96 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.231 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.427 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 27.4 mm-40 -61.58 -43.14 99.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.468 0.652 . . . . 0.0 109.772 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.42 ' HA ' ' CE2' ' A' ' 5' ' ' PHE . 4.4 t80 -68.15 -49.16 62.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.373 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' HG12 ' A' ' 15' ' ' ILE . 24.4 t70 -59.78 -46.06 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 0.0 111.438 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 m -68.68 -25.78 64.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -75.11 -51.6 13.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.826 0.346 . . . . 0.0 110.555 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.479 ' HB ' ' CB ' ' A' ' 78' ' ' PHE . 38.4 pt -65.22 -19.32 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.617 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.18 59.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.623 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -71.43 160.22 33.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.975 0.417 . . . . 0.0 110.861 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.496 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 4.8 m-20 -81.28 34.46 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.169 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -145.32 170.61 15.97 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.194 -174.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -72.16 105.44 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.02 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 14' ' ' ALA . 81.6 t -109.25 106.79 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.736 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.749 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -102.73 111.14 31.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.309 0.575 . . . . 0.0 111.116 175.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.668 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 44.8 t -110.69 131.15 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.294 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -109.32 110.82 22.09 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CD2' HD12 ' A' ' 55' ' ' LEU . 72.0 m-85 -70.77 107.72 4.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -162.93 151.37 14.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.298 0.571 . . . . 0.0 112.32 -178.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -120.03 158.66 26.34 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.0 p -81.11 -3.41 51.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -77.11 -16.63 59.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -172.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -98.26 -176.33 3.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.01 -60.19 1.98 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.375 -0.44 . . . . 0.0 113.153 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.621 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 82.0 Cg_exo -50.58 -49.22 17.32 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.968 2.445 . . . . 0.0 112.445 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.0 p -50.77 -36.94 39.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.692 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.737 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 39.8 ttpt -66.09 -54.32 27.22 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.06 0.225 . . . . 0.0 110.602 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.49 -45.99 91.91 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.808 HG13 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -75.25 -18.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.289 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -56.0 -56.38 31.31 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.128 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 33.4 Cg_endo -66.41 -32.16 41.13 Favored 'Trans proline' 0 C--N 1.359 1.127 0 CA-C-N 120.287 1.138 . . . . 0.0 112.492 171.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.534 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 33.2 mmt -64.27 -61.2 2.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.129 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.808 HD12 HG13 ' A' ' 36' ' ' ILE . 61.0 mt -64.41 -21.93 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.233 0.469 . . . . 0.0 111.647 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.693 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 11.2 tp10 -61.96 -43.78 98.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 109.675 168.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -65.6 -40.63 92.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.531 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.711 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 15.2 m-85 -68.09 -17.95 64.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.177 0.513 . . . . 0.0 110.854 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 p -87.24 -11.48 49.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -83.23 -31.11 27.18 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.711 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 28.2 pt20 -109.27 33.24 4.41 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.234 -176.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.444 ' H ' ' HD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -100.1 76.6 0.13 Allowed Pre-proline 0 CA--C 1.556 1.207 0 CA-C-O 121.496 0.665 . . . . 0.0 112.711 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 32.2 Cg_exo -58.21 -46.07 27.44 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.115 1.877 . . . . 0.0 114.242 -170.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.82 16.51 19.5 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -124.23 165.89 16.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.954 0.406 . . . . 0.0 111.486 -171.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 6.2 m-20 -115.59 131.89 56.8 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 1.6 m-85 -114.28 124.71 52.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.464 -173.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 23' ' ' VAL . 14.0 m-85 -139.85 151.54 45.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.733 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 38.1 mtmt -140.06 121.25 14.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD2' ' HB2' ' A' ' 5' ' ' PHE . 70.6 mt -78.42 141.02 38.63 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.506 -171.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.74 91.08 0.8 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 27' ' ' ALA . 2.3 p -59.53 -6.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -172.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.95 -32.97 15.77 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.48 -36.17 26.74 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.246 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.3 mm? -105.0 52.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.547 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.72 -40.29 22.59 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.04 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 7.4 m-20 -69.79 -38.53 76.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.455 0.169 . . . . 0.0 110.995 -177.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 60' ' ' LEU . 7.7 p -68.96 -37.53 77.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.435 . . . . 0.0 110.41 176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.8 73.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.029 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.4 mt-30 -70.91 -34.75 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 52.7 mttp -59.46 -43.99 93.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.553 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -91.55 10.52 27.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.146 -174.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 58.27 48.68 12.22 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.498 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.513 HG13 ' OG1' ' A' ' 74' ' ' THR . 71.8 t -78.64 118.58 26.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.83 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -124.25 -58.83 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.19 127.63 32.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.333 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.5 134.91 19.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.334 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 90' ' ' ALA . 64.9 Cg_endo -83.31 171.25 51.57 Favored 'Cis proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.855 -1.31 . . . . 0.0 112.035 -1.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.513 ' OG1' HG13 ' A' ' 69' ' ' VAL . 27.7 m -117.93 114.76 23.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.2 mm? -105.23 107.46 18.45 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.323 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.493 ' CD2' ' HG3' ' A' ' 86' ' ' LYS . 14.2 mt -126.25 112.7 16.04 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -87.14 116.89 25.52 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 70.3 m-85 -104.45 145.99 29.5 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.665 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 28.0 mtpt -143.83 120.96 11.46 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.969 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 38.8 m-80 61.14 21.85 12.22 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.715 0.634 . . . . 0.0 110.809 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.06 12.3 65.07 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -111.59 5.57 19.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.57 ' HG2' ' H ' ' A' ' 84' ' ' VAL . 27.4 tt0 70.36 177.17 0.27 Allowed 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.123 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.576 HG21 ' HD3' ' A' ' 79' ' ' LYS . 1.4 p -157.12 -31.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -159.32 164.29 34.94 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.82 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.493 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 66.7 tttt -148.61 122.88 9.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.594 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.49 132.24 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.78 79.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.299 0.571 . . . . 0.0 111.065 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.09 -172.86 35.88 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . . . -67.36 100.98 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 26.4 p-10 -124.07 63.55 32.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 90' ' ' ALA . 8.7 Cg_exo -70.75 -31.35 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 120.963 1.109 . . . . 0.0 110.098 172.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -89.65 -47.12 8.15 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.257 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -69.43 -16.31 63.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -177.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.696 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 7.1 tp -53.56 -38.29 33.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.114 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 169.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.686 ' HA ' HG22 ' A' ' 99' ' ' ILE . 36.0 mmtt -55.07 -41.7 71.86 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.937 0.773 . . . . 0.0 110.798 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -51.17 -53.72 32.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.523 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -80.49 -30.56 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 111.762 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -76.05 -39.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.982 -172.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.86 -41.4 14.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.708 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.93 75.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.621 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 35.4 m-80 -107.26 -73.1 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.879 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.246 0.883 0 O-C-N 123.983 0.802 . . . . 0.0 112.632 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.905 0.383 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 52' ' ' PHE . 0.2 OUTLIER -122.63 135.6 62.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 177.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.43 HG22 ' HD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -84.12 148.43 26.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.087 -175.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.29 122.68 47.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.317 171.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.673 ' H ' HD22 ' A' ' 55' ' ' LEU . 12.4 m-85 -76.16 164.06 26.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.193 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -121.61 -20.26 6.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 61.1 p -131.63 155.12 48.12 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.296 -0.253 . . . . 0.0 111.312 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -57.29 -36.09 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 t -57.71 -41.15 81.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.572 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 19.6 mm-40 -59.59 -43.53 93.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.211 0.529 . . . . 0.0 110.125 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.467 ' HD1' HG21 ' A' ' 23' ' ' VAL . 7.4 t80 -67.07 -53.2 33.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.465 ' HA ' HG12 ' A' ' 15' ' ' ILE . 10.9 m-20 -61.49 -37.19 82.76 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 111.781 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.822 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -69.14 -48.55 62.09 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.0 110.579 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 12' ' ' ASP . 34.2 pt -67.02 -20.69 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.97 -8.6 59.43 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.084 0.468 . . . . 0.0 111.306 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -75.73 152.58 37.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.889 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.413 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 2.3 m-20 -80.37 35.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.102 0.477 . . . . 0.0 111.634 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 4.4 ptpt -134.7 -179.06 5.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 0.0 111.346 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 103' ' ' ALA . 1.3 tm? -84.36 108.26 17.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.445 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.763 HG13 ' CE1' ' A' ' 53' ' ' TYR . 78.3 t -112.88 106.92 21.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.019 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.698 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -103.34 106.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.341 0.591 . . . . 0.0 110.952 176.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 53' ' ' TYR . 59.3 t -106.23 136.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.634 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB3' ' HG3' ' A' ' 54' ' ' LYS . . . -118.1 115.45 24.85 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.161 0.505 . . . . 0.0 110.249 170.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' HG21 ' A' ' 69' ' ' VAL . 98.5 m-85 -70.06 109.96 4.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.544 ' CZ ' HD12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.78 159.24 31.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -163.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -147.53 135.88 21.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.159 173.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -83.88 -5.7 59.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -170.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 1.1 p90 -89.28 57.59 4.1 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.9 p -157.41 -176.72 6.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.26 -53.04 3.22 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.205 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' O ' ' HG2' ' A' ' 35' ' ' MET . 87.9 Cg_exo -49.07 -43.0 37.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.561 2.174 . . . . 0.0 112.075 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -58.13 -35.17 71.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -62.4 -46.55 88.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.628 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.624 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 20.7 ptm -77.26 -45.92 24.8 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.635 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -75.79 -23.31 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.439 -176.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -55.06 -49.53 91.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.092 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.624 ' HD2' ' O ' ' A' ' 35' ' ' MET . 23.3 Cg_exo -66.67 -38.3 18.81 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.498 1.465 . . . . 0.0 112.442 171.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 mmt -63.94 -58.29 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CG1' HG12 ' A' ' 36' ' ' ILE . 12.9 mm -56.21 -33.61 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.91 -49.17 78.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.248 0.547 . . . . 0.0 110.328 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -62.93 -47.33 83.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.262 0.553 . . . . 0.0 110.144 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 6.0 m-30 -64.52 -17.57 64.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.842 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 52' ' ' PHE . 11.3 p -86.49 -13.37 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.873 0.844 . . . . 0.0 108.828 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -88.77 -19.35 26.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.328 169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -125.26 33.1 5.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.764 ' HE2' ' N ' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -110.26 82.94 2.86 Favored Pre-proline 0 N--CA 1.478 0.954 0 CA-C-O 121.752 0.787 . . . . 0.0 111.659 169.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.13 -46.29 29.15 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.864 2.376 . . . . 0.0 114.561 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -112.71 6.33 18.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -105.63 165.08 11.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.954 -0.466 . . . . 0.0 110.743 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.45 123.23 27.67 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.71 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.764 ' N ' ' HE2' ' A' ' 47' ' ' TYR . 1.2 m-85 -92.24 131.74 37.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.763 ' CE1' HG13 ' A' ' 21' ' ' VAL . 7.4 m-85 -130.82 135.3 47.61 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.298 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.617 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -125.57 120.78 31.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.673 HD22 ' H ' ' A' ' 5' ' ' PHE . 5.9 mt -99.99 168.42 9.86 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.383 -171.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.0 p-10 -104.69 104.08 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.991 0.9 . . . . 0.0 108.824 169.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -10.73 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.243 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.03 -33.84 65.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.081 0.467 . . . . 0.0 109.993 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -94.61 -36.39 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.903 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 3.7 mm? -97.97 47.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.058 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -77.17 -39.12 27.94 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.886 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.44 -45.24 88.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 5.3 p -66.91 -37.76 80.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' A' ' 69' ' ' VAL . . . -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.112 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 78.3 mt-30 -62.8 -34.03 76.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HE2' ' OD2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -72.1 -24.97 61.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.7 9.54 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.998 0.428 . . . . 0.0 110.84 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 59.06 45.28 14.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.653 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 25' ' ' PHE . 72.5 t -74.74 117.3 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.908 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -133.24 -0.05 3.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.408 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.69 164.86 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.714 0.293 . . . . 0.0 111.056 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 36.9 mtm -124.21 111.47 28.5 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.012 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.535 ' CB ' ' HE1' ' A' ' 26' ' ' TYR . 4.0 Cg_exo -77.63 170.32 71.27 Favored 'Cis proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.583 -5.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.42 ' OG1' HG13 ' A' ' 69' ' ' VAL . 77.1 m -115.29 112.38 22.32 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 158.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.602 ' CD2' ' HB2' ' A' ' 24' ' ' ALA . 6.0 mt -118.63 107.94 14.32 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.741 -167.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.466 ' CD2' ' HG2' ' A' ' 86' ' ' LYS . 5.4 mt -125.26 112.46 16.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.197 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.92 130.21 38.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.631 176.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 46.1 m-85 -111.11 154.15 24.69 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.143 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 27.8 ttpp -137.4 113.88 10.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.824 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 43.62 46.27 6.06 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.17 0.918 . . . . 0.0 111.941 -177.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 7.09 52.49 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.647 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.73 9.4 16.38 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 122.436 -0.449 . . . . 0.0 110.612 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 30.8 tt0 66.8 173.0 0.25 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.776 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.5 p -146.96 -32.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.728 0.299 . . . . 0.0 110.36 172.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -158.16 162.04 37.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.131 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 76' ' ' LEU . 2.3 tmtp? -143.33 107.8 4.82 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.77 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.68 143.91 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -155.71 84.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.614 0.721 . . . . 0.0 111.74 -171.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.09 81.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.644 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.526 ' HA ' ' CD ' ' A' ' 73' ' ' PRO . . . 45.13 74.76 0.12 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.05 0.54 . . . . 0.0 111.867 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 20.0 p-10 -123.59 75.53 54.69 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -171.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.577 ' O ' ' HE2' ' A' ' 43' ' ' PHE . 7.7 Cg_exo -74.07 -37.01 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.358 1.372 . . . . 0.0 110.4 166.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -87.4 -41.65 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -74.03 -17.78 60.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.517 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.603 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 1.9 tp -63.14 -36.08 74.47 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 118.697 -1.201 . . . . 0.0 108.17 170.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.655 ' HG2' ' CE2' ' A' ' 43' ' ' PHE . 1.8 mmmp? -58.62 -33.73 70.36 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.389 0.431 . . . . 0.0 110.634 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.1 tm0? -57.23 -54.95 40.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.63 173.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -71.81 -47.23 54.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.671 . . . . 0.0 111.229 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -61.44 -49.03 86.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.737 -172.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.35 -33.96 17.78 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -170.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.2 38.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.749 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -88.63 -54.65 4.06 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.195 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.582 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.535 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG21 ' HE3' ' A' ' 54' ' ' LYS . 1.2 m -93.82 145.11 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 173.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.525 ' CG2' ' HD2' ' A' ' 53' ' ' TYR . 1.3 m -74.03 144.76 44.96 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.463 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -111.63 118.56 36.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.595 172.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.682 ' H ' HD22 ' A' ' 55' ' ' LEU . 12.6 m-85 -71.22 163.37 27.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 110.063 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -112.33 -25.01 9.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.762 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.613 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 27.1 p -138.58 159.37 42.25 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . . . -54.42 -39.29 67.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -53.67 -38.82 64.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.141 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.613 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 70.8 mm-40 -64.83 -50.46 66.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.519 0.675 . . . . 0.0 109.951 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.28 -48.1 81.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.497 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.546 ' HA ' HG12 ' A' ' 15' ' ' ILE . 7.2 m-20 -58.87 -35.34 72.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.349 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -74.64 -29.27 61.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.52 -39.56 24.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.172 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.818 HG22 HG11 ' A' ' 21' ' ' VAL . 43.8 pt -66.99 -22.28 29.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.698 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.77 -9.8 59.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.977 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.97 149.4 49.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.779 0.324 . . . . 0.0 110.507 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.31 39.19 0.31 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.214 0.53 . . . . 0.0 110.87 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 19' ' ' LYS . 13.0 ptmt -147.32 173.75 12.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.817 -177.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.653 ' CD2' HG11 ' A' ' 84' ' ' VAL . 1.3 tm? -76.43 110.89 11.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.286 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.818 HG11 HG22 ' A' ' 15' ' ' ILE . 3.8 p -95.29 130.7 43.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.8 ' HB ' HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -122.63 101.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.71 0.766 . . . . 0.0 109.71 169.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.637 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 57.7 t -109.12 143.28 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.874 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . . . -124.28 120.51 32.41 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 83.7 m-85 -71.03 121.61 18.54 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.293 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.794 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 2.3 m-85 -119.99 177.78 4.86 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.127 0.489 . . . . 0.0 110.837 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.16 130.03 9.36 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 167.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -7.53 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.488 . . . . 0.0 111.873 -174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -107.57 11.43 28.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.179 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.943 ' SG ' ' HD2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -111.53 136.98 49.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.647 0.737 . . . . 0.0 111.649 -176.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.66 -41.46 50.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.589 -1.187 . . . . 0.0 114.325 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.943 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 16.5 Cg_exo -67.5 -27.96 38.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 CA-C-N 120.302 2.051 . . . . 0.0 110.441 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 58.9 m -55.26 -44.39 75.54 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.378 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.715 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 66.0 mttm -64.25 -51.33 64.12 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.561 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.675 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 24.4 ptm -62.05 -49.34 76.37 Favored 'General case' 0 C--O 1.252 1.185 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.64 ' O ' HG12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -76.04 -14.63 15.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.035 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 33' ' ' CYS . . . -58.12 -49.68 92.26 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.971 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 24.5 Cg_exo -67.44 -35.1 24.46 Favored 'Trans proline' 0 C--N 1.36 1.156 0 CA-C-N 120.377 1.17 . . . . 0.0 111.645 169.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.433 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 97.1 mmm -62.36 -60.95 2.82 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.474 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.595 HG21 ' HD3' ' A' ' 54' ' ' LYS . 61.9 mt -65.07 -22.52 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.013 -0.429 . . . . 0.0 111.615 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 39.4 tt0 -63.36 -46.67 85.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.522 0.677 . . . . 0.0 109.474 169.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 14.6 tptm -60.88 -37.17 81.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.694 0.759 . . . . 0.0 109.532 175.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.673 ' HA ' ' HG2' ' A' ' 46' ' ' GLN . 2.6 m-30 -76.76 -14.66 59.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.751 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.815 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 46.1 p -74.62 -16.13 60.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.48 -24.1 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.023 171.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.673 ' HG2' ' HA ' ' A' ' 43' ' ' PHE . 12.8 mm100 -76.35 -38.66 55.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.073 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.604 ' CE1' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -104.03 101.9 28.62 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.0 Cg_endo -83.89 -19.07 5.1 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.077 2.518 . . . . 0.0 111.599 169.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.46 -22.22 19.73 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 111.161 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . . . -109.07 140.21 42.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.672 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 1.4 m-20 -91.1 117.52 29.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.586 0.708 . . . . 0.0 111.643 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.815 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 1.3 p90 -89.11 115.04 26.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.698 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.672 ' CE1' ' HB3' ' A' ' 51' ' ' ASP . 4.3 m-85 -133.41 150.7 51.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 171.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.659 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 9.7 mtmp? -143.99 119.39 10.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 6.8 mt -97.37 158.58 15.39 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -168.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.02 113.22 26.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.203 0.525 . . . . 0.0 110.009 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.727 ' HB ' ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -65.76 -14.53 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -170.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.3 -29.17 62.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.12 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -105.72 -18.96 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.721 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HG ' HD13 ' A' ' 55' ' ' LEU . 3.9 mm? -106.87 45.28 0.99 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.28 0.562 . . . . 0.0 110.417 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 65' ' ' GLN . . . -76.85 -34.01 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.415 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 2.9 m-20 -71.17 -43.53 67.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.51 0.195 . . . . 0.0 110.802 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 8' ' ' ALA . 3.7 p -62.2 -39.74 85.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.76 81.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.161 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 49.7 mt-30 -71.46 -36.0 71.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.078 0.466 . . . . 0.0 110.496 -175.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 44.2 mtmt -62.45 -36.84 83.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.792 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.49 15.59 25.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.368 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 60.32 38.04 19.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.514 172.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.56 110.05 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.473 . . . . 0.0 111.008 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -109.6 -44.74 3.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.932 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.12 153.98 38.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.556 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.43 140.18 18.58 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.755 0.312 . . . . 0.0 110.317 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 72.9 Cg_endo -79.87 160.66 86.74 Favored 'Cis proline' 0 C--O 1.236 0.38 0 C-N-CA 123.276 -1.552 . . . . 0.0 112.629 -3.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 22.6 m -129.67 119.8 24.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.11 -178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.583 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 4.4 mm? -104.06 108.4 19.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.664 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.5 mt -120.99 114.3 21.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.679 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.8 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -94.21 133.47 37.69 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.883 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.676 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 4.1 m-85 -117.53 156.03 28.76 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.436 -175.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.716 ' HG2' ' ND2' ' A' ' 80' ' ' ASN . 65.3 tttm -144.29 116.83 8.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.173 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.716 ' ND2' ' HG2' ' A' ' 79' ' ' LYS . 7.0 p30 45.66 36.22 2.55 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.198 0.999 . . . . 0.0 112.664 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.93 5.93 76.96 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.254 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -115.58 14.61 16.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.742 0.271 . . . . 0.0 110.849 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 78' ' ' PHE . 27.6 tt0 67.67 173.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.414 176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.653 HG11 ' CD2' ' A' ' 20' ' ' LEU . 1.6 p -148.99 -33.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.932 0.396 . . . . 0.0 110.039 172.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.567 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -155.82 162.86 40.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.596 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -146.29 110.89 5.16 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.032 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.1 t -122.51 125.92 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.79 84.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.697 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.1 78.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.743 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 51.29 80.86 0.08 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 16.7 p-10 -124.47 87.24 54.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.439 ' O ' HG22 ' A' ' 95' ' ' ILE . 5.7 Cg_exo -77.76 -38.89 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.523 1.482 . . . . 0.0 111.373 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 96' ' ' LYS . . . -88.51 -44.55 10.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.913 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 97' ' ' GLN . . . -68.68 -17.08 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.273 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.716 ' O ' ' HB ' ' A' ' 99' ' ' ILE . 2.1 tp -58.69 -38.3 70.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 99' ' ' ILE . 12.8 mmmm -59.57 -36.25 75.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.162 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -51.91 -59.65 4.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.792 173.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -72.69 -36.22 67.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.345 0.593 . . . . 0.0 111.356 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.803 -171.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.21 -32.75 19.62 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.852 0.358 . . . . 0.0 111.327 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.91 -42.53 48.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.792 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.567 ' ND2' ' HB2' ' A' ' 85' ' ' ALA . 66.9 m-80 -86.29 -53.99 4.7 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.621 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.802 175.902 . . . . . . . . 1 1 . 1 stop_ save_